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ABSTRACT 
Obesity has been associated with an increased risk of developing some gynaecological 
cancers, and with delayed help-seeking.  The thesis aims were to identify factors predictive of 
extended (i.e. ‘delayed’) time to help-seeking for women seeking help for potential symptoms 
of gynaecological cancers, particularly looking at the role of obesity on time to help-seeking.  
Qualitative and exploratory research further investigated health beliefs and help-seeking 
attitudes of women experiencing gynaecological cancer symptoms and built a framework for 
understanding women’s complex journeys toward medical help-seeking.  Additionally, the 
research assessed for differences in time to help-seeking and cancer awareness across groups 
with varying body mass indexes (BMIs) and different ethnic groups.  Findings suggested that 
women have a limited awareness of gynaecological cancers, nevertheless, low awareness of 
gynaecological cancers was not associated with help-seeking delay.  Thesis studies showed 
that obese women were not more likely to delay help-seeking when compared to non-obese 
women, and that attendance at preventative screenings was a predictor of delayed help-
seeking.  In conclusion the thesis provided an understanding of the often-complex transition 
through the menopause and challenged assumptions in the literature about the association 
between obesity, help-seeking and preventative screenings.  Future research should further 
explore the complex relationship between BMI and help-seeking for gynaecological cancer 
symptoms. 
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THESIS OVERVIEW 
Chapter 1 provides a clinical overview of gynaecological cancers, related symptoms, 
epidemiology, causes and risk factors, diagnostic pathways, treatments and outcomes.  
Chapter 2 provides a review of symptom perception and help-seeking behaviour theories and 
models to identify theories that inform the thesis research.  Chapter 3 provides a summary of 
the aims and the research plan for the following empirical chapters.  Chapter 4 presents results 
of a qualitative study that explored healthcare professionals’ perspectives about the potential 
barriers, beliefs and behaviours of the obese women seeking help for symptoms of 
gynaecological cancer from their services.  Results highlighted that healthcare professionals 
perceived that obese women have a poor understanding of the risks and symptoms of 
gynaecological cancers and that women experience obesity as both a physical and emotional 
barrier to medical help-seeking for potential symptoms of gynaecological cancers.  Therefore 
healthcare professionals suggested that intervention and healthcare provisions may be needed 
to encourage obese women to seek help sooner and that healthcare services should be adapted 
to accommodate the specific needs of obese women.  
Chapter 5 used a multiple regression analysis to identify predictors of delayed help-
seeking for symptoms of gynaecological cancer.  The results identified that increased body 
mass index, living in a neighbourhood perceived by participants as high in crime and, 
interestingly, an individual’s participation in regular preventative health behaviours (e.g. 
attendance at cervical and breast screenings) were predicted to extend time to help-seeking.  
Chapter 6 presents an additional analysis that mapped the dynamic process of help-
seeking and associated behaviours involved in seeking medical help for PMB, and compared 
differences in help-seeking and gynaecological cancer awareness across different groups of 
obese and non-obese women and different ethnic groups (White European and Black, Asian 
xxiii 
 
 
and minority ethnic groups).  No differences were found across groups regarding time to help-
seeking and gynaecological awareness.  Furthermore, gynaecological cancer was not 
associated with time to help-seeking.  The results of Chapter 6 provided an interesting and 
comprehensive view of the journey to help-seeking, including the presence of concerns prior 
to seeking help, women’s participation in self-management behaviours, and successful 
alternative routes to care (i.e. non-GP methods of help-seeking).  Furthermore this study 
presented contradictory findings regarding the relationship between BMI and time to help-
seeking, suggesting that the two may exist in a curvilinear relationship. 
 Chapter 7 details a qualitative study that explored the experiences and beliefs of seven 
obese women in their journey toward help-seeking for PMB, and identifies how women make 
sense of these experiences.  Results of this study identified three superordinate themes to 
describe this complex experience and included the ambiguous nature of PMB and the 
menopausal experience that enmeshed the two experiences together in the context of aging, an 
experience of the body as chaotic and the perception of the PMB investigation as a necessary 
intrusion. 
 Chapter 8 provides a general discussion relating back to the literature, discusses the 
research limitations, suggest directions for future research and intervention, and outlines the 
theoretical and practical implications of the present research to formulate an overall 
conclusion for the PhD. 
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CHAPTER 1: GYNAECOLOGICAL CANCER- A CLINICAL REVIEW 
 
Overview 
Gynaecological cancers encompass a varied group of site-specific tumours located 
within the female reproductive system (Figure 1.1), and account for just under a quarter of all 
diseases in women according to the most recent UK statistical reports of incidence in 2011 
(Cancer Research UK, 2014a).  This chapter provides the clinical information necessary to 
build a knowledge base for gynaecological cancer research in the UK and outlines incidence 
and mortality rates for gynaecological cancers, risk factors, signs and symptoms, treatments 
and outcomes to enable understanding of the burden of the disease, and to identify factors 
associated with help-seeking behaviours and survival outcomes.  
 
2 
 
 
 
      
Figure 1.1. Female reproductive organs diagram. Adapted from Cancer Research UK (2013a) 
with permission for public use. 
Gynaecological cancers include: (a) endometrial cancer (i.e. cancer of the womb, 
endometrium or uterus), (b) cervical cancer (i.e. cancer of the cervix uteri or the neck of the 
womb), (c) ovarian cancer (i.e. cancer of the ovaries, which may include fallopian tube 
cancers), (d) cancer of the vulva, and (e) cancer of the vagina. 
Each site has distinct incidence and mortality rates, causes and risk factors, signs and 
symptoms, diagnostic pathways, treatments and survival rates (US Department of Health and 
Human Services, 2012).  All gynaecological cancers are defined by the presence of a primary 
malignant tumour or cancerous cells that originate in a specific area of the body.  Spreading 
occurs when malignant cells break away from the primary tumour and move through the 
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blood stream and lymphatic system (Figure 1.2.) to reach a new area, often dividing to form 
new tumours known as secondary cancers or metastases  (Shayan, Achen, Stacker& 2006; 
Cancer Research UK, 2013b).  As with all cancers, morbidity is determined by the site-
specific stage of disease, which describes the extent of cancerous spread throughout the body. 
 
      
Figure 1.2. Lymphatic system diagram. Retrieved with public use permission from Cancer 
Research UK (2013b). 
Cervical cancer affects an area in the lower part of the uterus, often called the neck of 
the womb.  Cancer of the vulva is an uncommon cancer of the entrance of the vagina (Figure 
1.3.).  Cancer of the vagina is the most rare of all gynaecological cancers, affecting the 
vaginal canal.  Cancer of the ovaries commonly affects the outer surface layer of the ovary 
(i.e. epithelial ovarian cancer), and can also originate within the cells that produce the eggs or 
 
   
4 
 
 
ova (i.e. germ cell tumours) or within the structural tissue cells that hold the ovaries together 
(i.e. stromal tumours; American Cancer Society, 2014a).  Endometrial cancer (i.e. womb or 
uterine cancer) is the most common of all gynaecological cancers, and is defined by cancer in 
the lining of the uterus (i.e. the endometrium; Cancer Research UK, 2014a).  The uterus is a 
muscular, pear-shaped organ at the top of the vagina.  Cancer that begins in the muscle layers 
of the uterus rather than the lining is categorised as uterine sarcoma.  
 
      
 
Figure 1.3. Diagram of the vulva: Outer part of female genitalia. Retrieved with public use 
permission from Mayo Foundation for Medical Education & Research (2014). 
Incidence and Mortality 
Gynaecological cancers have the second highest incidence of any female cancer in the 
UK, behind breast cancer and ahead of colorectal and lung cancer (Cancer Research UK, 
2014a).  Cervical cancer is globally the fourth most common cancer amongst women, with the 
highest incidence reported in developing countries (Ferlay et al., 2013a), and endometrial 
cancer is the sixth most common cancer, with the highest incidence rate reported in developed 
countries (Ferlay et al., 2013b).  Ovarian cancer is globally the seventh most prevalent cancer 
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amongst women (Ferlay et al., 2013a).  Cancers of the vagina and vulva account for less than 
7% of all reported diagnoses of gynaecological cancers (Cancer Research UK, 2014a).  
Recent reports suggest that endometrial cancer is the most common of all gynaecological 
cancers diagnosed in the UK, and that ovarian cancer has the highest morbidity (Cancer 
Research UK, 2014a).  The Cancer Research UK (2014a) report presents the number of 
gynaecological cancer cases diagnosed in the UK from most prevalent to least: (a) 
endometrial cancer, n = 8475; (b) ovarian, n = 7116; cervical, n = 3064; vulva, n = 1203; 
vaginal, n = 256. Mortality rates for the disease are dependent upon the stage at time of 
diagnosis, with early diagnosis greatly increasing chance for survival (Memon, 2009).  
Many gynaecological cancers affect women of post-menopausal age (average post-
menopausal age is 51; Sankaranarayanan & Ferlay, 2006).  Conversely, cervical cancer often 
affects women of younger ages, and rates increase steadily until women reach 39 years of age 
when the incidence rates begin to reduce (Memon, 2009).  Like most gynaecological cancers, 
endometrial cancer is rarely diagnosed before age 34 with approximately 73% of cases 
diagnosed between the ages of 40 and 75 (Howlader, et al., 2014) and incidence rates increase 
after age 40, reaching its highest incidence by the age of 64 (Memon, 2009).  
Two out of every three women (67.4%) who are diagnosed with cervical cancer and 
58% of women diagnosed with cancers of the vulva and vagina in the UK will survive at least 
five years after diagnosis (i.e. five-year relative survival rate) (Cancer Research UK, 2014b).  
Nevertheless, cancers of the vulva and vagina are rare and account for less than one per cent 
of all cancer deaths in women (Cancer Research UK, 2014a).  The five-year survival rate for 
ovarian cancer is about 46%, if diagnosed while still in the early or localised stages this rises 
to over 80% (Cancer Research UK, 2014b).  Mortality rates for ovarian cancer exceed that of 
other gynaecological cancers considerably, which is suggested to be due to late-stage 
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presentation (i.e. cancer not diagnosed until in an advanced stage), indicated by 56% of cases 
presenting in emergency services (Public Health England, 2015).  Late-stage presentation is 
suggested to be due to the non-specific or vague presentation of symptoms that often occurs 
in women (e.g. bloating, feeling full quickly; Goff, Mandel, Melancon, & Muntz, 2014 ).  
Endometrial cancer has a mortality rate accounting for three per cent of all cancer deaths, with 
a five-year survival rate of 79% (Cancer Research UK, 2014b).  A steady increase in 
endometrial cancer incidence and morbidity may be associated with the growing prevalence 
of female obesity (Bray, dos Santos Silvia, Moller & Weiderpass, 2005; Calle & Kaaks, 
2004), given that the literature reports a strong association with obesity and the development 
of endometrial cancer (Bhaskaran et al., 2014; Lane, 2008; Reeves et al., 2007; Stevens, 
Jacobs, Patel, Sun, Gapstur, & McCullough, 2014; World Cancer Research Fund/American 
Institute for Cancer Research, 2013).  This is important, because endometrial cancer is 
reported to have the highest associated risk of all the “obesity-related” cancers (i.e. breast, 
colon, oesophageal, endometrial, ovarian, kidney and pancreas; Polednak, 2008).  
Risk Factors 
Common risk factors for gynaecological cancers include: (a) post-menopausal age 
(with the exception of cervical cancer; Calle, Kaaks, 2004); (b) genetic factors (i.e. family 
history of breast or colon cancer; Gayther & Pharoah, 2010); (c) hormonal imbalance of 
progesterone/oestrogen (commonly caused by hormone replacement therapy [HRT], breast 
cancer oestrogen treatments, infertility, late menopause or infrequent menstrual cycles; La 
Vecchia & Boccia, 2014; Tinelli, Vergara, Martignago, Leo, Malvasi & Tinelli, 2008);  (d) 
sexually transmitted infection (Bosch, Lorincz, Muñoz, Meijer, & Shah, 2002; Grulich, van 
Leeuwen, Falster, & Vajdic, 2007); (e) obesity and comorbid disease (i.e. diabetes, 
hypertension; Bray et al., 2005; Starup-Linde et al., 2014; Memon, 2009);  (f) lifestyle factors 
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(e.g. smoking and poor diet; National Cancer Intelligence Network, 2014; Web, 2015; Parkin, 
Boyd, & Walker, 2011). See Table 1.1. 
Genetic risk factors for ovarian and endometrial cancers include the BRCA1 gene (i.e. 
breast cancer gene; Gayther & Pharoah, 2010).  Additionally, a family history of bowel 
cancer (i.e. HNPCC gene) or endometrial cancer increases the likelihood of developing 
endometrial cancer (Watson, Vasen, Mecklin, Jarvinen, & Lych, 1994).  A primary risk factor 
for cancers of the cervix, vulva and vagina is the human papilloma virus (HPV; Bosch et al., 
2002).  HPV is a sexually transmitted infection and includes a group of viruses that affect 
cells lining the cervix. It is defined by abnormal tissue growth and pre-cancerous cellular 
changes on the cervix, which can also present as genital warts.  HPV is present in nearly all 
cases of cervical cancer in the UK (Parkin, Boyd & Walker, 2011), and is the cause of pre-
cancerous lesions in cervical cancer (i.e. CIN), vaginal cancer (i.e. VAIN) and cancer of the 
vulva (i.e. VIN) (Basta, Adamek, & Pitynski, 1999; Kumar, Abbas, Fausto, & Mitchel, 2007).   
Hormonal exposure from oral contraceptives (in particular those containing 
progesterone) is a common risk factor for cervical cancer (La Vecchia & Boccia, 2014). 
Conversely, it is suggested that the use of oral contraceptives reduces the risk of developing 
endometrial and ovarian cancers (Havrileski, 2013; Salehi, Dunfield, Phillips, Krewski, 
&Vanderhyden, 2008) by increasing exposure to oestrogen, unopposed by progestins, which 
otherwise increases the risk of developing endometrial and ovarian cancers (Kaaks, 
Lukanova, & Kurzer, 2002; Sueblinvong & Carney, 2009), resulting in a thickened 
endometrium.  This relationship between hormones and increased risk for developing 
gynaecological cancers is associated with the use of oestrogen-only HRT and hormonal 
treatments for breast cancer or infertility (infertility increasing the length of time women are 
exposed to oestrogen, which is low during periods of pregnancy; Pearce, Chung, Pike, & Wu, 
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2009; Jensen, Sharif, Olsen, & Kruger Kjaer, 2008). 
The hormonal association is strongest in endometrial cancer, which is described as a 
hormonal carcinogenesis, identifying hormones (i.e. oestrogens and progestins) as the main 
factor in driving cell proliferation and growth of cancer cells (Tinelli et al., 2008).  Other 
known hormonal-related cancers include breast, ovarian, testicular, thyroid and osteosarcoma 
(Henderson & Feigelson, 2000).  Excess exposure to unopposed oestrogen affects the uterine 
tissue by stimulating a proliferation of cells (Lukanova et al., 2004; Pike, Pearce, & Wu, 
2004), resulting in a thickened lining of the uterus (i.e. endometrium).  Any prolonged 
exposure to oestrogen can increase the risk of developing endometrial cancer, as is the case 
with women who experience late menopause or early menarche (Pike et al., 2004) and obese 
women (Kaaks, Lukanova, & Kurver, 2002).  Furthermore, once through the menopause all 
oestrogen becomes unopposed, resulting in an increased risk for the development of 
endometrial cancer (Calle & Kaaks, 2004).  
Obesity as a Risk Factor 
Obesity is defined by the World Health Organisation (WHO; 2000) in categories of 
body mass index (BMI), which measures weight and height and is defined as an individual’s 
weight in kilograms divided by the square of his or her height in meters (kg/m!).  Individuals 
are categorised as overweight when their BMI measures at 25 or above, and obesity is 
measured at 30 or above.  Obesity is a common risk factor in the development of some 
gynaecological cancers (e.g. ovarian and endometrial; Bhaskaran et al., 2014; Olsen et al., 
2013; Reeves et al., 2007; Stevens et al., 2014; World Cancer Research Fund /American 
Institute for Cancer Research, 2013).  The association with obesity and gynaecological cancer 
is reported to be due to the storage of oestrogen in body fat, which is significantly increased in 
obese individuals (Kaaks, Lukanova, & Kurver, 2002).  
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A recent meta-analysis suggests that the risk for developing endometrial cancer is 
higher in women with adulthood obesity, and this risk increases by 81% with the amount of 
weight gained during adulthood (relative risk of 1.81, 1.66 – 1.98 increase per 5 kg/m!  BMI 
increase; Stevens et al., 2014), and an increase in cervical cancer at a relative risk of 1.1, 1.03 
to 1.17 (Kmeitowicz, 2014). Findings of the ovarian cancer and obesity link are less clear, 
however findings suggest that obesity may increase the risk for developing low-grade serous 
invasive ovarian tumours by 13% for every 5 kg/m! increase in BMI (relevant risk 1.13, 1.03 
– 1.25; Olsen et al., 2013), and mixed findings suggest that the use of HRT increases risk by 
up to 10% for every 5 kg/m! BMI increase (relevant risk 1.10, 1.07 – 1.03; Collaborative 
Group in Epidemiological Studies of Ovarian Cancer, 2012; Olsen et al., 2013).  An opposite 
effect is found in endometrial cancers, suggesting that obesity is linked to a higher risk of 
developing endometrial cancer amongst those who have never used HRT (Crosbie, Zwahlen, 
Kitchener, Egger, & Renehan, 2010).   
A report from World Cancer Research Fund/American Institute for Cancer Research 
(2013) suggests that obesity alone may account for four out of ten endometrial cancer 
diagnoses worldwide.  Obesity can affect cancer growth by influencing the levels of 
hormones and growth factors in the body (Hursting, Lavigne, Berrigan, Perkins, & Barrett, 
2003). Furthermore, abdominal fat increases insulin resistance, which causes the pancreas to 
compensate by increasing insulin production and promoting cancer cell growth, increasing the 
risk for colon, endometrial and pancreatic cancers (Calle & Kaaks, 2004).  Adipose tissue (i.e. 
fat tissue) synthesises oestrogen for post-menopausal women (Calle & Kaaks, 2004) and 
increases the conversion of androgen to oestrogen (Westley & May, 2013). Additionally, 
unopposed oestrogen is associated with a low-grade chronic inflammatory state, and promotes 
inflammation of uterine tissue (Hale, Hughes & Cline, 2002), which enables tumour cell 
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proliferation and cancer growth (Rexrode et al., 2003).  The hormonal influences facilitate 
thickening of the endometrium, subsequently increasing morbidity from gynaecological 
cancers, such as endometrial cancer (Calle & Kaaks, 2004). 
Obesity and obesity-related diseases (i.e. diabetes and hypertension) are suggested to 
increase the risk factors of cervical, ovarian and endometrial cancers (Memon, 2009; Starup-
Linde et al., 2014), however, this relationship may be partially related to overweight and 
obese women’s reduced attendance in cervical screening programmes (Maruthur, Bolen, 
Brancati, & Clark, 2009), and increased diagnoses of polycystic ovary syndrome (i.e. Stein-
Leventhal Syndrome) or endometrial hyperplasia (Hardiman, Plillay, & Atiomo, 2003).  
Diagnoses of endometriosis (i.e. a condition of uterine lining growth beyond the uterus) or 
ovarian cysts are additional risk factors for ovarian cancer that can affect obese populations 
(Borgfeldt & Andolf, 2004; Kim, Kim, Chung, & Song, 2014).  Furthermore, obesity and 
diabetes have been associated with symptoms of post-menopausal bleeding (PMB) and the 
development of endometrial cancer.  Obese women are 19%, and diabetic women are 21% 
more likely to experience PMB than women without these risk factors (Breijer, Timmermans, 
Doorn, Mol, & Opmeer, 2010).   
There are inconsistent findings to suggest that lifestyle factors may increase the risk 
for gynaecological cancers (e.g. sedentary lifestyle, smoking, eating a diet high in lactose and 
saturated fat; Braaten, Weiderpass, & Lund, 2009; Memon, 2009; Web, 2015).  Incidence is 
associated with socio-economic deprivation amongst cancers of the vulva, vagina and cervix, 
however, incidence rates of endometrial and ovarian cancer are reported slightly higher 
amongst more affluent groups than the more deprived (National Cancer Intelligence Network, 
2014).  Findings suggest that a low socioeconomic status may be associated with a general 
reduction in cancer survival (National Cancer Intelligence Network, 2014) and may be due in 
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part to an increase in smoking habits and poor diet amongst lower educated populations, this 
increases the likelihood of developing comorbid diseases, further increasing cancer mortality 
(Braaten, Weiderpass, & Lund, 2009).  An American study showed that socioeconomic status 
was a greater independent predictor of endometrial cancer survival than race or ethnicity, and 
that both higher income and hysterectomy surgery were associated with increased survival 
rates (Madison, Schottenfeld, James, Schwartz, & Gruber, 2004). 
Review of the literature highlights obesity as a key risk factor for the development of 
gynaecological cancers and reduced attendance at regular preventative screenings (Maruthur 
et al., 2009; Phelan, Burgess, Yeazel, Hellerstedt, Griffin, & van Ryn, 2015; Puhl & 
Brownell, 2006; Puhl & Heuer, 2009), thereby increasing the likelihood of morbidity amongst 
obese women diagnosed with gynaecological cancers.  
Protective Factors  
There are a number of factors that protect against the likelihood of developing 
gynaecological cancers.  Those most commonly reported are: The use of oral contraceptives 
with progesterone, hysterectomy, multiple pregnancies (i.e. periods of time with low exposure 
to oestrogen and increased progesterone) and HPV prevention behaviours (i.e. vaccination, 
condom use, abstaining from sex; Bosch & Harper, 2006; Muñoz et al., 2010; Winer et al., 
2006).  A strong relationship has been found between a reduction in the risk for ovarian 
cancer and oral contraceptive use with hysterectomy surgery (25 - 28% risk-reduction), and 
oral contraceptive use suggested to reduce the risk by up to 50% with ten or more years of 
regular use (retrieved from Havrilesky et al., 2013).  Being pregnant more than once may 
reduce the risk of ovarian and endometrial cancers by up to 55%, further reducing risk with 
each additional birth (Havrilesky et al., 2013).  Additionally, HPV prevention behaviours, 
implantation of an intrauterine device and an increased intake in Vitamin A have all been 
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suggested to reduce the risk for cervical cancer (Castellsague et al., 2011; Zhang, Dai, Zhang, 
& Wang, 2012).  Inconclusive evidence suggests that a diet high in cruciferous vegetables 
(e.g. broccoli, kale, cauliflower, Brussels sprouts, cabbage) and low in dairy and animal fat 
may reduce the risk for ovarian cancer (Bosetti et al., 2012; Memon, 2009).  Furthermore, 
physical activity may reduce the risk of endometrial and ovarian cancers by up to 20% (Cust, 
2011). See Table 1.1. 
Signs and Symptoms 
Signs and symptoms for gynaecological cancers vary by site.  Signs are defined as 
biologically based and are objective bodily sensations (Scott, 2010).  From the 
acknowledgment of these biological signs comes the recognition of symptoms, where 
symptoms are defined as the subjective experience of a physiological change (Scott, 2010).  
Symptoms are only experienced by the affected person and are often unknown to others until 
the experience is communicated (Pennebaker & Brittingham, 1982).  Understanding the signs 
and symptoms of gynaecological cancers is essential in conceptualising the psychological 
factors that may lead an individual to seek help.  Individuals are more likely to seek help for 
severe or salient symptoms (i.e. symptoms that interfere with daily life), however the non-
specific and often vague symptoms of gynaecological cancers may increase delay for 
gynaecological cancer symptoms (Evans, Ziebland, & McPherson, 2007).  See Table 1.1 for a 
summary overview of the incidence, risk factors, protective factors and symptoms of 
gynaecological cancers. 
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Table 1.1. 
Gynaecological Cancers in the UK: A Summary Table 
Cancer type Incidence Risk Factors Protective Factors Symptoms 
Cervical n = 3064 Family history.  Cervical Screening. Abnormal vaginal bleeding (post-coital, between  
  HPV. Intrauterine device. periods, post-menopausal) or abnormal  
  Oral contraceptives  Protected sex  discharge. 
  (w/progesterone). or abstinence.  
  Obesity.   
  Low SES.   
Vulva n = 1203 Post-menopausal age. Cervical Screening. Persistent itching, burning or pain of the vulva. 
  Family history.  Protected sex  Persistent rash, ulcer or lump on the vulva. 
  HPV. or abstinence. Changes on the colour or texture of the vulva skin. 
    Low SES.    
Vaginal n = 256 Post-menopausal age.  Cervical Screening. Abnormal vaginal bleeding (post-coital, between  
  Genetic factors.  Protected sex or  periods, post-menopausal) or abnormal discharge. 
  HPV. abstinence. Urination urgency and increased frequency. 
  Low SES.  Vaginal pain during sexual intercourse. 
Ovarian n = 7116 Post-menopausal age.  Oral contraceptives  Pelvic or abdominal pain or pressure. 
  Genetic factors: BRCA1.  (w/progesterone). Bloating. 
  Obesity. Hysterectomy. Urination urgency and increased frequency. 
  HRT. Multiple pregnancies. Increased abdominal size. 
   Physical activity. Abnormal bowel habits. 
Endometrial n = 8475 Post-menopausal age.  Oral contraceptives  Abnormal vaginal bleeding (between periods,  
  Genetic factors: BCRCA1 &  (w/progesterone). post-menopausal). 
  HNPCC & family history Hysterectomy.  
  of endometrial cancer Multiple pregnancies.  
  Obesity & diabetes. Physical activity.  
Adapted from Centers for Disease Control and Prevention (2014) and Cooper, Polonec, Stewart, & Gelb (2013). 
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Cancers of the cervix, vulva and vagina can take years to develop and usually first 
present at healthcare services in the early stages (i.e. pre-cancerous cells).  Early stages of 
cervical cancer (pre-cancerous or pre-invasive carcinoma) are commonly asymptomatic and 
are often detected during regular cervical screening tests.  However, when abnormal cells 
become cancerous (i.e. invasive carcinoma) symptoms include abnormal vaginal bleeding or 
discharge, and some women may experience discomfort or pain during sex (National Institute 
for Care and Health Excellence [NICE], 2005; Center for Disease Control and Prevention 
[CDCP], 2014).   
Common symptoms of cancer of the vulva include persistent pain, burning or itching 
of the vulva, ulcers, lumps or wart-like growths on the vulva, or a mole that changes shape or 
colour over time (CDCP, 2014).  Symptoms for cancer of the vulva can affect the labia 
majora, labia minora, and the clitoris (Souhami & Tobias, 2003).  Most women who 
experience symptoms of cancer of the vulva are unaware of their association with cancer and 
often choose to seek medical help only once symptoms increase in salience, for the 
development of an ulcer with pain, or an affected lymph node on the groin that has persisted 
or worsened (Evans, Ziebland, & McPherson, 2007).  Common symptoms of vaginal cancer 
include abnormal vaginal bleeding, urinary frequency, vaginal pain during sexual intercourse 
and rectal discomfort in advanced stages of the disease (NICE, 2005; CDCP, 2014).    
Early stage ovarian cancer is often asymptomatic, however, when symptoms present 
they are frequently vague or non-specific (Cooper, Polonec, Stewart, & Gelb, 2013). 
Common symptoms include: abdominal pain or pressure, bloating, changes in bowel or 
bladder habits, unexplained increase in abdominal size, appetite loss, fatigue, lower back pain 
or pain during sex (CDCP, 2014; Goff et al., 2004).   
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Ninety per cent of endometrial cancer cases present with a distinct symptom of 
vaginal bleeding (i.e. PMB, bleeding between periods, heavier periods than normal, abnormal 
vaginal discharge; NICE, 2005; CDCP, 2014).  PMB is defined as an episode of bleeding 
twelve months or more after the last menstrual period (Scottish Intercollegiate Guidelines 
Network, 2002).  PMB can be caused by endometrial hyperplasia, associated cell tumours of 
the ovary (Koukourakis et al., 2008), and can also be a symptom of cervical and vagina 
cancers (Rosenfeld, 2009).  One in ten women presenting with PMB are diagnosed with 
endometrial cancer (Newell & Overton, 2012), however, due to the specific nature of the 
symptom and greater awareness of the abnormality of bleeding after menopause, many of the 
cases are diagnosed early (Brand, Dubuc-Lissoir, Ehlen, & Plante, 2000).  Obese women have 
been identified as at high-risk of PMB and endometrial cancer (Breijer, et al, 2010; Feldman, 
Cook, Harlow, & Berkowitz, 1995). 
Due to the somewhat vague nature of some signs and symptoms of gynaecological 
cancers, the literature suggests that an individual’s subjective experience of their symptoms is 
often what drives a women to seek medical help and influences delay in diagnosis (Cooper et 
al., 2013; Evans, Ziebland, & McPherson, 2007).  Psychological factors that lead to help-
seeking are explained in Chapter 2. 
Diagnosis 
The process for diagnosing gynaecological cancers varies across sites.  Women with 
symptoms often present initially to primary care physicians in general practice surgeries, and 
symptoms commonly include an irregular menstrual cycle, PMB, post-coital bleeding, 
palpable abdominal or pelvic mass, or vaginal discharge (NICE, 2005).    
The UK healthcare service operates on a gatekeeping system, which means that 
primary care is the first point of contact when seeking-help for symptoms of cancer, and in 
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most cases this is the only route to specialist care (Vedsted & Olsen, 2011).  Within this 
system, the UK follows strict guidelines for the diagnosis of gynaecological cancers and will 
therefore be described in this section, in accordance with the current national guidelines 
(NICE, 2005; Pan Birmingham Cancer Network, 2015).  
When presenting with symptoms of gynaecological cancers in the UK a doctor will 
conduct pelvic or vaginal examinations to determine the diagnostic pathway.  If clinical 
features raise suspicion for cancer an urgent referral is made to the gynaecological cancers 
referral team (Pan Birmingham Cancer Network, 2015).  For cervical cancer, a cervical smear 
test (i.e. papanicolaou cervical smear test [PAP]) is performed intravaginally to test for pre-
cancerous and malignant cells present on the opening of the cervix and a biopsy is used to 
determine suspicion of cancer (NICE, 2005).  Nevertheless, if presenting symptoms raise 
suspicion of cervical cancer, a General Practitioner (GP) may be referred directly to a 
gynaecologist who will undertake an examination and a biopsy of the suspicious areas.  In 
some cases the PAP smear test result may indicate abnormality as pre-cancer.  A 
gynaecological specialist will then conduct a colposcopy test where a microscope is placed 
inside the vagina to visualise the cervix and an excision will be conducted to cut away the 
affected cervical area (NHS Cancer Screening Programmes, 2010).  A cone-shaped biopsy is 
sometimes used to remove a larger area of cells (Cox, 1999; NHS Cancer Screening 
Programmes, 2010).   
If a woman presents to her GP with suspicious symptoms of the vulva or vagina the 
doctor will conduct a pelvic examination and will make an urgent referral to a gynaecological 
specialist if cancer is suspected (e.g. symptoms of unexplained lumps or bleeding of the vulva 
due to ulceration; NICE, 2005; Royal College of Obstetricians and Gynaecologists, 2006).  If 
a patient presents with symptoms of itching or pain in the vagina or vulva the doctor may 
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choose to treat the patient for infection or dryness and make a referral if symptoms persist 
after treatment (NICE, 2005).  When referred, a gynaecological specialist will conduct a full 
pelvic examination (i.e. checking the groin lymph nodes and rectum), and often a colposcopy 
and biopsy will be performed to visualise and test the lesion (Royal College of Obstetricians 
and Gynaecologists, 2006).  Tests will determine the stage of the cancer, and recommended 
treatment.  Most cancer diagnoses of the vulva and vagina are squamous cell carcinomas (i.e. 
affecting cells in the epidermal layer of the skin), accounting for 90% of all cancers of the 
vulva and 80% of vaginal cancer cases (Daling & Sherman, 1996; Woolas & Shepard, 1999).   
If a woman presents at a GP surgery practice with symptoms indicative of ovarian 
cancer she will be referred for an ultrasound test at secondary care, and where cancer is 
suspected an urgent referral (to be seen within two weeks) will be made to a gynaecological 
specialist who will conduct a full vaginal examination and may test blood for increased levels 
of CA125 protein (i.e. a potential indicator of ovarian cancer; Menon et al., 2009; NICE, 
2011).  If cancer is detected further tests will be ordered to determine the stage of cancer.  
Tests may include: (a) vaginal or abdominal ultrasounds, (b) x-ray, (c) CT scan, (d) MRI 
scan, (e) laporoscopy (i.e. visual scope of ovaries via surgical abdominal insertion and 
biopsy), (f) abdominal fluid or chest fluid aspiration (i.e. to remove fluid build-up and check 
for cancer cells), or a laparotomy (i.e. a wider incision through the abdomen allowing for 
visual examination and biopsy of the affected area or full removal of cancerous cells if 
possible; NICE, 2005).   
For suspicion of endometrial cancer, a GP may conduct blood and urine tests and 
perform an internal vaginal examination.  If a woman who is not on HRT or is on Tamoxifen 
hormonal treatment for breast cancer and presents with PMB in a UK GP practice an urgent 
(2-week) referral will be placed for the woman to see a gynaecological specialist (Butler et 
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al., 2010; NICE, 2005; Pan Birmingham Cancer Network, 2015).  A gynaecological specialist 
may conduct vaginal or abdominal ultrasounds, imaging scopes (i.e. hysteroscopy) and may 
take a biopsy (i.e. small sample of cells removed from the affected area; NICE, 2005).  If 
cancer is detected further tests will be ordered to determine the size and location (i.e. staging) 
of the cancer.  Tests may include: (a) blood tests, (b) a chest x-ray (to identify spreading), (c) 
computerised tomography (CT) scan, (d) magnetic resonance imaging (MRI) scan, and/or (e) 
positron emission tomography (PET) scan (NICE, 2005).  The policy for PMB Clinics in the 
UK provides national standardised guidelines for the referral of suspected cancer malignancy 
when presenting with PMB.  PMB clinics provide a fast and effective pathway to 
investigation with the aim of excluding cancer as the cause (Butler et al., 2010; NICE, 2005; 
Pan Birmingham Cancer Network, 2015).  The pathway ensures that patients are seen by 
gynaecological specialists within 2 weeks of referral and that if a patient requires assessment 
and treatment they are able to do so within 31 days of referral.  Patients diagnosed with a 
gynaecological cancer must begin treatment within 62 days of referral to improve survival 
and treatment outcomes.  
 The stage of a cancer determines the relative size and location or spread of the cancer. 
Cancer cells are also graded to estimate the rate at which the cancer will grow or develop. 
Three grades exist to rate cancer cells ranging from low-grade or slow-growing cells (i.e. 
similar appearance to normal or well differentiated) to high-grade or fast growing cells (i.e. 
highly abnormal or poorly differentiated; Odicino, Percorelli, Zigliani, & Creasman, 2008; 
Prat, 2014; Sobin, Gospodarowicz, & Wittenkind, 2009).  Prognosis and survival are 
improved greatly when cancer is detected early.  See Table 1.2, depicting the stages of cancer 
development for each gynaecological cancer type.
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Adapted from Odicino et al. (2008), Sobin, Gospodarowicz and Wittekind (2009). 
Table 1.2.    
 
Staging of Gynaecological Cancers Using a Combined Staging System of FIGO & AJCC (TNM) 
 
Cancer Type Stage Description 
Endometrial 1.A-B Cancer contained in uterus lining begins to grow in 
muscular wall. 
 2 Cancer spread to cervix. 
 3.A-C.ii Cancer affecting outer uterus and/or ovaries and fallopian 
tubes grows to vagina and to abdominal lymph nodes 
(stage 3C.ii). 
 4.A-B Cancer spread beyond uterus to surrounding organs 
(bowel/bladder to distant body organs. 
Ovarian 1.A-B Cancer contained in one ovary and spreads to both 
ovaries. 
 1.C Stage 1A or 1B and cancer cells found on surface of one 
ovary, or in fluid taken from abdomen, or an ovary 
ruptured. 
 2.A-B Cancer spread outside ovaries to pelvis. Uterus/fallopian 
tubes or other pelvic organs. 
 2.C Stage 2A or 2B and cancer cells found in abdominal fluid. 
 3.A-C Small tumours in abdomen, <2cm tumours grow to 
tumours larger than 2cm with spread to nearby lymph 
nodes & bowel. 
 4 Cancer affected more distant organs. 
Cervical 1.A.i-ii. Cancer contained within cervix and visible via 
microscope: from <3mm and <7mm wide to 3-5mm deep 
and 7mm or less wide. 
 1.B.i-ii Cancer larger, but still confined in cervix: <4cm to >4cm. 
 2.A-B Cancer affected upper part of vagina: <4cm to >4cm 
grows to cancer affecting tissues next to cervix. 
 3.A-B Cancer spread to lower vagina to pelvic tissues. 
 4.A-B Cancer spread to bladder/bowel and to distant organs. 
Vulva  1.A-B Cancer <2cm and grows to 1mm or less into the skin of 
vulva or perineum then grows to cancer >2cm or grows 
>1mm into skin. 
 2 Cancer at any size that has spread to nearby structures 
(e.g. urethra, vagina, anus). 
 3 Cancer spread to the lymph nodes in the right/left side of 
the groin. 
 3.A-B One/two lymph node metastases, <5mm or one lymph 
node, >5mm to three or more lymph nodes, >5mm or two 
or more >5mm. 
 3.C Any lymph node metastases. 
 4.A-B Cancer spread to nearby structures or lymph nodes and 
spreads beyond pelvic lymph nodes to distant organs. 
Vaginal  0-1 Pre-cancerous lesion (commonly due to HPV infection) 
grows to small sized cancer contained within the vagina. 
 2-3 Between stages 1 and 4. 
 4 Cancer spread to the lymph nodes in the pelvis or organs. 
further away. 
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Treatment and Outcomes 
Each site-specific cancer uses different treatment methodologies including surgery, 
radiotherapy and chemotherapy, and often a combination of these to remove, minimise or 
weaken the cancer and to relieve negative side effects as a means of improving quality of life 
in more advanced stages.  See Table 1.3 showing the gynaecological cancer treatments used 
for each gynaecological cancer type. 
Table 1.3.  
Gynaecological Cancer Treatments 
Treatments 
Cervical Vulva Vaginal Ovarian 
Endo-
metrial 
Surgery Lymph node removal ✓ ✓ ✓ ✓ ✓ 
  Removal of the cervix ✓ 
    
  Partial/full vulva removal ✓ ✓ 
   
  Vaginal canal removal 
  
✓ 
  
  
Cervix &/or womb 
removal (hysterectomy)   
✓ ✓ ✓ 
  
Removal of ovaries & 
fallopian tubes (salpingo-
oophorectomy) 
   
✓ ✓ 
  
Non-reproductive pelvic 
organs removal 
(debulking surgery) 
✓ ✓ 
 
✓ 
 
Tissue 
removal 
Remove small tumour & 
surrounding tissue  
✓ ✓ 
  
Biopsy ✓ ✓ ✓ ✓ ✓ 
Abdominal fluid removal & testing 
   
✓ ✓ 
Radiotherapy 
  
Internal ✓ ✓ ✓ ✓ ✓ 
External ✓ ✓ ✓ ✓ ✓ 
Chemotherapy ✓ ✓ ✓ ✓ ✓ 
Progesterone hormone treatment 
    
✓ 
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Early stages of cervical cancer (i.e. spread from the cervix to the upper part of the 
vagina) may be treated with a cone biopsy, surgical removal of the cervix (i.e. radical 
trachelectomy) or removal of the pelvic lymph nodes (i.e. lymphadenectomy) to detect further 
spread (Shaw, Luesley, & Monga, 2011).  Internal or external radiotherapy may also be used 
post-surgery to reduce the risk of recurrence.  It may be used in combination with 
chemotherapy (i.e. chemo-radiation) for larger, more invasive, tumours (Shaw, Luesley, & 
Monga, 2011). 
Surgery is the most common form of treatment for cancer of the vulva and involves 
removal of the affected skin, surrounding healthy skin, lymph nodes and tumours on either 
side of the groin (Shaw, Luesley, & Monga, 2011).  Lymph node biopsy is used to test lymph 
nodes on either side of the groin before removal.  For early stages, removal of a one 
centimetre area of affected tissue will be conducted (Shaw, Luesley, & Monga, 2011).  When 
cancer has spread to more advanced stages a radical partial or complete vulvectomy may be 
conducted to remove part (i.e. upper, one or both sides) or all of the lymph nodes of the groin 
(Shaw, Luesley, & Monga, 2011).  If a vulvectomy is performed the surgeon will also 
conduct a surgical reconstruction to place a protective skin over the area.  For very advanced 
stages of cancer, pelvic organ removal surgery will be conducted, like that of cervical cancer.  
Internal or external radiotherapy may be given pre or post-surgery to reduce the cancer size 
before operation, or to ensure all cancer is removed after surgery (Shaw, Luesley, & Monga, 
2011).  Chemo-radiation may also be used in advanced stages to suspend cancer spread and 
manage symptoms in palliative care. 
In early stage cancer of the vagina, surgery may be used to remove the tumour along 
with the surrounding tissue.  For more advanced stages, a vaginectomy may be performed (i.e 
removal of the vagina) followed by a vaginal reconstruction to create a new vagina (Cancer 
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Research UK, 2013e).  Additionally, a radical or total hysterectomy may be performed, 
removing the womb, cervix and pelvic lymph nodes (Shaw, Luesley, & Monga, 2011).  
Internal or external radiotherapy and chemotherapy is often used in combination for moderate 
stages, for younger women who still wish to have children or before surgery to reduce the size 
of the cancer (Shaw, Luesley, & Monga, 2011). 
 Women diagnosed with Stage I ovarian cancers usually undergo a surgical total 
abdominal hysterectomy and salpingo-oophorectomy (i.e. removal of the ovaries, fallopian 
tubes, uterus and cervix).  In most cases the surgeon will also remove the fatty tissues close to 
the ovaries (i.e. omentum) and abdominal fluid (i.e. abdominal or peritoneal washing) and 
may perform lymph node biopsies to assess for cell grade (Shaw, Luesley, & Monga, 2011; 
Souhami & Tobias, 2003).  For younger women who wish to have children, the unaffected 
ovary and uterus will not be removed.  Women diagnosed with stage two and three ovarian 
cancer will undergo a total abdominal hysterectomy and salpingo-oophorectomy along with a 
more serious surgery described as de-bulking surgery to remove as much of the tumour as 
possible, the omentum, lymph nodes of the abdomen and pelvis, the appendix, abdominal 
lining and potentially a piece of the bowel (Shaw, Luesley, & Monga, 2011).  Chemotherapy 
may be used pre and post-surgery to decrease the tumour size for surgery and to aid in 
recovery.  Women diagnosed with stage four ovarian cancer may be given chemotherapy to 
decrease the tumour size or radiotherapy to reduce pain and bleeding and improve quality of 
life in palliative care (Shaw, Luesley, & Monga, 2011). 
 Most endometrial cancers are caught in an early stage (Plataniotis & Castiglione, 
2010).  This is likely due to the distinct nature of PMB symptoms, and have not yet spread 
beyond the uterus, as such most cases are treated by surgical removal of the uterus (i.e. 
hysterectomy; Shaw, Luesley, & Monga, 2011; Rose, 1996).  Usually a total removal of the 
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uterus, fallopian tubes and both ovaries (i.e. hysterectomy with bilateral salpingo-
oopherectomy) is recommended along with abdominal fluid testing and removal of lymph 
nodes close to the uterus.  Surgery is occasionally followed by radiation therapy to reduce the 
risk of recurrence (Shaw, Luesley, & Monga, 2011; Souhami & Tobias, 2003).  Radiotherapy 
is delivered internally (i.e. through the vagina) or externally (i.e. over the body) and primarily 
to individuals who are unable to have surgery due to health issues (e.g. for morbidly obese 
patients with anaesthetic risks during surgery), or in cases of cancer recurrence after a 
hysterectomy (Shaw, Luesley, & Monga, 2011).  Hormonal treatment with progesterone or 
chemotherapy treatment may also help to shrink the cancer and improve symptoms for 
individuals in advanced stages of palliative care (Shaw, Luesley, & Monga, 2011).  
Importance of Early Diagnosis 
For most cancers the survival rate is associated with the stage at time of diagnosis, 
highlighting the importance of early detection and screening.   
According to recent data from the International Cancer Benchmarking Partnership, the 
UK has lower survival rates one year after diagnosis for some cancers (including ovarian 
cancer) when compared to other countries with similar cancer control strategies (Coleman et 
al, 2011).  It is hypothesised that this may be due to the later stage of cancer at time of 
diagnosis, which would result in poorer survival rates after one year.  However, due to the 
lack of accurate recording of staging in gynaecological cancers in the UK, data to confirm this 
hypothesis are not readily available (Department of Health, 2012; Low, Simon, Wardle, & 
Memon, 2013b).  For example, vaginal and vulval cancers UK figures on stage distribution 
are not available, which may be because these cancers are significantly more rare when 
compared to the incidence of the other three (Cancer Research UK, 2014a; Low et al., 2013b).  
Additionally the stage-distribution figures for diagnosis of endometrial cancer in the UK are 
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not readily available, although it has been reported that most cases are diagnosed in the early 
stages (Plataniotis & Castiglione, 2010).  However, given survival rates differ greatly between 
early and late stage gynaecological cancers, showing 98% survival for Stage 1 endometrial 
cancers and 35% for Stage 4 (Cancer Research UK, 2014c), and 98% survival for Stage 1 
ovarian cancers and 41% for Stage 4 (Cancer Research UK, 2014d) evidence suggests that 
early diagnoses may be beneficial.  A study by Torring, Frydenberg, Hansen, Olesen, 
Hamilton, and Vedsted (2011) found that increased time to diagnosis from presentation at 
primary care predicted higher mortality in patients presenting with symptoms of colorectal 
cancer, highlighting that lower survival rates for later stage diagnosis may be due to 
diagnostic (system) delays and poorer management of women diagnosed at more advanced 
stages (Low et al., 2013b).  Nevertheless encouraging women to seek help promptly may 
improve outcomes. 
For cervical cancer, 75% of women in the UK are diagnosed at Stage I.  This 
relatively high percentage of early stage diagnoses is likely a result of the national 
standardised screening programme for cervical cancer (NHS Cancer Screening Programmes, 
2012).  Amongst the five sites for gynaecological cancers, cervical cancer is the only one to 
have a national standardised screening programme, whereby PAP smear tests and 
vaccinations are used to test for, and prevent HPV infection that may occasionally also 
present in other HPV-related cancers (i.e. cancers of the vulva and vagina).  Vaccinations are 
available to young women aged 11 to 26 years in all developed countries (Dowling, 
Klabunde, Patnick, & Ballard-Barbash, 2010; Whitlock, Vesco, Eder, Lin, Senger, & Burda, 
2011).  HPV vaccines (e.g. Gardasil and Cervarix) help to protect women against the most 
common strains of HPV (Bosch & Harper, 2006; Koutsky et al., 2002).  Vaccinations are 
recommended for adolescent and pre-adolescent young women before they become sexually 
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active (Department of Health England, 2013).  The UK cervical screening programme invites 
women from 25 to 64 years of age to attend routine cervical smear tests (Department of 
Health England UK, 2013).  Currently there is no national screening programme for ovarian 
cancer in the UK, however, results of randomised controlled trials suggest that a simple blood 
test (i.e. testing for a protein CA125) and vaginal ultrasound are promising new approaches in 
the detection of early-stage ovarian cancer and data from an ovarian cancer screening trial 
called The United Kingdom Collaborative Trial of Ovarian Cancer Screening may influence 
policy to implement a blood test screening programme for ovarian cancer and transvaginal 
ultrasounds screening for endometrial cancer amongst post-menopausal women in the NHS 
(Buys et al., 2011; Jacobs et al., 2011; Skates, 2013).  Ovarian cancer may also be detected by 
pelvic examination at regular PAP smear visits, however this is more effective in detecting 
later stages of ovarian cancer (Westhoff, Jones, Guiahi, 2011).  
Given the differences between early and late stage survival rates at time of diagnosis 
for gynaecological cancers and the current lack of screening programmes for other 
gynaecological cancers (i.e. endometrial and ovarian), reducing the number of later stage 
diagnoses in unscreened women is suggested to improve outcomes (Low et al., 2013b).  
Therefore, encouraging women with symptoms to promptly seek help by consulting their GP 
is important, particularly given the number of women who do not seek help at an early stage 
and are instead diagnosed with a gynaecological cancer through emergency presentation or by 
death certificate only (30% of ovarian, 8% of uterine and 12% of cervical cancer diagnoses; 
National Cancer Intelligence Network, 2010).  Encouraging women to seek help through 
primary care may prevent such late stage diagnoses. 
Despite acknowledging that encouraging prompt help-seeking for symptoms may 
increase GP consultation rates (Stapley and Hamilton, 2011), it is likely that the rate of 
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women not seeking help from the GP is greater (Low et al., 2013b).  While acknowledging 
that these symptoms are not likely to be cancerous, it is still suggested that women should be 
encouraged to seek help as a means of increasing earlier cancer diagnoses and allowing for 
the detection of other potentially treatable conditions, such as endometriosis, fibroids, polyps, 
infections and skin irritation or dryness due to a lack of hormones after the menopause (Low 
et al., 2013b).  
Early Detection Amongst Obese Women 
Obese individuals have been suggested to be less likely to participate in screening 
programmes than non-obese women (Aldrich & Hackley, 2010; Amy, Aalborg, Lyons, & 
Keranen, 2005; Aphramor, 2012), resulting in more advanced presentations of gynaecological 
cancers for these women (Ardnt, Sturmer, Stegmaier, Ziegler, Dhom, & Brenner, 2002; 
Maruthur et al., 2009).  Obese women are reported to have greater body dissatisfaction, which 
may impact on the decision to seek medical help, and may act as a barrier to help-seeking and 
participation in gynaecological and breast screening programmes (Alegria Drury & Louis, 
2002; Ridolfi & Crowther, 2013) even when controlling for factors such as age, race, 
socioeconomic status, and comorbidities (Aldrich & Hackney, 2010).  Reasons for non-
attendance in health screening programmes for obese women also included embarrassment, 
accessibility barriers (i.e. mobility, socioeconomic barriers) perceived weight-stigma as 
experienced through poor doctor-patient communication (Aldrich & Hackney, 2010; Phelan 
et al., 2015; Puhl & Heuer, 2008) and concerns about limitations with equipment (i.e. 
weight/size restrictions for equipment; Aldrich & Hackney, 2010; Uppot, 2007).   Similar 
factors have been suggested to facilitate the delayed presentation of obese women at 
healthcare services, with lack of symptom and disease knowledge and negative previous 
experiences of weight-stigma in healthcare being the key barriers to healthcare utilisation for 
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obese women (Befort et al., 2006; Phelan, Burgess, Yeazel, Hellerstedt, Griffin, & van Ryn, 
2015; Soliman et al., 2008).  Still, it should be acknowledge that research to date has not 
specifically looked at obese women seeking help for potential symptoms of gynaecological 
cancers.  If reduced survival rates for obese women presenting with gynaecological cancer 
symptoms is explained by a reduction in attendance at screenings (Maruther et al., 2009), 
obese women should be encouraged to seek help promptly for symptoms of gynaecological 
cancers, particularly given that the national screening programmes in the UK are limited to 
cervical screenings only. 
Role of the Healthcare Professional in Early Detection 
Healthcare professionals also play a role in the early detection and diagnosis of 
gynaecological cancer symptoms by recognising the vague or non-specific symptoms 
indicative of some gynaecological cancers and responding by providing appropriate referrals 
down the diagnostic pathway.  Furthermore healthcare professionals play a key role in 
influencing help-seeking behavioural amongst patients and encouraging prompt help-seeking 
for symptoms.  
Literature suggests that delay in early detection and help-seeking may be due to a 
reduced awareness about the symptoms and risks of gynaecological cancers (Boxell et al., 
2012; Sheikh & Ogden, 1998; Jayde, White & Blomfield, 2010; Soliman et al., 2008).  This 
lack of awareness is further perpetuated by the vague and non-specific symptoms of 
gynaecological cancers, which may lead to misinterpretation of symptoms as benign by 
patients and healthcare professionals who may relate symptoms to benign (Evans, Ziebland, 
& McPherson, 2007) or weight-related issues (e.g. bloating, changes in bowel habits, back 
pain), thereby acting as a barrier to individuals requiring help for malignant symptoms of 
gynaecological cancers (Macleod et al., 2009; Smith, Pope, & Botha, 2005).  Furthermore, a 
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study on medical help-seeking delay, by Amy and colleagues (2005) attributed delayed help-
seeking gynaecological  cancer symptoms amongst obese women to disrespectful interactions 
and perceived attitudes of healthcare professionals which stigmatised overweight and obese 
women.  Furthermore, a study exploring the barriers and facilitators of help-seeking for breast 
and cervical cancers reported that women believed that a positive and trusting relationship 
with their GPs facilitated help-seeking amongst all women regardless of size (Marlow, 
McGregor, Nazroo, & Wardle, 2014). Therefore findings highlight the importance of 
healthcare professionals beliefs and perspectives as well as gynaecological cancer knowledge 
in encouraging women to seek help promptly for symptoms and in facilitating early detection 
and timely diagnoses of gynaecological cancers amongst obese and non-obese women alike. 
To date, research has not investigated to beliefs and perceptions of healthcare 
professionals working with obese patients, which could inform investigation into early 
detection and diagnoses of gynaecological cancers amongst this group.  Healthcare 
professionals’ research can illuminate important perspectives on issues that affect quality of 
care and disease outcomes (Clark, 2005) and provide insight into the identification of patient 
barriers to care and the experience of health services (Al-Busaidi, 2008).  Such research can 
inform patient research to develop a cohesive understanding of the patient and healthcare 
professionals perspectives on barriers and motivators of help-seeking for symptoms of 
gynaecological cancers, given that both the patient and the healthcare professional play key 
roles in early detection and the utilisation of healthcare services.  
Early detection of most cancers is dependent upon individuals recognising a symptom 
as meeting sufficient severity to seek medical help (Rob et al., 2009), this includes symptoms 
of gynaecological cancers (Macleod, Mitchell, Burgess, Macdonald, & Ramirez, 2009).  
However, given that many of the symptoms of gynaecological cancers are non-specific and 
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associated with a variety of benign conditions (e.g. bloating, gas pains, indigestion, urinary 
urgency, lower back pain) the nature of the symptoms may contribute to delayed help-seeking 
and diagnosis of gynaecological cancers (Evans, Ziebland, & McPherson, 2002), which may 
contribute to later stage disease at time of diagnosis, particularly for ovarian cancer (Ryerson, 
Eheman, Burton, McCall, Blackman, Subramanian, 2007).  However, we also know that the 
healthcare professional plays a role in the early detection and diagnosis of symptoms and 
recognising such non-specific symptoms as potential symptoms of cancer.   
The rate of growth and early signs of cancer may vary by cancer type, therefore the 
evidence for this association in gynaecological cancers is not as clear as the evidence for other 
common cancers.  For example a study by Ardnt and colleagues (2002) identified that patients 
with poorly differentiated tumours of the breast were more likely to delay seeking help, 
leading to later-stage diagnosis and poorer outcomes.  This study and others (e.g. Caplan, 
2014) suggest that difficulty recognising a symptom influences time to help-seeking and stage 
of diagnosis for breast cancer.  The CDCP (2014) in the United States recommends that 
individuals should seek help for gynaecological symptoms within two weeks of initial 
presentation, however an exception is made for abnormal vaginal bleeding, for which 
immediate care is recommended (Cooper et al., 2013).  Nevertheless, limited research has 
been done to investigate time to help-seeking for potential symptoms of cancer with more 
research investigating awareness of gynaecological cancer symptoms and anticipated or 
hypothetical time to help-seeking (Cooper et al., 2013 Low et al., 2013a; see Jones & 
Johnson, 2012), or asked non-temporal questions about weather or not women sought help for 
symptoms and their primary pathway to diagnosis (Low et al., 2013b). 
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Summary 
Gynaecological cancers vary by incidence, risk factors, signs and symptoms, 
treatments and outcomes.  Nevertheless, it is clear that these forms of cancer are associated 
with a strong worldwide disease burden.  Early detection and prompt help-seeking can 
improve treatment and survival outcomes and allow for treatment of non-cancerous 
gynaecological conditions.  However, gynaecological cancer symptoms present particular 
challenges with the recognition of vague and non-specific symptoms, which are often not 
recognised as warning signs of cancer or are not severe enough to seek medical help. 
These issues are particularly important amongst obese women, who are at higher risk 
of developing gynaecological cancer and are more likely to delay attendance at regular 
screenings, further increasing their risk of later stage diagnosis for gynaecological cancers, 
particularly ovarian, cervical and vulval cancers, which can be diagnosed as a result of regular 
screenings.  Therefore, understanding what leads women to seek help and what influences the 
process of delay is essential to inform help-seeking research and intervention development in 
this population given that this information is not yet known. Despite the high incidence of 
gynaecological cancers some individuals still delay seeking help and it is important to identify 
populations at greatest risk of delay.  The following chapter provides an overview of the 
health behaviour theories that built and understanding for medical help-seeking behaviour and 
provides insight into the psychological investigation of help-seeking for symptoms of cancer. 
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CHAPTER 2: LITERATURE REVIEW- PSYCHOLOGICAL HELP-SEEKING 
THEORY 
 
The process of help-seeking is a dynamic one wherein an individual recognises, 
interprets and responds to a bodily change or symptom by making an active decision to 
towards move toward health by communicating an appraised health issue to another (Cornally 
& McCarthy, 2011).  This chapter reviews help-seeking theories and models in the contexts 
of physical health and illness, where help-seeking is defined as a response to observed health 
changes and a process toward health-seeking behaviour (O’Mahony & Hegarty, 2009).  The 
chapter introduces help-seeking by first outlining what a symptom is, then presenting an 
overview of the key theories and models that inform our understanding of help-seeking 
behaviour, followed by a description of the factors that are known to influence processes of 
symptom perception to appraisal.  Finally, specific constructs that affect decision-making 
processes and associated behavioural responses are described. 
Symptoms and Behavioural Response 
What is a symptom? The decision to seek help begins with a complex process of 
symptom perception (i.e. noticing a symptom) and interpretation (i.e. understanding of a 
symptom).  This process can be viewed as the recognition of biologically based and objective 
bodily sensation(s) identified as signs, wherein a sign is a signal of abnormality that is 
detectable by the individual as well as others (Scott, 2010).  Signs often act to evaluate or 
determine severity of disease and formulate strategies for clinical management (Dodd et al., 
2001).  Alternatively, symptoms are defined as the subjective experience of a physiological 
event (Scott, 2010), which can include changes in the biopsychosocial functioning, sensations 
or cognitions of an individual (Dodd et al., 2001).  A symptom is conceptualised as a 
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multidimensional experience of a bodily condition that is experienced by the affected person 
as a departure from normal functioning (i.e. bodily change), and which is not understood by 
others until this experience is communicated (MacBryde & Blacklow, 1983; Rhodes & 
Watson, 1987).  Physical symptoms are described through the biomedical and cellular 
functioning mechanisms.  Nevertheless, some experiences are described by psychologists and 
psychiatrists as somatic symptoms, which acknowledges the influence of psychological and 
social processes on the perception and potential development of symptoms (Kroenke, 2003). 
For example, somatic symptoms of chronic obstructive pulmonary disease can include: 
fatigue, anorexia and weight loss (Dorwick, 2005).  The two terms physical and somatic are 
used synonymously in the research literature without defining the cause of symptoms.  It is 
important for the purpose of the present thesis, that both the biological and psychosocial 
perspectives of symptoms be acknowledged given that many symptoms cannot be explained 
by the biomedical model (e.g. medically unexplained symptoms, somatic symptom disorder, 
functional somatic syndromes; American Psychiatric Association, 2013; Barsky & Borus, 
1999; Reid, Wessely, Crayford, & Hotopf, 2010).  In the current chapter physical symptoms 
are understood as perceived changes in bodily functioning.  This view includes both normal 
and pathological physiological functioning and acknowledges the influence of cognition, 
emotion and environmental factors on the perception and experience of symptoms.  
Behavioural response to symptoms.  When the UK’s National Health Service was 
established in 1948, the process of help-seeking was built on the assumption that if 
individuals perceived themselves to be unwell and in need of medical attention they would 
intuitively seek out the help of medical services (Hardey, 1998).  It is now common 
knowledge that individuals who feel unwell often do not seek help, and those who seek help 
are at times not unwell (Last, 1963; Moffat, 2010). This phenomenon is referred to as the 
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illness iceberg (Last, 1963).  Hannay (1979) described this phenomenon in a UK survey study 
which showed that a significant number of serious conditions were found to be reported (e.g. 
anaemia, diabetes, cancer, bronchitis), whilst many were never brought to the attention of GPs 
and many patients who attended GP services did not receive appropriate referrals for serious 
conditions, whereas others with more “trivial” symptoms did.  A review by Verbrugge and 
Ascione (1987) found that individuals experiencing physical symptoms often chose to self-
manage through non-prescription medication and reduced physical activity.  Results of the 
study highlighted a key difference in the behavioural responses to acute and chronic health 
problems, such that acute illness responses were motivated by the desire for immediate, short 
term symptom relief, and chronic illness responses involved strategies of care over time.  
Self-management strategies were determined by an individual’s personal characteristics (i.e. 
social roles and attitudes) and available resources.   
The above research highlights the important role GPs play in help-seeking, as they are 
often the first point of contact for individuals seeking help for physical symptoms.  
Nevertheless, there remain many individuals who do not seek medical help  (e.g. individuals 
who self-manage symptoms) while others seek help for trivial symptoms or seek help but do 
not receive critical referrals for serious conditions. 
Understanding help-seeking behaviour: Overview of the key theories and of models   
Previous research allows for development of inquiry into the complex psychosocial 
influences on symptom perception and the decision to seek medical help.  Furthermore, it is 
important to acknowledge from the beginning that deciding to seek help is only one of many 
possible responses to symptom perception, thus it does not predict medical help seeking alone 
(Scott, 2010). 
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The Andersen Delay Model (Andersen, Cacioppo, & Roberts, 1995; Safer, Tharps, 
Jackson, & Leventhal, 1979) proposes a general framework that presents sequential stages 
from the detection of a physical symptom to treatment, assuming treatment is necessary (See 
Figure 2.1.). Andersen’s delay model is a five-stage model that describes decisional processes 
which each have the potential to delay presentation to healthcare services, subsequently 
delaying diagnosis and treatment (Andersen, Cacioppo, & Roberts, 1995; Scott, Walter, 
Webster, Sutton, & Emery, 2013).  Delay can be measured in days or years after an initial 
symptom is detected to the time an individual seeks help or receives a diagnosis (Safer et al., 
1979) and is often based on the clinical implications of delay on a disease (i.e. the morbidity 
and mortality).  Nevertheless, there is no consensus on a definition of delay within the 
literature and definitions are often disease specific (Scott & Walter, 2010; Sisler, 2003; 
Walter, et al., 2012).  
In a study employing the Andersen model (Andersen et al., 1995) to understand 
gynaecological cancer delay amongst other cancers, and Hansen and colleagues (2008) further 
clarified the stages by identifying factors most responsible for the delay in each stage amongst 
men and women with various cancer types (including ovarian and endometrial cancers).  
Proposed stages of delay included patient delay (e.g. appraisal of symptoms as not serious 
enough to seek medical attention), healthcare professional (HCP; e.g. symptoms 
misdiagnosed as benign by GP or referral not made) and system delay (e.g. appointment and 
referral delays).  Patient delay included the perceptual delay stage (which was added to 
Figure 2.1 to take into account factors that influence sensory perception) and is understood as 
the time between the presence of a physical symptom and actual detection of the symptom by 
the individual.  Appraisal delay (i.e. misattribution) refers to the time between first detection 
of a symptom and inferring it as a result of illness, and illness delay refers to the time between 
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inferring illness and realising that one needs medical care.  The complete Andersen et al. 
(1995) model of help-seeking behaviour includes three additional stages of healthcare delay: 
a) behavioural delay (i.e. time from the decision to seek medical attention to the action or first 
contact with medical care), b) scheduling delay (i.e. time from contacting healthcare to 
attending the scheduled appointment) and c) treatment delay (i.e. time between first 
healthcare visit and treatment onset), which may also be preceded by a referral delay (added 
to Figure 2.1 to include alternate diagnostic pathways).  Furthermore, scheduling delay may 
be described as a system delay if a patient is unable to book an appointment with his/her GP 
due to insufficient appointment availability or a patient delay if the patient fails to attend their 
scheduled appointments with a HCP.  HCPs are described as providers of clinical services 
(i.e. with the ability to order investigations, diagnose, treat, or engage with treatment 
providers; Weller et al., 2012).  Previous literature suggests removal of the term delay (e.g. 
Corner, Hopkinson, & Roffe, 2006; de Nooijer et al., 2001; Scott et al., 2013; Walter et al., 
2012), as there is an implied responsibility that accompanies the term and often blames the 
patient without investigating the external factors that have impacted on a patient’s delay.  
These external factors may be those outside of a patient’s control (e.g. accessibility of 
services, healthcare scheduling delay).  Furthermore, definitions of delay are often ambiguous 
or are reported without providing evidence for impact of delay on clinical outcomes (Walter 
et al., 2012), thus time-interval replaced this term in Figure 2.1 as suggested by Walter et al. 
(2012) in their review of the model.  This lays the foundation for the focus and structure of 
this chapter, which describes an overall process of help-seeking rather than a focus on delay.  
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Figure 2.1. Adapted Andersen’s stage model of help-seeking behaviour. Adapted from The 
General Model of Total Patient Delay proposed by Andersen, Cacioppo, and Roberts (1995). 
In a systematic review, Walter et al. (2012) found support for the use of Andersen’s 
stage model by acknowledging clearly identifiable stages and the acknowledgment of 
potential delays in understanding the process of help-seeking for symptoms of cancer.  There 
is strong evidence to suggest that appraisal represents the stage of greatest delay, suggesting 
that it is attributable to 60% of the overall delay, and was most significantly impacted in 
women diagnosed with gynaecological cancer and those undergoing investigation for breast 
symptoms (Andersen et al., 1995; Scott, 2010) (discussed in the section below).  Evans, 
Zeibland and McPherson (2007) report that delay is often due to a misattribution of symptoms 
to benign conditions, and similar findings were reported in the Smith et al. (2005) and Gould, 
37 
 
 
Fitzgerald, Fergus, Clemons and Baig (2010) studies.  Petrie and Weinman (2003) describe 
Andersen’s stage model as useful in acting as a basic road map for the journey toward help-
seeking, which provides the names of towns one will pass through, though it does not provide 
any information about these towns.  Therefore, the model creates a basic framework for 
understanding the decisional stages one encounters when progressing toward medical help-
seeking, however, it does not enable understanding for how these decisions enable movement 
from one stage to the next or how one comes to decide to seek help.  Walter et al. (2012) 
criticised Andersen’s separation of stages, suggesting that illness and appraisal delay should 
not be represented by independent stages, given that patients may experience a symptom as 
immediately concerning and seek help immediately (conceivably merging these two stages), 
while others may seek help for symptoms without acknowledging it as a sign of illness.  This 
merging of stages creates a challenge when assessing the distinct stages of appraisal, illness 
and behavioural delay, and in describing how an individual comes to perceive that they are 
not well.  Furthermore, the model depicts a linear movement through stages and does not 
allow changes in one’s interpretation and appraisal of symptoms, nor does it include the 
psychosocial influences on these decisions (Scott et al., 2013; Scott, McGurk, & Grunfeld, 
2007; Walter et al., 2012).  
Criticisms of help-seeking models describe the false presumption that patients seek 
help for symptoms primarily for the purpose of treatment, when many patients will often seek 
medical advice for other reasons (e.g. reassurance, social contact, symptom relief; St. Claire, 
2003).  Before discussing these psychological and psychosocial factors that influence help-
seeking it is important to gain a broader understanding of the theoretical underpinnings that 
guide this processes (of perception, appraisal, and making the decision to act and behave).    
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Symptom perception, appraisal and help-seeking behaviour theory  
Information processing. The decision to seek help begins with the initial detection of 
bodily change(s), interpretation and the subsequent appraisal of these changes as potential 
symptoms of illness.  To gain an understanding of this information processing system we 
revisit the biological and psychological models from Chapter 1, which are presented here in 
greater detail to build an understanding of the complex processes involved in symptom 
perception.  The biological model approach to information processing describes a data-driven 
symptom perception in which somatic sensations are experienced and rated by quality (e.g. 
salience or severity) and quantity (e.g. persistence or variety).  This process is described as a 
bottom-up objective process of symptom recognition (Scott, 2010; St. Claire, 2003) and 
assumes passivity of the experiencer.  The biological approach provides an incomplete 
understanding of the process of symptom perception given that it does not take into account 
the environmental factors and cognitions that affect somatic awareness and symptom 
recognition (Andersen, Cacioppo, & Roberts, 1995).  For example, the biological approach to 
explain pain would suggest that the level of pain is proportionate to the amount of tissue 
damage, and individuals with greater tissue damage would experience a greater degree of 
pain.  However, the experience of pain is influenced not only by the biological processes 
within the body, but also by social, cultural and psychological factors (Keefe, Lefebvre, Egert, 
Affleck, Sullivan, & Caldwell, 2000).  The Beecher (1956) study presented evidence of 
World War II soldiers who reported little or no pain despite the severe injuries they endured 
in battle.  The psychological model, on the contrary, uses a conceptually driven approach that 
recognises the influence of cognitions (i.e. expectations, beliefs, understandings) and 
emotions in an active approach to the perception of bodily sensations.  It describes a top-down 
process that emphasises the relationship between how one understands their symptoms and 
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how one experiences bodily sensations.  Using the example described above, an individual 
may experience severe pain and distress with a minor injury, while another with more severe 
injuries may experience minor pain with little or no distress, depending on influencing factors 
in their environment.  Both models interact, allowing an individual to identify a symptom, 
label it, and interpret the bodily information as attributable to disease or an otherwise benign 
condition.  Pennebaker (1982) proposes that perceiving physiological stimuli functions as an 
identical process to that of receiving environmental stimuli (e.g. auditory and visual 
information), therefore physiological sensing is subject to similar biases.  Cacioppo and 
colleagues (1986) posited that this process of attribution exists in all human beings, as we are 
all motivated to develop an explanation for the presence of any bodily sensation.  
Nevertheless, as we have seen in the previous chapter and the section above, the 
frequent ambiguity of symptoms create issues when attempting to recognise and interpret 
symptoms as severe enough to require medical help.  Furthermore, the identification of the 
appraisal stage as the stage of greatest delay, suggests that there are additional cognitive-
perceptual processes that are influenced by psychosocial factors (e.g. emotional state, 
sociocultural environment, one’s understanding of illness and previous experience of illness; 
Pennebaker, 1982; Cioffi, 1991).  Therefore the information-processing models are not 
adequate in understanding all key influences. 
The following sections will therefore describe a series of models that outline the 
processes of help-seeking, from symptom perception to medical help-seeking behaviour, and 
will present an overview of three key models that build a foundation for the present PhD 
research. 
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Symptom perception model. The beginning of the help-seeking process begins with 
the detection of a physiological change or symptom (i.e. symptom perception), thus it is 
important to gain an understanding of this crucial first stage, before introducing help-seeking 
models that focus on the detection and appraisal of health-threats and the volitional actions 
taken toward help-seeking behaviour more specifically.  Contrary to the assumptions of the 
biomedical model, non-physiological factors exist and influence whether symptoms will be 
perceived and how they will be interpreted.  Here, the Symptom Perception Model (Gijsbers 
van Wijk & Kolk, 1997; Kolk, Hanewald, Schagen, & Gijsbers van Wilk, 2003) is presented 
to gain an understanding of the biological, psychological, and social factors that influence the 
perception of bodily changes and symptoms.  While several integrative models of symptom 
perception have been described in the literature (e.g. Cioffi, 1991; Kirmayer & Taillefer, 
1997; Pennebaker, 1982; Petersen, van den Berg, Janssens, & Van den Bergh, 2011), one key 
model is presented in this chapter.  The Symptom Perception Model incorporates the 
cognitive-perpetual model (Cioffi, 1991) and the competition of cues hypothesis (Pennebaker, 
1982), highlighting a number of psychological, social and environmental factors that 
influence symptom perception (Goodwin, Fairclough, & Poole, 2013).  See Figure 2.2.  
Despite the recognition of attributional processes in the model, these processes are not 
described in as much detail as the previous perceptual processes, therefore the self-perception 
processes will form the primary focus of this section. 
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Figure 2.2. Symptom Perception Model. Adapted from Gijsbers van Wijk & Kolk (1997) and 
Kolk et al. (2003). 
Based on Pennebaker’s (1982) research, the model assumes: (a) humans have a 
limited capacity to process information at any one time, receiving more information than they 
are able to process at any given time; (b) attention to sensory information is selective; (c) 
sensory information alternates between information from the external (environmental) and 
internal (bodily) sensory information producing a competition of cues, to win the attention of 
the limited attentional resources available at any one time; (d) perception involves both 
bottom-up (data-driven) and top-down (conceptually driven) processes which work 
concurrently; (e) the small amount of information received by one’s attention is partially 
determined by their cognitive and personality traits and partially due to the clarity and 
intensity of available information (Gijsbers van Wijk & Kolk, 1997).  
42 
 
 
The model identifies psychological, environmental, social and biological factors that 
affect the level of attention given to bodily signals, recognising that novel somatic 
information (e.g. pain) is likely to have greater attention-grabbing properties than other 
existing bodily signals.  This is due to a concept called attention-regulation that decides to 
what degree sensory information is selected for processing, and is based on the assumption 
that only a small amount of information is actually processed into awareness, despite the 
myriad of sensory receptors activated in the body at any one time (generating information 
about bodily organs and internal functioning; Kolk et al., 2003).  
The symptom-perception model introduces three key concepts that influence how 
somatic information is perceived, thus determining whether a somatic sensation will be 
attended to, and further appraised as a symptom.  These concepts include: Self-directed 
attention toward the body (i.e. selective attention to normal physiological processes), 
disposition (e.g. negative affect) and external environmental factors (i.e. ratio of information 
from the body to information from the environment) that influence attention to and awareness 
of bodily sensations.  Selective attention to the body is expected to lower the threshold for 
symptom detection (Kolk et al., 2003), thereby heightening the sensitivity for somatic 
information processing (Cioffi, 1991; Pennebaker, 1982).  Moreover, selective attention is 
associated with heightened physiological or emotional arousal (Rief & Barsky, 2005).  
Negative affectivity is defined as “the tendency to experience and report negative mood 
states” (Kolk et al., 2003, p.2344) and examples include anger, depression, fear, anxiety and 
guilt (Watson & Clark, 1984).  Negative affectivity increases selective attention to bodily 
sensations (Gendolla, Abele, Andrei, Spur, & Richter, 2005; Watson & Pennebaker, 1989) by 
lowering the detection threshold for physical sensations, making bodily changes more easily 
detectable by consciousness.  Several studies have reported an association between negative 
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affect and increased symptom reporting (e.g. Vassend & Skrondal, 1999; Williams & Wiebe, 
2000).  Furthermore, Kolk et al. (2003) suggests that individuals with high negative affect are 
more likely to have a higher selective attention to the body, therefore proposing that selective 
attention mediates the indirect effect of negative affect on reporting of symptoms.  
Finally, given a limited aptitude for attention, there is on-going competition between 
internal cues of the body and external cues of the environment (competition of cues 
hypothesis; Pennebaker, 1982).  Therefore, the more demands placed on one’s attention by 
their external stimuli, for example in upholding daily life responsibilities of work and family, 
the less one is aware of their bodily sensation, unless the external stimuli becomes a stressor 
and emotionally distressing.  Conversely, when the external environment lacks stimulation, 
attention is directed elsewhere, often internally to heighten attention to bodily sensations.  
Experimental studies investigating the perception and reporting of symptoms post-exercise 
indicated that individuals reported physiological sensations (e.g. heart rate and fatigue) more 
intensely when placed in the low environmental stimuli condition or when conditions were 
manipulated to draw attention to bodily functions of heart rate and breathing (through the use 
of headphones), as opposed to a highly stimulating environmental condition (Pennebaker & 
Lightner, 1980; Fillingim & Fine, 1986).  This competition of cues hypothesis assumes that 
individuals play a passive role in receiving somatic information within their environment.  
Nevertheless, individuals are veritably engaged in active perceptual processes, which require 
the perceptions and appraisal of various somatic information.  Symptoms are appraised by an 
individual once sensations are brought to attention and labelled as physical symptoms.   
Appraisals are developed through cognitive representations of symptoms constructed 
from prior experiences with, or ideas about, illness and disease that form easily accessible 
templates for efficient information processing (i.e. illness schemata; Kolk et al., 2003).  
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Interpretations about a given symptom experience are then made in line with the schema, thus 
guiding our interpretation of symptoms, which may change based on the chosen schema.  
Schemata reduce the amount of information processing required to interpret and create 
meaning from one’s environment, nevertheless they are also subject to distortions and biases 
(e.g. Henderson, Orbell, & Hagger, 2009), and allow for various interpretations and 
attributions to be made during the process of symptom perception.  For example, fatigue and 
body aches could be attributed to somatic illness, as a symptom of the flu, a sign of emotional 
distress (e.g. depression) or as a response to environmental stressors, such that these are 
interpreted as bodily responses to overworking and exhaustion from the work place.  
Therefore, whether or not a symptom is experienced as physical or psychological is 
determined by the attribution given to a particular somatic sensation.  In contrast, Watson and 
Pennebaker (1989) suggest that a mind-body Cartesian dichotomy of symptom perception 
must be abandoned to accept that psychological and physical symptoms are inseparable in the 
experience of psychosomatic distress.  
The symptom-perception model provides a broad approach to conceptualising the 
symptom perception process and provides insights into the effects of perceptual processes on 
the interpretation and appraisal of symptoms, whereby symptom perception is a product of 
somatic cuing, environmental and psychological influences (Gijsbers van Wijk & Kolk, 
1997).  The broad nature of the symptom-perception model allows for its use to be adapted to 
respond to a variety of health threats and has been used to explain the perception of symptoms 
for both common medical symptoms and medically unexplained symptoms (Kolk et al., 2002, 
2003).   
Nevertheless, despite the symptom perception model’s claim to include psychological, 
biological and environmental influences to perception, the model remains almost entirely 
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psychological.  For example, the variable of external information is underdeveloped in the 
model and without description of external influences on a symptom.  Furthermore, the 
symptom perception model contributes very little to the attributional stages of help-seeking 
(e.g. labelling a symptom), but does recognise differences in how individuals come to notice a 
symptom.  However, a strong emphasis in this model is on attention as it describes the early 
processes of the appraisal stage, which we now know is the stage accountable for the greatest 
delay.  While the symptom perception model presents an intrapsychic understanding of 
recognising potential somatic information, it does not adequately place the person in a 
relationship with their social context nor does it describe the influences of previous health 
experiences on the perception of somatic information.  Therefore it is important to build an 
understanding of the psychological, social, environmental and biological factors that all play a 
role in the perception and interpretation of symptoms.  In the following sections we will 
review common theories for understanding the processes that occur between symptom 
perception and seeking medical help and will describe key factors that influence the processes 
discussed. 
Social cognitive theory.  Social cognition theory forms an underlying framework for 
understanding the succeeding decisional processes toward volitional health behaviours, and 
contributes to the understanding of an individual’s response to their physiology, as well as 
describing how cognitive, affective, situational and social factors contribute to health and 
illness behaviours (Bandura, 1998; Gijsbers, van Wijk, & Kolk, 1997).  Furthermore, it 
provides a framework for understanding the processes required for an individual to decide or 
be motivated to seek help and take action. 
This process of decision into action is informed by the concept of self-regulation, a 
key concept of the social cognition theory of health behaviour, it describes the importance of 
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goal setting, and striving to achieve a goal that ensures that one is behaving in accordance 
with one’s values, self-perceptions and personal goals (Fiske & Taylor, 1991; Mischel, 
Cantor, & Feldman, 1996).  This process involves three key cognitive processes of clear goal-
setting, being motivated to achieve this goal as an “active agent” who determines his or her 
own behaviour, and taking volitional action to achieve their goals (de Ridder & de Wit, 2006; 
Gollwitzer, 1993).  This dynamic process acknowledges challenges that one may face in 
achieving a goal, therefore the process allows for continuous evaluation of progress and goal 
re-formulation to achieve and maintain an important health behaviour in a changing 
environment (Abraham, Norman, & Conner, 2000; Gollwitzer, 1993; de Ridder, & de Wit, 
2006). 
Many social cognition models elucidate how health decisions are arrived upon and 
describe the processes that enable decisions to be translated into action.  Some examples of 
continuous (non-stage model) theories and models include: the Health Belief Model 
(Rosenstock, Strecher, & Becker, 1988), Social Cognitive Theory (Bandura, 1986, 1997), the 
Theory of Reasoned Action (Fishbein & Ajzen 1975), Theory of Planned Behaviour (Ajzen & 
Fishbein, 1980; Ajzen, 1991), Leventhal’s model of Self-Regulation (Leventhal, Meyer, & 
Nerenz, 1980; Leventhal, Nerenz, & Steel, 1984), Protection Motivation (Rogers, 1983), 
Health Action Process Approach (Schwarzer, 2008) and Implementation Intentions 
(Gollwitzer, 1999).  These models are considered social cognition models, given that they 
describe cognitive and affective (i.e. beliefs and attitudes) factors as primary determinants of 
health behaviour and acknowledge secondary factors of social, structural, cultural and 
personality as either primarily or completely mediated by these manipulatable cognitive and 
affective factors (Sutton, 2004).  The health belief model, theory of reasoned action and social 
cognitive theory have all been successfully implemented into interventions, however, the 
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predictive power of these models have not yet been validated (Glanz & Bishop, 2010; Ogden, 
2003).  
Social cognitive models differ by the factors described, and their assumptions, or 
focus on behavioural processes (i.e. appraisal, decision, behavioural stages).  Nevertheless, 
they share the same basic assumptions as the social cognitive theory and, despite the lack of 
consensus of terminology within the theories; they are more alike than dissimilar (Sutton, 
2004).  Scientific testing of social cognitive theories has been met with difficulty given the 
challenge in comparing benefits of using one theory over another (Noar & Mehrotra, 2011) 
and due to similar factors being labelled differently and presented as distinctly separate 
concepts (Sutton, 2004).  
Given the myriad of social cognition models available in the literature, two of the most 
influential models will be discussed here, with a focus on Leventhal’s Self-Regulation Model 
(SRM; Leventhal, Benyamini, Brownlee, Diefenbach, Leventhal, Partrick-Miller, & 
Robitaille, 1997; Leventhal, Brissette, & Leventhal, 2003).  The two most common help-
seeking theories include the SRM, which identifies a help-related behaviour as a response to a 
health-threat (i.e. a perceived symptom), and the Theory of Planned Behaviour (Ajzen, 1991; 
Ajzen & Fishbein, 1980) which predicts behaviour by proposing the cognitive factors of 
intention to perform a behaviour, either increasing or decreasing the likelihood of performing 
a behaviour (de Nooijer, 2002a).  In both models, the help-seeking process begins with the 
perception of a health threat (i.e. symptom).  
The theory of planned behaviour (Ajzen & Fishbein, 1980) was derived from the 
theory of reasoned action (Fishbein & Ajzen 1975), proposing that a person’s intention to 
perform any behaviour can be predicted by three main factors (i.e. individual attitudes toward 
a behaviour), subjective norms (i.e. whether or not others believe the behaviour should be 
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performed), and perceived control in one’s ability to perform a behaviour (Ajzen, 1991; Ajzen 
& Fishbein, 1980).  The theory further claims that behavioural intention is the strongest 
predictor of behaviour (de Nooijer et al., 2002a).  In contrast to the self-regulation theory, the 
theory of planned behaviour focuses on the behaviour (i.e. procedural response) as opposed to 
the initial health-threat and posits specific factors that determine a given behaviour.  The 
theory of planned behaviour asserts that the likelihood of engaging in a particular behaviour is 
determined by evaluating the behaviour (i.e. is this something I want to do?), and the assumed 
barriers to performing the behaviour (i.e. am I able to do this?).  The appraisal forms the 
outcome of this evaluation, which includes the subjective norms about the behaviour, 
effectiveness and expected consequences. 
In research, interventions attempt to change an individual’s intention to seek medical 
help by focusing on individual psychosocial factors.  Perceived behavioural control has been 
associated with Bandura’s (1997) social cognitive theory construct of self-efficacy, in that an 
individual’s belief in their ability to perform a behaviour, and their perceived behavioural 
control predict the behavioural outcome (Ajzen, 1991).  This model has applications in cancer 
prevention by incorporating concepts of anticipated regret and moral obligation, which are 
also involved in help-seeking intentions and behaviour (O’Mahony & Hegarty, 2009).  
Authors of the de Nooijer et al. (2003) study reported that providing knowledge of cancer 
symptoms, discussing potential barriers, and emphasising the moral obligation to seek help 
may incite intentions to seek help and avoid feelings of regret which are associated with help 
avoidance behaviour.  These additional social cognitive components may affect an 
individual’s decision to seek medical help rather than seeking the help of a friend (i.e. lay 
adviser), which may also suggest public attitudes about healthcare services and illness beliefs 
in general (Burgess, Bish, Hunter, Salkovskis, Michell, Whelehan & Ramirez, 2008; 
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Rosenstock, 1965).  The process of identifying and labelling an individual’s symptom(s) is 
not addressed within the theory of planned behaviour, which is reported by Hunter, Grunfeld, 
& Ramirez (2003) as the strongest predictor of behaviour.  Furthermore, the emphasis on 
intention as the primary predictor of behaviour is not consistently supported in reality, given 
that rational decision-making is not always the method used when responding to a symptom 
or illness (Coiffi, 1991).  Sheeran (2002) identified this concept as the intention behaviour 
gap in a meta-analysis investigating the relationship between intentions and behaviour within 
this model.  Findings suggested only 28% of the variance in behaviour was explained by 
intentions, identifying a key issue in the use of this model.  This concept is now commonly 
termed the intention-behaviour gap, and is one of the most significant problems of this model.  
The theory of planned behaviour provides a general understanding of factors that 
influence help-seeking (individual attitudes toward a behaviour, subjective norms and 
perceived behavioural control), nevertheless this theory is by no means complete and should 
include the influence of cognitive-perceptual factors in predicting help-seeking behaviour 
(Coiffi, 1991).  Gollwitzer (1999) suggested the implementation of a self-regulatory concept 
of goal setting (i.e. implementation intentions) to bridge the intention-behaviour gap. De 
Ridder and de Wit (2006) posit that the self-regulation model is the most complete and 
appropriate solution to the gap, given that it acknowledges the inconsistencies between an 
individual’s identified health goals and their failure to strive toward such goals (Baumeister & 
Heatherton, 1996).  Health behaviour research can benefit from a self-regulation approach, of 
which the primary task is to engage in a dynamic process of long-term goal striving, while 
working to control one’s immediate needs to meet the set goal (Mischel, Cantor, & Feldman, 
1996; de Ridder & de Wit, 2006).  Furthermore, the SRM accounts for the perception and 
appraisal of symptoms from the moment they are experienced.  
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Leventhal’s self-regulation model. The Self-Regulation Model of Illness Cognition 
and Behaviour (SRM), also known as the Common Sense Model of Self Regulation, is one of 
the most widely used models of illness perception and behaviour (Leventhal et al., 1997; 
Leventhal, Brissette, & Leventhal, 2003).  The SRM was a result of Leventhal’s prior work 
on the impact of fear messages in health communications on positive health behaviour (e.g. 
wearing seatbelts; Leventhal, 1970).  The SRM works as a dynamic volitional process in 
accordance with the self-regulation theory discussed in the previous section.  It follows an 
adaptive system whereby psychological and behavioural responses to a faced health threat 
(i.e. coping responses) are guided by one’s cognitive representation of danger (i.e. illness 
representations) and emotional representations of danger (which function independently in 
parallel process; Nerenz & Leventhal, 1983).  See Figure 2.3 for a diagram presentation of the 
model.  Illness representations are a key construct of the SRM that builds an understanding of 
the cognitions associated with the recognition of a health threat (Wearden & Bundy, 2010; 
Cameron & Moss-Morris, 2010; Leventhal, Brissette, & Leventhal, 2003).  An individual’s 
illness representations guide action planning, and both are necessary to produce a behavioural 
outcome.  Therefore, it is a parallel cognitive-processing model of how people cope and 
actively regulate the response to illness danger (i.e. identifying the health threat and asking, 
‘what can I do about this?’).  It further regulates a response of emotional control (i.e. 
acknowledging how they feel and asking, ‘what can I do to make myself feel better about 
this?’).  Coping responses are further guided by appraisal heuristics, which assume rules 
about the way in which symptoms are interpreted, thereby affecting decisions regarding the 
perceived need to seek medical care (Hale, Therharne, & Kitas, 2007; Scott et al., 2013).  
Heuristics form the development of an individual’s representations of illness (Scott et al., 
2013).   
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Figure 2.3. The Self- regulation Model. Adapted from Leventhal, Brissette & Leventhal 
(2003, p.46 & p.50). 
The five illness representations integrate within an individual’s existing schemata (i.e. 
normative beliefs and understandings), enabling one to make sense of their somatic and 
biological symptoms, thus guiding behaviour (i.e. coping responses; Cameron & Moss-
Morris, 2010; Hale, Treharne, & Kitas, 2007).  Illness beliefs include: (a) Identity: Illness 
label or diagnosis that is associated with beliefs about a presenting symptom (e.g. stress, 
cancer or the flu); (b) Cause: Cause(s) of illness that are developed to make sense of a 
symptom and includes beliefs of controllability (e.g. hereditary factors, stress, diet, exercise); 
(c) Timeline: Expected duration of illness identified in time models of acute, cyclic or chronic 
and is shaped by experience and knowledge of an illness; (d) Consequences: The impact of an 
illness on physiological, psychological, social and economic aspects of daily life; (e) 
Control/Cure: The ability to self-manage an illness and the belief that the illness is curable or 
incurable through treatment.  Evidence suggests that inaccurate labelling of symptoms (i.e. 
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identity representations) can lead to increased delay in seeking medical care (Cameron, 
Leventhal, & Leventhal, 1993; Dracup, Moser, Eisenberg, Meischke, Alonzo, & Braslow, 
1995; Scott, 2010).  A study by Sissons Joshi (1995) showed how causal representations of 
illness shape illness beliefs by reporting that 33% of individuals who were diagnosed with 
diabetes believed that understanding the causes of their illness was unhelpful.  This suggests 
individuals may have believed that their illness was due to uncontrollable causes (e.g. 
hereditary).  The SRM is an exceptionally appropriate model to apply across cultures, given 
that illness beliefs are experienced globally and can be assessed by the Illness Perceptions 
Questionnaire (IPQ & IPQ-R; Moss-Morris, Weinman, Horne, Cameron, & Buick, 2002).  
However, due to the experiential and contextual nature of illness beliefs, cognitions and 
behaviours are primarily defined by an individual’s social world and culture, thus the specific 
health-beliefs may differ across cultures (Baumann, 2003; Adams & Salter, 2007).  
Leventhal’s SRM framework describes the behavioural, cognitive and emotional responses 
(e.g. fear or anxiety) that are generated in this parallel process to regulate an experienced 
threat of illness and consequently influence an individual’s health behaviour, and allows one 
to understand the many different ways in which individuals seek help when they are not 
seeking help from HCPs (e.g. self-medicating with over-the-counter pain relievers, diet 
change, consulting a friend or family member). 
The SRM has been employed to identify barriers to help-seeking for cancer (e.g. 
Hubbard et al., 2014; Scott, McGurk, & Grunfeld, 2007) and to identify the psychological 
processes and heuristics involved in choosing to seek medical help for cancer symptoms 
(Facione, 2002). The SRM provides an effective theoretical framework from which to build 
an understanding of the various illness-related beliefs that affect help-seeking behaviour.  
Furthermore, this model provides room to consider the differences in illness experience 
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amongst diverse cultures of the world (Cameron & Morris, 2010).  Unlike the previously 
discussed stage models this model provides a dynamic framework for understanding help-
seeking that allows for continuous re-appraisal of new and existing information and changes 
to be made to coping responses.  Therefore, the SRM adds considerably to the Symptom 
Perception Model (Gijsbers van Wijk & Kolk, 1997; Kolk et al., 2003) by following the 
process through to the appraisal of symptom(s), making the decision to seek help, and taking 
action toward medical help seeking.  
This Chapter presented sections according to Andersen’s road map and has discussed 
the symptom perception and appraisal stages through discussion of key help-seeking theories 
(Figure 2.4).  The following sections will present additional psychological factors that 
influence each stage of the help-seeking process, beginning with the stages discussed, and 
will then continue to discuss the following processes according to the roadmap (i.e. making 
the decision to seek help, acting on the decision to seek help, and attending the first 
appointment with a HCP).  
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Figure 2.4. Andersen’s roadmap discussed thus far. Adapted from The General Model of 
Total Patient Delay proposed by Andersen, Cacioppo, and Roberts (1995). 
Symptom perception and appraisal. Andersen, Cacioppo and Roberts (1995) 
posited key psychological principles of symptom perception and appraisal (Andersen, 
Cacioppo, & Roberts, 1995; Cacioppo et al., 1986), suggesting that all individuals are 
motivated to understand the symptoms they experience, and that one’s knowledge of 
symptoms and/or illness influences the experience of a particular symptom (see Cacioppo, 
Andersen, Turnquist, & Tassinary, 1989).  Therefore, one’s knowledge (i.e. illness schemata) 
is used to determine which symptoms are associated with illnesses.  Individuals are often 
inclined to attach a non-threatening explanation to a symptom experienced (known as the 
concept of optimistic bias).  Optimistic bias acts to prevent chronic negative worry, creating a 
lack of concern that can increase delayed presentation to healthcare.  The final principle posits 
that symptoms have consequences that affect health and salience of symptoms.  These 
principles work together to influence the psychophysiological comparison process that 
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supports a generally positive view of a person’s physiological condition (Andersen, Cacioppo, 
& Roberts, 1995)  
Cacioppo and colleagues (1986) further acknowledge that when bodily changes do not 
exceed a threshold of interference (i.e. are not salient), they are normalised and dismissed, 
thus saving cognitive energy by not appraising every bodily change as it occurs.  This enables 
bodily functioning to continue undisturbed (Bradley, Calvert, Pitts, & Redman, 2001).  
Unforeseen bodily changes, or those that exceed the threshold of interference, are experienced 
as abnormal and are therefore labelled as symptoms.  Alonzo (1979, 1984) refers to this when 
describing a similar concept, whereby individuals strive for social equilibrium through a 
containment of daily health issues, which are directed by social and life expectations and 
responsibilities.  Alonzo (1979) posits that bodily sensations and illness do not emerge in 
isolation, but rather are embedded in an individual’s daily social context.  The containment 
concept describes a relationship with one’s social world, whereby it is not until signs and 
symptoms cause disequilibrium within this framework that an individual may be motivated to 
seek help (Alonzo, 1984). 
The perception of symptoms involves constant monitoring of bodily sensations, which 
functions in a feedback loop enabling the development of an overall picture of one’s health 
and illness.  Once symptoms are perceived, memories are recalled through an active memory 
search to enable comparison between the experiencing symptom and an individual’s illness 
schemata (Leventhal et al., 1997).  This provides meaning (i.e. appraisal) to a symptom 
through activation of illness schemata (Cacioppo et al., 1986).  Illness schemata are employed 
to set a plan for the implementation of coping strategies (e.g. symptom monitoring, self-
medicating or medical help-seeking; Leventhal, Brissette & Leventhal, 2003).  The impact of 
this comparison discrepancy, between the actual experience of the symptom and the prior 
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symptom expectation, is portrayed through the example of individuals experiencing 
myocardial infarction (i.e. heart attack; Perry, Petrie, Ellis, Horne, & Moss-Morris, 2001).  In 
this study, patients held expectations that they would experience sudden symptoms of 
collapse, dizziness, irregular heartbeat, and loss of consciousness, which did not match with 
their actual experience of symptoms.  The study’s findings suggest that both symptom 
perception and appraisal of symptoms are influenced by contextual and situational cues.  An 
example of this can be seen in cases of medical students’ disease, which describes the 
likelihood for medical students to perceive themselves as experiencing symptoms that are 
under their current study.  This is due to the development of new knowledge, creating a new 
illness schema that instils fear, thereby heightening one’s sensitivity to bodily changes (i.e. 
selective attention).  
As specified in the previous sections, the help-seeking processes are influenced by 
non-physiological factors, such as environmental cuing, attitudes, beliefs and one’s 
sociocultural context.  The literature highlights various different factors that influence these 
processes.  Key factors discussed in the following sections include: (a) Sociocultural and 
demographic factors (Bener, Honein, Carter, Da’ar, Miller, & Dunn, 2002; Calnan, 1983; 
Rosenstock, 1965), (b) previous health-seeking habits (e.g. attitudes toward medical help-
seeking, present chronic diseases, comorbidities and past prevention behaviours; O’Mahony 
& Hegarty, 2009; Quine & Rubin, 1997), (c) emotional disposition (e.g. anxiety, negative 
affect, depression; Banks, Beresford, Morrell, Waller, & Watkins, 1975; Barsky, Goodson, 
Lane, & Cleary, 1988; Kolk et al., 2003; Robbins & Kirmayer, 1991; Watson & Pennebaker, 
1989), (d) illness knowledge and beliefs (e.g. illness schema, illness representations, 
comparison of symptom expectations and experience, and disease vulnerability/risk; Bish, 
Ramirez, Burgess, & Hunter, 2005; Cacioppo et al., 1986; de Nooijer et al., 2001, 2002a, 
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2002b; Leventhal, Brissette & Leventhal, 2003; Perry, et al., 2001; Sheikh & Ogden, 1998), 
(e) fear (de Nooijer et al., 2001; Leventhal, Brissette, & Leventhal, 2003; Macleod et al., 
2009; Safer et al., 1979; Sheikh & Ogden, 1998), (f) beliefs about medical services (Cornally 
& McCarthy, 2011; de Nooijer et al., 2001; Sheikh & Ogden, 1998), and (g) social influences 
(e.g. social support and social capital; Nosarti, Crayford, Roberts, Elias, McKenzie, & David, 
2000; O’Mahony, 2001; Rosenstock, 1965; Song & Chang, 2012). 
Factors influencing the processes of perception to appraisal.  Of the factors listed 
above, four key factors are presented here with empirical evidence demonstrating their 
influence on symptom perception and appraisal.  St. Claire (2003) describes the difficulty in 
trying to identify objective bodily signs as separate from subjective symptoms, which 
veritably work together to influence the interpretation and appraisal of symptoms.  Help-
seeking behaviour is an outcome of the constant interchange that occurs between an 
individual’s characteristics (i.e. past experiences, life expectations) and sociocultural 
contextual factors (i.e. social and cultural understandings and expectations), which therefore 
influence symptom perception, interpretation, decision-making and medical help-seeking 
behaviour (Andersen, Paarup, Vedsted, Bro, & Soendergaard, 2010; Saint Arnault, 2009; 
Unger-Saldana & Infante-Castaneda, 2011).  St. Claire (2003) posits that the way one 
perceives their bodily sensations is embedded in dominant lay cultural assumptions that build 
knowledge of how a body should function, and how it is experienced within a particular 
culture.  This is further supported by sociocultural help-seeking literature (e.g. Alonzo, 1979; 
Hay, 2008; Zola, 1973).  An example of this is demonstrated by empirical studies suggesting 
a relationship between an individual’s sociocultural context and their experience of pain 
(Bates, 1987; Callister, 2003; Rollman, 1998).  Johnson-Umezulike (1999) suggested a 
correlation between the intensity of pain experienced and ethnicity in a study of elderly 
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African American and Caucasian participants.  The findings showed that African Americans 
reported a higher pain response than Caucasian participants (Johnson-Umezulike, 1999).  A 
study by Nayak, Shiflett, Eshun and Levine (2000) found a difference in pain tolerance 
amongst Indian participants residing in the United States and those in East India, wherein the 
East Indian residents had a higher tolerance to the pain stimulus (i.e. placing one’s hand in a 
bucket of 0-2 degree Celsius water).  However, cultural research often fails to distinguish the 
difference between race, culture and religion, thereby producing results that are biased to a 
particular population only and may not be generalisable across wider cultural contexts.  
Previous health-seeking habits, particularly in individuals with pre-existing 
comorbidities, may bias both attention to bodily sensations and the appraisal of symptoms 
(Barsky, Ahern, Bailey, Saintfort, Lui, & Peekna, 2001), suggesting situational and 
environmental influences on the experience of symptoms.  
 Emotional disposition is one of the most influential factors of symptom perception 
and was tested by Pennebaker and Brittingham (1982) in a study which placed young, healthy 
volunteers into experimental conditions that manipulated physiological and emotional states.  
Findings showed that participants whose emotional states were manipulated reported 
inaccurate information relating to their perception of their own heart rate and fatigue.  
Findings are consistent with investigations that link anxiety and negative affect with a 
heightened attentional focus to bodily sensations (Watson & Pennebaker, 1989), negative 
appraisal of symptoms (Sensky, Macleod, & Rigby, 1996) and increased symptom reporting 
(Watson & Pennebaker, 1989).  Beecher’s (1956) naturalistic observational study investigated 
the relationship between pain perception and emotional states by studying a sample of 
soldiers and civilians.  Findings suggested that soldiers who sustained severe wounds (i.e. 
with predictable high levels of pain) requested pain relief (i.e. morphine) 33% of the time, in 
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comparison to civilians with minor wounds (i.e. moderate levels of pain) who requested pain 
relief 80% of the time.  The offered explanation for this difference was explained by the 
meanings attached to the individuals’ injuries, such that civilians perceived their wounds to 
represent a negative, detrimental, event in their life, and soldiers perceived this as a ‘ticket to 
safety’, which removed them from the negative and highly stressful experience of war.  Key 
findings of this study indicated that an individual’s social context and associated emotions 
moderate the experience of pain, and that pain is not always indicative of symptom severity.  
The latter finding is supported in the case of experiencing cancer symptoms, wherein early 
signs of illness does not indicate severity sufficient to warrant the decision to seek medical 
attention (i.e. often lacking symptom salience and pain), which may account for the increased 
delay in the appraisal stage for individual’s experiencing symptoms of cancer (Melzack & 
Wall, 1988).  
Factors influencing processes of symptom appraisal to the decision to seek help.  
The accurate perception of symptoms is crucial to facilitate the subsequent appraisal 
processes and guide the decision and action toward help-seeking (St. Claire, 2003).  One’s 
illness knowledge and beliefs (i.e. illness schemata) play a key role in facilitating the 
interpretation of symptoms and the decisions to seek help.  As described earlier, help-seeking 
is only one possible response to the experience of symptoms.  For example, an individual may 
decide to self-manage by self-medicating, monitoring symptoms, initiating life-style changes, 
and seeking lay advice.  Individuals whose symptoms are severe enough to merit medical 
help-seeking often do not present to medical care (Last, 1963) and symptoms of cancer 
represent the greatest delay in the appraisal processes.  In the Andersen et al. (1995) study of 
appraisal delay, focus was directed specifically on the distinct symptoms of gynaecological 
cancer (e.g. bleeding, pain, open sores and lumps), and although symptoms were clearly 
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salient and painful they were not appraised with sufficient severity to seek medical help in 
60% of the women sampled.  This is likely due to incorrect symptom labelling (i.e. identity), 
which is driven by one’s illness-schema.  
Symptom perception (i.e. detection) and appraisal processes are therefore suggested to 
be subject to many influences, biases and distortions that employ the use of schemata to 
selectively search out evidence to confirm the label chosen (Pennebaker & Skelton, 1981).  
The initial label is likely to be confirmed as a result of this biased perception of symptoms.  
For example: If after many weeks of working long hours at a job an individual begins to feel 
body aches, this may prompt a search for confirming evidence (e.g. fatigue and tiredness 
behind the eyes).  The body aches may otherwise be interpreted into a new symptom set and 
labelled as such (e.g. flu) and will then be accompanied by additional symptoms (e.g. sore, 
throat, sweats and headache) that act as confirmatory evidence for this label.  Anderson and 
Pennebaker (1980) presented evidence for this process by placing individuals into different 
experimental conditions, subjecting each group to identical sensory inputs (i.e. vibrating 
Emory board placed on the middle finger).  Each participant was primed to receive different 
expectations about the sensation prior to the stimulus input (i.e. painful or pleasurable and no 
description was given to the control group).  Results showed that participants rated the 
sensation in accordance with the given expectation, therefore those in the pain group 
experienced the sensation as painful, the pleasure group experienced pleasure and the control 
group experienced a neutral sensation respectively.  Findings suggested that subtle 
manipulations of expectations (i.e. schemata) influence the quality of an experienced bodily 
sensation and subsequent appraisal, highlighting the subjective experience of symptom 
perception. 
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Illness schemata further influences the perception of symptoms and their subsequent 
appraisal, however illness schemata includes more than just symptoms and labels and as such 
is described through illness representations.  Therefore, for every experience of illness, an 
individual develops a cognitive schema that enables them to understand and label their 
symptoms (identity), generate expectations for the duration of the illness (timeline), the 
cause(s), the severity of illness (consequences) and the effectiveness of treatment options 
(controllability).  Other schema-guided influences include the schema of population 
prevalence, which suggests that the more rare the symptom, the more severe the disease and 
the schema of the sufferer, which reduces the likelihood that symptoms will be appraised to a 
particular illness if the knowledge of symptoms for that illness do not match their experience 
(Croyle & Jemmott, 1991; Salovey, Rothman, & Rodin, 1998).  
Emotional factors also play a role in influencing appraisal, given that the experience of 
known serious symptoms (e.g. breast lump) may cause initial distress sufficient to motivate 
help-seeking.  Alternatively, an emotionally driven appraisal may form a barrier to help-
seeking, whereby the anticipation of the negative consequences cause fear in accordance with 
one’s illness schema.  An example of this is described in the Sherwin (1996) study, which 
showed that fear was most present in help-seeking for breast cancer symptoms when 
individuals had known someone close to them with the disease.  Individuals are intrinsically 
driven to avoid negative emotion and to understand their experience of symptoms (Andersen, 
Cacioppo, & Roberts, 1995).  Emotional avoidance can therefore greatly affect the appraisal 
of symptoms, resulting in a mislabelling of symptoms that is driven by emotion rather than 
rational thinking (Andersen et al., 1995; St. Claire, 2003).  
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The model of pathways to treatment.  The Model of Pathways to Treatment (Scott et 
al., 2013; Walter, Webster, Scott, & Emery, 2012) integrates current help-seeking theory and 
key factors that influence the overall process, thereby creating a model that acts within stages 
while allowing room for dynamic parallel processing (Walter et al., 2012; Figure 2.5).  This 
model was developed to provide a more detailed description of the events and processes that 
take place between the detection of a bodily change(s) and the start of treatment.  For the 
purpose of this PhD, this model provides a way of thinking about the processes involved after 
an individual detects a somatic change to their attendance at their initial appointment with a 
HCP.  Given this, the model will only be discussed in this capacity and stages or processes 
following attendance to the HCP (e.g. diagnosis, start of treatment) will not be discussed in 
detail in this chapter. 
The model was developed in response to a critique of Andersen’s stage model (Walter 
et al., 2012) and incorporates theories of Symptom Perception (Pennebaker, 1983; Gijsbers 
van Wijk & Kolk, 1997), Social Cognition Theory (Bandura, 1997) and the SRM (Leventhal, 
Brissette, & Leventhal, 2003).  As such it is a dynamic, cyclical model of pathways allowing 
for multidirectional movement through the many potential pathways to treatment, and focuses 
on both the motivators in the process of seeking help as well as the barriers (Scott et al., 
2013).  The model does not establish distinct starting points in the process, which allows a 
combination of events to be experienced with one symptom, and the flexibility of the model 
acknowledges that not all events must be experienced to progress through the process toward 
treatment (Scott et al., 2013).  For example, women who are asymptomatic may detect a 
symptom as a result of regular screening, where an abnormality was found as a result of a 
national screening programme. In this context, the woman does not seek help for the 
symptom.  Furthermore, after an individual chooses to seek help for a symptom the HCP may 
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deliver falsely reassuring test results or advise the patient to monitor symptoms and return 
again when intermittent symptoms return or worsen.  This is represented in the model by the 
dashed lines, process arrows and linked processes (Scott et al., 2013).  The model presents 
events, processes and time intervals, as well as incorporating key factors that shorten or 
extend the time of each interval.  
  
 
      
Figure 2.5. The model of pathways to treatment.  Adapted from Walter et al. (2012) to 
include processes to first consultation with a HCP only. 
The model of pathways to treatment denotes five events that act as key time points 
experienced by an individual along their pathway to treatment.  As described earlier, the 
detection of bodily change(s) is often known only to the experiencer, and is subject to bias 
and changes in one’s environment.  Thus, they may not be indicative of illness.  The event, 
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perceives reason to discuss the symptom with HCP (‘perceives reason to seek medical help’ in 
Figure 2.5.), describes the time point at which an individual perceives that their bodily 
change(s) are abnormal and this may provide reason for an individual to seek medical help.  
Due to the subjective nature of symptom experience the motivating factor for help-seeking is 
not a need, but rather a perceived reason to seek help (Bradshaw, 1972).  The reasons given 
for consulting medical care have crossovers with the SRM and include cognitive reasons (i.e. 
illness representations), consequences (e.g. disruption of daily life caused by symptoms), a 
perceived inability to cope with symptoms (e.g. failed attempts at self-management) and 
emotional states (e.g. anxiety, concern or need for reassurance; Scott et al., 2013).  Unlike the 
Andersen’s stage model, this model does not assume nor require an attribution of illness for 
medical help-seeking to take place, given that some symptoms may be detected at regular 
appointments for screening or comorbidity management (Scott et al., 2013).  The combination 
of the appraisal and illness time intervals provides room for alternate pathways to be 
undertaken.  HCPs define a patient’s initial experience of discussing symptoms.  If the first 
consultation is not with a HCP this interaction is considered self-management behaviour and 
not medical help-seeking.  
The events of diagnosis and start of treatment define the timing of formal medical 
diagnosis and treatment or palliative management of symptoms.  These two events indicate 
the completion of the diagnostic journey, the end of the time to presentation interval and the 
start of the time to diagnosis interval (Scott et al., 2013).  Although the focus of this chapter is 
pre-diagnosis, it should be acknowledged that for many individuals the start of treatment may 
lead to further symptom appraisal and help-seeking due to side effects and new development 
that could lead to additional medical consultations or may resolve before the start of treatment 
(pre-treatment interval; Scott et al., 2013).  Furthermore, additional events are acknowledged 
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and may occur along the pathway, including booking and attending an appointment with 
primary care, receiving a referral to specialist care, visiting specialist care, negotiation of 
treatment plan, and completion of treatment (Bairati, Fillon, Meyer, Her, & Larochelle, 2006; 
Dang-Tan et al., 2008; Davies, van der Molen, & Cranston, 2007; Evans et al., 2007). 
Intervals are defined as time periods between events and include appraisal (i.e. 
between detection to perceiving a reason to discuss symptoms with a HCP) help-seeking (i.e. 
between perceiving a reason to discuss with a HCP to first consultation), diagnostic (i.e. 
between first appointment with a HCP and receipt of formal diagnosis) and pre-treatment (i.e. 
between formal diagnosis and start of treatment).  The intervals allow for variations within 
each of the processes. 
“Processes are defined as the cognitive, emotional, behavioural, organizational or 
structural actions that occur within intervals, the outcome of which may lead to the next 
event” (Scott et al., 2013, p. 51).  Processes within the appraisal interval determine responses 
to bodily change(s) and include the initiation of non-help-seeking behaviours (i.e. self-
management).  The processes within the help-seeking interval combine the behavioural and 
scheduling delays discussed in Andersen’s model to describe processes that lead to the 
decision to seek help and the process of planning and arranging appointments.  Processes 
within the diagnostic interval include referrals, several appointments, additional tests or 
investigations, and for some cancers may involve complex processes of secondary care and 
defined diagnostic pathways (Walter et al., 2012).  If a patient is asked to re-attend when 
symptoms persist or worsen, the patient will return to the appraisal interval within the model 
(Evans, Zeibland &McPherson, 2007).  
Contributing factors are identified as key factors that influence these processes, timing 
of events and interval durations.  Factors include patient (i.e. individual, sociocultural or 
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contextual factors), HCP and healthcare system (i.e. aspects of health care services that can 
impact patient and professional decisions and behaviour), and diseases (i.e. clinical and 
physiological aspects of a condition) factors.  
This integrated model of help-seeking is generalisable across symptoms and cancer 
sites, and there is evidence for its usefulness in the investigation of both short and long 
appraisal intervals (Walter et al., 2012) with acute and chronic symptoms.  This model can 
also be altered to include disease specific symptoms, diagnostic pathways and alternative 
pathways to care that could include seeking help from an emergency department, sexual 
health walk-in clinic, GP service, regular preventative screening appointment, and attendance 
at regular appointments for comorbidities.  The key strength of this model is its distinct 
intervals with clearly defined start and end points that enable application of this model across 
research and clinical settings and addresses conceptual criticisms of existing medical help-
seeking models (Scott & Walter, 2010). 
Making the Decision to Seek Help and Taking Action or Delaying 
In previous sections theories for help-seeking were discussed along with detailed 
descriptions of the processes involved. Factors were presented which influence movement 
from symptom perception to appraisal.  The following sections will discuss the factors which 
influence how one moves from appraisal to making the decision to seek help, and 
subsequently taking action toward or away from medical help-seeking.  
Often an individual’s experiences with healthcare can influence help-seeking 
behaviour, as was shown in Koldjeski et al.’s (2005) study, where individuals who 
experienced ovarian cancer symptoms were misdiagnosed as having benign illnesses on their 
first contact with healthcare services (i.e. by GPs).  It was suggested that this misdiagnosis 
might have made patients less likely to return, for those who may have believed that returning 
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would waste their time as well as the time of the HCP’s (Robb et al., 2009; Smith, Pope, & 
Botha, 2005).  Furthermore, negative attitudes toward consulting a HCP may facilitate delay 
more than painful or salient symptoms facilitate help-seeking.  This is due in part to beliefs 
about medical services, suggesting that the behaviour of help-seeking will not be effective or 
that experience of consulting a HCP will be a negative experience (see Chapter 4).  Scambler 
and Scambler (1985) reported that 33% of women consulting a HCP for distressing menstrual 
symptoms did not believe that treatment would be effective in relieving their symptoms.  
Additionally, Safer et al. (1979) presented evidence that beliefs about the consequences of 
illness impacted the help-seeking behaviour, reporting that patients who had imagined 
negative consequences as a result of their illness, such as imagining themselves on the 
operating table, took twice as long to seek medical help than individuals who did not have a 
negative view of the consequences.  Findings suggest that for some individuals the decision to 
seek medical help may take longer to arrive upon, particularly for those experiencing more 
serious illness, which may be associated with negative treatment consequences (e.g. cancer 
treatment).  
Many patients choose to engage in self-management rather than seeking medical help 
(Whitaker, Macleod, Winstanley, Scott, & Wardle, 2015).  There is evidence to suggest that 
self-management often plays a key role in increasing time to help-seeking.  For example, a 
study conducted by Mesfin, Newell ,Walley, Gessessew and Madeley (2009) found that 
patients who self-managed (i.e. seeking alternative medicine and religious forms of treatment) 
delayed seeking medical care for more days (31 days) than those who did not (15 days).  
Furthermore, individuals may choose to self-manage, given that this may pose less of an 
interference with their daily life responsibilities, consequently delaying presentation to 
healthcare services.  
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As was described above, individuals employ a myriad of coping strategies, which may 
not include medical help-seeking.  The Protection Motivation Theory (Rogers, 1983) outlines 
a process for the implementation of coping strategies and responses, as well as the 
management of a perceived discrepancy between the situational demands and one’s ability to 
meet the demands.  The theory outlines processes of appraisal (threat and coping appraisal), 
which result in the intention to perform adaptive (protective motivation) coping responses to a 
health threat or maladaptive responses that place the individual at risk to their health (e. g. 
avoidance and denial; Boer & Seydel, 1995).  Four factors are proposed which determine an 
individual’s response behaviour and include: (a) the severity of the threat (e.g. myocardial 
infarction or death), (b) vulnerability to the threat (e.g. individuals likelihood of experiencing 
the health threat; Boer & Seydel, 1995), (c) efficacy of the recommended behaviour on 
reducing the threat (e.g. treatment effectiveness), and (d) an individual’s ability to perform the 
behaviour (i.e. response efficacy and self-efficacy).  In a review by Milne, Sheeran & Orbell 
(2000), authors reported that the protection motivation theory has been used to understand and 
predict behaviour associated with early detection and threat prevention behaviours (e.g. breast 
self-examination; Maddux, 1993).  
As discussed in the SRM, emotions such as fear can motivate or hinder behavioural 
responses to a threat (de Nooijer et al., 2001; Macleod et al., 2009; Smith, Pope, & Botha, 
2005).  Fear is described as an intervening variable that impacts perceptions of severity and 
vulnerability to a threat appraisal (Boer & Seydel, 1995; Stainback & Rogers, 1983) and the 
decision to seek help is two-fold, given that individuals experiencing a fear response to a 
health threat may be motivated to seek medical help to reduce their negative emotional 
response or may choose to avoid the emotion by choosing not to seek help and appraising the 
symptom as benign, as described by the theory of planned behaviour (Ajzen & Fishbein, 
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1980; Ajzen, 1991).  
Action Toward Help-seeking Behaviour  
Having reached the decision to seek help one might assume that making an 
appointment and subsequently attending this appointment might follow automatically, 
especially in a country such as the UK that offers free national healthcare.  However, this is 
not the case as we know from the evidence presented in the first section, with nearly 12% of 
individuals failing to present to their GPs with significant symptoms that merited medical care 
(Hardey, 1998).  It is reasonable to assume that an even greater proportion of patients fail to 
convert their decision to seek help into action by contacting medical services to book an 
appointment.  It has been suggested that the “gatekeeping” system of UK healthcare (as 
described in Chapter 1) may be a structural barrier partially responsible for limiting the help-
seeking behaviours of its citizens (see Vedsted & Olesen, 2011; Andersen et al., 2011).  
However, when we focus on the psychological aspects of help-seeking we become aware of a 
gap between an individual’s intention to seek help and their behaviour.  An Orbell and 
Sheeran (1998) study supported this criticism by reporting that 57% of women, who stated 
intention to attend cervical screenings a year later, did not re-attend for their scheduled 
screenings.  Further meta-analyses suggest that one’s intention only predicts 20-30% of 
intended behaviour.   
Sociodemographic factors are reported in the literature to impact help-seeking 
behaviour with individuals of a low socioeconomic background being less likely to utilise 
healthcare services due to an inability to access care (e.g. lack of public transport or 
affordable parking; Low, Waller, Menon, Jones, Reid, & Simon, 2013a; St. Claire & Turner, 
1998).  Alternatively one’s environment, in particular their social environment, can act as a 
motivating factor for help-seeking, suggesting that and support networks can encourage 
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medical help-seeking behaviour (Calnan, 1983; Chatwin & Sanders, 2013; Mwaka, Okello, 
Walinga, & Walter, 2015).  However, some social networks increase delay by acting as lay 
advisers for individuals seeking help, thereby substituting the role of the HCP with often-
uninformed advice (Elliot-Binns, 1973). 
Integrating Models of Help-seeking 
In order to summarise the theoretical information and influential help-seeking factors 
presented in this review, an integrated model of help-seeking has been developed to create a 
comprehensive picture of the models, and to place it within the context of gynaecological 
cancer and the empirical chapters to follow. 
A help-seeking study for breast cancer, Hunter, Grunfeld and Ramirez (2003) 
highlighted the value of employing multiple models in the initial stages of research to 
incorporate key components of help-seeking models (including the SRM) Furthermore 
additional factors should be integral into a comprehensive help-seeking model.  Such factors 
should include sociocultural, economic, personal, and healthcare system factors that influence 
time to help-seeking for women seeking help for gynaecological and other cancers.  This 
suggestion is supported by evidence reported in a recent review by Whitaker, Scott and 
Wardle (2015) that identified the important impacts of external factors along the many 
intervals of the help-seeking journey from perception and detection of a symptom to 
attendance with a HCP.  It is therefore important that help-seeking theories include symptom 
perception processes to build a comprehensive framework from which to gain an 
understanding of help-seeking for symptoms. In response to the previously identified 
suggestions for a more integrated and comprehensive help-seeking theory, an integrated 
model is suggested (Figure 2.6) that incorporates the key elements of each of the three key 
models employed in the current thesis and influencing factors that impact these dynamic 
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processes.  When combined, these models produce a comprehensive model of help-seeking 
that encompasses the processes of symptom perception, symptom appraisal, selection and 
monitoring of coping responses (e.g. self-management) as well as making the decision to seek 
help from a HCP. 
Given the complex biopsychosocial influences and the dynamic cognitive processes 
involved in seeking help for gynaecological cancers, an integrated model is proposed to 
acknowledge the many influences (both known and unknown) on the journey toward help-
seeking for potential symptoms of gynaecological cancers. Given that it is grounded in the 
Model of Pathways to Treatment framework (Scott et al., 2013; Walter et al., 2012), the 
integrated model of help-seeking is a generalisable model across different symptoms and 
cancer sites.  Further evidence suggests that it may be useful in the investigation of both short 
and long appraisal intervals with acute and chronic symptoms of illness (Walter et al., 2012), 
making it suitable for the various symptoms indicative of gynaecological cancers.  This model 
can also be altered to include disease-specific symptoms, alternative pathways to care and 
diagnostic pathways (Walter et al., 2012) that could include seeking help from an emergency 
department, sexual health walk-in clinic, GP service, regular preventative screening 
appointment and attendance at a regular comorbidity management appointment (e.g. for 
diabetes or hypertension).  Therefore, in the context of gynaecological cancers this model 
could be used to examine help-seeking for the vague and non-specific symptoms indicative of 
this cancer type.  
72 
 
 
 
Figure 2.6. Integrated Model of Symptom Perception (Gijsbers van Wijk & Kolk, 1997; Kolk et al., 2003), Leventhal’s Self-Regulation (Leventhal, 
Brissette, & Leventhal, 2003), and the Model of Pathways to Treatment (Scott et al., 2013; Walter et al., 2012).    
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Conclusions and Moving Forward 
Theory enables us to create a framework for understanding how an individual comes 
to recognise bodily symptoms and form associations with potential illness, thereby 
influencing help-seeking behaviour.  However, more research is needed to understand the 
barriers to medical help-seeking behaviour.  Furthermore, many of the help seeking theories 
do not account for the role of sociocultural dimensions and the impact of situation and context 
on medical help-seeking behaviour.  Sociocultural dimensions include familial and social 
context as well as cultural beliefs, norms and experiences.  Methodological application of 
Andersen’s stage model is said to apply more comfortably to the Western healthcare system.  
Nevertheless, due to issues highlighted in this chapter an integration with more dynamic 
models of SRM (Leventhal, Meyer, & Nerenz, 1980; Leventhal, Nerenz, & Steel, 1984) and 
the Model of Pathways to Treatment (Scott, McGurk, & Grunfeld, 2007; Walter et al., 2012) 
is necessary.  Therefore an integration of the models is introduced to gain an understanding of 
the dynamic cognitive processes that are involved in the experience of appraising a symptom 
ad coming to the decision to seek medical help, within the context of seeking help for 
potential symptoms of gynaecological cancer.  
A review of the gynaecological cancer and help-seeking literature presented in this 
thesis is presented in summary in the following chapter to build a foundation for the PhD 
research and how the proposed studies aim to fill gaps in the literature. 
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CHAPTER 3: DRAWING CONCLUSIONS OF THE LITERATURE- DIRECTIONS 
FORWARD 
 
Aims 
The purpose of the current chapter is to briefly highlight key findings from the 
literature reviews into gynaecological cancers and psychological help-seeking theory in 
Chapters 1 and 2 respectively, and to use this information to present a research plan that 
detail, with explicit goals, for the remainder of the PhD. 
Key Point Summary: Chapter 1 
Gynaecological cancers vary by incidence, risk factors, signs and symptoms, 
treatments and outcomes.  Nevertheless, it is clear that these forms of cancer hold a strong 
worldwide disease burden accounting for approximately a quarter of all diseases in women 
(Ferlay et al., 2013a).  A review of the literature highlighted that the prevalence of 
gynaecological cancer in women of postmenopausal age is very high, with endometrial cancer 
reported at the highest incidence rate and ovarian cancer with the highest mortality for 
developed countries.  Common causes and risk factors for the development of gynaecological 
cancers include post-menopausal age, genetic factors, hormonal imbalance (e.g. caused by 
HRT, breast cancer treatment, or obesity), infertility, sexually transmitted infection, and 
common lifestyle factors (e.g. low socioeconomic status, smoking and poor diet).  Early stage 
gynaecological cancers often present with vague or non-specific symptoms, with the 
exception of endometrial cancer, which primarily presents with a distinct symptom of post-
menopausal bleeding (PMB).   
The National Institute for Clinical Excellence, clinical guidelines (2005) provide 
distinct diagnostic pathways for each cancer site, dictating diagnostic practices for 
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gynaecological cancers in the UK.  Mortality is regularly determined by the stage of cancer at 
time of diagnosis, which determines the course and effectiveness of each treatment.  
Therefore, early detection and prompt help-seeking can significantly improve treatment and 
survival outcomes for gynaecological cancers.   
Key Point Summary: Chapter 2 
Understanding what leads women to seek help and what influences the process of 
delay is essential to inform help-seeking research in this population.  Despite the high 
incidence of gynaecological cancers, some individuals still delay when seeking help, therefore 
it is important to identify populations at greatest risk of delay.  The literature provides an 
overview of the health behaviour theories for use in applied psychological investigation into 
help-seeking for symptoms of cancer. 
A review of help-seeking theory supports the understanding that medical help-seeking 
is not an event but a series of stages and processes that include the perception of somatic 
information, the appraisal of this information, and the associated decision-making processes 
that determines how one responds to an appraised symptom.  Help-seeking theories should 
include clearly identified contextual, cognitive, emotional and social factors and should lay a 
framework for dynamic and parallel processes rather than rational decision making points or 
discrete stages. 
The current research is informed by reviewed models of the Symptom Perception 
Model (Gijsbers van Wijk & Kolk, 1997; Kolk, Hanewald, Schagen, & Gijsbers van Wilk, 
2003), the adapted Andersen’s General Model of Total Patient Delay (Cacioppo, and Roberts, 
1995), the Leventhal’s Self-Regulation Model (Leventhal et al., 1997; Leventhal, Brissette, & 
Leventhal, 2003) and the Model of Pathways to Treatment (Scott, Walter, Webster, Sutton, & 
Emery, 2013; Walter, Webster, Scott, & Emery, 2012) which, when integrated, produce a 
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more complete theory of help-seeking behaviour from the perception of a symptom to 
attending an appointment with a healthcare professional (HCP).  Additional factors have been 
identified to influence the help-seeking process and include biopsychosocial and 
environmental influences of the dynamic process of medical help-seeking.  
Moving Forward 
Literature suggests that women report weight barriers to healthcare, which may 
contribute to delay in the utilisation of gynaecological health services.  The specific factors 
that contribute to obese women delaying help-seeking for symptoms of gynaecological cancer 
have not previously been identified.  This research is timely given the increasing relevance of 
obesity as a public health concern and the strong association with increased risk, morbidity 
and mortality for a range of different cancers.  Although it would be preferable to reduce 
levels of obesity, the current situation demands a focus on improving help-seeking behaviour 
amongst obese women to improve survival outcomes.  Specific factors that influence delay 
amongst this patient group have not been studied in the context of gynaecological cancer 
services, and given the increased risk and morbidity for gynaecological cancers amongst 
obese women, early detection and prompt help-seeking for women experiencing symptoms of 
gynaecological cancers should be an important focus for research. 
Research Plan 
The proposed research will account for limitations inherent in delay research (see Scott 
& Walter, 2010) through adherence to a theory driven approach, a mixed methods approach 
that employs a broad sweeping quantitative questionnaire as well as an in-depth qualitative 
interview study to examine the process of help-seeking for women experiencing symptom(s) 
of gynaecological cancer (Chapters 5 - 7).  See Figure 3.1 to provide an overview of the areas 
of help-seeking investigated in each empirical chapter.
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Figure 3.1. Empirical chapter outline according to help-seeking intervals. 
The aims of the thesis are as follows: (a) to explore the health beliefs and help-seeking 
attitudes of normal weight, overweight and obese women (Chapters 4, 5 & 7), (b) to identify 
predictors of delay in help-seeking amongst normal weight and overweight/obese women and 
to acknowledge differences between obese and non-obese women in their time to help-
seeking (Chapter 5), (c) to understand the experience and process of help-seeking for obese 
women (Chapters 6 & 7) and (d) to identify whether differences exist across ethnicities 
regarding knowledge about gynaecological cancers.  As such, the PhD will address the 
following research questions:
Detectable	physiological	change	occurs	
Decides	to	seek	medical	a6en7on	
Acts	on	decision	by	making	an	appointment	
Receives	ini7al	medical	a6en7on	(e.g.	GP)	
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Perceptual	
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(a) What can we learn about help-seeking from the perspective of HCPs? (Chapter 4) 
(b) Do knowledge and beliefs about gynaecological cancers (i.e. risk factors and 
symptoms) differ between obese and non-obese women? (Chapters 4 & 5) 
(c) Do knowledge and beliefs about gynaecological cancers (i.e. risk factors and 
symptoms) differ across different ethnic groups? (Chapters 4 & 5) 
(d) Do knowledge and beliefs about gynaecological cancers (i.e. risk factors and 
symptoms) differ between women who extend time to help-seeking and those who 
do not? (Chapter 5) 
(e) What are the predictors of delay in help-seeking amongst normal weight,  
overweight and obese women? (Chapter 5) 
(f) Are there differences between obese and non-obese women regarding time to help-
seeking? (Chapter 5 & 6) 
(g) Are there differences across ethnicities regarding time to help-seeking? (Chapter 
6) 
(h) What is the experience of an obese woman seeking help for potential symptoms of 
gynaecological cancers? (Chapter 6 & 7) 
These questions were examined in four studies. The development of the questionnaire 
study reported in Chapters 5 and 6 were informed by comprehensive literature reviews 
(Chapters 1 & 2) and results of the first study (Chapter 4), which informed the development 
of measures in Chapter 6 as well as the interview schedule for Chapter 7.  
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Structure of the following Chapters 4 to 8 
Chapter 4: A qualitative analysis of healthcare professionals’ beliefs about obese 
women seeking help for symptoms of gynaecological cancer presents results of a qualitative 
study with the purpose of exploring HCPs’ perspectives about the potential barriers, beliefs 
and behaviours of help-seeking amongst the obese women that attend their services.  Semi-
structured interviews were undertaken with 20 HCPs that specialise in gynaecological cancer 
services (i.e. consultants, nurses, psychologists, radiologists, general practitioners) in 
Birmingham Women’s NHS Foundation Trust and University Hospitals Birmingham NHS 
Foundation Trust.  Data were analysed using the Framework analysis method.  The aims of 
this study were two-fold, (a) to explore HCPs’ perspectives on the use of gynaecological 
services amongst obese patients presenting with symptoms of gynaecological cancers and (b) 
to explore HCP’s beliefs about the potential barriers and motivators that influence help-
seeking amongst obese women in their service.  Furthermore, Chapter 4 builds a foundation 
for patient research into the predictors of delay for obese women seeking help for 
gynaecological symptoms (Chapters 5 and 6). 
Chapters 5 and 6 present two separate patient studies that answer research questions 
from b to g, the patients’ perspective.  The development of these studies was informed by 
literature reviews and the results of Chapter 4.  Chapter 5: Predicting help-seeking for 
symptoms of post-menopausal bleeding, presents a quantitative study which examined 
predictors of delay and barriers to help-seeking for symptoms of gynaecological cancer 
amongst a non-stratified sample of 164 women of variable BMIs (19.5 – 45.10) attending 
their first appointment at a Sandwell and West Birmingham Hospitals NHS Trust PMB clinic 
after being referred for a suspicious symptom of cancer (i.e. PMB).  The questionnaire 
examined sociocultural and demographic factors, body image satisfaction, objective body 
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size/body weight, mood, illness perceptions, previous health behaviours, social capital and 
gynaecological cancer awareness, assessed these factors and how they may be associated with 
time to help-seeking for symptoms of post-menopausal bleeding.  A multiple regression 
analysis was conducted to identify the predictor(s) of extended time to help-seeking by 
identifying key variables that predict extended time to help-seeking for women experiencing a 
potential symptom of gynaecological cancers (i.e. PMB).  
Chapter 6: Mapping the help-seeking journey, presents an additional analysis that 
maps the dynamic process and associated behaviours involved in seeking help for PMB, and 
compares differences in help-seeking amongst different groups of obese and non-obese 
women and White-European and British Asian and Minority Ethnic groups in time taken 
along the journey of help-seeking from detection to PMB referral. 
Chapter 7: The lived experiences of obese women seeking help for post-menopausal 
bleeding- A qualitative IPA study, explores the experience and beliefs (i.e. illness perceptions 
and body image) of seven obese women (BMI > 35.9) in their journey toward help-seeking 
for PMB and identifies how women make sense of this experience.  Participants were 
recruited from the questionnaire study and data collection was achieved through an open-
ended in-depth qualitative interview.  Data was analysed using Interpretative 
Phenomenological Analysis to explore the meaning of the help-seeking experience amongst 
obese women. 
The final Chapter (Chapter 8: General discussion) provides a summary of research 
findings and a general discussion relating back to the literature to discuss the research 
limitations, suggest directions for future research and/or interventions, to outline the 
theoretical and practical implications of the research, and to formulate an overall conclusion 
for the PhD. 
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The British Psychological Society guidelines for ethical practice were adhered to in the 
design and conducting of the research studies that form this thesis.  Ethical approval was 
granted by the appropriate NHS and University Ethical Review Committees and local NHS 
Research and Development Centres.  Please see Appendix A for all ethical approval letters.
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CHAPTER 4: A QUALITATIVE ANALYSIS OF HEALTHCARE 
PROFESSIONALS’ BELIEFS ABOUT OBESE WOMEN SEEKING HELP FOR 
SYMPTOMS OF GYNAECOLOGICAL CANCER 
 
Introduction 
Obesity has widely been reported as one of the risk factors for gynaecological cancers 
(Bhaskaran, Douglas, Forbes, dos-Santos-Silva, Leon, & Smeeth, 2014); Lane, 2008; Reeves, 
Pirie, Beral, Green, Spencer, & Bull, 2007), namely endometrial (Stevens, Jacobs, Patel, Sun, 
Gapstur, & McCullough, 2014) and some ovarian cancer sub-types (Olsen et al., 2013).  This 
is a significant issue given that over one quarter of women in the UK and one third of women 
in the USA are estimated to be overweight or obese (Organisation de Cooperation et de 
Developpement economiques [OECD], 2014; Stevens et al., 2012).  Furthermore, although 
the relationship between BMI and surviving gynaecological cancers is currently not fully 
understood, obesity has been found to play an important role in treatment outcomes for some 
gynaecological cancers (Backes, Nagel, Bussewitz, Donner, Hade, & Salani, 2011; Olsen et 
al., 2013; Reeves et al., 2007).  The survival rate of all gynaecological cancers is dependent 
upon their stage at the time of diagnosis, highlighting the importance of screening tests, early 
detection and prompt help-seeking particularly for those who have an increased risk of 
developing the disease.  Nevertheless, the often vague and non-specific symptoms of 
gynaecological cancers pose a challenge to the appraisal of symptoms as severe enough to 
require medical help (Koldjeski et al., 2005; Macleod, Mitchell, Burgess, Macdonald, & 
Ramirez, 2009; Smith, Pope, & Botha, 2005).   
In terms of help-seeking behaviour, obese women have been found to be less likely to 
attend gynaecological cancer screening tests in comparison to non-obese women, despite 
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being at higher risk of developing gynaecological cancers (Aldrich & Hackley, 2010; 
Maruthur, Bolen, Brancati, & Clark, 2009).  Furthermore, they are more likely to seek 
healthcare services at a later and more advanced stage of breast and gynaecological cancers 
(Arndt, Stürmer, Stegmaier, Ziegler, Dhom, & Brenner, 2002; Maruthur et al., 2009).  A 
number of factors have been suggested to facilitate such a delay in help-seeking and 
presentation of obese women to healthcare services.  Such factors include: (a) perceived 
weight-stigma amongst healthcare professionals (HCPs; Alegria Drury & Louis, 2002; Puhl 
& Brownell, 2006; Phelan, Burgess, Yeazel, Hellerstedt, Griffin, & van Ryn, 2015; Puhl & 
Heuer, 2009), (b) embarrassment of one’s body during gynaecological examinations (Amy, 
Aalbord, Lyons, & Keranen, 2005; Ridolfi & Crowther, 2013), (c) lack of symptom and 
disease knowledge (Soliman et al., 2008), and/or (d) concerns regarding lack of suitable 
equipment to enable examination of women with larger body sizes (Amy et al., 2005; Uppot, 
2007). 
HCPs play a key role in influencing patient health behaviour change and help-seeking 
(Puhl & Heuer, 2009; Jackson, Wardle, Johnson, Finer & Beeken, 2013; Rose, Poynter, 
Anderson, Noar & Conigliaro, 2013).  A review conducted by Rose and colleagues (2013) 
suggested doctor-patient communication that included weight-loss advice positively 
influenced patients’ weight-loss.  A study conducted by Hebl and Xu (2001) reported that 
clinicians communicated less positively with obese women when compared to women of 
normal weight, furthermore clinicians often believed that overweight or obese patients were 
less likely to comply with medical advice (e.g. to lose weight) or benefit from psychological 
therapies (e.g. counselling for comorbid depression).  This is important because studies have 
shown that when a doctor and patient hold differing opinions about a patient’s motivation for 
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weight-loss or health, positive communication regarding positive and preventative healthy 
lifestyle choices are exceedingly difficult (Befort et al., 2006).  
A study on medical help-seeking delay, by Amy and colleagues (2005) found that 
patients’ decisions to delay care was often related to their treatment and to communications 
with HCPs.  Concerns included disrespectful interactions and perceived negative attitudes of 
HCPs, the anticipation of receiving unsolicited weight-loss advice and a lack of size 
appropriate equipment available in clinic (i.e. gowns, examination tables and equipment).  A 
study exploring the barriers and facilitators of help-seeking for breast and cervical cancers 
paralleled findings from the previously mentioned study, however they also found that 
women believed that having positive and trusting relationships with their General 
Practitioners (GPs) facilitated help-seeking (Marlow, McGregor, Nazroo, & Wardle, 2014). 
To date, minimal research has focused on the experiences of HCPs working with 
obese women in gynaecological cancer services.  An exploration thereof would further our 
understanding of this patient group’s delayed help-seeking behaviours, given that HCPs have 
direct experience of working with this client group and are well-placed to provide insight into 
healthcare service barriers and factors that impact the utilisation of services.  Although factors 
have been suggested in the literature to describe obese-specific influences that may act as 
barriers to general medical help-seeking, specific factors have not been studied in the context 
of gynaecological cancer services.  Given the increased risks for disease and poorer outcomes 
for gynaecological cancers amongst obese women, early detection and prompt help-seeking 
for women experiencing symptoms of gynaecological cancers should be an important focus 
for research.  Therefore, the aims of this study are: (a) to explore HCPs’ perspectives on the 
use of gynaecological services amongst obese patients presenting with symptoms of 
gynaecological cancers; (b) to explore HCPs’ beliefs about the potential barriers and 
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motivators that influence help-seeking amongst obese women presenting with symptoms of 
gynaecological cancers; (c) to provide suggestions that inform the development of 
interventions to encourage prompt help-seeking behaviours in this patient group.  The 
findings of this study build the foundation for the following studies (Chapters 6-8), which 
investigate predicting factors and processes of help-seeking behaviour in obese women with 
potential symptoms of gynaecological cancers. 
Methods 
Context 
The study was sponsored by the University of Birmingham under the Research 
Governance Framework and received ethical approval from the Science, Technology, 
Engineering and Mathematics Ethical Review Committee at the University of Birmingham 
(Reference number: ERN_12-1420) and the Birmingham Women’s Hospital NHS Foundation 
Trust (Reference number: 13/BWH/NO89).  See ethical approval letters in Appendix A. 
Sample and recruitment  
HCPs were identified for recruitment by the researcher (S. T.) through Internet 
searches of hospital gynaecologic and oncology consultants and potential participants were 
selected based on their working in direct contact with obese women in gynaecology and 
gynaecology oncology (gynae-oncology) services across four hospital sites (City Hospital, 
Birmingham Women’s Hospital, Sandwell Hospital and Queen Elizabeth Hospital)1.  
Consultants and clinic managers further identified other members of the cancer support team 
(i.e. radiographer, psychologist, nurses).  A convenience sampling technique was employed 
and participants who met the above criteria of current employment as a HCP in 
gynaecological cancer care services, and who were in weekly clinical contact with patients, 
                                                
1 City, Women’s, Sandwell and Queen Elizabeth Hospitals are the four major NHS hospitals 
that provide gynae-oncology services to Birmingham. 
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were contacted by the researcher via letter or email providing information about the study and 
inviting them to participate in an interview exploring HCPs’ perspectives on obesity and 
gynaecological cancers (see Appendix B & C for cover letter & information sheet for 
participants).  Interested participants agreed to participate by emailing the researcher to 
arrange an interview date in their place of work.  The sample consisted of HCPs working in 
the professional contexts of nursing, oncology, general practice, and other members of the 
direct care team (i.e. clinical psychologist, radiologist). 
Participants 
Thirty HCPs were identified as suitable participants.  Twenty participants agreed to 
take part in the study (response rate 71%).  Of the 20 participants, 8 were male and 12 were 
female.  Their ages ranged from 30 to 68 years (M = 45; SD = 2.5).  Fifty-five per cent (n= 
11) of the participants were of a white ethnic origin, and 5% (n=1) black ethnic origin.  
Descriptive statistics are presented in Table 4.1.  
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Table 4.1. 
HCP’s Descriptive Statistics 
 
Sociodemographic characteristics of sample       N(n=20)  % 
Age 
     <40 yrs 5 25 
   40- 49 yrs 8 40 
   <50 yrs 7 35    
Gender 
     Male 8 40 
   Female 12 60 
   Race/ethnicity 
     White/ White British 11 55 
   Black/ Black British 1 5 
   South Asian/ Asian British 3 15 
   Chinese/ other Asian ethnic grps 2 10 
   Mixed Race/Other 3 15 
   Professional Role 
     Gynaecologic consultant 2 10 
   Gynaecologic oncology consultant/surgeon 5 25 
   Specialist gynaecology nurse 1 5 
   Gynaecologic oncology advanced nurse 
practitioner/certified nurse specialist 5 25 
   General Practitioner 2 10 
   Gynaecologic oncology staff nurse 2 10 
   Other: Member of cancer care team (i.e. clinical 
psychologist, registrar, radiographer) 3 15 
   Education/Job Relevant Qualification 
     General Nursing 4 20 
   Certified Nurse Specialist 2 10 
   Masters Level/Postgraduate 4 20 
   Medical Degree & Further Specialist qualification 10 50 
   Years Since Qualification  Mean 9; Range (2-26) 
  
Interview Schedule and Procedure  
A semi-structured interview schedule was developed through a literature review 
(Chapters 1 and 2) and through discussions with clinical, health and research psychologists 
working at the University of Birmingham and in the Sandwell and West Birmingham 
Hospitals NHS Trust.  The interview schedule was piloted in an interview with a clinical 
psychologist working in gynaecological cancer care at one of the approved sites.  Minor 
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changes were incorporated into the interview schedule as a result of the pilot interview, 
whereby questions were reordered to facilitate clarity and ensure a conversational format.  
Questions in the interview schedule addressed the main aims of the present study (described 
on pages 3 - 4) (see Appendix D for the interview schedule).  Participants were encouraged to 
share their opinions and experiences of working with obese women in gynaecological 
services.  Question topics addressed the experiences of working with overweight or obese 
patients, clinical challenges specific to obese patients, such as advising patients to lose 
weight, and perceptions of gynaecological cancer awareness (i.e. risks & symptoms) amongst 
this group. They also addressed beliefs about the patient process of seeking help, including 
attitudes towards vaginal examination and interpretations of perceived barriers to patient care. 
Prior to the commencement of the interview all participants were provided with a 
paper copy of the study information sheet and were given the opportunity to ask questions.  
Written consent was then acquired.  Interviews were conducted face-to-face (from January to 
September, 2013) and ranged from 15 to 61 minutes (mean 37 minutes).  Interviews were 
recorded and transcribed verbatim. 
Data Analysis 
Data were analysed using the ‘Framework’ method (Ritchie & Lewis, 2003), which is 
a common qualitative method used in applied health and social policy research in the UK 
(Patel, Ferner, & Grunfeld, 2011).  Framework analysis does not follow one epistemological 
stance, but aims to holistically explore an individual’s subjective understandings of their 
experience within their social world (Ward, Furber, Tierney, & Swallow, 2013).  The 
development of a thematic framework provides a systematic method of synthesising interview 
data to compare data across and within individual cases (Gale, Heath, Cameron, Rashid, & 
Redwood, 2013).  Framework analysis allows for an integration of both inductive and 
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deductive theme development whereby the themes are selected to specifically answer research 
questions.  Therefore, framework analysis was selected as the ideal methodology to for an 
exploratory study into the experiences of HCPs in their interactions with obese patients, and 
their perceptual realm beliefs about delay amongst this group.  This study also aims to 
identify potential barriers and motivators of help-seeking from the perspective of the 
healthcare professionals as a means of informing practice.  See Table 4.2 for study aims and 
research questions.   
Table 4.2. 
 
Study Aims and Research Questions 
Specific aims for the HCP interview study   Research questions that address each 
aim 
1 To explore HCPs’ perspectives on the use 
of gynaecological services amongst obese 
patients presenting with symptoms of 
gynaecological cancers. 
  What are HCP’s perceptions of obese 
women’s use of gynaecological cancer 
services? 
2 To explore HCPs’ beliefs about the 
potential barriers and motivators that 
influence help-seeking amongst obese 
women presenting with symptoms of 
gynaecological cancers. 
  What are the HCPs’ beliefs about the 
barriers and motivators for help-seeking 
amongst obese women with symptoms 
of gynaecological cancers?  
3 To provide suggestions to inform 
interventions developed around 
encouraging earlier help-seeking 
behaviours in this patient group. 
  What interventions may be developed to 
encourage obese women to seek help 
sooner?  
 
A five-step process of analysis was followed: (a) Data immersion, (b) coding and 
thematic framework development, (c) indexing and charting, (d) summarising data in an 
analytical framework, and finally (e) synthesising the data with interpretation.  
Step 1: Data immersion.  The researcher read each transcript and made notes of her 
reflections, thoughts and general impressions.  The first three transcripts were reviewed by the 
researcher’s supervisors (M. L., E. G. & R. H.) to ensure that the data were of high descriptive 
quality, and that each research question was answered. 
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Step 2: Coding and thematic framework development.  A process of ‘open coding’ 
was conducted on half of the interviews using NVIVO software (QSR International, Version 
10) to paraphrase or label sections of each transcript that could potentially answer one or 
more of the research questions.  A working index was then created using the coding structure 
developed in the previous step, which represented working themes and sub-themes according 
to specific research questions.   
Step 3: Indexing and charting into the framework matrix. The index was then 
applied back to the complete dataset to work as a structured thematic framework for the rest 
of the data analysis. A framework matrix was created to chart the data into themes for each 
participant.  
Step 4: Summarising and organising the existing framework. In this step each case 
was summarised using key themes and a more concise framework was created to detail 
themes and subthemes that specifically met the research aims across cases. Subsequently, 
15% (n = 6) of the cases were analysed independently by a second researcher (L. A.) to 
determine agreement in interpretation of the data.2  Differences in theme titles were resolved 
through discussion with research supervisors, resulting in the name of a theme being changed 
from ‘negative judgments received from HCPs’ to ‘perceived HCP negative attitudes about 
obesity’ to avoid exaggerated interpretation of participants’ narrative.  Furthermore this theme 
was combined with low body-esteem due to the association revealed between body image and 
perceived HCP’s negative attitudes of obesity. 
 Step 5: Synthesising the data with interpretation.  The data was then reviewed and 
synthesised to map connections between themes and clearly describe the experiences and 
beliefs of HCPs working with obese women in gynaecological cancer care. 
                                                
2 Inter-rater reliability co-efficient is inappropriate to report for this type of qualitative data 
due to lack of empirical support for its use (Armstrong, Gosling, Weinman & Marteau, 1997).  	
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Results 
 A total of seven superordinate themes emerged to describe (a) the perceptions of 
HCPs about obese women in gynaecology services and (b) the perceived barriers and 
motivators for help-seeking amongst obese women with symptoms of gynaecological cancers.  
Additionally, HCPs provided insight into potential interventions for improving help-seeking 
amongst this group.  Superordinate themes and subthemes are described in the two sections 
below.  
HCP perceptions about obese women in gynaecology services 
 Participants estimated that 47% (range 14% - 80%) of women who are seen in 
gynaecological clinics were overweight and 30% (range 10% - 60%) were obese.  Three 
superordinate themes emerged to describe the role of obesity in the help-seeking process and 
service provision in gynaecological cancer services: (a) low disease knowledge or willingness 
to act (i.e. low awareness of obesity as risk factor for disease, acceptance of obese body size), 
(b) practice adapted to accommodate for obesity (i.e. special accommodations/equipment 
needed, treatment risks, complications and examination difficulties, challenges of advising for 
weight loss), (c) the unpleasant patient experience (i.e. embarrassment with body exposure 
and special adaptations made during examination, obesity-related judgmental attitudes from 
professionals). 
Theme 1.1.  Low disease knowledge or willingness to act.  All respondents were in 
agreement that the obese patients who attended their service were at an increased risk of 
developing chronic diseases and some gynaecological cancers (i.e. endometrial/womb & 
ovarian).  Participants reported that they experienced patients to have a poor awareness of the 
association between obesity and the development of gynaecological cancers.  Some 
professionals further stated that participants might be aware of their risk for developing other 
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chronic diseases, such as diabetes and heart disease, but not necessarily gynaecological 
cancers.  
HCP11: People are aware of obesity and heart disease risks.  I think people are less 
aware of the link between obesity and chronic obstructive airways disease and cancer.  
(Male, Gynae-oncology Consultant) 
 
HCP14: They interviewed one of my patients and she basically said, “I had no idea 
[obesity] caused this cancer.”  Womb cancer from obesity...is actually not as known 
as you think it should be.  Not in the lay public anyway.  (Female, Gynae-oncology 
Consultant) 
Participants also highlighted the clinical challenges they have experienced when 
educating patients about the indirect relationship between the symptoms they are experiencing 
and their increased risk of developing a disease.   
HCP10: The challenge is encouraging women to relate their symptoms and their 
weight.  There's a big disconnect…  They do not understand how weight can be 
responsible for troubles.  (Male, Gynaecology Consultant) 
Despite patients having some knowledge of their risks for developing disease, 
participants reported that they might choose not to change their behaviour and accept their 
larger size as unalterable.  Participants described a perceived acceptance amongst obese 
patients of their larger body size as a product of life-long obesity, past failed attempts at 
weight-loss, and older age.  This acceptance of a larger size was described as a potential 
barrier to help-seeking in the context of aging and potential gynaecological cancer symptoms.  
HCP12: But to be honest, the patients that come in that do carry the extra weight, they 
tend to know that their weight is an issue, but they don’t seem to act on it.  They seem 
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to think, “Oh well at my age it doesn’t really matter.” (Female, Gynaecological Nurse 
Specialist) 
 Theme 1.2.  Practice adapted to accommodate obesity.  Participants described 
specialised adaptations and equipment necessary to appropriately care for obese female 
patients in the gynaecological services, which included: hoists for mobilisation, longer 
speculums for examination, and larger MRI/CT scanners, measuring scales, wheelchairs, 
gowns, chairs, tables and beds.  Respondents reported the potential for delayed treatment 
when appropriate equipment was unavailable. 
HCP4: I had a lovely lady the other day and I had to measure her girth because she 
had a very big BMI.  I had to sellotape two tapes together, which was horrible 
because we hadn’t got a tape measure long enough and she then had to wait to use the 
extra wide scanner, which delayed her treatment.  If they’re less mobile a hoist for 
lifting [is necessary], which is very difficult for everybody, and in [the] extended 
recovery unit we’ve had to buy a whole load of bariatric equipment; so extra big 
commodes for heavy women, extra big beds, big wheel chairs and stuff like that.  
(Female, Specialist Gynae-oncology Nurse) 
 When asked about what it was like to treat obese women in their service, participants 
reported clinical challenges, surgical risks and treatment delays caused by obesity (e.g. 
anaesthetic risks, examination difficulties, radiotherapy, scanning complications, financial 
burden and surgery risks).  Participants acknowledged risks and potential implications of 
obesity on patient care, in which obesity and comorbid diseases may reduce treatment 
effectiveness, positive outcomes, and further complicate the recovery process. 
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HCP12: It tends to be more difficult to locate the cervix.  And it’s harder to do 
hysteroscopies on larger weight than it is on normal weight ladies. (Female, 
Gynaecological Nurse Specialist) 
 
HCP9: Challenging.  We are dealing with obese patients and on top of that they may 
have other inter-current illnesses from underactive thyroid, heart disease, to 
orthopaedic problems from the stress they put on their back ... [and] blood pressure.  
Secondly, access to the organs that we need to get to, take out.  Thirdly, recovery with 
wound infections, because fat does not have the same blood supply as muscle.  
Intensive recovery services, because you’re probably not aware that obese women 
under-breathe.  (Male, Gynae-oncology Consultant) 
 To reduce the risks and challenges associated with diagnosing and treating obese 
patients in gynaecological care, professionals may advise patients to lose weight.  Participants 
acknowledged the clinical importance and challenges associated with this.  Participants 
agreed that occasionally weight-loss might be necessary prior to commencing treatment.  The 
excerpt below describes how a woman’s inability to lose weight delayed her treatment. 
HCP2: And she knew and I knew, and I said to her, “We would normally do this and 
here we are watching you sitting on a potential cancer coming out and I can’t do it 
because you are just too risky to put asleep.”  
RESEARCHER: Right, and what happened in her case? 
HCP2: To the best of my knowledge she’s still being monitored [for cancer growth, 
because treatment is too risky]. (Male, Gynae-oncology Consultant) 
Nevertheless, participants described how they might prioritize patient weight-loss but 
only according to complex parameters.  
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HCP19: If I’m referring someone for suspected endometrial cancer it’s about the 
bottom of my priority list to be advising about her weight, because quite frankly she’s 
got more important things to worry about.  She can’t lose weight in two weeks that’s 
going to make any difference.  However, following somebody up in a less acute 
situation then you just say, “You know you’re a bit on the overweight don’t you?” 
(Female, GP) 
 Participants reported challenges with discussing obesity related risks and delivering 
weight-loss advice in a supportive and sensitive manner that maintains a positive and 
effective doctor-patient relationship.  Participant narrative about weight-loss discussions 
prioritised effective doctor-patient communication for practical rather than patient-centred 
reasons.  As such, respondents described unsuccessful communication attempts as having the 
ability to cause patient upset, which may increase the likelihood of delayed in patient help-
seeking for current and future gynaecological symptoms.  Some HCPs reported their own 
embarrassment in initiating the weight-loss conversation with patients, often choosing not to 
discuss weight management as a way of avoiding the possibility of offending a patient.  When 
the researcher asked if a participant had ever advised a patient to lose weight, a 
gynaecological oncology nurse explained how she avoided discussions about weight by 
offering suggestions that could lead to weight-loss without mentioning weight itself. 
HCP6: To be honest with you, no I haven’t, because I feel that that’s one thing I’m 
still very sensitive [about this], especially to women.  So I’ve never really told them 
directly about, “Yes you need to lose weight.” No I haven’t.  It's really bad, because I 
should as a healthcare professional, but it’s difficult to say things that will not offend 
them.  So, I say it very indirectly like, exercise, healthy lifestyle, healthy this. (Female, 
Gynae-oncology Staff Nurse)   
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 Additionally, the clinical time limitations in GP practice may also limit the 
opportunities for professionals to discuss weight-loss plans with patients.  For example: 
HCP20: It is one of those things that sometimes you don’t want to raise with a patient, 
because you’re very short of time and you know that if you sort of say, “Oh and by the 
way you need to lose weight”, you’re opening this other of can of worms that, you 
know, you ought to deal with that same day, but when you’re running short of time it’s 
difficult to.  So sometimes you might not raise it even if you know that it needs to be 
addressed.  (Female, GP) 
 Although clinicians can be an important resource for patients trying to make healthier 
lifestyle choices, it was acknowledged that advising patients to lose weight could be 
challenging.  Participants reported that successful weight management occurred when HCPs 
were able to provide patients with information and resources, including clearly structured 
individual weight-loss plans.  
HCP14: Unless you have a clear plan for it it’s unhelpful.  I do say, “I think because 
you’re bigger this has contributed to your cancer.” But I think it’s unhelpful to say, 
“lose weight”, and not give people a clear structure for how to lose weight, because 
it’s very naïve to think that these people have got SO little understanding of 
themselves that they cannot see that they are fat.  (Female, Gynae-oncology 
Consultant) 
Respondents reported that some doctors might focus excessively on a patient’s weight 
issue and neglect to attend to a patient’s primary concern for the visit, which may be 
perceived by the patient as blaming or “beating them up” in an attempt to manage weight.   
HCP10: The moment you start talking about weight you are beating them up.  They 
know all about weight, ''No this is a heavy period.  It's got nothing to do with weight.'' 
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So you try to create awareness and acceptance and it creates a strained relationship.  
It's not easy…They know they are overweight but that's not why they came.  You can 
see how frustrated they are.  (Male Gynaecology Consultant) 
Furthermore, respondents highlighted the importance of engaging in supportive 
conversations with patients and described that non-supportive language regarding weight-loss 
was seen to suggest “patient blame” and was often interpreted by the patient as insensitive or 
derogatory (e.g. blaming the patient for not losing weight after agreeing to lose weight at their 
previous visit; labelling obesity as the cause for all or most medical problems; labelling 
patient as big, fat or obese).  Participants believed that patients who had previous negative 
experiences in communications with their doctors initiating weight-loss discussions were less 
likely to attend regular health screening appointments. 
HCP3: Doctors can actually be quite derogatory and nursing staff, especially in GP 
practices, [be-]cause you go to be screened and all of a sudden you’ve been put in for 
diabetic checks because you are large, and then you’re given grief about, ‘you need to 
go on a diet because you are so big’[…].  People then don’t attend follow up for their 
smear result because if they go back then their gonna have the, “I hope you’ve 
changed your diet? Have you done this? Have you thought about this?” (Male, 
Radiographer) 
 Theme 1.3.  The unpleasant patient experience.  An experiential interview question 
required participants to place themselves in the shoes of their obese female patients.  When 
asked how they would experience their service if they were an obese female, participants 
identified common barriers associated with their own services (e.g. waiting room seats with 
arm rests that do not fit larger body sizes, limited access to larger sized wheelchairs, and 
examination tables that are too narrow or too high and difficult to get up onto for those with 
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mobility issues due to obesity), along with the recognition of discomfort experienced when 
the subject of weight arises in clinic, the potential for patient embarrassment when undressing 
for examination, and discomfort during examination. 
HCP9: I suspect that first of all, I might feel embarrassed about displaying my body to 
anybody and that might prevent me to go and see somebody.  Secondly, when I do go 
and see somebody I might have difficulty fitting into the chair that they have in the 
waiting room, in the consulting room, particularly if those chairs have side arms.  
Because, you know, my bottom might to be too large for those. […] Maybe problems 
with access if there were no lifts or escalators, because I might have difficulty 
climbing the stairs.  I would have a problem with doctors looking for my cervix, they 
would spend a lot of time fiddling around and would cause me more discomfort or 
even pain doing so.  (Male, Gynae-oncology Consultant) 
HCPs’ perceived barriers and motivators for help-seeking amongst obese women with 
symptoms of gynaecological cancers 
Four super-ordinate themes emerged to describe HCPs’ beliefs about the barriers to 
help-seeking experienced by obese women.  These included: (a) poor understanding of the 
risks and symptoms of gynaecological cancers, (b) obesity as a physical barrier (i.e. mobility, 
symptom recognition/interpretation difficulties), (c) low body-esteem (i.e. embarrassment) 
and perceived HCPs’ negative attitudes about obesity (experienced by patients at previous 
clinic visits), and (d) sociocultural and economic barriers (i.e. language, religious and 
cultural values).   
Four participants stated that from their own professional experience obesity was not a 
barrier to help-seeking, although participants identified ways in which obesity might be a 
potential barrier for obese women to seek help for symptoms of gynaecological cancers.  
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These participants stated that body size does not pose a barrier in the recognition of symptoms 
of gynaecological cancer. 
HCP14: I don’t think that the fact that they’ve got an altered body, because they are 
eating quite a lot should mean that then they are not in touch with what’s going on.  I 
don’t feel that anyway.  (Female, Gynae-oncology Consultant) 
Theme 2.1.  Poor understanding of the risks and symptoms of gynaecological 
cancers.  Some participants identified a difference between experiencing distinct symptoms 
(e.g. post-menopausal bleeding) and more vague symptoms (e.g. abdominal pain, bloating) of 
gynaecological cancers, explaining that obesity would not play a role in experiencing distinct 
symptoms of post-menopausal bleeding, as most women are aware of its abnormality and 
risks posed by this symptom.   
HCP2: For cases of abnormal bleeding, particularly in the womb cancer women tend 
to take action.  (Male, Gynae-oncology Consultant) 
HCPs agreed that patients might experience difficulties when identifying and 
interpreting the often-vague symptoms of gynaecological cancers, and further understanding 
the risk that obesity has on the development of the disease.  The presence of other diseases, 
illnesses and comorbidities associated with obesity (e.g. cardiovascular disease, hypertension, 
type 2 diabetes, polycystic ovary syndrome) may create a challenge in interpreting symptoms, 
given that obesity-related symptoms may mimic those of gynaecological cancers (e.g. 
abdominal bloating, irregular bleeding, stomach pains). 
HCP16: With ovarian cancer, abdominal symptoms of an abdominal mass may be 
more difficult to detect than in a slim or normal build woman... Symptoms like 
irritable bowel, where they get pains sort of [like gynaecological symptoms]... Obesity 
100 
 
 
can sometimes mask the symptoms, [which may lead to a] disadvantage in recognition 
or awareness of symptoms.  (Female, Gynae-oncology Nurse Specialist) 
According to some HCPs, the vague and non-specific symptoms of many 
gynaecological cancers may lead to misinterpreting symptoms as benign by patients as well as 
HCPs.  This can delay help-seeking and further delay treatment.  
HCP7: Ovarian cancer is quite delayed by the time they go to the GP because they 
don’t realise kind of that they have any problem.  You know, they put it down to the 
normal kind of symptoms like abdominal bloating or distension, so that kind of stuff.  
(Male, Gynae-oncology Registrar) 
Patients are motivated to seek help by the salience of symptoms or when the 
experience of their symptoms worsen, become too painful or unmanageable.   
HCP10: They have symptoms or problems that you just cannot ignore, so with your 
abdominal distension you cannot eat […], your bowels, waterworks aren’t working 
properly or you’re bleeding down below in a haemorrhagic kind of way.  You know, 
your pads [are] all over the place... Take a vulva cancer, it can sit there, go along for 
a period, then it becomes painful and your Panadol doesn’t get rid of the pain, and 
you need to go up on the pain killers.  You are in a position where you have to see a 
doctor or stay in pain.  (Male, Gynaecology Consultant) 
Theme 2.2.  Obesity as physical barrier.  Despite the four HCPs who initially did 
not acknowledge obesity as a help-seeking barrier, the majority of HCPs perceived obesity to 
be a potential barrier, reporting that the physical barrier of obesity is an important factor that 
affects one’s mobility and ability to undertake self-examination behaviours.  Barriers for 
those with mobility problems included experiencing physical difficulty in getting up onto the 
examination table during clinic visits, which was perceived to be physically straining to the 
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patient.  HCPs further discussed potential embarrassment due to assumed difficulties 
encountered by a consultant during examinations, which could be complicated by a patient’s 
larger size. 
HCP16: But I have had conversations with obese ladies that presented late and we 
often say, you know, “When did you have the symptoms and you know, if you had 
these symptoms you could have come earlier”.  […] They’re just embarrassed, 
because they think we’d have difficulty examining them.  Or getting [them] on and off 
the table… (Female, Gynae-oncology Nurse Specialist) 
In addition, participants recognised the potential physical challenges of self-
examination and interpreting abdominal or pelvic organ swelling as a potential symptom of 
gynaecological cancers for many obese women. 
HCP2: For vulva cancer there could be an irritation, and [they’re] not being able to 
visualise it.  The slimmer you are, obviously the easier.  You could see situations like 
in ovarian, dealing with symptoms that we associate with [cancer, such as] abdominal 
distension, so you could have quite a big cyst in there and I suppose if you’re obese, 
potentially not recognise this compared to somebody who is slim.  (Male, Gynae-
oncology Consultant) 
These clinical challenges may additionally impact on future help-seeking behaviour as 
a consequence of previous negative experiences in clinic.  Previous negative experiences in 
clinic were described as any negative experience that a patient has experienced in clinic, and 
includes negative psychological and physical impact whilst in contact with a HCP (as 
discussed above). 
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Theme 2.3.  Low body-esteem/ embarrassment and perceived HCP negative 
attitudes about obesity.  HCPs perceived that low body-esteem (i.e. negative self-evaluation 
of one’s body) amongst obese women could act as a potential barrier to help-seeking.  Body-
esteem was used as a term to describe the perceived embarrassment and discomfort women 
often experience when revealing their bodies during vaginal and pelvic examination and an 
embarrassment of one’s size or weight in the context of perceived/assumed negative 
judgement from HCPs by patients during clinic visits.   
HCP16: They say that they’re embarrassed with their perception of how we may treat 
them or may look at them... (Female, Gynae-oncology Nurse Specialist) 
Respondents described their assumption that some GPs may falsely interpret 
presenting symptoms as a comorbid condition and therefore a consequence of their patients’ 
obesity.  This initial judgment may encourage patients to withhold information about new 
symptoms that may be unrelated to any comorbidity, but represent a distinct symptom of 
gynaecological cancers. 
HCP18: I think there is a perception from overweight women that they’re going to be 
judged because of their weight.  I think there are issues around how some GPs… talk 
to patients and label them.  Ultimately I think that a lot of overweight women feel that 
anything that they go to their GP about will be labelled as a weight-related problem.  
(Female, Gynae-oncology Specialist Nurse) 
Some participants believed that patients avoided seeking health advice from a HCP 
due to previous negative experiences where weight-loss was the primary issue under 
discussion.  Specifically, one participant discussed a patient’s apprehension about attending a 
doctor’s appointment, knowing she would be told once again to lose weight.  In such cases a 
103 
 
 
patient may feel a sense of embarrassment about their own body size and their lack of weight-
loss since their last visit. 
HCP15: When they go and see their GP each time they get lectured about dieting, 
because of the diabetes and things like that, so they may not mention any bleeding or 
issues like that... If they go in with another problem which could be linked with their 
obesity they are trying to avoid another lecture about their weight problems.  (Female, 
Gynae-oncology Specialist Nurse Practitioner) 
The doctor-patient relationship was viewed as a key mediator of prompt help-seeking 
for symptoms.  Female patients could be motivated by their GP to participate in regular 
screenings, and for those who regularly visit their GP for comorbidity management these 
visits could be an opportunity to learn about the importance of early detection and help-
seeking for abnormal symptoms.  
HCP10: The GPs always give out information encouraging bleeding women to report 
in menopause.  (Male) 
Theme 2.4.  Sociocultural and economic barriers.  It is not always possible to 
separate obesity from the general factors that might act as barriers for all women regardless of 
size.  This highlights the importance of also acknowledging sociocultural and economic 
barriers (i.e. language, cultural customs, religion) that could impact on an obese woman’s 
decision and ability to seek help for symptoms of gynaecological cancers.  Such barriers 
included a link between obesity and socio-economic deprivation, which respondents 
described as influencing an individual’s views of their self-worth and esteem. 
HCP14: Socio-economic status is intimately associated with obesity.  It's difficult to 
distinguish [what] the cause of the mind-set [of the patient is], "No-one will listen to 
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me anyway” Um, you know, “The world’s against me.” (Female, Gynae-oncology 
Consultant) 
The perceived difficulties with language for non-English speaking patients included 
interpretation, mistranslations or withholding of diagnostic information.  Respondents 
observed that often families restricted communication of negative information or diagnosis to 
protect the patient.   
HCP11: Younger generations come in as interpreter and want to protect the patient 
from negative diagnostic information.  They don't want to tell mum that she's got a 
cancer.  (Male, Gynae-oncology Consultant) 
Participants identified Muslim women and women of South Asian origin as often 
experiencing limited access to health information, and practicing cultural and religious 
customs that may impact help-seeking, such as a patient’s preference to be examined by a 
female doctor, potentially involving a longer waiting period.  
HCP13:  Many women from Pakistani and Bengali background refuse a male doctor 
and request a female for gynaecology.  Some of them leave the clinic despite the fact 
that we are telling them they may be having cancer.  (Male, Gynaecology Consultant) 
Cultural barriers were perceived not only amongst the migrant or ethnic minority 
groups, but also amongst indigenous white British patients, reporting that often elderly white 
British women did not wish to bother their doctor with general health problems and that they 
interpreted their symptoms to be related to aging.  This was referred to as the “stiff upper lip” 
phenomenon.   
HCP2: Reluctance of people to seek advice from their doctor due to the ‘English stiff 
upper lip’ thing, ‘don’t bother the doctor’ and that was one of the barriers.  (Male, 
Gynae-oncology Consultant) 
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Participants discussed the significant impact that a patient’s community and social 
network has on the help-seeking process by stating that often patients approach family or 
friends with questions regarding symptoms prior to consulting a HCP.  Respondents 
perceived that a patient’s help-seeking practices were often motivated by family or friends 
who had received a gynaecological cancer diagnosis in the past, or by direct encouragement 
from family or friends.   
HCP15: Maybe because of the BRACA [breast cancer gene mutation], history of 
breast cancer as well... or friends her age who have recently had cancers.  So she was 
quite anxious because of the situation with other friends, which made her access the 
GP quite quickly because she didn’t want to go down that route.  (Female, 
Gynaecological Oncology Specialist Nurse) 
Suggested Interventions  
Participants provided some insightful suggestions for future interventions that were 
informed by their own experience.  Community education was suggested to engage the public 
in gaining knowledge of the symptoms of gynaecological cancers (e.g. through media and 
information distribution in public stores, community weight-loss programme and primary care 
settings).  Furthermore, participants expressed that education should also target HCPs by 
focusing on improving doctor-patient communication when addressing the associated risks of 
obesity and the possible emotional and sociocultural barriers that may affect help-seeking for 
gynaecological cancers. 
It was suggested that gynaecological awareness should be addressed by an 
intervention to provide the public with information regarding symptoms and risk factors for 
gynaecological cancers, and highlighting the importance of early presentation to healthcare.  
Participants suggested that leaflets should be available during regular comorbid disease 
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appointments in GP practices and other healthcare services including specialist weight-loss 
programmes.  
HCP15: If you’re targeting them who come in with the comorbidities, educating them 
about the symptoms so they would attend earlier with the symptoms.  So, “you have 
lost lots of unopposed oestrogen, you are at risk of endometrial cancer if you do have 
any bleeding go to your GP straight away.  So that you can catch cancers at an earlier 
stage rather than later.” (Female, Gynaecological Oncology Advanced Specialist 
Nurse) 
 
HCP9: We can go to weight watchers and all of the weight reducing organisations to 
solicit their help in distributing literature about cancers. (Male, Gynaecological 
Oncology Consultant) 
All participants agreed that interventions should be run within communities as well, as 
well as in the primary care settings.  Information should therefore be made available in 
community weight-loss associations, supermarkets, fast food restaurants, public toilets, and 
leaflets may also be mailed to homes.  
HCP11: The classic response to that is in GP surgeries, but if these are people that 
haven’t accessed healthcare that’s a pretty pointless thing to do.  So where do people 
go? They go to supermarkets, restaurants, fast-food restaurants, toilets.  But I would 
target supermarkets first, because if there’s one building in a town now that people 
access on more regular basis than anywhere else it would be a food outlet.  And I 
suppose that’s where the problem starts isn’t it.  Leaflets at checkouts. (Male, 
Gynaecological Oncology Consultant) 
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Participants expressed the importance of educating patients about the increased risk 
for disease and morbidity that is associated with obesity, and the necessity of doing so in a 
serious and supportive manner.  This can motivate women to seek help for symptoms.  
HCP2: You can be nice to them or you can frighten the life out of them. The 
perception is abnormal [cervical] smear means cancer.  We know that’s not true, but 
nobody ever shouts about that.  So it’s a little frightener.  One way that you can do 
things is be blunt and put up. But to say, you’re doing too much of this you’re doing 
too much of this [sigh].  Yeah, you get tired of it, you get fed up, and-but you do get an 
impact when you tie in obesity with cancer-with symptoms of cancer.  So obesity is 
associated with cancer, “your risks are increased by this if you have symptoms you’re 
one of the people we should be targeting to get to the doctor”. (Male, Gynaecological 
Oncology Consultant) 
 Interventions were suggested to encourage obese women to seek help for 
gynaecological symptoms including community run interventions to improve awareness of 
the risk factors and symptoms involved in gynaecological cancers (e.g. through media and 
information distribution in public stores, community weight-loss programme and primary care 
settings).  A service run intervention was suggested by participants to train HCPs about the 
importance of supportive doctor-patient communications during the clinical encounter with 
obese women. Furthermore, sociocultural factors should be taken into account in the 
development and application of interventions. 
Discussion and Conclusion 
 The aims of this study were to explore HCPs’ perspectives on (a) the use of 
gynaecological services amongst obese patients presenting with symptoms of gynaecological 
cancers, (b) to explore their beliefs about the potential barriers and motivators that influence 
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help-seeking amongst obese women presenting with symptoms of gynaecological cancers, 
and (c) to provide suggestions for possible interventions amongst this population (as a 
secondary aim).  HCPs working in gynaecological cancer services described a range of factors 
that present as difficulties and challenges for obese women in their practice, the reasons they 
believe these women to be at increased risk of developing cancer, and the general and specific 
factors that may influence patients’ decisions to seek help for symptoms.  
HCPs hold specific beliefs about the obese women who seek help from their services, 
and described these patients as a challenging group to work within the context of 
gynaecological cancer services.  The impact of reading these quotes from the patients’ 
perspective should be recognised as some may find the quotes judgmental or highly sensitive, 
however it is apparent in the narratives that the HCPs have to prioritise the patient’s needs for 
best care, and that these barriers are discussed with the aim of highlighting possible changes 
to practice in an often practical rather than patient-centred way, with the exception of the 
nurse narratives which appear to be more patient-centred in describing the experience of 
patients in their clinics.  Additionally, it should be acknowledged that the research topic itself, 
and the questions asked, which addressed the barriers to help-seeking and challenges in 
working with this population, may have impacted participant responses given the nature of the 
open-ended interview schedule that required participants to explore how obesity could 
possibly pose as a challenge rather than asking them closed ended questions with yes or no as 
available responses.   
The clinical challenges of obesity (e.g. anaesthetic risks, examination difficulties, 
radiotherapy, limited access to suitable equipment, scanning complications and surgery risks) 
were reported to be important factors in impacting the quality of patient care, diagnosis and 
treatment (Ferrante et al., 2009; Whittemore et al., 2005).  Given the increasing incidence of 
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obesity and endometrial cancer (World Cancer Research Fund/American Institute for Cancer 
Research, 2013; Reeves et al., 2007), it is necessary for services to provide obese women with 
the best quality care by ensuring that clinical equipment is available to accommodate larger 
body sizes (Whittemore et al., 2005).   
Further clinical challenges arise when patients lack the awareness of risks associated 
with their weight, particularly those that increase the risk for chronic disease (Soliman et al., 
2008), and when patients feel a body dissatisfaction that leads to the experience of 
embarrassment during their clinic visits (Amy et al., 2005; Ridolfi & Crowther, 2013).  
Nevertheless, some women were perceived to have accepted their obese size, which may 
make it more difficult for women to understand their risks and reduce their weight (where 
they believe obesity is not a concern), however evidence does not exist in the literature to 
suggest that fat acceptance correlates with a low body awareness or low disease-risk 
awareness.  Furthermore, respondents reported challenges in discussing weight and weight-
loss with their patients.  To cope with these challenges, participants described the ways in 
which they adapt their practice to serve the needs of this growing population.  
A key finding suggests that HCPs believe that discussing obesity-related risks and 
advising patients to lose weight can be an essential clinical role for HCPs in the UK and 
worldwide (Rose et al., 2013; Jackson et al., 2013).  However, despite public health initiatives 
in the UK and clinical guidelines that require HCPs to discuss weight-related issues and assist 
with in weight management programmes (De Normanville, Payne, & Ion, 2011; National 
Institute for Clinical Excellence [NICE] guidelines, 2014; Royal College of General 
Practitioners, 2014), HCPs continue to find weight-related discussions with their patients to 
be a difficult and uncomfortable experience (Jackson et al., 2013).  Participants justified not 
doing so according to specific conditions (e.g. prioritising treatment over discussion of 
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weight, not wanting to “insult” the patient).  For example, participants perceived that some 
patients might experience such discussions as blaming or shaming, particularly when patients 
had failed to lose weight since their last appointment (Alegria Drury & Louis, 2002).  Such 
discussions were also described as having the potential to increase feelings of embarrassment, 
particularly while undressing for examination, and when anticipating clinical difficulty during 
examination due to an individual’s larger size (Smith, Pope, & Botha, 2005).  Despite the 
clinical difficulties, respondents reported that patients who have positive or supportive 
relationships with their doctors are more likely to feel comfortable to seek help for symptoms, 
adhere to treatment, and have better health outcomes than patients who have a negative or 
absent relationship with a HCP (Auer, Sarol, Tanner & Mitchel, 2000; Phelan et al., 2015; 
Befort et al., 2006; Bogart, Bird, Walt, Delahanty & Figler, 2004).  This highlights the 
importance of positive and supportive communication in doctor-patient encounters.  
Participants were concerned about harming the doctor-patient relationship through 
discussions of weight, given that negative doctor-patient relationships can discourage future 
patient healthcare utilisation (Ferrante et al., 2009; Puhl & Heuer, 2009; Bocquier et al. 2005).  
Therefore, clinicians may benefit from training that provides helpful ways to empathetically 
address weight-loss concerns with their patients in clinic, such as engaging in supportive 
conversation with patients regarding weight-loss, and providing structured individual weight-
loss plans with follow-up visits (Jackson et al., 2013).  Although weight-loss plans are most 
suited to primary care services, all HCPs in both primary and secondary care services should 
be trained to discuss weight concerns in a respectful manner that encourages healthy lifestyle 
changes amongst women, despite previous unsuccessful weight-loss efforts (NICE, 2014). 
The results of this study identified that HCPs believe obese women face a number of 
psychological, cultural, economic and at times physical barriers in their journey toward 
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medical help-seeking for gynaecological cancers symptoms.  Key findings suggested that 
HCPs believe obese women to have a poor understanding of the symptoms and risks of 
gynaecological cancers, which is described as a key factor that may lead to the delay in help-
seeking (Boxell et al., 2012; Sheikh & Ogden, 1998; Jayde, White & Blomfield, 2010; 
Soliman et al., 2008) for this group.  This lack of awareness is further perpetuated by the 
vague and non-specific symptoms of gynaecological cancers, which may lead to 
misinterpretation of symptoms as benign by patients and HCPs who may relate symptoms to 
weight-related issues (e.g. bloating, changes in bowel habits, back pain), thereby acting as a 
barrier to individuals requiring help for malignant symptoms of gynaecological cancers 
(Macleod et al., 2009; Smith, Pope, & Botha, 2005).  
The literature suggests that body image disturbance and embarrassment to expose 
one’s body during clinical examination is a common barrier to the utilisation of medical 
services for obese patients (Alegria, Drury, & Louis, 2002; Amy et al., 2005; Ridolfi & 
Crowther, 2013; Smith, Pope, & Botha, 2005).  Findings were similar to literature reporting 
that non-attendance in preventative health screening programmes amongst obese women was 
due to barriers of weight-stigma and dismissive or derogatory language received from HCPs 
during clinic visits (Phelan, et al., 2015; Puhl & Brownell, 2006; Puhl & Heuer, 2009) and 
concerns about limitations with equipment relating to weight and or size restrictions for 
equipment (Uppot, 2007).   
Participants described various ways in which the context around women could 
influence help-seeking.  HCPs associated economic deprivation with obesity and lower 
awareness of disease risks with delayed help-seeking.  These general, contextual and cultural 
factors are important to consider when investigating the experience of seeking help for 
gynaecological symptoms given that they have been shown to impact attendance at regular 
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cervical screenings amongst minority ethnic groups (Marlow, Waller, & Wardle, 2015).  
Nevertheless, it is difficult to separate one’s context and social world from obesity, given the 
associations with obesity, sociodemographic and lifestyle factors (Gold et al., 2000).  A study 
by Ogden et al. (2001) highlighted this relationship with obesity in a study which reported 
that patients believed their obesity was due to medical problems and economic deprivation.  
Nevertheless, further investigation is needed to identify linkages between economic 
deprivation and obesity (Evans, Newton, Rutas, MacDonald, Morris, 2000) in the context of 
medical help-seeking, which the results of this study highlight may also be associated with 
self-worth or esteem.  Furthermore, an individual’s social milieu and disclosure to one’s 
social network has been shown to impact help-seeking by influencing a patient’s perception 
of symptom severity, whereby lay persons may provide information regarding a symptom that 
can encourage prompt help-seeking (Burgess et al., 2008; Calnan, 1983; Ramirez, 
Westcombe, Burgess, Sutton, Littlejohns, & Richards, 1999).  An individual’s cultural 
context may further act as a barrier to help-seeking, where non-English speaking patients or 
those with low literacy skills have limited access to cancer awareness information (i.e. 
brochures written in English, posters, advertisements) and where effective doctor-patient 
communication may be limited (Szczepura, 2005).  A review of the literature supports the 
findings of this study, suggesting that social and religious beliefs may impact delay in help-
seeking for symptoms (e.g. Muslim females waiting to see a female doctor; Chaliha & 
Stanton, 1999; Szczepura, 2005), different cultural health beliefs and practices (Bener et al., 
2002), and the ‘British stiff upper lip’ (Forbes et al., 2013).  Results also suggested that 
healthcare provision should be sensitive to the needs of religious or cultural groups (Karliner, 
Jacobs, Hm Chen, Mutha, 2007; Szczepura, 2005).  Therefore, social and cultural influences 
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as well as physical accommodations should be considered in the development of an 
intervention to improve help-seeking.  
HCPs offered insight into healthcare service barriers and factors impacting the help-
seeking behaviours of obese patients.  Participants provided information regarding the 
potential physical, psychological and social barriers to help-seeking, and discussed important 
clinical challenges that HCPs face in working with obese women in gynaecological services.  
Results initially suggest a need to improve awareness of gynaecological symptoms and risk 
factors amongst obese women, and the need for service improvement to sensitively 
accommodate obese patients in cancer care and GP services.   
Limitations and Future Directions 
 Results of the study may have been limited by the lack of gender variability recruited 
for nurses, in which all eight participant nurses were female, and responses may have differed 
if the study obtained the male nurse perspective.  Nevertheless, there were no obvious gender 
differences in the responses of the sample as a whole.  
With the growing number of overweight and obese patients, practices must be able to 
accommodate larger sizes with the availability of appropriate equipment including larger 
sized MRI and CT scanners, wheelchairs, examination tables, beds, and hoists for 
mobilization.  Clinicians may benefit from training on time-efficient and supportive 
communication skills to discuss weight-related risks and to prioritise the appropriateness of 
weight-loss along the treatment pathway.  Training may further increase clinicians’ self-
efficacy to discuss and support weight-loss amongst this population and aid in maintaining a 
positive doctor-patient relationship while raising awareness of cancer risks amongst obese 
patients. 
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The results of this study build a foundation for patient-focused research and identifies 
a potential need for an intervention to increase public awareness about symptoms and risk 
factors for gynaecological cancers (in primary care and community settings), the need to 
provide supportive environments which handle the specific needs of this group in a sensitive 
manner and the need for intervention development to acknowledge the wider cultural factors 
that can further impact help-seeking for all women experiencing symptoms of gynaecological 
cancers (Low, Simon, Waller, Wardle, & Menon, 2013a; Low, Waller, Menon, Jones, Reid, 
& Simon, 2013b). 
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CHAPTER 5: PREDICTING HELP-SEEKING FOR SYMPTOMS OF POST-
MENOPAUSAL BLEEDING 
 
Introduction 
Obesity has been associated with an increased risk of developing some gynaecological 
cancers, including endometrial and ovarian cancers.  Endometrial cancer is the most common 
gynaecological cancer and it has the strongest obesity-related risk of 81% for every 5 kg/m
2 
increase in Body Mass Index (BMI; Stevens, Jacobs, Patel, Sun, Gapstur, & McCullough, 
2014).  In addition, women report that barriers related to their weight contribute to a delay in 
the utilisation of healthcare services, encompassing gynaecological and breast cancer 
preventative screening programmes (Amy, Aalbord, Lyons, & Keranen, 2005; Aldrich & 
Hackley, 2010; Aphramor, 2012).  However, it is unknown whether a similar relationship 
exists when women are actively experiencing symptoms indicative of gynaecological cancers, 
given that the specific factors that contribute to obese women extending the time to 
presentation at healthcare services for symptoms of gynaecological cancer have not been 
identified by previous research. 
Obesity and related comorbidities, including diabetes and hyperplasia (Hardiman, 
Plillay, & Atiomo, 2003), have been associated with post-menopausal bleeding (PMB) and 
the development of endometrial cancer (See Chapter 2; Bray, dos Santos Silvia, Moller, & 
Weiderpass, 2005; Breijer et al., 2010; Memon, 2009).  Endometrial cancer is a hormonal 
carcinogenesis, which means that the storage of oestrogen in body fat can cause a thickening 
of the womb lining (i.e. the endometrium) that leads to PMB in obese women (Memon, 2009; 
Tinelli, Vergara, Martignago, Leo, Malvasi, & Tinelli, 2008).  This key risk factor is 
associated with increased morbidity in endometrial cancer (Calle & Kaaks, 2004), despite it 
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being typically characterised by a high survival rate when compared to other gynaecological 
cancers (Cancer Research UK, 2014b).  Furthermore, the reviewed literature suggests that 
disease awareness impacts on time to help-seeking (Jones & Johnson, 2012), and that there 
may be a low awareness of the risks, particularly those associated with obesity and the 
development of gynaecological cancers amongst the general public (Soliman et al., 2008).  
Therefore, obese women are at an increased risk of developing gynaecological cancers and of 
receiving later-stage diagnosis and treatment. 
Post-Menopausal Bleeding (PMB) 
PMB is defined as an episode of bleeding twelve months or more after a woman’s last 
menstrual period (Scottish Intercollegiate Guidelines Network, 2002).  PMB can be due to 
endometrial hyperplasia and associated cell tumours of the ovary (Koukourakis et al., 2008) 
or a symptom of cervical or vagina cancers, although of the cancers it is more commonly a 
symptom of endometrial cancer (Newell & Overton, 2012; Piura, Yanai-Inbar, Rabinovich, 
Zalmanov, & Goldstein, 1999).  An estimated 95% of women diagnosed with endometrial 
cancer present at healthcare services with the symptom of PMB (Brenner, 1996; Parkin, Bray, 
Ferlay, & Pisani, 2001).  Due to the strong link between obesity and the development of 
endometrial cancer, it is important to study associated symptom(s) and to assess public 
knowledge of gynaecological cancers and obesity-related risk.  
Help-seeking for PMB is a complex and dynamic process.  Despite the distinct nature 
of the symptom it should not be assumed that individuals would seek help for symptoms of 
PMB.  Although PMB is commonly recognised by patients as an abnormal experience or a 
warning sign for cancer by many menopausal and post-menopausal women given that 
intermittent bleeding is a common, yet often concerning symptom of the menopause 
(Brunswick, Wardle, & Jarvis, 2001; De Nooijer, Lechner, & De Vries, 2002a; Trivers, 
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Rodriguez, Hawkins, Cooper, Polonec, Gelb, & Purvis Cooper, 2008), it often lacks the 
salience needed to appraise the symptom as severe enough to seek medical attention, given 
that the bleeding does not usually cause pain and may not interfere greatly with daily 
functioning (Quaife et al., 2014).  Consequently, women experiencing PMB may not seek 
help unless they have an awareness of the symptom as a warning sign of cancer (Robb et al., 
2009).  
Not recognising a symptom as suspicious is one of the most common reasons given by 
cancer patients for delayed help-seeking (Chapple, Ziebland, & McPherson, 2004; Smith, 
Pope, & Botha, 2005).  A review by Jones and Johnson (2012) highlights the importance of 
this awareness and the surprising lack of knowledge amongst women regarding the risks of 
PMB.  For example, findings of the Johnson and colleagues’ (2011) study reported that half 
of the women who experienced abnormal bleeding were not aware that it was a warning sign 
for possible cancer and half waited more than one month before seeking medical help.  
Overall findings of the literature suggest a lack of awareness of symptoms of gynaecological 
cancers (Boxell et al., 2012; Jayde et al., 2010; Low, Waller, Monon, Jones, Reid, & Simon, 
2013a), particularly amongst individuals of minority ethnic groups (Lindau, Tomori, Lyons, 
Langseth, Bennett, & Garcia, 2002; Soliman et al., 2008).  
Aims and Hypotheses 
The present study aimed to: (a) identify predictors of help-seeking for PMB amongst 
women in the general population, to (b) examine whether extended time to help-seeking 
differs between obese and non-obese women, to (c) to examine whether awareness about 
gynaecological cancers (risk factors and symptoms) differs between obese and non-obese 
women, and (d) to examine whether awareness about gynaecological cancers and extended 
time to help-seeking differs across ethnic groups.  The factors examined included 
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sociocultural and demographic factors, body image satisfaction, objective body measures (i.e. 
BMI & waist-to-hip ratio; World Health Organization [WHO], 2000; WHO, 2008a), mood, 
illness perceptions (i.e. timeline, consequences, control, illness coherence, emotional 
representations) (Leventhal, Brissette & Leventhal, 2003), previous health behaviours, social 
capital and gynaecological cancer awareness.  It was hypothesised that a negative body 
image, an obese BMI, low awareness of the risk factors and/or symptoms of gynaecological 
cancers would predict an extended time to help-seeking.  It was further hypothesised that 
previous, positive health behaviours would predict timely, more immediate help-seeking, and 
that aspects of social capital and illness perceptions, namely social support, illness control and 
coherence would predict time to help-seeking.  Lastly, it was hypothesised that differences 
exist between obese and non-obese women regarding extended time to help-seeking, and that 
differences exist in awareness of gynaecological cancers amongst groups of obese and non-
obese women, as well as White-European and South Asian, Asian and Black African/other 
ethnic groups.  
Method 
Design 
The study employed a questionnaire design to explore whether there is a relationship 
between sociocultural and demographic factors, body image satisfaction, objective body size, 
mood, illness perceptions, previous health behaviours, social capital and gynaecological 
cancer awareness to identify potential differences across groups of ethnicity and obesity, and 
to further identify whether factors of obesity and ethnicity are associated with extended time 
to help-seeking for symptoms of PMB.  See Appendix G for the Study Design Flow Chart. 
The research project was sponsored by the University of Birmingham under the 
Research Governance Framework (Reference number: RG_13-315), and was approved by the 
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Black Country Committee of the National Research Ethics Service (14/WM/0117), and the 
Directorate of Research and Development of the Sandwell and West Birmingham Hospitals 
NHS Trust (Reference number: 13CAN71) to conduct the study at the City Hospital in 
Dudley and the Sandwell Hospital in Sandwell, Birmingham, West Midlands. See Appendix 
A. 
The study consisted of a non-stratified sample of 164 women with variable BMIs who 
were approached when attending their first appointment at a West Midlands PMB clinic after 
receiving an urgent referral for a suspicious symptom of cancer (i.e. post-menopausal 
bleeding or abnormal vaginal discharge).  
Recruitment and Sampling 
Patients were recruited from Sandwell and West Birmingham Hospitals NHS Trust.  
Potential participants were approached during their first visit to the PMB clinic and asked if 
they wished to participate in the study by the researcher and/or staff nurses in the waiting 
room, while they waited to be seen by the clinician (all patients were verbally informed that 
their participation in the study would not delay their visit to see the clinician).  Participants 
who expressed an interest in participating were provided with a questionnaire pack and given 
the option to complete the questionnaire in clinic, while the researcher was present to aid with 
completion, or to take it home to return to the researcher by post.  The questionnaire pack 
included an information sheet (see Appendix H), a consent form (see Appendix I), a debrief 
form (see Appendix J) and the full questionnaire (see Appendix F) with a paper-tape measure 
and a pre-paid and addressed envelope for return if they wished to complete the questionnaire 
at home.  
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Measures 
A number of factors (e.g. Sociocultural and demographic factors, body image 
satisfaction, illness perceptions, disease awareness) have been shown to delay help-seeking 
behaviour in women with gynaecological cancers.  A comprehensive literature review was 
conducted (Chapters 1 & 2) to identify psychological scales and measures examining factors 
associated with increased time to help-seeking in this group of patients in order to best answer 
the study’s research questions.  The development of the questionnaire incorporated the 
theoretical framework of Leventhal’s Self Regulation Model (SRM; Leventhal, Brissette, & 
Leventhal, 2003), the structure of the adapted Andersen’s model of help-seeking (Andersen, 
Cacioppo, & Roberts, 1995) and factors and conceptual understandings of the help-seeking 
process from the Model of Pathways to Treatment (Scott et al., 2013; Walter et al., 2012), 
with a strict adherence to the study aims of exploring the journey to help-seeking and 
collecting quantitative information to test the hypotheses that specific factors influence help-
seeking behaviour for PMB. 
 Methodology 
Limitations present in delay and help-seeking literature informed the development of 
the questionnaire, accounting for concerns with the term delay (addressed in Chapter 2), and 
the retrospective study of help-seeking behaviour.  Many help-seeking studies target 
individuals post-diagnosis, thus allowing for recall error and biased sampling (Finn et al, 
2007).  The present study therefore employed techniques to enhance recall in retrospective 
methods (Scott & Walter, 2010) through the use of a questionnaire, flow chart and open-
ended recall of symptoms experienced employed during a pre-diagnosis stage.  The study 
accounted for limitations inherent in help-seeking research through adherence to a theory-
driven approach, a focus on symptom interpretation and dynamic patient processes in help-
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seeking (Andersen, et al., 2009; Scott & Walter, 2010).  Furthermore, the study followed the 
Aarhus statements checklist for help-seeking research (see Appendix M). 
Four staff nurses and healthcare assistants, who worked daily with the target 
population in PMB clinics in Birmingham, piloted the questionnaire.  Staff gained feedback 
from clinic patients and colleagues regarding the appropriateness of the questions, wording 
and overall presentation of the questionnaire.  As a result of this, wording was simplified and 
shortened to form more concise sentences that met the needs of the patients and enhanced 
comprehension, as well as increasing the likelihood of questionnaire completion during time-
limited clinic appointments.  Furthermore, the flow chart was simplified for ease of use by 
removing excess options that were deemed inappropriate for the population (e.g. period 
cycles). 
Demographic information.  Specific health beliefs often differ across cultures 
(Baumann, 2003; Adams & Salter, 2009).  Therefore the demographics section was developed 
to comprehensively record important components of culture, ethnicity and socio-economic 
status.  The demographic form included eleven questions to determine age, marital status, 
employment, personal deprivation, education, years of residence, country of origin, religion, 
ethnicity, and generations of English language speaking in the family (see Appendix F).  To 
measure personal deprivation participants were asked to indicate their agreement with each 
statement (e.g. “I have no car available”; “I do not own a home”) by ticking the box next to 
each statement (Health Education Authority, 1995; McKay, 2010).  Ticked statements were 
scored with a 1 and non-ticked statements were scored with a 0 (total score range 0 – 5), 
therefore higher scores indicated higher levels of deprivation (see Appendix E).  Furthermore, 
to account for the multi-diverse population of Birmingham, the demographics section 
included items of cultural integration and acculturation (i.e., years of residence, language and 
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generations of English language speaking), as informed by the literature highlighting the 
importance of migration factors in research with samples that are rich in cultural diversity 
(Bhopal, 2012; Phillimore, 2012). 
Objective measures of obesity.  Two measures of weight and body size included 
BMI and waist-to-hip ratio.  Each participant’s BMI was measured (height in metres and 
weight in kilograms) in clinic by a medically trained staff.  BMI was calculated by the 
formula suggested by the WHO (2000), namely BMI = x KG / y M².  Waist-to-hip ratio was 
calculated using a self-measure of hips and waist in centimetres (WHO, 2008a), and was 
measured using a tape-measure provided.  The measure of waist-to-hip ratio was chosen as an 
additional objective measure of health (Bhopal et al., 1999; National Obesity Observatory, 
2012), and is an ethnically reliable measure of weight-related health (Ashwell & Hsieh, 2005; 
Hsieh & Yoshinaga, 1995).  According to the WHO (2008a), women with a waist-to-hip ratio 
of .8 or more are considered at risk of suffering from cardiovascular diseases and diabetes, 
and are categorised as obese and in an unhealthy body size.  Obesity was defined according to 
WHO (2000) BMI weight categories (Underweight BMI < 18.5; Normal weight BMI 18.5 – 
24.9; Overweight BMI 24 – 29.9; Obese BMI 30 – 39.9; Morbidly obese BMI > 39.9). 
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Body image.  The Body Shape Questionnaire 16A (BSQ16A; Evans & Dolan, 1993; 
see Appendix F) measured body image satisfaction.  The BSQ16A is a validated 
questionnaire employing 16 items on a six-point Likert scale questionnaire. The BSQ16A is 
suitable for the non-clinical assessment of body satisfaction, is identified as useful in studies 
of normal weight and obese samples.  Permission to use this scale was granted from authors 
of the questionnaire (Cooper et al., 1987; Evans & Dolan, 1993) for use in the present 
research.  Participants were asked to answer questions relating to how they have been feeling 
about their body over the past four weeks, and they were asked to indicate how often they 
thought about the their body shape with responses to items scaled from 1 (‘never’) to 6 
(‘always’) (e.g. “Has eating even a small amount of food made you feel fat?”).  Total scores 
ranged from 16 to 96.  Outcome variables were defined by Evans and Dolan (1993) with total 
scores of 38 to 51 indicating ‘mild concern with shape’, 52 to 66 indicating ‘moderate 
concern with shape’ and scores over 66 indicating ‘marked concern with shape’.  Reliability 
analyses showed good reliability (α = .94) for the scale (see Appendix K for reliability 
statistics of each scale). 
Illness Perceptions.  The Revised-Illness Perceptions Questionnaire (IPQ-R; Moss-
Morris et al., 2002; see Appendix F) is a validated questionnaire used to measure illness 
representation subscales of timeline, timecycle, severity of perceived consequences, illness 
coherence, perceived personal control over one’s condition, perceived control that treatment 
has over the condition and emotional representations of illness.  This scale has been used in 
gynaecological and cancer research (Gould, Brown, & Bramwell, 2009) with good internal 
consistency (α = 0.67 - 0.87) and retest reliability (0.46 – 0.87) (Moss-Morris et al., 2002).  
Free access for use of the IPQ-R and permission to adapt the questionnaire to suit specific 
illness populations was provided on the free access website (The Illness Perception 
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Questionnaire Website, 2015).  IPQ-R consisted of thirty-eight statements on a five-point 
Likert scale from one (‘strongly disagree’) to five (‘strongly agree’) (e.g. perceived control: 
“What I do can determine whether my current problem gets better or worse”).  An additional 
question asked participants to identify three possible causes of their symptom in an open-
ended question (see Chapter 6 for perceived causes).  Scoring was conducted in accordance 
with the IPQ-R scoring protocol (total possible scores ranged from 38 to 190; Moss-Morris et 
al., 2002; Weinman, Petrie, Sharpe, & Walker, 2000). Wording of the items were altered 
slightly to suit the target population for the study, replacing the word ‘illness’ with ‘condition’ 
or ‘symptoms’.  The Identity scale was removed, given that the current study was exploring 
one primary symptom (PMB).  The reliability statistics for each subscale ranged from reduced 
to good reliability for timeline (6 items: α = 0.74), cyclical timeline (4 items: α = 0.59), 
consequences (6 items: α = 0.69), illness coherence (5 items: α = 0.81), personal control (6 
items: α = 0.47), treatment control (5 items: α = .65) and emotional representations (6 items: α 
= 0.835) (see Appendix K).   
Gynaecological cancer awareness.  Gynaecological cancer awareness was measured 
by two sections that assessed for knowledge of symptoms indicative of gynaecological 
cancers and risk factors that increase the likelihood of developing gynaecological cancers (see 
Appendix F).  The development of the symptoms and risk factors awareness scales were 
informed by previous research into help-seeking for gynaecological cancer symptoms (Forbes 
et al., 2013; Low, Simon, Waller, Wardle, & Menon, 2013b; Lockwood-Rayermann, 
Donovan, Rambo, & Kuo, 2009) and risk factors (Bosetti et al., 2012; Evans, Ziebland, & 
McPherson, 2007; Jemal et al., 2013; Memon, 2009; Rose, 1996; Salehi, Dunfield, Phillips, 
Krewski, & Vanderhyden, 2008).  Each section listed potential symptoms or risk factors and 
instructed participants to indicate ‘yes’ or ‘no’ next to each symptom or risk factor to identify 
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whether they believed each was indeed a symptom or risk factor for gynaecological cancers.  
The awareness scores for each section were calculated by allocating a score of 1 to each item 
that participants correctly identified as a symptom of gynaecological cancers, and of 0 for 
each incorrect response (total possible score 0 - 17).  A reliability statistical test revealed 
reduced reliability for the two scales of symptom (17 items: α = 0.50) and risk factor 
knowledge (20 items: α = 0.54) (see Appendix K). 
Participants’ perception of their personal disease risk was assessed by a comparative 
risk measure that included three questions placed at the end of the risk factor section of the 
questionnaire (see Appendix F).  The first question asked participants to indicate ‘yes’ or ‘no’ 
to the question, “Have you ever felt at higher risk for disease than others around you?”  The 
following two questions asked participants to describe their perceived risk of developing 
cancer from when they first sought help (i.e. via GP, emergency services, or another method) 
to the date of their first visit to secondary care (at the time of participation in the questionnaire 
study).  Participants were asked to indicate whether they felt more at risk of developing 
cancer than others around them, at similar risk, or less at risk than others.  Items were scored 
from 0 (perception of being less at risk) to 2 (more at risk).  A score of 1 indicated that a 
participant perceived herself to be at similar risk to others.  Only the first question was used in 
the current study analysis to avoid redundancies amongst the variables. 
Mood.  The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 
1983; Appendix F) was used as a validated mood questionnaire.  The HADS has been used to 
measure mood in cancer research (Vodermaier & Millman, 2011).  Permission to use the 
HADS in the present research was received by the publisher and distributer (GL Assessment 
Limited, 2014).  To complete the HADS questionnaire, participants indicated responses to 
fourteen statements relating to depressed or anxious mood over the past week (e.g. ‘I feel 
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cheerful’; ‘Worrying thoughts go through my mind’).  Each statement was scored from 0 (e.g. 
‘[I feel cheerful] Most of the time’; ‘[Worrying thoughts go through my mind] Very little’) to 
3 (e.g. ‘Never’; ‘A great deal of the time’).  Outcome scores calculated depression and anxiety 
into separate subscales that ranged from 0 (normal) to 21 (severe).  The reliability statistics 
showed good reliability for each subscale of Anxiety (7 items: α = 0.86) and Depression (7 
items: α = 0.79) (see Appendix K). 
Social capital scale.  A shortened version of the Integrated Questionnaire of Social 
Capital scale (Campbell, Wood, & Kelly, 1999; Grootaert, Narayan, Jones, & Woolcock, 
2004; National Centre for Social Research and University College London, 2011; Appendix 
F) was developed and used to measure five core dimensions of social capital (i.e. 
neighbourhood belonging and enjoyment, neighbourhood safety/crime, community 
activity/participation, social support and contacts; Narayan & Cassidy, 2001).  The political 
engagement dimension was removed due to time limitations in clinic and lack of relation to 
the overall research aims.  Social capital was measured using fifteen questions with ‘yes’ or 
‘no’ as possible responses.  Neighbourhood enjoyment and social cohesion was measured by 
the first six questions of the neighbourhood section (e.g. “Is it a place you enjoy living in?”) 
and included a question measuring the length of time residing in the neighbourhood (ranging 
from less than 1 year to more than 10).  Reliability tests revealed a reduced reliability for this 
subscale (6 items: α = .50) (see Appendix K for reliability tests of each subscale).  Crime and 
safety was measured by the last three questions of the neighbourhood section (e.g. “I have had 
a personal experience of theft, mugging, break-in or other crime in the last 12 months”) and 
was found to have poor reliability (3 items: α = -.03).  Community participation was 
measured by community activity, which also included engagement in religious activities (e.g. 
“I participated in a voluntary group or local community group in the past fortnight”).  The 
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reliability statistic for the community participation subscale revealed reduced reliability (4 
items: α = .21).  Social support was measured by social contacts, using a question that asked 
the participant to indicate which statement best describes their social relationships out of a 
possible of four responses (i.e. “close contact with friends and relatives”, “either friends or 
relatives”, and “no close contact with friends/relatives”).  The final question asked 
participants to identify the number of contacts a participant made with family or friends over 
the past fortnight.  Responses were scored into three groups with four or more contacts scored 
as 3, two to three contacts scored as 2 and zero to two contacts scored as 1. 
Health history questionnaire.  Previous health behaviours and beliefs were assessed 
by a nine-item scale labelled as the health history questionnaire (HHQ) which was informed 
by DiSipio, Newman, Whiteman, Eakin and Aitken (2006) and assessed aspects of health 
behaviour in subscales of preventative screenings and examinations, health improving and 
health harming behaviours, self-perception of obesity, and current comorbidities (Appendix 
F).  Possible responses to each statement were placed on a five-point Likert scale to allow for 
responses that varied from 1 (‘strongly disagree’) to 5 (‘strongly agree’).  The first, second 
and sixth items of the scale addressed participation in preventative screenings and self-
examination behaviour (e.g. “I conduct regular breast self-checking behaviour”), and tests 
revealed a reduced reliability for this subscale (3 items: α = .26) (see Appendix K for 
reliability tests of each subscale).  The second and third items of the HHQ addressed 
behaviours that aid in improving health (i.e. healthy diet and physical activity) and showed a 
reduced reliability statistic (2 items: α = .53).  Items four and twelve addressed health 
harming behaviours (i.e. smoking and drinking alcohol) and were shown to have poor 
reliability statistic (3 items: α = -.42).  The seventh item addressed participants’ perception of 
their body weight and size (i.e. “My body weight is overweight or obese”), and the eighth 
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item addressed present comorbidities (i.e. “I have a chronic health condition that is different 
from the condition which has brought me in today”).  Items in the scale were developed to 
suit the target population of post-menopausal women. 
Journey to the Clinic and the outcome variable. The ‘Journey to the Clinic’ (see 
Appendix F) was an open-ended section of the questionnaire designed to follow the 
theoretical models of the adapted Andersen model of help-seeking (Andersen, Cacioppo & 
Roberts, 1995) and the SRM (Leventhal, Brissette, & Leventhal, 2003).  The first aim of this 
section was to measure the outcome variable of participants’ time to help-seeking, from when 
they recognised their symptom to the moment they sought medical help for it (Chapter 5).  
The second aim of this section was to map the process of help-seeking according the 
theoretical models (i.e. from recognition, appraisal to help-seeking; Chapter 6), and to 
describe the overall process of help-seeking for all participants and the differences that exist 
therein amongst different groups (e.g. obese vs. non-obese, White European vs. non-White 
European; Chapter 6).  The wording and order of the ‘Journey to the Clinic’ section was 
informed by a review of the help-seeking literature (see Chapter 2) which suggests that 
symptom recognition begins with the initial detection of bodily change(s) that are 
subsequently appraised as symptoms of illness.  Additional questions were added that 
identified self-management behaviours engaged in prior to help-seeking (Scott & Grunfeld, 
2009) and the different routes to medical help, or ‘methods of help-seeking’ (Public Health 
England, 2015), according to the Model of Pathways to Treatment (Scott et al., 2013; Walter, 
et al., 2012). 
For the purpose of the present study analysis this section measured the outcome 
variable of time to help-seeking (see Chapter 6 for further details regarding the Journey to the 
Clinic questions and flow-chart).  The outcome variable of extended time vs. timely help-
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seeking was defined by calculating the days between the first question on the flow chart (i.e. 
“When did you first notice your post-menopausal bleeding symptom?”) and the question that 
asks “What date did you attend your first doctors appointment?” 
Outcome variable: Time to help-seeking.  Given that delay has not been clinically 
defined in the context of help-seeking for symptoms of PMB, extended time to help-seeking 
is defined by increased risk of morbidity with this symptom.  It is therefore defined by the 
clinical recommendation that patients seek help immediately for the symptom of PMB (NICE, 
2005), and is supported by the two-week urgent care pathway (Pan Birmingham Cancer 
Network, 2015).  The Center for Disease Control and Prevention (CDCP, 2014) in the United 
States recommends that individuals should seek help for gynaecological symptoms within two 
weeks of initial presentation; however, an exception is made for abnormal vaginal bleeding, 
for which immediate care (although not defined) is recommended (Cooper, Polonec, Stewart, 
& Gelb, 2013).  Nevertheless, due to the UK guidelines, extended time to help-seeking is 
defined in the present study as two or more weeks, as stated above.  It should be noted that the 
outcome variable was calculated from rough estimates provided by participants.  Participants 
provided the date they first recognised their symptom of PMB (referred to as ‘recognition of a 
bodily change’) and the date they attended their first appointment with a healthcare 
professional for their symptom of PMB.  Approximate estimations were rounded up or down 
based within two-week increments.  For example, if a participant stated that the date in which 
they sought help or recognised a symptom was in the first couple of weeks of the month, they 
were encouraged by the researcher to decide if it was in the first week or the second. 
Otherwise, any range of dates, if greater than two weeks were not included in the study (given 
that this would skew the data).  Therefore, three participants who stated that they recognised 
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their symptoms in “September, 2013”, “The summer, 2014”, and “October, 2014” were not 
included in the analyses. 
The date at presentation of healthcare services includes their first contact with a 
healthcare provider, which includes attendance at a general practitioner’s, regular cervical 
screening, comorbidity appointment for another condition or emergency services. 
Participants 
The total response rate for participants who completed the questionnaire in clinic or at 
home was 67% (176 out of 264 patients recruited to the study).  Of the patients who 
participated in the study, 65% (n = 115) completed the questionnaire in the clinic and 35% (n 
= 61) returned the questionnaires via mail. Of the 176 participants who returned 
questionnaires 12 did not complete the necessary measures for inclusion in the analysis (i.e. 
did not complete the outcome measure of time to help-seeking), consequently 164 participants 
were included in the analysis. Ages ranged from 38 to 85 years (M = 58.76, SD = 8.96).  
Many of the women under 50 years of age were not post-menopausal or were medically 
induced postmenopausal due to hormonal treatment (e.g. breast cancer treatment). Thirty-one 
women (19% of the sample) measured with a normal BMI (BMI =18.5 – 24.99) and 20% (n = 
32) women were overweight (BMI = 25 – 29.9). The mean BMI of the sample was 32 (range 
= 19. - 69, SD = 8.82), with 41% (n = 68) of the participants measuring as obese and 15% (n 
= 25) as morbidly obese (BMI > 39.9).  The BMIs of eight participants (5% of the sample) 
were not measured due to mobility problems (e.g. in a wheelchair). Participants self-reported 
their ethnicity, with 69% (n = 129) of White European ethnic origin, 10% (n = 17) of a South 
Asian/Asian British ethnic origin, 6% (n = 10) of a Black African ethnic origin and 1% (n = 
3) reporting their ethnicity as ‘Other’.  Table 5.1 provides an overview of participants’ 
demographics.
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Table 5.1.  
Socio-demographic Characteristics of the Sample 
 N (n=164)       % Mean SD 
Age <50 yrs 15 9.1% 58.76 8.96 
50 - 65 yrs 111 67.7%   
 
> 66 yrs 38 23.2%         
Body Mass  Normal Weight (BMI = 18.5 -  31 18.9% 31.81 8.82 
Index 24.9)     
 Overweight (BMI = 25 - 29.9) 32 19.5%      Obese (BMI = 30 - 39.9 68 41.5%      Morbidly Obese (BMI > 40) 25 15.2%     Not measured (due to mobility problems) 8 4.9%   
      
Level of  Less than compulsory 13 7.9%    Education Completed compulsory level 98 59.8%    
 
Further/Higher Education 45 27.4%    
Did no disclose 8 4.9%   
      
Marital  Single 30 18.3%    Status Married 83 50.6%    
 
Widowed 22 13.4%    
 
Divorced/ separated 24 14.6%    Did not disclose 5 3.1%   
      
Personal  None 106 64.6%    Deprivation Minimal 47 28.7%    
 
Moderate 8 4.9%    
 Did not disclose 3 1.8%   
      
Ethnicity White European 129 68.7%    
 
Black African/ Other 13 7.9%    
 
South Asian/Asian British 17 10.4%    Did not disclose 5 3.1%   
      
Years  British Born 140 85.4%    Residence < 20 yrs 17 10.4%    in UK 10 - 20 yrs 4 2.4%      < 10 yrs 3 1.8%          
 Religion Catholic/Christian 107 65.2%   
 
Muslim 3 1.8% 
  
 
Sikh 9 5.5% 
  
 
Hindu 3 1.8% 
  
 
Other 8 4.9% 
  
 
None 27 16.5% 
  Did not disclose 7 43% 
      
Generations  Non-English Speaking 4 2.4% 
  English in First generation 12 7.3% 
  Family Second generation 15 9.2% 
 All of family English speaking 125 76.2% 
   Did not disclose 8 4.9% 
  Note: Missing values were not reported: BMI (n = 8); Education (n = 9); Personal Deprivation (n = 8); Ethnicity 
(n = 6); Marital Status (n = 7); Religion (n = 7). 
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  Clinical investigation outcomes revealed that 50% of the participants (n = 80) were 
discharged from the PMB service after confirmation of a benign biopsy or determination of 
‘no apparent problem’ at their initial visit.  The PMB investigations (i.e. pelvic examinations 
and scans) revealed benign polyp(s) or fibroid(s) in approximately 17% of participants (n = 
28).  For fourteen per cent of participants (n = 24) bleeding was due to another problem (e.g. 
pre-menopausal period bleeding, urinary issues, womb prolapse, atrophic vaginosis, problems 
with contraceptive coil), or the patient was incorrectly referred to the service prior to stopping 
hormone replacement therapy.  Table 5.2 presents an overview of the sample’s clinical 
outcomes of the PMB examination. 
Table 5.2. 
Clinical Outcome of PMB Investigation 
 
 N (n=164) % 
Endometrial cancer 
 
8 4.9% 
Cervical pre-cancer 
 
1 0.6% 
Monitoring ovarian cyst 
 
8 4.9% 
Hysterectomy (due to cancer risk) 
 
10 6.1% 
Discharged after investigation/benign biopsy 
 
80 48.9.2% 
Benign Polyp(s)/ Fibroid(s) 
 
28 17.1% 
Discharged due to non-attendance at follow-up 
 
5 3.0% 
Other Cause (e.g. urinary issue, womb prolapse, 
atrophic vaginosis, problem with coil) 
 
19 11.6% 
Incorrect referral from GP   5 3.0% 
 
Procedure 
The data for the present study was collected at two Sandwell and West Birmingham 
Hospitals NHS Trust sites of City Hospital (from 2 PMB clinics) and Sandwell Hospital 
(from 3 PMB clinics).  The primary method of questionnaire completion was in-clinic during 
the participant’s initial visit to the PMB clinic.  Those who did not wish to complete the 
questionnaire in clinic were given the opportunity to take it home to complete and return to 
the researcher (S.T.) via post.  The researcher was available in clinic to provide assistance in 
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completion of the questionnaire, either by answering questions required for completion or by 
reading the questionnaire aloud to participants, namely for visually impaired participants or 
those unable to read written English.  Participants who did not speak English were able to use 
the assistance of a professional interpreter, if available, while waiting for their visit in clinic, 
or by a family member in clinic or at home.  
To improve the questionnaire response rate, follow-up questionnaire packs were sent 
to participants’ homes, if questionnaires were not returned to the researcher within two weeks 
of a participant’s initial clinic visit.  The two-week follow-up time was determined to be 
within a timeframe that did not interfere with the recent recall of the help-seeking process, 
and was deemed suitable for access to participants prior to diagnosis, given that diagnosis and 
treatment must begin within sixty-two days from referral to the PMB clinic (NICE, 2005; Pan 
Birmingham Cancer Network, 2015).  
Preparing data for analysis 
 Reverse coding.  Reverse coding was conducted on raw data collected from the IPQ-
R and the HHQ.  Selected items (Questions 1, 4, 6, 9, 14, 15, 20, 22, 26, 28, 29, 33, 35) of the 
IPQ-R were reverse coded according to the scoring protocol (Moss-Morris et al., 2002; 
Weinman, Petrie, Sharpe, & Walker, 2000), and (Appendix F). These items corresponded 
respectively with the original IPQ-R question order of Timeline 1, Treatment control 23, 
Timeline 4, Consequences 8, Illness coherence 24, Control 15, Illness coherence 25, Control 
17, Timeline 18, Control 19, Emotional representations 36, Illness coherence 26, and Illness 
coherence 27.  Additionally, data from the HHQ (Items 4, 7 – 9) were reverse scored. 
Exploring data for outliers and correlation.  Descriptive statistics of all variables 
were conducted in order to examine the present data for possible outliers (see Appendix M).  
Inevitably, outlying scores were revealed in the data, namely in the outcome variable of time 
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to help-seeking in days, HADS depression scale, IPQ-R consequences sub-scale, waist-to-hip 
ratio, BMI, categories of ethnicity, HHQ comorbidities subscale, and the Social Capital 
subscales of neighbourhood belonging, safety and crime, and number of contacts.  Most 
researchers suggest that outliers should be changed and dealt with accordingly to improve the 
distribution of the data.  However, in the current study it was decided that, due to the 
population and nature of the scales, which are likely to describe a population with variability 
and extremes, changing the outliers might mask statistical effects and correlations, and 
ultimately affect the outcome of analyses.  Therefore, the data from the present study were not 
transformed to conform to a normal distribution.  
A review of the ethnicity factors revealed that there were not enough participants in 
each group to use these variables in the analysis (see Appendix N), the ethnicity category was 
collapsed to include three groups of ethnic categories (i.e. White European, South Asian and 
Black African/ other). All variables (Appendix E) 
All variables were further explored in a correlation matrix to identify any strong, 
highly significant correlations between them and with the outcome variable to inform 
imputation of variables into a multiple regression model (Appendix O).  From the variables 
30 were selected to be included in the analysis.  The statistical analysis was supported and 
conducted by the statistician and psychologist, CJ (as acknowledged in acknowledgments). 
Data Analysis Plan 
To answer the following research questions, a robust forward stepwise regression 
model with cross-validation was conducted to identify key predictors of extended time to 
help-seeking by two-weeks or more. 
(a) What are the predictors of delay in help-seeking amongst normal weight, 
overweight and obese women?  
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(b) Are there differences between obese and non-obese women regarding time to help-
seeking?  
An independent sample t-test was conducted to identify potential differences between 
obese and non-obese women regarding gynaecological cancer awareness. 
(c) Do knowledge and beliefs about gynaecological cancers (i.e. risk factors and 
symptoms) differ between obese and non-obese women? 
A one-way between ANOVA was conducted to compare the effect of ethnicity on 
gynaecological awareness in White European, South Asian, and Black African/ other 
ethnicity (see Appendix P). 
(d) Do knowledge and beliefs about gynaecological cancers (i.e. risk factors and 
symptoms) differ across different ethnic groups?  
Finally an independent sample t-test was conducted to identify potential differences in 
gynaecological cancer awareness between women who extended their time to help-seeking 
past two-weeks and those who did not. 
(e) Do knowledge and beliefs about gynaecological cancers (i.e. risk factors and 
symptoms) differ between women who extend time to help-seeking and those who 
do not? 
Results 
Statistical analysis 
Descriptive statistical analysis revealed a skewed distribution of time (days) to help-
seeking from the moment women first experienced a symptom to the moment they sought 
medical help for their symptom of PMB (range 0 – 3960, Median = 13.5; M = 136.29, SD = 
497.30).  Out of the total number of participants who provided the outcome variable data (n = 
164), 43% (n = 70) within one week (up to and including 7 days), with 24% (n = 39) within 
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three days, 72.6% (n = 119) sought help within one month, 13.5% (n = 22) sought help 
between one and two weeks and 27% (n = 44) took more than one month to seek help.  The 
outcome variable showed that 51.8% (n =85) took two weeks or more (14 days or more) to 
seek medical help after the detection of PMB.  See Appendix M for descriptive statistics to 
describe scores per measures presented by groups of non-obese and obese women, and ethnic 
groups of White European, South Asian and Black African/ other as well as descriptive 
information for women who extended time to help-seeking and those who did not.   
 Given that nearly a third of the sample took more than one month to seek help (range 
was from 1 month to 11 years).  See the descriptive statistics comparison of groups table 
presented in Appendix M.  Descriptive statistical analyses revealed differences between 
participants who sought help within two weeks (i.e. timely help-seekers) and those who 
extended their time beyond one month (i.e. markedly ‘delayed’/ extended time) in regards to 
the acculturation variable, ‘Generations of English speaking in the family’, such that 82% (n 
= 68) of timely help-seekers identified their family as native English speakers across four 
generations compared to only 66% (n = 33) of markedly extended time to help-seekers.  
Predictors of extended time to help-seeking 
The second phase of the analysis was concerned with identifying the predictors of 
time to help-seeking for PMB symptoms amongst women.  In order to develop a predictive 
model of time to help-seeking (in days) the 164 participants were randomly divided into two 
samples in a 7:3 ratio (Keith, 2006).  The larger sample (n = 115) was used to estimate the 
parameters of the regression model, and the smaller sample (n = 49) was retained for cross-
validation of the predictive model. 
Model estimation.  Model selection was based upon minimising the Akaike 
Information Criterion (AIC; Akaike, 1973) and conducted using R statistical analysis software 
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(see Appendix P for R code of regression model analyses).  The AIC is a measure of the 
relative quality of a statistical model for a given set of data.  Model selection using the AIC is 
considered superior to using R2 as a measure of goodness-of-fit (Spiess & Neumeyer, 2010).  
This is because the R2 statistic does not penalise for model complexity.  The stepwise 
algorithm may converge on a model that is over-fitted to the idiosyncrasies of the sample and, 
as a consequence, shows poor generalisability to novel datasets drawn from the same 
population.  In contrast, the AIC measure stringently penalises for model complexity and, as a 
result, stepwise regression models developed using this measure of model quality tend to 
show greater external validity when exposed to validation samples (O'Sullivan & Perr, 2013).  
Model estimation was undertaken in two stages.  Firstly, the 30 potential predictor 
variables (see Table 5.3) were entered in a forward stepwise regression model using AIC as 
the measure of model quality.  
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Table 5.3.  
Potential Predictor Variables Entered into Stepwise Regression 
1. BMI Social Capital 
    17. Neighborhood Belonging 
2. Waist-to-hip Ratio    18. Neighborhood Safety/Crime 
    19. Community Activity 
Mood:     20. Social Support 
   3. Anxiety     21. Social Contacts 
   4. Depression   
    22. Body Shape (BSQ-16A) 
Acculturation:   
   5. Years in  Gynaecological cancer awareness: 
     UK    23. Risk Factor Knowledge 
   6. Generations     24. Personal risk 
     Of English     25. Symptom Knowledge 
     Language  
 Health History Questionnaire (HHQ): 
Ethnicity    26. Preventative Health Behaviours  
   7. White European    27. Health Promoting Behaviour 
   8. Black African/Other    28. Health Harming Behaviour 
   9. South Asian/Asian British    29. Perceived Body Weight 
    30. Comorbidities 
Illness Perceptions Questionnaire (IPQ):  
   10. Timeline  
   11. Timecycle  
   12. Consequences  
   13. Personal Control  
   14. Treatment Control Outcome Variable:  
   15. Illness Coherence    2wks or more= extended time to help- 
   16. Emotional Representation    seeking 
 
The forward selection algorithm converged on a statistically significant model (F = 
20.22; p < 0.01) containing four predictor variables.  This model had a squared multiple 
correlation of 0.426, indicating that approximately 42.6% of the variability in extended time 
to help-seeking could be predicted by the Preventative Health Behaviours, BMI, 
Neighbourhood Safety/Crime and Emotional Representations of illness (e.g. fear).  Table 5.4 
reports the parameter coefficients and associated significant tests for this model.  
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Table 5.4. 
Regression Parameters for the Prediction of Extended Time to Reporting for Medical 
Treatment 
 
Estimate Std. Error t value Pr(>|t|) 
Outcome Variable -196.617 40.9651 -4.8 5.09E-06 
     
HHQ: Preventative Health Behaviours 143.4061 16.1433 8.883 1.49E-14 
     
BMI 1.5189 0.8233 1.845 0.0678 
     
Social Capital: Neighbourhood Safety -32.6574 20.8406 -1.567 0.12 
     
IPQ: Emotional Representation 0.8379 1.3874 0.604 0.5472 
 
Table 5.4 demonstrates three variables that are non-significant, because they correlate 
with each other, however as the p value indicates, they contribute valuable information into 
the model.  
The second stage of model estimation examined the stability of these regression 
parameters in 5000 bootstrap samples from the estimation data.  Within each of the bootstrap 
samples, the sign of the parameter and the statistical significance of the parameter were 
recorded.  These data are presented in Table 5.5.  
Table 5.5. 
The Stability of Regression Parameters in 5000 Bootstrap Samples From the Estimation Data 
Parameter 
% Significant (% of time 
variable produced change) 
% Positive 
coefficient  
% Negative 
coefficient 
HHQ: Preventative 
Health Behaviours 100 100.0 0.000000 
    
BMI 69.23077 99.70414 0.295858 
    
Social Capital: 
Neighbourhood Safety 58.87574 0.591716 99.40828 
    
IPQ: Emotional 
Representation 28.10651 86.39053 13.60947 
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Preventative Health Behaviours evidenced stable behaviour, producing a statistically 
significant positive coefficient in each of the 5000 bootstrap samples.  BMI and 
Neighbourhood Safety/Crime demonstrated a high degree of consistency in the sign of the 
parameter coefficient and both of these parameters were statistically significant in greater than 
50% of the bootstrap samples.  Despite results showing a positive coefficient in only 86% of 
the bootstrap samples for Emotion Representation, this parameter was statistically significant 
in only 28.1% of the samples showing that as emotional representation scores increase (e.g. in 
representations of fear) extended time to help-seeking increases.  Accordingly, as Emotional 
Representation displayed a high degree of variability, the bootstrap parameter estimates may 
be responsive to idiosyncratic features of the bootstrap samples and are likely to show poor 
generalisation.  Therefore, the performance of the two models (i.e. the full four variable 
model and a reduced model with Emotional Representation removed) was assessed in the 
cross validation sample. 
Cross validation.  The performance of two models was assessed in the 46 participants 
reserved for cross validation.  The first model contained all four variables from the forward 
stepwise regression procedure.  The parameter coefficients of this model are presented in 
Table 5.4 and the analysis of variance (ANOVA) and goodness of fit measures (MSE, F and 
R2) are presented in Table 5.6.  
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Table 5.6. 
ANOVA and Goodness-of-fit Measures (SE, F and R2) for the Regression Model Containing 
HHQ: Preventative Health Behaviours, BMI, Social Capital: Neighbourhood Safety and IPQ: 
Emotional Representation. 
 
Degrees of 
Freedom 
Sum of 
Squares 
Mean 
Squares F p(F) R2 
Model 1 4 168601.09 42150.27 7.24 <0.001 0.545 
       
Error 34 197870.72 5819.73 
  
 
       
Total 38 309425.23 
   
 
 
This model showed a statistically significant prediction of the cross validation sample 
(F = 7.24, p < 0.01) and evidenced an R2 value in excess of that observed in the estimation 
sample.  
The second statistical model only retained the three variables that evidenced a high 
degree of consistency in their performance within the 5000 bootstrap samples from the 
estimation data.  The parameter coefficients of this model are presented in Table 5.4 and the 
parameter estimates presented in Table 5.7. 
Table 5.7. 
Regression Parameters in the Reduced Model for the Predictions of Extended Time to Help-
seeking 
 
Estimate Std. Error t value Pr(>|t|) 
(Outcome Variable) -184.293 36.3471 -5.07 1.58E-06 
     
HHQ: Preventative Health 
Behaviours 141.1043 15.8863 8.882 1.24E-14 
     
BMI 1.6517 0.8036 2.055 0.0422 
     
Social Capital: Neighbourhood 
Safety -32.9664 20.7599 -1.588 0.1151 
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This model showed a statistically significant prediction of the cross validation sample 
(F = 9.24, p < 0.01) and an R2 value of 0.527, that was minimally different from the complete 
model reported in Table 5.6 and was in excess of that observed in the estimation sample. See 
Table 5.8.  
Table 5.8. 
ANOVA and goodness-of-fit measures (MSE, F and R2) for the reduced regression model 
containing HHQ: Preventative health behaviours, BMI and Social Capital: Neighbourhood 
safety 
 
Degrees of 
Freedom 
Sum of 
Squares 
Mean 
Squares   F    p(F) 
                
R2 
Model 2 3 
35 
38 
  163071.2 54357.08 9.47882 0.000101 0.527 
Error   200710.4 5734.583 
   Total   309425.2 
     
In conclusion, the reduced regression model containing the HHQ subscale of 
Preventative Health Behaviours, BMI and the Social Capital subscale of Neighbourhood 
Safety/Crime showed good prediction of the cross validation data of this model and did not 
reduce the performance of this equation relative to the model containing all four variables.  
Accordingly, the reduced model should be considered to give the best compromise between 
parsimony and predictive utility, and its performance in the cross validation sample would 
suggest excellent generalisability.  Surprisingly, findings suggest that an individual’s 
participation in regular preventative health behaviours (e.g. attendance at cervical and breast 
screenings) and an increase in BMI are predictive of extended time to help-seeking.  
Furthermore, individuals who perceived a high level of safety in their neighbourhoods sought 
help sooner than those from neighbourhoods that would be perceived as being high in crime.  
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Gynaecological Awareness 
For the third phase of the analysis, two independent sample t-tests were conducted to 
compare gynaecological cancer awareness about risk factors and symptoms amongst obese 
and non-obese women (Appendix P).  The results of the t-test revealed that there was no 
significant difference in symptom knowledge amongst obese (M = 10.79, SD = 2.57) and non-
obese (M = 10.85, SD = 2.47) women; t (158.33) = .16, p  > .05.  Additionally, a second t-test 
revealed that there was no significant difference in risk factor knowledge amongst obese (M = 
12.60, SD = 2.85) and non-obese (M = 12.88, SD = 2.75) women; t (159.51) = .62, p > .05.  
Findings of the t-tests suggest that obese and non-obese women do not differ in their 
awareness of the symptoms and risk factors of gynaecological cancers.   
A one-way between ANOVA was conducted to compare the effect of ethnicity on 
gynaecological awareness in White European, South Asian, and Black African/ other 
ethnicities (see Appendix P).  There was not a significant effect of ethnicity on symptom 
knowledge (F (2, 164) = 1.32, p > .05).  Additionally, there was not a significant effect of 
ethnicity on risk factor knowledge (F (2, 164) = .441, p > .05).  Taken together, these results 
suggest that an individual’s ethnicity does not affect their knowledge of the symptoms and 
risk factors of gynaecological cancers (Table 5.9a). 
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Table 5.9a. 
Mean and Standard Deviation for Symptom and Risk Factor Awareness Across Ethnicities. 
 N Mean Std. 
Deviation 
Total Possible 
        Score 
Risk Factors  
 
White European 130 12.87 2.619 5 
Black African/ other 11 12.13 2.802 7 
South Asian/Asian 
British 
17 12.20 3.438 5 
Total 158 12.74 2.722 5 
Symptoms  
 
White European 131 10.97 2.496 3 
Black African/ other 11 11.22 3.003 6 
South Asian/Asian 
British 
17 10.09 2.399 5 
Total 159 10.89 2.522 3 
 
A descriptive analysis was conducted to identify if differences existed across the 
groups of obesity and ethnicity in knowledge of obesity as a risk factor.  Results found that 
71% (n = 116) of women in the study were able to correctly identify obesity as a risk factor 
for the development of gynaecological cancer and 28% (n = 46) did not identify obesity as a 
risk factor. 
A chi-square test revealed no significant difference between the groups of obesity in 
relation to knowledge of obesity as a risk factor for gynaecological cancers (X2(1, N = 155) = 
.454, p > .05; Appendix . See Table 5.9b.  Furthermore a chi-square test revealed no 
significant difference between the groups of ethnicity in relation to knowledge of obesity as a 
risk factor for gynaecological cancers (X2(2, N = 158) = .7054, p > .05; Appendix P). 
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Table 5.9b. 
Knowledge of Obesity as a Risk factor Across Groups of Ethnicities (White European, Black 
African/Other, and South Asian/Asian British) and Non-obese or Obese. 
 Obesity As Risk factor 
[knowledge] 
Total 
Incorrect Correct 
Ethnicity White European 33 97 130 
Black African/ other 4 7 11 
South Asian/Asian British 5 12 17 
Total 42 116 158 
Obese 
Non-obese 17 51           68 
Obese/Morbidly obese 26 61           87 
Total 43 112         155 
 
A final additional analysis was conducted to compare gynaecological cancer 
awareness about risk factors and symptoms with extended help-seeking (see Appendix P) 
using an independent samples t-test.  No significant difference was found in symptom 
knowledge amongst women who sought help within two weeks (M = 10.77, SD = 2.68) and 
those who sought help after two weeks (M = 10.91, SD = 2.43); t (160.42) = -1.86, p  > .05.  
Additionally, there was no significant difference in risk factor knowledge amongst women 
who sought help within two weeks (M = 12.41, SD = 2.99) and after two weeks (M = 13.18 
SD = 2.25); t (151.84) = -1.86, p > .05.  Findings of the t-tests suggest that awareness of 
symptoms and risk factors for gynaecological cancers does not differ between the women 
who delay seeking help and those who do not.  
Discussion 
The present study aimed to: (a) identify predictors of help-seeking for PMB amongst 
women, to (b) assess for possible differences that exist between obese and non-obese women 
regarding time to help-seeking, to (c) examine whether awareness about gynaecological 
cancers (risk factors and symptoms) differ between obese and non-obese women, and to (d) 
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examine whether awareness about gynaecological cancers (risk factors and symptoms) and 
time to help-seeking differs across ethnic groups.  
Summary of Findings 
Despite the distinct nature of PMB, nearly half of the sample (49%) took two or more 
weeks to seek help from a medical professional. The regression model revealed interesting 
findings suggesting that engagement in preventative health behaviours, increased BMI and 
participants who lived in neighbourhoods characterised by high crime rates were more likely 
to extend time to help seeking for PMB.  The results of the multiple regression analyses 
showed excellent prediction of the cross validation data, and the reduced model was 
suggested to provide the best predictive utility and excellent generalisability.   
A surprising predictor variable identified by the regression model suggested that 
women who regularly attended preventative health screenings were more likely to delay 
seeking help.  This finding challenges reports in the literature suggesting that previous 
attendance at preventative health screenings shortens time to help-seeking (O’Mahony & 
Hegarty, 2009; Quine & Rubin, 1997).  However, these findings may be explained by 
negative previous interactions with healthcare professionals (HCPs) during screenings, which 
influence future healthcare utilisation (Gould, Fitzgerald, Fergs, Clemons, & Baig, 2010; 
Marlow, Waller, & Wardle, 2015) and may discourage future help-seeking for symptoms.  
Alternative explanations for understanding this association may be that attendance at regular 
screening programs may be presenting a false sense of safety to women (e.g. women may 
assume that if there was a problem it would be found at the screening) which inadvertently 
discourages women from seeking help for additional related symptoms experienced between 
screening appointments, such that women may wait until their next scheduled screening to 
raise concerns about new symptoms rather than booking an appointment with their GP.  
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Moreover, screening services may not be perceived by patients to be an appropriate setting to 
raise concerns about symptoms.  Nevertheless, such results have not been supported in the 
literature.  
The finding that increased BMI predicts extended time to help-seeking parallels 
previous research in preventative screenings and help-seeking for cancer symptoms, which 
suggest that obese women are more likely to seek healthcare services at advanced stages of 
the disease (Arndt, Stürmer, Stegmaier, Ziegler, Dhom, & Brenner, 2002; Maruthur, Bolen, 
Brancati, & Clark, 2009).  However, the relationship between BMI and time to help-seeking 
is not explained by body image dissatisfaction.  Nevertheless, descriptive statistics showed a 
slightly higher percentage of obese women in the timely help-seeking group (i.e. those who 
sought help within two weeks) when compared to markedly extended time to help-seeking 
individuals (i.e. those who took more than one month to seek help).  Therefore results may 
suggest a possible non-linear relationship between the variables of BMI and time-to-help-
seeking such that a positive relationship may exist between BMI and time to help-seeking 
until a certain point, after which point there may be no relationship at all or the relationship 
may switch directions all together.  This may occur at extremes of underweight or morbidly 
obese women.  Alternatively, these seemly contradictory findings may be explained by the 
skewed distribution of time to help-seeking in the data which suggests a large range of days to 
help-seeking from zero days to eleven years, with more than half of the sample seeking help 
within two weeks of detection. 
Furthermore, the multiple regression analyses revealed that individuals who reported 
high levels of safety within their neighbourhoods sought help sooner than those who reported 
being affected by a personal experience of crime in their neighbourhood.  It is known that an 
association often exists between neighbourhoods with higher crime rates and economically 
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deprived populations (Higgins, Robb, & Britton, 2010).  Therefore, this finding may be 
explained by low socio-economic status and crime that is associated with poorer health 
literacy, reduced cancer awareness and reduced engagement in healthcare (Boxell et al., 2012; 
Whitaker, Scott, & Wardle, 2015).  Consequently, individuals who experience regular crime 
in their neighbourhoods are more likely to live in economically deprived areas and are also 
more likely to experience greater disease morbidity and increased time to help-seeking when 
compared to those who reside in more affluent areas (Hansen, Olesen, Sørensen, Sokolowski, 
& Søndergaard 2008; Madison, Schottenfeld, James, Schwartz, & Gruber, 2004; National 
Cancer Intelligence Network, 2009a; National Cancer Intelligence Network, 2014).  This may 
be due to a prioritisation of competing lifestyle issues and concerns (e.g. maintaining personal 
safety, financial stability and job security) over issues of health or prevention and encouraging 
participation in risky health behaviours (e.g. tobacco smoking, unhealthy diet, reduced 
exercise) (Pampel, Krueger, Denney, 2010).  Individuals who live in neighbourhoods 
characterised by greater social capital (e.g. less crime, greater neighbourhood belonging and 
enjoyment, available community activities, social support) are more likely to have greater 
access to health information, increased health literacy (including cancer awareness) and are 
more likely to access healthcare services (Whitaker, Scott, & Wardle, 2015; Shaw, Egan, & 
Gillespie, 2007) when compared to individuals with a low social capital.   
No differences were found in symptom or risk factor knowledge for gynaecological 
cancers between ethnicities, and no relationship was found between gynaecological cancer 
awareness and time to help-seeking. Evidence shows that awareness of symptoms and risk 
factors for gynaecological cancers did not differ between women who delay seeking help and 
those who do not.  Findings suggested that women were able to identify just over half of the 
symptoms and risk factors correctly (at 64% and 63% respectively).  This low-moderate level 
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of awareness reflects research conducted in ovarian cancer knowledge (Low et al., 2013a).  
Low public awareness of symptoms of gynaecological cancers are reported in the previous 
literature (Boxell et al., 2012; Jayde, White & Blomfield, 2010; Low et al., 2013a; Sheikh & 
Ogden, 1998; Soliman et al., 2008).  Nevertheless, findings suggested that more than half of 
the women were able to correctly identify obesity as a risk factor for the development of 
gynaecological cancers, and there were no differences in obesity risk knowledge across 
groups of obesity and ethnicity.  Therefore, future research should investigate the awareness 
of risk factor knowledge amongst a larger sample across the UK. 
Limitations and Future Research 
The key limitations of the current study include (a) recruitment limitations and 
questionnaire complexity, (b) methodological issues (i.e. the self-report and retrospective),  
(c) the inclusion of people who sought help via cervical screening and not at presentation at 
GP surgeries, (d) the limited sample size, which may not have had sufficient power given the 
cross-validation sample, and (e) the categorisation of ethnicities into groups. 
Due to the exploratory nature of the current study, the questionnaire was complex, 
covering many different topics in a long questionnaire packet.  Inevitably, some 
questionnaires were returned incomplete.  Additionally, limitations exist within the present 
study, such as the fact that the procedure of completing the questionnaires took place from 
two different experiential time points (in clinic prior to seeing consultant at the PMB service 
and at home after seeing the consultant for PMB).  Time of questionnaire completion (before 
or after clinic appointment) may have affected participants’ level of anxiety, and their scores 
respectively.  This is due to reassurance often received from consultants during appointment 
visits, which may influence women to have more positive illness beliefs after their 
appointment.  Furthermore, the perceived causes and gynaecological knowledge scales may 
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have been influenced by the consultant’s explanation of the patient’s bleeding and thus may 
not represent the patient’s belief of cause or gynaecological cancer awareness prior to seeking 
help from the PMB clinic.  Nevertheless, each participant was informed by the researcher to 
complete the questionnaire, recalling the beliefs that they had when they first walked in the 
PMB clinic door, before visiting the consultant and receiving information about their 
condition.  Furthermore participant questionnaires may have been completed with or 
interpreted by a family member that was better able to understand English.  This lack of 
structure leaves room for false information to be entered into the questionnaire and includes 
influences of other individuals’ culture, ethnicity, gender specific beliefs and interpretation of 
language.  In summary, a total of 34% (n = 61) of the participant responses were potentially 
biased by a participant’s ability to recall how they felt when they first attended the PMB clinic 
(within one month of attendance), the findings from the IPQ, and intervening factors involved 
in completing the questionnaire at home.  Nevertheless, as with recall questionnaire studies, 
each questionnaire is limited by the participant’s ability to recall dates.  
The objectivity of the outcome measure may be challenged given that they were 
obtained from self-report estimation dates that were rounded up or down respectively by two 
weeks, making approximation dates for the beginning, middle and end of the month.  
Therefore a more objective measure would have been to obtain exact dates from GP record 
systems and triangulate with estimate s that are rounded to the nearest one or two weeks for 
all participants and map the journey to help-seeking accordingly (by one or two week 
intervals, rather than using number of days).  Nevertheless, these issues are common 
challenges in help-seeking research, which primarily uses retrospective data collection 
methods (Scott & Walter, 2010). 
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Additionally, women who attended the PMB clinic via attending a cervical screening 
rather than seeking help for a symptom may have affected the findings given that they did not 
report a concern prior to seeking help, which was developed under the assumption that ‘time 
of concern’ would be the first phase of the help-seeking journey, raising questions about the 
definition the interval of ‘detecting or recognising a bodily change’. 
Limitations may exist with the sample size, which may not have had sufficient power 
given the cross-validation sample to include and the unexpected lack of association between 
many of the variable.  Therefore, there may have been variables that were not acknowledged 
by the multiple regression analysis, due to the subtle relationships and small sample size.   
Additionally, the study may have benefited from the use of a non-parametric test, however 
given the exploratory nature of the study given that parametric tests are recommended for 
both skewed and non-normal distributions and non-parametric tests are recommended when 
the study is better represented by the median or studies with a low sample size or power.   
Therefore the multiple regression using AIC was an appropriate analysis for use in the current 
study.  Nevertheless, the results of the study future research should consider the use of a non-
parametric test.   
Given that the current study did not investigate clinical evidence for the use of this 
defined time to help-seeking cut-off point, future research should be conducted to investigate 
the clinical evidence for this definition of delay to identify potential for increased risk of 
malignancy after a determined number of days post detection of PMB. 
The current study revealed that the relationship between BMI and time to help-seeking 
is not explained by body image dissatisfaction, as suggested by the literature.  Therefore, this 
relationship should be further explored to understand how BMI influences time to help-
seeking.
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CHAPTER 6: MAPPING THE HELP-SEEKING JOURNEY 
 
Introduction 
This chapter presents an additional analysis to the study reported in the previous 
chapter, and maps the dynamic process and associated behaviours involved in seeking help 
for PMB symptoms and compares differences in help-seeking across groups (i.e. White 
European vs. Black, Asian and Minority Ethnic groups (BME); obese vs. non-obese) along 
specific intervals of the help-seeking journey, from open-ended data provided in the 
questionnaire.  
Literature suggests that individuals engage in numerous self-management behaviours 
in an attempt to resolve their symptom(s) prior to seeking medical help (Birt et al., 2014; 
Scott & Grunfeld, 2009; Whitaker, Macleod, Winstanley, Scott, & Wardle, 2015) and that 
concerns about a symptom must be present for an individual to seek help for symptoms.  
However, to date, a timeframe has not been identified between concern and help-seeking 
(Macleod, Mitchell, Burgess, Macdonald, & Ramirez, 2009; Walter et al., 2012) and no 
model has been developed to identify the activities and the self-management techniques that 
women engage in prior to seeking help for potential symptoms of gynaecological cancers. 
 Previous research has reported that obese (BMI > 29.9) women present later to 
services with more advanced disease (Arndt, Sturmer, Stegmaier, Ziegler, Dhom, & Brenner, 
2002; Maruthur, Bolen, Brancati, & Clark, 2009) and BME groups may delay help-seeking 
for symptoms of cancer more than White European populations (Macleod, Mitchell, Burgess, 
Macdonald, & Ramirez, 2009; Ramirez, Westcombe, Burgess, & Sutton, 1999; Sadler, 
Jothimani, Zanetto, & Anderson, 2009).  Nevertheless, there is mixed evidence on the effect 
of ethnicity of help-seeking.  For example, Trivers et al. (2011) reported a contradictory 
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finding that Black American women were more likely to seek help when they had a personal 
concern for developing gynaecological cancers.  
To the best of our knowledge only one study has been published that maps patients’ 
journeys from recognition of initial bodily change(s) to cancer diagnosis in a qualitative 
methods study (Molassiotis, Wilson, Brunton, & Chandler, 2010).  To date, no visual model 
has been developed to comprehensively map the journey of help-seeking for PMB and 
identify possible differences in the journey pathways of different groups (i.e. of various BMIs 
and ethnicities). 
Theoretical Framework 
The present study maps patients’ journeys to the clinic, primarily according to the 
Model of Pathways to Treatment (Scott, Walter, Webster, Sutton, & Emery, 2013) and the 
Self-Regulation Model (SRM; Leventhal, Brisette, & Leventhal, 2003) from the moment 
women recognised a change or symptom(s) in their body to the moment they sought help for 
their symptoms and received a referral to attend a PMB clinic.  Additionally, this section 
identifies behaviours that patients engaged in prior to medical help-seeking, the presence of 
concern and the perceived cause for participants’ bodily symptom(s).  Nevertheless, the 
journey to medical help-seeking does not assume nor require an attribution of illness for 
medical help-seeking to take place, given that some symptoms may be detected at regular 
appointments for screening or comorbidity management (Scott et al., 2013).  This is therefore 
taken into account by mapping the different routes to medical care.  The present study tests 
the dynamic aspects of the SRM (Leventhal, Brisette, & Leventhal, 2003) at different 
intervals during the journey and adds additional factors of self-management behaviour and 
concern, as identified in the Model of Pathways to Treatment (Scott, Walter, Webster, Sutton, 
& Emery, 2013). 
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Aims and hypothesis  
The aims of this study were to: (a) map the experience of obese women seeking help 
for potential symptoms of gynaecological cancers, and to (b) identify whether differences 
exist between obese and non-obese women and White-European and BME groups regarding 
time to help-seeking.  It is hypothesised that differences will exist between obese and non-
obese women and White European and BME groups in time taken along the journey of help-
seeking from detection to PMB clinic referral.  
Method 
Design 
The present study was part of the independent measures questionnaire design 
reported in Chapter 5; a mixed method design was adopted, addressing the last three pages of 
the questionnaire (Appendix F), which employed open-ended questions and a flow-chart 
design measure to map the journey of help-seeking for women with PMB, and to explore 
possible differences in terms of weight and ethnicity amongst groups. 
See Chapter 5 Method for information about Participants, Recruitment and Sampling.  
Measures 
Journey to the Clinic and Flow Chart.  The Journey to the Clinic section of the 
questionnaire (Appendix F) was developed to follow the structure of the adapted Andersen’s 
Model of Help-seeking (Andersen, Cacioppo, & Roberts, 1995), the principals of the SRM 
(Leventhal, Brissette & Leventhal, 2003) and the Model of Pathways to Treatment (Scott, 
Walter, Webster, Sutton, & Emery, 2013; Walter, Webster, Scott, & Emery, 2012).  This 
section employs open-ended questions to comprehensively map a participants’ journey to the 
clinic from the moment they recognised the symptom, became concerned about it, first sought 
medical help and were referred to the PMB clinic.  Additional components were added to the 
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models in the flow chart to allow for assessment of the self-management behaviours that 
participants engaged in prior to seeking medical help and the different routes individuals took 
to seek medical help (e.g. General Practitioner surgery, emergency services, gynaecological 
screenings), according to the Model of Pathways to Treatment (Scott, Walter, Webster, 
Sutton, & Emery, 2013; Walter, Webster, Scott, & Emery, 2012).  
The first question in the Journey to the Clinic section identified the detection of bodily 
change(s) and asked “When did you first begin to notice that there was a change/symptom(s) 
in your body?” and “What bodily change did you experience?”.  To answer the first question, 
space was provided for participants to fill in the day, month and year.  Here, the symptom was 
broadly defined as the issue/condition that brought the patient into the PMB clinic and was 
later specified in the flowchart as PMB.  Therefore, this initial question allowed participants 
to develop their own definition of the symptom that was meaningful to their personal 
experience.  The second question addressed concern as a potential reason to discuss the 
symptom with the healthcare provider (HCP).  Concern was measured by asking “When did 
you first realise that the symptom(s)/changes(s) was something to be concerned about?” 
Again, the participant was asked to recall the day, month and year that they experienced their 
concern.  If the participant was never concerned about the symptom, or was concerned only 
after their visit to seek medical advice (e.g. in response to the HCP’s concern about their 
symptom as a risk of cancer), a lack of concern was noted.  
The next two pages employ the use of a flowchart to map the dynamic journey to the 
clinic.  The flowchart maps the participants’ journey of help-seeking along four time 
intervals, from the first recognition of a bodily change (i.e. PMB) to recognition of concern 
(as measured by the previous page), making contact with a HCP to arrange consultation, 
attending a doctor’s appointment and receiving a referral to be seen at the PMB clinic.  
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Therefore, the journey to the clinic involves appraisal of symptoms, active help-seeking and 
diagnostic intervals of help-seeking (Scott, Walter, Webster, Sutton, & Emery, 2013; Walter, 
Webster, Scott, & Emery, 2012). 
The first question asked participants to place a date in the box that represents when 
they first noticed their symptom of PMB.  The second question addressed the self-
management behaviour that individuals took part in prior to seeking help by asking, “What 
did you do in response to this? (Select all that apply)”.  Eleven possible responses (e.g. I 
looked up the symptom online) were provided, including an open-ended ‘other’ response.  
Arrows directed the participant to the next question or corresponding questions relating to the 
answers selected.  For example, if the participant indicated, “I confided in another person” as 
one of their responses to the second question, they moved to the box marked 2a, where they 
indicated who they confided in from the seven possible responses provided.  Question 3 asked 
if any of these responses remedied the problem and, if so, for how long.  This question was 
not used in the analysis, as it yielded minimal data, suggesting that most participants indicated 
that self-management strategies did not relieve them of their bleeding symptom. 
On the second page of the flowchart, number four of the flowchart asked, “After your 
initial response to your symptom what did you do?”  Three possible responses were provided 
to map the pathways to secondary care for PMB. Responses included: (a) seeking help from 
emergency services, (b) booking an appointment with a doctor and (c) other, which allowed 
individuals to write how they sought help (e.g. at a regular diabetes check-up, at a cervical 
screening, walk-in clinic).  Each response indicated different pathways to medical help-
seeking and each mapped distinctive pathways to secondary care (PMB clinic) according to 
National Institute for Clinical Excellence Guidelines (NICE; 2005) for PMB pathways to 
treatment.  The emergency services pathway asked participants to provide the date of 
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attendance at emergency services, followed by an indication of whether they received a 
referral immediately from the emergency services to attend the PMB clinic (“yes” or ”no”).  If 
participants indicated ‘no’ for this question, they were asked how many times they had to visit 
a doctor before they were referred.  If a participant booked an appointment through their GP 
surgery, they were asked to provide the dates (day, month, year) when they contacted the 
service and attended the booked appointment.  The third question for this pathway was 
identical to the emergency pathway.  If participants indicated that they sought help through 
the third pathway (“other”), an arrow guided participants to the next box that asked, “What 
route did you take when you sought medical help?”  Possible responses included, “booked a 
doctor’s appointment”, “sought emergency services” or was “referred immediately to post-
menopausal bleeding clinic”.  If participants were not immediately referred, they were 
directed by an arrow to answer the referral question described above.  The time between the 
last three time intervals include patient, HCP and system responsibility in time to help-
seeking, (e.g. patient’s non-attendance at a scheduled appointment, lack of clinic availability 
for an appointment, or cancellation of appointments by the clinic or HCP). 
Perception of Causes.  The Illness Perception Questionnaire (IPQ-R; Moss-Morris et 
al., 2002; Weinman, Petrie, Sharpe, & Walker, 2000) was used to identify participants’ 
perceived causes for their PMB symptom according to the SRM (Leventhal, Brissette, & 
Leventhal, 2003).  This was assessed through an open-ended question at the end of the IPQ-R 
(Appendix F), which asked participants to identify three possible causes of their symptom. 
Procedure 
See Chapter 5 for detailed description of the questionnaire study procedure. 
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Data Analysis Plan 
Descriptive analyses were conducted to gain an understanding of the patients seeking 
help for PMB and to provide descriptive and comparative information to understand that 
processes toward help-seeking for 164 women.  This study was developed to be an 
exploratory mapping study, which measures the time to help-seeking through the dynamic 
processes between events involved in the journey to medical help-seeking, as reported by 
participants.  Information will be presented using a flowchart diagram that details the time to 
help-seeking (i.e. timely = within two weeks; extended = two or more weeks) for all 
participants, and the differences in time to help-seeking across the dichotomised groups of 
obesity (i.e. obese and non-obese) and ethnicity (i.e. White European and BME groups).   The 
present study answers the following research questions. 
(a) Are there differences between obese and non-obese women regarding time to help-
seeking?  
(b) Are there differences across ethnicities regarding time to help-seeking?  
(c) What is the experience of an obese woman seeking help for potential symptoms of 
gynaecological cancers?  
Due to small sample numbers for each of the following minority ethnic groups South 
Asian/South Asian British (n = 17), Black African/ Black British (n = 13),the data were 
further collapsed into dichotomous ethnicity categories of White European and BME.  
Numeric values for time between events (e.g. symptom detection, concern, help-seeking 
according to type and receipt of referral for PMB) could not be established in several cases 
due to incomplete questionnaires returned; hence, this portion of the analysis is limited to 
those participants who fully completed the journey to the clinic flow chart (n = 164).  Time 
between key events was calculated as number of days between events (as time intervals) and 
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many represent estimates provided by patients.  Descriptive statistics were calculated and 
used to report median scores and ranges, namely to account for skewed distributions.  The 
final flowchart reports were reviewed by supervisors for clarity.  See Figures 6.1 - 6.3 for 
flow charts. Additionally, the number of self-management behaviours and the types of self-
management behaviours were analysed using frequency tables and descriptive statistics.  
Results 
To further describe the sample a bivariate cross-tab analysis was conducted to identify 
possible differences between the variables of ethnicity (i.e. White European and BME) and 
obesity (i.e. obese vs. non-obese) in relation to BMI.  A Chi-square test revealed no 
significant differences between White European and BME participants and obesity according 
to BMI (X2(1, N = 161) = .012, p > .05).  A second Chi-square test revealed no significant 
differences between White European and BME participants and waist-to-hip ratio (X2(1, N = 
152) = .035, p > .05).  See Appendix Q.   
Perceived symptom causes 
Twenty-five per cent (n =39) of the participants identified their symptom of PMB as 
caused by a natural aging process, and 20% (n = 31) stated that they believed the bleeding 
was caused by menopause.  Eighteen per cent (n = 28) stated they didn’t know what was 
causing their bleeding and 13% (n = 20) stated that they believed cancer was the cause.  Table 
6.1 shows the perceived causes of PMB reported by participants.  
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Table 6.1. 
Perceived Causes for PMB at Time of Secondary Care (PMB Clinic) Visit 
 
 
n (N= 154)      % 
Natural part of the aging process 39 23.8% 
Menopause 31 18.9% 
‘Don't know’ 28 17.1% 
Cancer 20 12.2% 
Polyps or Fibroids 15 9.1% 
Side-effect or complication with medication 14 8.5% 
Overweight 13 7.9% 
Mood: Stress or depression 13 7.9% 
Poor diet/ lack of exercise 11 6.7% 
Hormone problems 11 6.7% 
Hormone replacement therapy 9 5.5% 
Womb prolapse issue 8 4.9% 
Side-effect of past surgery (pelvic/ gynaecology surgery/ caesarean) 7 4.3% 
Problems with ovaries 7 4.3% 
Bladder infection or flu 6 3.7% 
No cause 5 3.0% 
Problems with cervix 5 3.0% 
Other 17 10.4% 
        Hereditary or bad luck 4 2.4% 
        Sexual intercourse  4 2.4% 
        Bowel or stomach problem 4 2.4% 
        Indication that they are not yet menopausal 3 1.8% 
        Back problems 2 1.2% 
        Vaginal dryness 2 1.2% 
        Diagnosis of breast cancer 2 1.2% 
        Never given birth 1 1.2% 
        Problem with intrauterine device (i.e. coil) 1 1.2% 
Did not report causes 10 6.1% 
 
Self-management behaviour 
Sixty-five per cent (n = 107) of participants engaged in at least one self-management 
behaviour prior to seeking medical help for their symptom.  Specifically, 32% (n = 52) 
engaged in only one behaviour (M = 2.28, SD = 1.42.), 31% (n = 51) engaged in two self-
management behaviours, 27% (n = 44) engaged in three to four behaviours and 8% (n = 13) 
engaged in more than four self-management behaviours (see Figure 6.1).  More than half 
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(58%) (n = 95) of the participants confided in another person (31% with a family member) 
before seeking help from medical services (see Table 6.2).  Thirty-eight per cent (n = 62) 
monitored their symptoms to see whether they would improve or worsen, and 21% (n = 34) 
sought out advice or information from the Internet.  Only one person (.6%) took over-the-
counter or alternative medicine in an attempt to relieve them of their PMB symptom(s). 
Table 6.2. 
Types of Self-management Behaviour Engaged in Before Medical Help-seeking 
 
Self-management behaviour  n (N= 164) % 
Confided in another person (for advice/support)  95 57.9% 
        Family member  51 31.1% 
        Significant other  19 11.6% 
        Friend  24 14.6% 
        Pharmacist  3 1.8% 
Monitored symptoms to see whether they would improve  62 37.8% 
Looked up the symptom online  34 20.7% 
Assumed it was normal  23 14.0% 
Tried not to think about it  24 14.6% 
Assumed it was due to another condition (e.g. diabetes, anaemia)  16 9.8% 
Over the counter medicine/ alternative medicine  1 .6% 
Altered my diet/ exercise   5 3.0% 
Did not indicate self-management behaviours   1 .6% 
 
Method of help-seeking 
 
 Each participant was given an option on the flow chart to identify how they sought 
medical help (i.e. visiting Emergency services, GP surgery or Other).  Seventy-seven per cent 
(n = 126) of the participants sought help through their GP surgery, 19% (n = 32) sought help 
through other means (e.g. mentioned PMB to doctor during attendance at regular screening, 
attendance at healthcare service for other chronic comorbid condition, attendance at 
healthcare service for other problem) and 4% (n = 6) of the participants sought help via 
emergency services (Appendix Q).  
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Figure 6.1. Journey to the clinic flow-chart for all participants. (Continued on next page). 
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Figure 6.1. [Continued] Journey to the clinic flow-chart for all participants. 
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Mapping the help-seeking journey: Mapping differences  
See Figure 6.1 for flow chart presentation of results from detection of the symptom to 
referral to PMB clinic.  Analyses of variances (ANOVAs) were conducted across all four 
events to identify differences across methods of help-seeking and the time between each 
event, however, findings revealed no significant difference (see Appendix R).  Therefore, 
each time interval was mapped regardless of an individual’s help-seeking method. 
Days from detection to concern.  Ninety-one per cent (n = 150) of all participants 
reported that they were concerned prior to contacting a HCP and 12% (n = 20) reported that 
they were not concerned about the symptom prior to seeking help, suggesting that concern is 
often present before help-seeking, however, that it is not essential in the case of seeking help 
for PMB, particularly for those who sought help via preventative screening (Appendix Q).  
The total time (in days) from the moment participants detected PMB to the moment they 
became concerned about the symptom was approximately 30 days (Median = 0, range 0 – 
1810, M = 30.40, SD = 68.90; Appendix S).  See Figure 6.1. A Chi-square test revealed no 
significant difference between the groups for the presence of concern before seeking help (X2 
(2, N = 162) = 1.26, p > .05) amongst obese and non-obese women. An independent samples 
t-test revealed no significant difference in the time from detection to concern for non-obese 
(Median = 0, range 0 - 1810; M = 33, SD = 214.46) and obese (Median = 0, range 0 – 761; M 
= 20.43, SD = 90.92) women; t (90.46) = .46, p > .05 (Appendix S).  See Figure 6.2. Findings 
suggest that obesity does not play a role in the time it takes to develop concern for the 
symptom after it is detected and before seeking help.  
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Figure 6.2. Journey to the clinic: Differences between obese and non-obese women. 
(Continued on next page) 
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Figure 6.2. [Continued] Journey to the clinic: Differences between obese and non-obese 
women. 
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A Chi-square test revealed no significant difference between the groups of ethnicity 
and the presence of concern before seeking help (X2 (2, N = 164) = .54, p > .05).  A t-test 
revealed no significant difference in the time from detection to concern for White European 
(Median = 0, range 0 - 1810; M = 27.13, SD = 176.84) and BME (Median = 1, range 0 – 761; 
M = 48.73, SD = 146.96) groups; t (50.19) = -.70, p > .05 (Appendix T).  Findings suggest 
that there may be no difference between the two groups of women who identify as White 
European or BME in time taken to develop concern for the symptom after detection and 
before seeking help. See Figure 6.3. 
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Figure 6.3. Journey to the clinic: Differences between White European and BME groups. 
(Continued on next page) 
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Figure 6.3. [Continued] Journey to the clinic: Differences between White European and BME 
groups
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Days from detection to booking.  For all participants, the total time (in days) from 
the moment they detected their symptom of PMB to the moment they contacted a HCP for an 
appointment to attend a healthcare service was approximately 130 days (Median = 7, range 0 
– 3960; M = 128.70, SD = 496.27; Appendix S; Figure 6.1).  An independent samples t-test 
revealed no significant difference in the time taken from detection to booking for non-obese 
(Median = 12, range 0 – 3031; M = 112.37, SD = 422.05) and obese (Median = 7, range 0 – 
3960; M = 152.82, SD = 572.17) women; t (151.79) = -.51, p > .05. (Appendix S; Figure 6.2).  
Findings suggest that there may be no difference between obese and non-obese women in the 
time taken to book an appointment with a medical service from the moment in which women 
detected their symptom of post-menopausal bleeding. 
An independent samples t-test revealed no significant difference in the time taken 
from detection to medical booking for White European (Median = 6, range 0 – 3960; M = 
109.20, SD = 471.95) and BME (Median = 13, range 0 – 2880; M = 174.68, SD = 552.58) 
women; t (35.90) = -.58, p > .05. (Appendix T; Figure 6.3).  Findings suggest that there may 
be no difference between the two groups of White European and BME (i.e. South Asian, 
Black Caribbean, Black African, Other Asian) women in the time taken to book an 
appointment with a medical service from the moment in which women detected their 
symptom. 
Days from booking to attendance to healthcare.  For all participants, the average 
total time (in days) from contacting a HCP to attendance at medical services for their 
symptom of PMB was approximately four days (Median = 1, range 1 – 150; M = 4.29, SD = 
14.32; Appendix S; Figure 6.1).  An independent samples t-test revealed no significant 
difference in the time taken from booking an appointment with a healthcare service and 
attending the clinic for non-obese (Median = 2, range 0 – 30; M = 3.68, SD = 5.37) and obese 
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(Median = 1, range 0 – 150, M = 4.90, SD = 19.28) women; t(100.63) = -.56, p > .05 
(Appendix R; Figure 7.2)  Findings suggest that obesity does not play a role in the time it 
takes to attend an appointment after booking.  This time includes service cancellations, clinic 
scheduling availability and patient cancelations and non-attendance at scheduled 
appointments.  
A t-test revealed no significant difference in the time taken from booking an 
appointment with a healthcare service and attending the clinic for White European (Median = 
1, range 0 – 150; M = 3.84, SD = 13.67) and BME (Median = 2, range 0 – 23; M = 3.48, SD = 
4.99) groups; t(124.29) = .24, p > .05 (Appendix T; Figure 6.3)  Findings suggest that 
ethnicity may not play a role in the time it takes to attend an appointment after booking.  
Referral from first visit.  Ninety-four per cent (n = 156) of all participants received 
an immediate referral upon their first visit to medical services and 6% (n = 10) required two 
or more visits to their medical services before receiving a referral for secondary care 
(Appendix S; Figure 6.1). Furthermore, the need for two or more visits was only present 
amongst those who sought help through the method of attending a GP surgery.  Therefore, 
women who attended GP surgery as their method of help-seeking were more likely to need to 
attend more than once before receiving a referral to secondary care; t(155) = 4.467, p = .00 
(Appendix S). 
A Chi-square test revealed no significant difference between non-obese and obese 
women regarding the number of visits to a HCP before referral to PMB specialist (i.e. 
immediate referral, two or more visits) (X2(3, N = 166) = 1.66, p > .05), suggesting that there 
may be no difference in the number of visits needed to receive a referral to secondary services 
for obese and non-obese women.  See Appendix R and Figure 6.2 for the flow comparison for 
non-obese and obese women. 
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A Chi-square test revealed no significant difference between White European and 
BME groups regarding the number of visits to a HCP before referral to the PMB clinic (i.e. 
immediate referral/ two or more visits) (X2(1, N = 161) = 3.49, p > .05; Appendix T), 
suggesting that there may be no difference in the number of visits needed to receive a referral 
to secondary services for the two ethnic groupings.  See Figure 6.3. 
Discussion 
The aims of the present study were to: (a) map the experiences of obese women 
seeking help for potential symptoms of gynaecological cancers, and to (b) identify whether 
differences exist between obese and non-obese women and White-European and BME groups 
regarding time to help-seeking.  Participants’ journeys to the clinic were mapped using a 
flowchart to identify: (a) the time between symptom detection and the presence of concern, 
(b) from detection to contacting medical services for help and (c) from appointment booking 
to attendance.  Despite the minimal differences identified from all events and across both 
groups of ethnicity and obesity, the mapping study provided an interesting and comprehensive 
view of the journey to help-seeking, including the presence of concerns most often present 
prior to seeking help and immediate referrals received from alternative routes to care (i.e. 
non-GP methods of help-seeking). 
Key findings parallel previous literature suggesting that appraisal represented the 
greatest ‘delay’ time along the help-seeking journey (Andersen, Cacioppo, & Roberts, 1995; 
Scott, 2010).  Body size was represented similarly across both groups of White European and 
BME groups.  Findings identified no differences across groups of ethnicity (White European 
and BME groups) and groups of obesity (non-obese and obese women) and time to help-
seeking through the three intervals toward help-seeking.  Nevertheless, may be due to a floor 
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effect caused by a skewed distribution whereby the mean BMI of the sample was obese or due 
to the non-normal distribution of days to help-seeking. 
This chapter highlighted the complex relationship between BMI and time to help-
seeking suggesting an overall non-significant relationship between obesity and time to help-
seeking throughout the points to help-seeking.  While acknowledging that the t-test used in 
this chapter is not a as highly sensitive a measure as the previous chapter’s multiple 
regression model, evidence supports the possible explanation for a curvilinear relationship, 
whereby the relationship between BMI and time to help-seeking may exist up to a BMI 
threshold (extremes of obesity).  Consequently, future research is needed to identify the 
relationship between BMI and help-seeking for gynaecological cancers, suggesting that future 
research should employ a design with a stratified sample to account for a curvilinear 
relationship and the complexities of understanding the relationship between BMI and medical 
help-seeking. 
Additional factors involved in the help-seeking journey 
Self-management behaviours.  Analysis of self-management behaviours revealed 
that a majority of women engaged in at least one self-management behaviour prior to seeking 
medical help for their symptom, with half engaging in two or more behaviours.  More than 
half of the participants confided in another person, most to seek the advice of a family 
member and some women chose to monitor their symptoms before contacting a HCP.  
Findings are consistent with the literature suggesting that individuals often engage in multiple 
self-management behaviours prior to seeking help (Birt et al., 2014; Scott & Grunfeld, 2009; 
Whitaker et al., 2015) and often seek help only after their attempts to self-manage the 
symptom(s) have failed (Scott et al., 2013).  Findings illustrate the important role of an 
individual’s social milieu and environment in one’s decision to seek help, given that 
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individuals may choose to seek help in response to lay advice received from family or friends.  
Furthermore, the length of time one chooses to spend monitoring a symptom may additionally 
be influenced by an individual’s environment and the context of the symptom interference 
(Andersen, Cacioppo, & Roberts, 1995; Macleod et al., 2009; Smith, Pope, & Botha, 2005). 
Method of medical help-seeking.  When choosing to seek help, more than half of the 
women sought help through their GP surgery and 19% sought help through other means (e.g. 
mentioned PMB to doctor during attendance at regular screening, attendance at healthcare 
service for other chronic condition, attendance at healthcare service for other problem), with 
few choosing to seek help via emergency services.  This finding confirms evidence from the 
literature suggesting that GP surgeries are commonly the first point of contact in medical 
help-seeking (Public Health England, 2015), although it may not always be the quickest route 
to care. It is important to note the alternative pathways to care where women received help 
and immediate referral to secondary care by mentioning their bleeding to a HCP during a 
routine comorbidity management check or a regular visit to medical services for screening 
(Scott et al., 2013).  Given that the cancer recommendation is to present immediately (NICE, 
2005, Cooper, Polonec, Stewart, & Gelb, 2013), findings highlighted the effective use of the 
urgent referral service from medical services outside of primary care.  In acknowledging the 
small data sample for the emergency services method of help-seeking, future research should 
investigate help-seeking for gynaecological cancer symptoms through emergency services to 
assess the experience of help-seeking for PMB via this pathway to secondary care.  
Nevertheless, it is still recommended that women seek the help of their GP when first 
experiencing signs of PMB (Public Health England, 2015) to minimise the burden on health 
resources for PMB pathways to care. 
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Perceived symptom causes.  Findings of the present study revealed that the majority 
of women did not identify their abnormal bleeding as a warning sign of cancer and many 
women believed PMB was due to a benign condition (Evans, Zeibland, & McPherson, 2007), 
or was part of a natural aging process or a side-effect of the menopause (Low, Whitaker, 
Simon, Sekhon, & Waller, 2015).  The study supports previous reports, which suggest that 
gynaecological cancer symptoms are frequently appraised as benign conditions and not 
symptoms of cancer (Andersen, Cacioppo, & Roberts, 1995; Cooper et al., 2012; Jones & 
Johnson, 2012; Whitaker, Winstanley, Macleod, Scott, & Wardle, 2015).  Understanding the 
perception of cause is important to understand what leads women to seek help, given that 
early detection of most gynaecological cancers is dependent upon women recognising a 
symptom as meeting sufficient severity (with concern as a reason) to seek medical help 
(Chapple, Ziebland, & McPherson, 2004; Macleod et al., 2009; Smith, Pope, & Botha, 2005; 
Quaife et al., 2014; Walter et al., 2012), nevertheless patients’ perceived causes may often be 
in line with the actual diagnosis given that one in ten patients presenting with PMB will 
receive a cancer diagnosis (Newell & Overton, 2012).  This is an important finding given 
contradictory findings in the literature which suggest that PMB is a distinct symptom, often 
recognised by women as abnormal and requiring medical attention (Brunswick, Wardle, & 
Jarvis, 2001; de Nooijer, Lechner, & De Vries, 2002a; Trivers et al., 2008).  
Limitations 
Non-significant findings may be explained by limitations existing with the 
methodological choices including timing of the study in the patients’ journeys (e.g. estimation 
dates, not at presentation at GP surgeries, inclusion of attendance at cervical screening and 
comorbidities rather than help-seeking for symptoms), and the collapsing of ethnic groups. 
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The study has been limited by the self-report and retrospective nature of the 
methodology, given that women may have difficulty accurately recalling the length of time it 
took for them to become concerned about a symptom or to contact healthcare services.  To 
overcome this limitation, the study would have needed to collect data from PMB and GP 
clinics regarding date of first contact and the number of contacts with the PMB clinic prior to 
their recent visit, given that previous visits to PMB fast-track the pathway to investigation and 
diagnosis. This may have provided a more objective measure of time to contacting or visiting 
healthcare services and would have allowed the number of prior visits to be measured as a 
factor that may have influenced time to help-seeking. Another option would have been to 
conduct a prospective study which followed women from the moment they contacted their GP 
to the moment they were seen at the PMB clinic, given that contacting women at the moment 
they detect PMB would not be feasible.  
Additionally, the current study did not ask individuals who sought help for their PMB 
via the cervical screening programme if they booked their appointment after the bleed or 
before. As such, it could not be determined if the screening was their method of help-seeking 
for the PMB or a convenience method for a different problem.  Nevertheless, it may be 
assumed that those who had PMB related concern prior to seeking help attended their 
screening for the primary reason of resolving their PMB concern, however this question will 
need to be addressed in future help-seeking research to confirm this association and to assess 
the different methods of help-seeking.  Additionally, the inclusion of women who attended 
the PMB clinic via attending a cervical screenings and incidental help-seeking for a 
comorbidity rather than seeking help for a symptom may have affected the findings given that 
they did not report a concern prior to seeking help. This measure was developed under the 
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assumption that ‘time of concern’ would be the first phase of the help-seeking journey, raising 
questions about the definition the interval of ‘detecting or recognising a bodily change’. 
The collapsing of ethnicities into the BME grouping encompasses a variety of 
cultures, races and religions that exist in the Birmingham and West Midlands region (Office 
for National Statistics, 2012), which are not distinguished or defined separately in the current 
study, therefore readers must be cautious when interpreting and generalising findings to wider 
cultural contexts.  Grouping ethnic minorities into one generalisable group can be problematic 
given that the UK’s ethnic diversity changes geographically throughout the nation.   
Furthermore the term ethnicity can include additional perceptions of cultural, socio-economic, 
socio-political and genealogical understandings in it’s definition (Vickers, Craig & Atkin, 
2012), and grouping Black, Asian and minority ethnic groups together does not assume 
homogeneity across these ethnic groups.   
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CHAPTER 7: THE LIVED EXPERIENCES OF OBESE WOMEN SEEKING HELP 
FOR POST-MENOPAUSAL BLEEDING- A QUALITATIVE IPA STUDY 
 
Introduction 
Previous research suggests that obese women may experience healthcare services 
differently than normal weight women, proposing that they may have concerns about 
exposing their bodies to a healthcare professionals (HCPs) due to low body esteem, and they 
may experience weight-related stigma in healthcare settings (Buxton & Snethen, 2013; 
Ogden, Clementi, 2010; Phelan, Burgess, Yeazel, Hellerstedt, Griffin, & van Ryn, 2015; Puhl 
& Heuer, 2008).  Given their increased risk of developing gynaecological cancers (e.g. 
endometrial cancer), it is important to understand the bodily experience of post-menopausal 
bleeding (PMB) for obese women and to gain knowledge of how these women make sense of 
their experience from detection of the symptom to medical help-seeking and attendance at 
secondary care services via the urgent referral pathway. 
Qualitative research in this area has focused primarily on the experiences of 
menopause and has employed different qualitative approaches to understand the biological, 
psychological and social changes that define this natural and yet complex experience of 
female midlife.  Qualitative research has explored the distressing ways in which women 
experience menopause with increased levels of anxiety, irritability, angst and depression 
(Murphy, Verjee, Berner, & Gerber, 2013; Nosek, Kennedy, & Gudmundsdottir, 2012), the 
emotional responses to aging (Lindh-Åstrand, Hoffmann, Hammar, & Kjellgren, 2007; Nosek 
et al., 2012; Ogle & Damhorst, 2005) and the great intensity at which the symptoms of hot 
flushes, night sweats, and vaginal dryness are experienced by women (Hinchliff, Gott, & 
Ingleton, 2010; Nosek et al., 2012).  A study conducted by Ballard, Kuh and Wadsworth 
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(2001) employed a grounded theory approach to explore the processes of change during the 
menopause and identified a process that moved from the expectations of menopausal 
symptoms, to the experience of symptoms, loss of control, a confirmation of menopause, and 
finally regaining control and experiencing freedom with the cessation of menstruation.  The 
women in this study acknowledged that menopause is a biomedical change, nevertheless, they 
placed greater importance on the social context in which menopause was experienced, 
emphasising the social challenges to intimate relationships, family life, friendships and 
increased work stress caused by menopausal bodily changes.  
Qualitative studies have explored the experience of common gynaecological 
symptoms and the patients’ perception of causes (e.g. Low, Whitaker, Simon, Sekhon, & 
Waller, 2015), such as fibroids (a common cause of PMB).  Fibroids are benign tumours on 
the endometrial lining and often cause symptoms of abnormal or prolonged vaginal bleeding 
for women of pre-menopausal age (Zimmermann, Bernuit, Gerlinger, Schaefers, & Geppert, 
2012).  Experiential studies conducted with women diagnosed with fibroids have revealed 
that women experience feelings of helplessness, fear, anxiety, sadness and defeat at the loss of 
control and the social restrictions caused by their inability to manage the associated symptom 
of heavy bleeding (Ghant, Lawson, Sengoba, Recht, Mendoza, McGuire, & Marsh, 2014; 
Nicholls, Glover, & Pistrang, 2004).  In a study that employed grounded theory, Ghant and 
colleagues (2014) posited that the experience of fibroids might facilitate the development of a 
negative self-image and concern regarding appearing pregnant, overweight or less attractive.  
Findings highlighted the negative personal and social impact of fibroids and associated 
symptoms. 
A focus group study explored the experiences of PMB and urgent referral to 
secondary care for investigation (Tarling, Gale, Martin-Hirsch, Holmes, Kanesalingham, & 
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Dey, 2013).  Each participant in the study (n = 15) underwent a hysteroscopy as part of her 
investigation.  The women in the study expressed a fear of cancer was a potential cause for 
their bleeding, as well as an increased anxiety felt in response to their expedited referral 
(along the cancer pathway) and a lack of knowledge about the urgent nature of their 
investigation.  Additional findings reported that patients expressed frustration and upset after 
discharge, which may have been due to a lack of support women that women required after 
investigation, particularly for those who did not receive a cancer diagnosis, suggesting a lack 
of resolve despite the PMB investigation. 
Finally, a study by Arbuckle and colleagues (2014) employed a thematic analysis in a 
cross-cultural exploration of the PMB experience.  Findings revealed that women defined the 
severity of the symptom by the amount of blood loss and sanitary protection necessary to 
control the bleeding.  Furthermore, findings identified challenges to daily life caused by 
vaginal bleeding or irregular spotting (e.g. physical activity restrictions, avoidance of sex, 
embarrassment and anxiety of bleeding through clothing, as well as an avoidance of social 
engagements due to anxiety about anticipated bleeding and interference with work).  
The way in which individuals experience their symptom(s), choose to seek help and 
interact with healthcare services is an embodied experience that is situated in the context of 
one’s environment and social world, which consequently shapes how individuals understand 
their experience.  Accordingly, research must understand an individual within their context 
(Alonzo, 1979; Baumann, 2003; Adams & Salter, 2009) to build a comprehensive 
understanding of patients’ experiences of help-seeking and utilisation of healthcare services.  
Larkin, Eatough and Osborn (2011) describe the embodied experience as the way in which we 
perceive and involve ourselves in and with the world.  Authors posit that all experiences are 
distinctly individual and also global, relational and cultural.  Therefore, the decision to seek 
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help often comes when symptoms cause disequilibrium within one’s social world (Alonzo, 
1984). 
Help-seeking for PMB is a complex, dynamic, and highly sensitive process.  It is both 
deeply personal and socially impacting.  Despite the more distinct nature of PMB, in 
comparison with other gynaecological cancer symptoms, literature suggests that while 
commonly identified by women as abnormal when experienced after the menopause 
(Brunswick, Wardle, & Jarvis, 2001; de Nooijer, Lechner, & De Vries, 2002a; Trivers, 
Rodriguez, Hawkins, Cooper, Polonec, & Gleb, 2008), PMB is sometimes misinterpreted as a 
sign of menopause (Cacioppo, Andersen, Turnquist, & Petty, 1986; Cochran, Hacker, & 
Berek, 1986) rather than a potential symptom of cancer (Jones & Johnson, 2012). 
Given that obese women are at increased risk of developing endometrial cancer, it is 
important that research explores the unique experiences of obese women with PMB to better 
understand the help-seeking process and inform practice.  The aims of the present study were 
to explore how obese women experience and make sense of their PMB or abnormal bleeding 
(for those who were found to not be post-menopausal) and their experiences of seeking help 
from a PMB specialist clinic via urgent referral. 
Method 
Participants 
Participants included seven obese women (BMI range 36 - 62, M = 44.53, SD = 10) 
who sought help for symptoms of abnormal bleeding and were seen by an NHS secondary 
care PMB clinic in the West Midlands via the urgent referral pathway (see Chapter 5).  Ages 
of the participants ranged from 48 to 61 years of age (M = 53, SD = 4).  Five participants 
reported their ethnicity as White British (71%); one participant was South Asian Indian and 
one was Black British.  Four participants sought help for their symptom of bleeding within 
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two weeks (range 0 – 305 days, M = 56, SD = 111).  One participant contacted a HCP within 
two weeks, but waited thirty days to be seen by her GP due to scheduling and personal 
availability.  Three patients were not yet post-menopausal and one patient experienced 
bleeding and the menopause as side-effects of her breast cancer treatment medication.  Three 
participants sought help via cervical screening appointments and two participants took part in 
the study upon their second visit to the PMB clinic, therefore they were referred immediately 
to the PMB clinic without needing to book an appointment at their GP practice.  The names of 
the participants were anonymised via the use of pseudonyms: Sue, Wendy, June, Carol, 
Michelle, Sharon and Stacy.  Please see Table 7.1 for descriptive information of the 
participants.  
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Table 7.1. 
Table of IPA Participant Descriptives 
 
Participant Age Ethnicity BMI Time to contacting HCP 
Time from 
booking to 
attendance 
Total time to 
help-seeking 
Method 
of Help-
seeking 
Visits 
to PMB 
clinic 
Investigation 
results 
Sue 52 White 36 11 days 30 days 41 days GP 1st No apparent 
  British     practice visit problem 
          
Wendy 50 South 54 2 days 0 days 2 days GP 1st No apparent 
  Asian     practice visit problem 
  Indian                  
June 61 White 37 30 days 7 days 37 days Cervical 1st Pre-cancer 
  British     Screening visit /cancer risk           
Carol 53 Black 62 305 0 days 305 days Cervical 1st No apparent 
  British  days   Screening visit problem 
          
Michelle 48 White 39 3 days 0 days 3 days GP 1st No apparent 
  British   
  practice visit problem 
          
Sharon 54 White 46 3 days 3 days 6 days Cervical 2nd Benign 
  British   
  Screening visit polyps 
          
Stacy 50 White 39 0 days 0 days 0 days GP 2nd No apparent 
   British   
  practice visit problem 
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Recruitment 
Participants were recruited via the questionnaire study (Chapter 5; See Appendix G for 
the Study Design Flow Chart) by indicating on the questionnaire consent form (Appendix I) 
that they agreed to being contacted regarding participation in a future research study.  
Consenting participants were selected for the present study by meeting the inclusion criteria 
of completing the questionnaire study, being within the BMI category for upper level of 
obesity (BMI > 35.9; WHO, 2000), and having confirmed an absence of a gynaecological 
cancer diagnosis as an outcome of the recent investigation for of PMB at the Sandwell and 
West Birmingham Hospitals NHS Trust sites of City Hospital and Sandwell Hospital.  The 
first 19 participants to meet the inclusion criterion were contacted via email, telephone or post 
using the contact details provided by the participant on the questionnaire consent form 
(Appendix I).  An interview date was scheduled at the time of contact and a patient 
information sheet for the interview study was provided prior to the interview date (Appendix 
U). 
A total of 76 participants (43.2%) met the inclusion criteria for participation. Of these, 
only 23 women (13.1% of total N) consented to future participation in the interview study.  
The first 19 participants to meet the criteria were contacted to participate (10.8% of total N), 
nine women (5.1% of total N) agreed to participate in the interview study after being 
contacted by the researcher and interviews were scheduled.  Two participants cancelled their 
interviews and did not reschedule, subsequently a total of seven women participated in the 
interview study. 
The small sample size of the study is reflective of Interpretative Phenomenological 
Analysis (IPA; Smith, Flowers, & Larkin, 2009) research.  The average sample size of IPA 
studies reported in the literature is n  = 15, nevertheless, this tends to be skewed by a handful 
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of larger studies, and the typical recommendation for IPA sample sizes falls between five and 
six or six and ten participants (Smith, 2010; Reid, Flowers & Larkin, 2005).  Given this, 
sampling was chosen to reflect the upper-end of the published recommendation as a way to 
provide enough evidence for an in-depth development of themes (Smith, 2010; Smith, 
Flowers, & Larkin, 2009). 
Data collection 
Before the commencement of interviews each participant was provided with a 
participant information sheet (Appendix U) and consent form (Appendix V) to read and 
consent to participate by written signature.  Additionally, each participant was verbally 
reminded about the overall purpose and aims of the study, the open-ended conversational 
style of the interview, the audio-recording requirement for transcription, confidentiality 
policies and their right to withdrawal from the study up until one month after participation. 
The interview schedule (Appendix W) was developed to explore the unique 
experiences of obese women seeking help for PMB, the help-seeking process and to 
understand how participants make sense of their experiences.  The process of the interview 
schedule development underwent an amendment after four interviews were conducted, 
transcribed and reviewed by the PhD researcher (S. T) and supervisor (M. L) for initial 
notations, researcher reflections and emerging themes.  The first four transcript data 
highlighted an inflexibility in the interview schedule such that the questioning structure and 
the many probing questions seemed to interfere with the experiential disclosure during the 
interviews and did not fully support the flexible and exploratory epistemological stance of an 
IPA study.  Therefore, after discussion of this potential concern with the researcher’s 
qualitative research supervisor (M. L.) it was agreed that further interviews would benefit 
from a simplified interview schedule to allow for a more open-ended and exploratory 
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approach to the participants’ telling of their experiences.  Questions regarding specific date 
recollection were removed, given that they had been previously addressed in the questionnaire 
study (Chapters 5 & 6) and their interference with the experiential aims.  Additionally, the 
menopausal experience was revealed as an important transitional experience prior to PMB for 
the first four participants.  Therefore, an exploratory question about the menopausal 
experience (i.e. “Could you please tell me about your experience with menopause?”) was 
added to place PMB in the context of aging. 
All interviews took place between 2 and 18 weeks after attending the PMB clinic and 
upon receipt of investigation of results identifying no diagnoses of cancer. According to the 
urgent referral pathway buildings (Pan Birmingham Cancer Network, 2015) all patients 
received results of investigation within two weeks of attendance at the PMB clinic.  
Interviews were conducted in Sandwell Hospital and City Hospital by the researcher  (S. T.), 
who is a trained phenomenological researcher.  Semi-structured interviews were conducted 
and audio-recorded using a Dictaphone.  Participants were invited to bring a partner, close 
friend or family member to the interview to aid in the recollection of events and to provide 
support during the interview, however, only direct quotes from the participant were used in 
the analysis.  At the end of each interview, participants were given the opportunity to ask 
questions or share any additional comments.  After completion of the interview each 
participant was given a debriefing form (Appendix X).  Interview times ranged from 44 
minutes to 76 minutes (M = 55, SD = 14.4).  Interviews were transcribed verbatim and all 
names were removed from the transcript to ensure the anonymity of each participant. 
Analysis 
The study employed the qualitative approach of IPA (Smith, Flowers, & Larkin, 
2009), which is an important qualitative approach in health psychology research and was 
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developed to be used specifically in the field of psychological research (Brocki & Wearden, 
2006; Todoraova, 2011).  IPA is a flexible approach that aims to understand the lived 
experience of participants and how participants themselves make sense of and attach 
meanings to their experience. 
IPA is a phenomenological, hermeneutic and idiographic approach (Smith & Eatough 
2007).  The phenomenological aim of IPA is to explore, in-depth, how a particular 
experiential phenomenon (e.g. an event, process or relationship) is being understood from the 
person’s experiential perspective in a given context and is grounded in Husserl’s philosophy 
of intentionality of consciousness in understanding the meaning of people’s experiences 
(Creswell, 1998).  The hermeneutic describes how the phenomenon reveals itself within the 
context of interpretation, where the researcher’s own pre-conceptions are required to make 
sense of another person’s lived experience (Shaw, 2010).  Therefore IPA functions to describe 
the participant’s experience as part of a whole lived experience that involves the interactional 
influences of the social world (e.g. environment, culture) and the interpretations of the 
participant attempting to make sense of their experience while at the same time the researcher 
is attempting to make sense of the participant’s sense making (Osborn & Smith, 2008).  These 
combined interpretations of meaning create a rich and robust understanding of an experience 
as well as the significance of the experience to the individual.  IPA is idiographic rather than 
nomothetic as a means of attempting to know in detail what the experience for each person is 
like and what sense each participant is making of what’s happening to him or her.  Each case 
is analysed individually before moving to the next to elicit insights that are commonly 
overlooked in nomothetic research, which aims to generalise across individuals.  Therefore, 
the IPA approach is an appropriate method to employ in this study as it provides 
multidimensional rigour to the analysis of health and illness from the patients’ perspective 
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(Biggerstaff & Thompson, 2008) while allowing for reflection and acknowledgement of the 
relational aspects that influence experience. 
A five-step process was followed to analyse each transcript independently before 
moving onto the next case to repeat these steps and finally establish a master table of themes 
and super-ordinate themes.  The steps performed for each case included reading and re-
reading each case multiple times, writing initial notations, developing emergent themes and 
forging links between themes to establish super-ordinate themes. 
Step 1: Reading and re-reading cases.  Each case was read and re-read at least three 
times after transcription.  The first two transcripts were reviewed by the researcher’s 
supervisors (M. L. & R. H.) to check for quality and richness of description from each 
interview.  While reviewing each case, the researcher noted first impressions and engaged in 
free association writing on a separate sheet of paper, paying particular attention to the 
hermeneutic dialog and careful listening to the interview dynamics.  
Step 2: Initial notation.  During this step the researcher noted exploratory comments 
in a free-coding process highlighting significant words, pauses, tense changes and apparent 
inconsistencies or juxtapositions in the transcription.  This was followed by a close, line-by-
line analysis and dictation on the transcript to identify objects of concern, namely significant 
concepts, thoughts or things described by the participant and subsequently to describe what 
the object of concern meant to the participant in comments labelled as experiential claims 
(Larkin, 2014; Larkin et al., 2006).  Two additional comment types were used to identify the 
participant’s stance or positionality against a whole section or paragraph to understand the 
participant’s narrative tone and mood on a ‘global’ level (Larkin, 2014).  Researcher 
reflections were also dictated to make note of the researcher’s questions that arose about her 
own preconceptions or involvement in the interview, and how these might influence her 
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interpretation of the participant’s experience (Larkin, 2014).  Comments were further coded 
using italics, bolded text and underlined words to identify descriptive, linguistic and 
conceptual content in the previously dictated comments. 
Step 3: Emerging themes.  To develop emerging themes the researcher engaged in a 
hermeneutic dialogue between the transcript and comments to assign concise descriptive titles 
to the meanings attached to the objects of concern.  
Step 4: Developing case summaries for theme development.  The researcher then 
created case summaries to highlight an organisation of themes and how they were represented 
within the data for each participant (Appendix Y). 
Step 5: Developing the master table of super-ordinate themes.  The researcher 
developed clear interpretative themes which were subsequently organised into a master table 
that illustrated the relationships between themes and across cases.  Case summaries and the 
master table were reviewed at different time points by the researcher’s supervisors (M. L., R. 
H. & B. G.) and collaborative changes were discussed and agreed upon to simplify and reduce 
the number of themes and enhance the organisation of the master table. 
Ethics 
Ethical approval for the study was granted by the Black Country Committee of the 
National Research Ethics Service (14/WM/0117) and the Directorate of Research and 
Development of the Sandwell and West Birmingham NHS Trust (Reference number: 
13CAN71) to conduct the study at the sites of City Hospital and Sandwell Hospital in Dudley 
and Sandwell, West Midlands respectively (Appendix A; see Chapter 5 for full information of 
Ethics). 
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Results 
Three super-ordinate themes emerged to describe the overall experience of obese 
women seeking help through PMB clinics with sub-themes used to describe, in detail, the 
experience of PMB and the process of sense-making each participant engaged in on their 
journey from detection to secondary care investigation.  Super-ordinate themes included: (a) 
The ambiguous enmeshment of PMB and the menopause: a dynamic process, (b) the 
investigation as a necessary intrusion and (c) the chaotic body.  The ambiguous enmeshment 
of PMB and menopause was experienced through the shock of the bodily change(s), the 
paradox of knowing that describes the fear of knowing and the challenges of facing the 
unknown.  In this ambiguous process the decision to seek help is described as the penny 
dropping moment, and the experience of help-seeking is described through the tunnel with no 
end that reflects the search for an answer to explain one’s experience.  The investigation as a 
necessary intrusion describes the patients’ experiences with the healthcare service to 
investigate PMB and includes a preference for the feminine approach to medical care and the 
impact of the doctor’s actions as louder than the words they speak.  The chaotic body is 
described through the impact of the shared vs. unique experience of PMB and the menopause, 
exposing the chaos of the body to outsiders, the mistrust and hatred of the body, the catch-22 
of weight-loss and health efforts, and the uncertain risk of weight that was highlighted 
through discussion of weight-related risks for disease.  A detailed table of themes can be 
found in Table 7.2. 
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Table 7.2. 
Master Table: Superordinate Themes, Sub-themes and Emerging Theme Tables  
1) THE AMBIGUOUS ENMESHMENT       Doctor's actions as louder than the words  
OF MENOPAUSE AND PMB they speak 
The shock Mirror doctor's concern 
Why am I bleeding again after so long? Fear muffles the information 
Bleeding is not normal (I shouldn't be 
bleeding) 
 
3) THE CHAOTIC BODY 
Feeling deflated and disappointment The shared vs. unique experience 
Its not just a period Shared family experience  
 The side-effect  
The paradox of knowing  
Wanting to know vs. the fear of knowing Exposing the chaos 
The burden of knowing Internal becomes external 
Preparing for the worst Aging as old and decrepit 
 The inescapable, uncontrollable,  
The penny dropping unsolvable 
Was fed up Unprotected outside home 
Going obsessed with it all The unpredictable social  
Oh shit embarrassment 
  
The tunnel with no end Mistrust and hatred of the body 
What's happening to me? The body as an unknown 
How long is this going to go on? I hate my weight 
Searching for the cause I hate my body 
Questions remain unanswered View self in disgust 
Without resolve  
Unable to close the book/ still up in the air The catch-22 of weight-loss and  
The problem continues health 
No-one has the answers The comorbidity hurdle (e.g. arthritic, 
Where do I fit in? asthma, exercise) 
 Weight-gain as a side-effect  
2) THE INVESTIGATION AS A  Weight-loss as the struggle 
NECESSARY INTRUSION  
The feminine approach The uncertain risk of weight 
The active listener Does weight impact gynaecological  
Old-fashioned understanding problems? 
Non-judgmental How does it impact health? 
The male doctor as dismissive and lacks   
female understanding  
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Ambiguous Enmeshment of PMB and the Menopause: A Dynamic Process 
 The first theme illustrates an uncertain ambiguity that ties the two experiences of 
menopause and PMB together in a confusing and enmeshed process.  This dynamic process is 
characterised by complex and continuous ambiguity that keeps resurfacing, hanging on and is 
never resolved, despite help-seeking and/or completion of the journey through the menopause 
(i.e. from peri-menopausal to post-menopausal).  In this experience many women faced 
confusion in understanding their bodily experiences and coming to the decision to seek help.  
Additionally, this sense of confusion continued despite participants’ medical help-seeking. 
The following sub-themes are used to describe the ambiguous and confusing enmeshment of 
these experiences. 
The shock.  This sub-theme describes how the initial response to menopause and 
PMB is met with shock and disappointment when women’s expectations of what should and 
shouldn’t be happening during this time in their lives were challenged. 
The excerpt below demonstrates how a participant, Michelle, attempted to make sense 
of her frightening first encounter with powerful hot flushes during her experience of the 
menopause. 
MICHELLE: ‘What? What’s this?’ You know I couldn’t understand it.  I thought, you 
know I was having a heart attack or-or, I don’t know what I thought.  I just thought- I 
panicked.  I had a panic attack, because I didn’t know what this was, because I’d 
never experienced anything that powerful before. 
During a moment of shock, Michelle fears for her life and understands her experience 
of hot flushes as a heart attack.  The shock is accompanied by fearing for the worst. 
For PMB, the initial shock of the bleed is made alarming and disappointing when it 
follows several months without periods.  This is because the episode of bleeding suddenly 
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shatters an expectation that women are through the menopause and will no longer need to 
experience menstruation in their lifetime.  An excerpt from Stacy provides a good example of 
the shock of her PMB and her experience as a stressful disappointment.  
STACY: I might have gone for months and months and months […], nothing for- I’m 
pretty certain it was about a year.  And then BANG that happened, and it was heavy. 
[…] I did find it very very stressful and to be honest when I did have the bleed I was 
really disappointed, because I thought I’d finished with periods. 
For those who were unsure whether their periods had ended, this period-free time 
(counted as time from their last period) acted as a temporal gauge for symptom severity and 
concern.  This temporal gauge was necessary to understand severity for those whose bleeding 
was not accompanied by feelings of being unwell or in pain (more typical signs of symptom 
severity).  Carol described how the only thing concerning about the bleed was the time that 
existed between her PMB and her previous episode of bleeding. 
CAROL: I was concerned only because it had been so long since I had seen any 
bleeding, but I wasn’t- I was concerned, but I wasn’t. 
Additionally, for both Michelle and Wendy they came to understand that they 
shouldn’t be bleeding by comparing their current experiences of bleeding with the quality of 
their previous periods prior to the menopause. 
MICHELLE: […] LOTS of blood. Erm… (sigh) Awful, just AWFUL pain, erm, 
irritability.  You know, just like you would a period, but it was just- it was more severe 
than a period. […] Clots about that size [she holds up fingers in the size of a golf ball] 
coming out you know.  Like liver. 
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WENDY: […] I thought there was something wrong with me, because the blood was 
like black. 
As you can see from the excerpts above, by comparing the present quality of one’s 
bleed with previous bleeding, and identifying the quantity of time between episodes of 
bleeding women develop a cognitive method to understand their experience of PMB. This 
method is then used to develop concern for bleeding as an abnormal symptom. 
These excerpts described the shocking experience of menopausal hot flushes and 
PMB, which often leave women with more questions than answers as they attempt to assess 
the severity of their symptoms and come to acknowledge the abnormality of their experiences 
by comparing them to their existing knowledge of the menopause and previous experiences 
with menstruation. 
The paradox of knowing.  This sub-theme identifies the paradoxical experience of 
desiring to make sense of and resolve a bodily concern, the acknowledgment of one’s 
inability to do so, and recognition of the burden that accompanies such knowledge.  Women 
face a conflict between wanting to know what is wrong and the fear of knowing, such that the 
knowing could be worse than unknowing.  Carol demonstrated this conflicting process, in a 
discussion of how she came to make the decision to seek help. 
CAROL: Well I wanted to know.  I think-I think I wanted to know.  I didn’t want to 
know, but I wanted to know.  I wanted to know that there was something physically 
wrong.  I don’t know-I don’t know.  I did want to know, and I just wanted, yea, I just 
wanted to know.  That’s why I made the decision to come to the clinic and mmm, I did. 
For Carol, this decision to seek help was made after her visit to the GP, where she 
attended a regular screening and was asked about any recent bleeding.  Therefore, for her, the 
decision to seek help was made by agreeing to attend her appointment at the PMB clinic after 
 195 
being given an urgent referral.  Once Carol was able to accept that she wanted to know what 
was wrong with her body she was able to make the decision to come to the clinic, however, 
the above excerpt demonstrates the confusing back-and-forth cognitive process that Carol 
engaged in prior to seeking help.  For Sharon, her decision to seek help came once she was 
able to acknowledge that her desire to know the reason for her bleeding and to resolve the 
problem had become stronger than the fear of knowing. 
SHARON: I’d rather have it checked and be told there’s nothing than be sitting and 
wondering and worrying unnecessarily, and just go get it sorted out and then it’s 
finished and you know what it is.  Even if it’s not very nice you know what it is and 
you can deal with it whatever way. 
The excerpt from Sharon explains how, regardless of the outcome of the investigation, 
for her, the benefits of knowing far outweighed the consequences of not knowing what was 
happening within her body.  
Carol further described the fear she experienced once she’d made the decision to take 
action to seek help, whereby she felt the need to be prepared results of an investigation that 
would confirm her worst fears.  
CAROL: I was a bit nervous, yea.  A bit nervous, yea, thinking I was going to walk out 
with the weight of the world on my shoulders. […] I don’t know, I had lots of thoughts 
didn’t I?  What was I gonna do?  How was I gonna tell people what was going on, and 
you know, what was gonna happen?  How I was gonna pay the bills.  You know, I was 
thinking like all sorts of things, all sorts of things. 
Here, Carol seems to generate the worst-case scenario and begins to prepare to receive 
information of the terrible unknown.  There is a great burden of worry in the future that 
weighs heavy on her shoulders as she attends her investigation at the PMB clinic.  
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This subtheme reveals a paradox of knowing that is experienced by women in a 
dynamic process of attempting to understand their bodily experiences and rationalise their 
decision to obtain the answers to their questions. 
The penny dropping.  This subtheme describes a pivotal experience or event that 
leads to the decision to seek medical help.  This experience is defined as the penny dropping 
moment and occurs across the many different personal contexts of bleeding that vary between 
intermittent, continuous, monthly bleeding and a ‘one-off show’.  Sharon describes her penny 
dropping moment in the excerpt below. 
SHARON: I don’t think it’s very pleasant.  It’s- there’s lots of different reasons.  The 
mess of it, the embarrassment of it and the fact that you can’t control it.  And even if 
you wear underwear that – with pads and stuff it still always manages to get around it 
somehow.  So I had- for the 11 days I had to have two or three towels on me and they- 
two or three towels on top of me and a shower curtain on top of the bed, you know on 
top of the bottom sheet.  Not because I didn’t- I didn’t bleed through in the night, but I 
was frightened to and I think I was going a bit obsessed with it all […] I think it makes 
you, well it made me feel dirty, like there’s something seriously the matter with me.  
And then Google it and everything.  As soon as you Google it, cancer is the first thing 
so you start thinking, Oh shit. 
For Sharon the interruption of continuous bleeding in her daily life reached a moment 
when ‘the mess of it, the embarrassment of it and the fact that you can’t control it’ had 
become too much for her to bear.  There was an all-consuming quality of the bleeding that 
interfered with all aspects of her life and she became ‘obsessed’ with the unpredictability of 
her next bleed.  This lack of control and desire to seek out the answers to understand what 
was happening in her body led her to seek out the Internet as a resource to gain knowledge of 
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the unknown.  For Sharon the knowledge of the unknown was shocking when she was faced 
with the possibility that cancer could be the cause for her bleeding. 
The tunnel with no end.  To reveal the unknown, women asked the questions ‘what’s 
happening to me’ (Wendy) and ‘how long is this going to go on’ (Carol).  In asking these 
questions women embarked down a long tunnel to find the answers that could help them 
make sense of their experience. 
Participant June described her initial response to her bleed as an attempt to locate the 
problem and understand the cause, which was then followed by additional attempts to 
understand the problem when the rationalised cause did not fit her understanding of what was 
happening within her body. 
JUNE: I thought, ‘where’s that coming from’ thinking, ‘have I scratched myself?’ 
[…][then] I thought it might be a cyst or a polyp or something, because my mum had 
fibroids many years ago when she was expecting my brother actually.  She was in her 
30s and I thought, ‘well maybe it’s something like that if it’s a family sort of inherited 
thing. […][then] Two or three [times I visited websites], because one of the ones- one 
of the sites I found, people that had it were still going through the menopause, so I 
thought, ‘well that doesn’t really apply to me’.  So I did have another search to see if I 
could find sort of- but there wasn’t a lot actually about people that had gone totally 
through the menopause for several years and then had the symptoms. 
June’s excerpt highlights the dynamic and changing process of trying to find answers 
that could help her come to make sense of her unique experience.  June described how she 
tried to make sense of her PMB by attempting to physically identify the location and possible 
acute cause of the bleed, however, when her attempts didn’t yield the appropriate answers she 
reflected upon her family history as a possible cause.  Ultimately she sought out the Internet 
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as a resource to answer her questions, and yet she remained unable to find the answers that 
could enable her to understand her experience.  This inability to make sense of experience by 
answering the question, “what’s happening to me?” led women further down the dark tunnel.  
Carol described how in trying to make sense of her experience she began thinking of possible 
causes for her bleed and her thinking became detrimental, quickly turning to thoughts that she 
may have cancer. 
CAROL: I was thinking like, I was thinking detrimental really, ‘I wonder if I’ve got 
cancer’. 
 Inevitably, in hopes of ending the search, women turned to knowledgeable HCPs, 
friends and family members to answer their questions and receive advice on how to relieve 
them of their unwanted bodily symptoms.  Nevertheless, their questions remained unanswered 
and often symptoms continued despite their seeking medical help. 
 The excerpt below from Stacy describes how attempts to seek advice from friends 
were unsuccessful in relieving her symptoms of menopausal hot flushes. 
STACY: Yea, and I’ve tried different things [to relieve hot flushes], because all of my 
friends are 10 and 15 years older than me.  We all met as part of a bereavement group 
and I’ve had different advice.  One’s told me to try ginger, cod liver oil, and I’ve tried 
everything, and for me nothing works for me at all [to relieve hot flushes]. 
 For most women there wasn’t a complete resolve after seeking medical help, questions 
remained unanswered, investigation results were unclear or ambiguous, and symptoms 
continued.  Despite receiving results that there was no concern, women did not feel that they 
were able to ‘close the book’, leaving them to continue wandering the tunnel and waiting for 
the end to come.  Sue described this experience as a feeling that things are ‘still up in the air’ 
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as her bleeding continues despite seeking help and receiving results that indicate ‘no apparent 
problem’. 
SUE: So really I feel a bit like- still a bit up in the air.  I-I know that they took a lining 
sample and that appeared to be okay.  There was a growth or whatever, but they’re 
not duly worried about that.  But that-that’s as far as I am.  So I don’t feel like I’ve 
been able to close the book on that bit. […] And unfortunately it’s all come back to 
square one now.  However, I’ve been told that there’s nothing horribly wrong down 
there so.  And then you kind of just have to remind yourself that perhaps this will just 
carry on for as long as it wants to carry on. 
For Sue, she was left to wait until her body ‘wants’ to stop, and she nor a HCP seem to 
be able to control her body.  Furthermore, no indication was provided to suggest how long her 
body would continue bleeding for, leaving her feeling as though ‘it’s all come back to square 
one’.  This lack of resolve after medical help-seeking was also experienced by women who 
received confusing or incomplete explanations for their bodily experiences. 
In the excerpt below, Carol describes her sustained feeling of confusion even after 
seeking medical help and receiving an explanation for her PMB from a HCP. 
CAROL: What they said was that they didn’t think that erm I’d started the menopause 
yet, because I’m still having bleeds.  Erm, and they- what they- the neck of my womb 
was still too thin or something, or too thick or whatever.  So that was a sign that I 
hadn’t started the menopause […] Well it’s supposed to mean that I’m still supposed 
to be having my periods, but I don’t. […] But I’m not having a proper period as such 
[…] it’s definitely not regular.  I don’t suppose that’s all part of the course? 
For Carol and the other women in this study the definition of ‘the course’ remained 
unclear and many women found it difficult to identify where their experiences fit into the 
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biomedical stages of the menopause (i.e. peri-menopausal, menopausal, post-menopausal).  
Another example of this is presented in Sharon’s excerpt below, where she expresses her 
frustration in trying to identify where she fits in with the stages of menopause, given that her 
experience of help-seeking did not answer key questions of how long she should be 
experiencing the intermittent bleeding before it would be defined as abnormal. 
SHARON: All I want to know is are there tests that you can say that, yea, “Yea, you’re 
in the middle. You’re coming towards the end.”  But I don’t even know if that exists 
so.  So, but he didn’t say it didn’t exist, other than, that all we know is when you’ve 
completely finished. […] I think for me I would rather have that kind of information.  
Erm, but I obviously didn’t get it. 
Sharon’s excerpt provides an understanding of the complex and often ambiguous 
stages of the menopause, and the lack of information provided by healthcare services 
regarding the process and experiences involved in the transition through menopause.  During 
this process many women experienced confusion when attempting to understand their bodily 
experiences and were unclear about the stage of menopause that they were in.  Consequently, 
they were unable to identify their experience as abnormal.  Much of this confusion was 
reflected in their experiences of coming to a decision to seek help and continued despite 
medical help-seeking and discharge from investigation, leaving them with unanswered 
questions (e.g. “how long will this go on for?”).  
The Investigation as a Necessary Intrusion 
 This theme describes the female patients’ interactions with healthcare services, the 
impact of the HCP in the experience of help-seeking and the uncomfortable, frightening and 
at times painful experiences of investigation that are necessary for patients to understand what 
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is wrong inside their bodies and is an essential step toward treatment for their symptom of 
PMB. 
The feminine approach.  The first sub-theme describes women’s preferences for a 
female doctor (i.e. General Practitioner) over a male doctor, detailing negative previous 
experiences where they felt misunderstood or wrongfully dismissed by a male doctor.  
Women described the feminine approach to care as characterised by active listening, and the 
ability to empathetically interact with female patients. 
Sue described how her experience of feeling dismissed by a male doctor when seeking 
help for symptoms of menopause influenced her to request a female doctor when seeking help 
for her recent experience of PMB. 
SUE: Erm it-it-it probably wasn’t, but how it felt was, ‘oh it’s women’s problems it 
will sort itself out.  It’s your age, this is what you have to expect’. He probably didn’t 
say that, but that’s how it felt- it came across. 
In her experience, Sue perceived the male doctor to be unable to understand her 
distinctly female experience and furthermore, his approach ‘came across’ as dismissive of her 
concern by assuming that it would ‘sort itself out’ without medical help.  This experience 
emphasised a discomfort that Sue felt with male doctors, which was reflected in her 
interpretation of her doctor’s response to her concern.  Sue later described how she 
experienced the feminine approach to care as more positive and comfortable. 
SUE: Erm well she actively listened, and she obviously knew more than I did, and she 
was reassuring, you know, straight away, “Right we’ll have these blood tests done, 
that blood test done”.  
Sue’s excerpt provides an example of women’s preference for a female doctor and a 
greater sense of comfort with being seen by a female rather than a male, given that a female 
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doctor possesses the capacity to understand and empathise with patients’ experiences of being 
a woman.  This is described clearly in June’s excerpt below. 
JUNE: I just thought, I’m more comfortable with a lady doctor […] Old fashioned I 
suppose […] Yea, just to be with somebody that understands what your going through 
(laugh). 
 This sub-theme highlights the important influence that doctors’ interactions can have 
on their patients’ help-seeking behaviours, such that women often chose to request a female 
doctor over a male doctor when booking their appointments for PMB at the GP service. 
Doctors’ actions as louder than the words they speak.  For many women, regular 
cervical screenings provide an opportunity to raise questions and concerns they may have 
about their gynaecological health, and for some the results of an investigation may reveal a 
problem or bodily concern that was not acknowledged by the patient prior to attending the 
screening.  For example, Carol was asked at her regular screening about any bleeding she was 
experiencing, and about the time since her last period.  When she responded that it had been 
‘about’ a year, the nurses who were examining her ‘sprung into action’ to contact the 
physician.  This left Carol feeling a worrying concern about her PMB that she hadn’t felt prior 
to attending the screening. 
CAROL: I think they tried to explain to me as plainly as possible that it was nothing to 
worry about, […] But I think that the way that things happened it was like, “Oh, that’s 
happened, I need to phone the doctor” and then they phone the doctor and the doctor 
said, “Refer to the clinic”, and […] I was like just watching all this happening and 
thinking, ‘I wonder if that’s like something serious like’ sort of thing.  So, I went away 
thinking not really about what they said, but more about what I was thinking about 
and that it might be something serious and I’m meant to get it sorted. 
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Carol’s witnessing of the communication between HCPs left an impression of concern 
that mirrored that of the HCPs’.  This concern seemed necessary for Carol to ‘get it sorted’ 
and she followed through by attending her secondary services appointment at the PMB clinic.  
This sub-theme revels the additional importance that is placed on the impact of the doctors’ 
responsive actions and behaviours regarding their concern for a patient’s bodily experience 
(or symptom), whereby the HCP’s concern was louder than the words of reassurance they 
spoke to the patient.  
 The helping intrusion.  As discussed in the first theme, a consideration of the costs 
and benefits of gaining knowledge during help-seeking is considered prior to seeking medical 
help, however, the experience of help-seeking involved additional consequences of physical 
discomfort as a result of examination, and included the psychological challenge of 
relinquishing one’s personal privacy to facilitate investigation toward treatment.  
 Wendy demonstrated the physical challenges of undergoing a vaginal examination in a 
dialogue with the researcher during the interview. 
WENDY: It wasn’t nice… It hurts… when they shove it in ya. […] It’s all right.  I was 
worried when I first went in.  Cause I don’t want it [the examination].  I told them I 
don’t want it.  They said okay, and I just got over it. 
RESEARCHER: What made it so that you were able to go through it? 
WENDY: Do you know, I don’t want cancer. 
 The excerpt above highlights the importance of examination.  Wendy describes how 
the consequence of her not allowing the doctor to perform the examination would have been 
much worse (i.e. the possibility of have undiagnosed and untreated cancer) than the physical 
discomfort and pain she would experience during the examination.  Furthermore, the fear of 
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cancer appeared to motivate her to just ‘get over it’ and endure the examination as worth it, 
despite the pain and discomfort. 
In addition to the physical discomfort of the investigation, Sue described the 
psychological difficulty of exposing her vulnerabilities to another person in the frightening 
experience of seeking help for an issue that is ordinarily kept so private in her everyday life. 
SUE: Opening up into, you know, what is kind of a private side of your life. […] Not 
many people find it easy to talk about what’s going on with your body and I think the 
worst thing is when YOU don’t understand it.  You feel a bit stupid as well… so the 
worry about opening up to people was frightening.  
Sue describes help-seeking as a challenging experience which requires her to give up 
her privacy and open up to allow an outsider in to view, touch and make conclusions about a 
body that was no longer familiar to her.  The necessary intrusion is an experience of a patient 
giving permission to an outsider (the physician) to cause physical and psychological 
discomfort during an exposure of one’s most private self for the primary purpose of gaining 
an understanding and resolving concerns of a body that had become chaotic and unknown. 
The Chaotic Body 
 The final superordinate theme describes the unpredictable embodiment of symptoms, 
which is experienced through a chaotic body during PMB and the process through the 
menopause.  The embodied issues of the chaotic body cannot be removed from the context of 
the aging process, the obese woman’s struggle with weight-gain and weight-loss, and the 
growing distrust or hatred toward their bodies in this view of the body in chaos. 
 Shared vs. unique experience.  In an attempt to understand, distinguish or normalise 
a body that felt out of control, women often compared their experiences to others.  Women 
shared their experiences of menopause with female family members and described how their 
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experience was different or perhaps more chaotic than others, leaving them to bear their 
experience alone. 
Carol explains how she came to assume that she was menopausal, by relating her 
experiences of the menopause to those of her family members (i.e. sisters and mother) in the 
shared ‘path’ of the menopause. 
CAROL: I started noticing the change, was probably back in October- November last 
year when I probably thought, because my sisters were going through it I probably 
thought I was going through it.  So I just assumed that everything that happened [was 
part of the menopause], because we were all more or less on the same path.  Like, 
‘This has happened’- ‘Oh yes I remember this happened’, and then the other one 
would say, ‘Nah this has happened’ and I would say, ‘Oh yea I remember that’s 
happened’, because there’s only like two years between us all. […] and my mum said 
that she went through when she was like in her 50s and whatever, so we just assumed 
that, you know, everyone was following everyone down.  Even my younger sister’s 
gone through it before [...]. 
The excerpt from Carol revealed a sense of comfort that she was able to share her 
experience of the menopause with her family members.  Sharing her experience of 
menopausal symptoms with women who were going through the menopause too, enabled her 
to feel supported, and their reassurance normalised the changes she was experiencing in her 
body, perhaps making them feel less chaotic and allowing her to feel less alone in her 
experience.  Contrariwise, Michelle’s experience of the menopause was very different from 
Carol’s and she felt that her experience of undergoing breast cancer meant that she 
experienced the menopause in a more severe and challenging way than those who 
experienced it naturally (i.e. without the side-effects caused by Tamoxifen treatment). 
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MICHELLE: […] it’s vile and like- like I went straight into it.  Like other people sort 
of- if they’re not on the Tamoxifen they gradually build up to it, because obviously 
they’re going into the menopause gradually.  I went in straight away. So it was like 
everything just went in, straight away (pshhhoow)! 
For Michelle, her experience of the menopause was unique only to her and she 
experienced it as a sudden and powerful ‘pshhhoow’.  With no-one to share her experience 
with, it felt more sudden and intense, creating a challenge for Michelle who was left to make 
sense of her experience on her own.  
This sub-theme portrays how the shared experience of menopause influenced one’s 
perception of their body by making the experience feel less chaotic and more normal amongst 
others, while the unique experience of menopause was more chaotic, abnormal, sudden and 
difficult to endure alone. 
Exposing the chaos.  This sub-theme describes the exposure of the chaotic body 
through the menopausal hot flushes and PMB experience.  Hot flushes were expressed as 
inescapable and exposing of women’s older age and PMB was experienced as restrictive and 
threatening to one’s ability to be social outside of their home. 
Michelle described the unavoidable exposure of her hot flushes that physically 
exposed her age to outsiders and brought with it a perceived negative judgment that she was 
old and ‘decrepit’.  
MICHELLE: […] I remember thinking when I was younger, women going through the 
menopause are like old. […] It’s like they’re looking at me and thinking, ‘Oh God 
she’s old and decrepit’ (laugh). […] I don’t feel old and decrepit, but other people 
who haven’t been in the menopause, that’s how they look at me, as being old and 
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decrepit.  Because I’m going through the menopause.  You know, I’m getting hot 
flushes and because you can see that.  You know, you can physically see it. 
Michelle’s experience of hot flushes in public places left her feeling misjudged as 
‘old’, and yet she felt unable to defend herself against the evidence of the hot flushes which 
defined her age as “old and decrepit” to outsiders.  
An excerpt from Sue describes a fear that the unpredictable nature of her body could 
expose her PMB to others in public, leaving her feeling unsafe and unprotected against 
embarrassment when she was outside the home. 
SUE: I couldn’t do as much as I wanted to do, and then I had to keep nipping back in 
and out of the house, and when you’re somewhere strange, rather than your own 
home, you-you’ve got to be protected don’t you? 
The excerpts presented in this subtheme revealed women’s fears that their chaotic 
body would be exposed.  This fear was interconnected with a feeling of mistrust in the body 
and it’s ability to function properly in the social world. 
Mistrust and hatred of the body.  Women described the recent development of a 
hatred toward their larger body size, within the past eight years, due in part to the 
consequences of age, other illnesses and uncontrollable weight-gain.  During this time some 
women described a loss of trust in their body, which had become unpredictable and 
unreliable.  
Michelle expressed feelings of hatred toward the appearance of her body, which was 
influenced by her recent weight-gain and the scars left behind after a breast biopsy surgery.  
Her hatred was further attached to her own loss of control over her body, such that she is no 
longer able to trust her body to not continue ‘falling apart’. 
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MICHELLE: I just hate it.  I hate my weight. I hate how I look.  I’ve got scars. […] 
Just really hate it.  I hate my body. […] HATED what- I’d got no control.  I’ve, my 
feelings, my body was going- just falling apart.  It felt as though, ‘Ah something else!’ 
You know, what else can go wrong? […] I’m getting a bit teary now [began to cry]… 
(Giggle). 
The chaotic nature of the menopausal and PMB experiences, in conjunction with other 
experiences of aging and illness, collectively influenced the creation of a pessimistic 
emotional sense of the body as no longer trust-worthy.  This struggle to cope with a chaotic 
body that is ‘just falling apart’ is experienced in frustration and discouragement.  In the above 
excerpt Michelle’s weight acts as yet more evidence that her bodily functioning is out of her 
control.  
The catch-22 of weight-loss and health.  Participants described a desire to lose 
weight and an increasing difficulty in losing weight, particularly after the onset of menopause.  
Women described how their comorbid conditions (i.e. arthritis, diabetes, asthma, 
hypothyroidism) and the medications used to treat them act as major hurdles to weight-loss 
efforts.  Stacy described a delicate interplay between her managing her asthma and exercising 
to lose weight, and the conflicting impact of her medication on increased weight-gain.  This 
conflict is described as a frustrating ‘catch-22’ in her excerpt below. 
STACY: I’m very aware that with my weight and my shape I can do so much to change 
it, but then if I start exercising I might make myself ill with my asthma, then I have to 
go onto steroids. Steroids naturally make me gain weight.  So for me it’s been like a 
catch-22.  So I’ve found it very very frustrating. 
The except above explains how despite having the awareness that weight-loss may 
improve health, the catch-22 of weight-loss and health creates a difficult situation where 
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women are forced to prioritise the two separately.  Consequently, treatments for comorbid 
conditions were prioritised over weight-loss.  Health is defined as treating or managing illness 
and weight-loss is forced to the side as a different priority and a greater challenge. 
The uncertain risk of weight.  The final subtheme reveals how at the end of the 
process of help-seeking for gynaecological symptoms and after engaging in the discussion 
about weight with the researcher, participants seemed to have a low awareness of the impacts 
of their larger weight or body size on their gynaecological health.  
Initially Michelle expresses an awareness that weight-loss may reduce her cancer risk, 
but in thinking about ‘how’ it would help she seems to be unable to see how any changes in 
her weight would help her overall health, given that she feels that she lives a healthy lifestyle 
defined by eating healthy foods.  When describing to the researcher what she could do to 
reduce her risk of cancer in the future, Michelle stated: 
MICHELLE: There’s nothing-nothing I can do.  I can lose weight I suppose.  But I 
have tried, haven’t I? I’ve tried hard haven’t I? 
RESEARCHER: Mmm.  And losing weight, what would that do?  How would that 
help?  
MICHELLE: [long pause] I don’t think it would.  You know, I eat healthily.  So I – 
you know, I do eat healthily, don’t we [looking at husband]? […] So, I think that’s the 
main thing- if you eat healthily.  If you eat-you eat healthily then you know, that’s a 
help.  But other than that there’s nothing you can do. There’s nothing… Nothing. Is 
there? (laugh). 
Similarly, for Carol, when asked by the researcher, “What do you know about weight 
and risk for diseases?” Carol responded: 
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CAROL: Oh, well the normal ones like erm diabetes and erm, heart attack and stuff 
like that. I’ve heard those ones, but nothing else really, and all the ones that can kill 
yah (laugh). 
Carol’s response suggests a low awareness of the life threatening nature of 
gynaecological cancers and the link between obesity and the development of endometrial 
cancer, of which PMB is the primary diagnostic symptom. 
Despite women’s continued desire to lose weight and their unsuccessful attempts to do 
so, women appeared to lack an understanding of how extra weight could impact the 
development of gynaecological issues and how they could approach weight-loss to improve 
their health and wellbeing. 
Discussion 
The aims of the present study were to explore how obese women experience and make 
sense of PMB and their experiences of seeking help from a PMB specialist clinic via urgent 
referral.  The help-seeking journey for PMB was explored using the IPA approach, and 
revealed novel findings that have not yet been reported by previous qualitative studies on this 
subject, which described an experiential process of making sense of symptoms and medical 
help-seeking.  Findings highlighted the ambiguous nature of PMB and the menopausal 
experience that enmeshed the two experiences together in the context of aging and a part of 
the complex journey through menopause.  
The overall experience of PMB is understood as fully embodied, complex, and 
embedded in a woman’s social context, which defines the expectations of what is to occur 
during midlife.  The social context influences symptom perception, appraisal and the decision 
to seek help (Calnan, 1983; Gold et al., 2000; Pennebaker, 1982; Whitaker, Scott and Wardle, 
2015).  Women described how the experience of menopausal symptoms and PMB carry with 
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them a fear of exposure (e.g. exposing menopause with experiencing hot flushes in public or 
PMB by bleeding through one’s clothes) during social engagements, and influences women’s 
social behaviours, making them feel unsafe whilst outside of their homes (Arbuckle et al., 
2014).  
The embodied issues of the chaotic body cannot be removed from the context of the 
aging process, an obese woman’s struggle with weight-gain and weight-loss, as well as the 
growing distrust or hatred toward their bodies in this view of a body in chaos.  An important 
aspect of this distrust was portrayed through women’s struggle with weight-loss despite their 
efforts to live a healthy lifestyle.  The ‘catch-22’ described a conflict between the 
dichotomous decision to choose to treat comorbid conditions (e.g. diabetes, hypertension, 
arthritis) over weight-loss, which suggests contradictory definitions of health and weight-loss 
that do not acknowledge the association between obesity and the development of comorbid 
diseases (Must, Spadano, Coakley, Field, Colditz, & Dieta, 1999).  Therefore, the findings of 
the present study suggest a lack of knowledge about the benefits of weight-loss (i.e. how it 
can help) in improving health and wellbeing and reducing the risk of developing some 
cancers, namely endometrial cancer.  Nevertheless, despite women’s lack of knowledge about 
the risk factors of obesity and gynaecological cancers (Soliman et al., 2008), and an expressed 
low body esteem or ‘hatred’ for their weight, women did not believe that their larger body 
size or personal body image played a role in their help-seeking experience or time to help-
seeking.  
Results of this chapter illustrated a dynamic process toward help-seeking which began 
with the experience of shock and a search to make sense of the experience by identifying the 
cause and acknowledging severity.  In an attempt to make sense of their symptom of PMB, 
many women chose to self-monitor their symptoms to see whether the bleeding would 
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reoccur in patterns, become heavier or whether pain would develop.  Findings suggest that the 
length of time that women chose to self-monitor a symptom was connected with how women 
made sense of their bodily change and how they assessed for the severity of their symptoms.  
It was apparent that assessing for the severity of PMB could pose as a challenge to many 
women whose symptom was not accompanied with feelings of pain or being unwell.  Thus, 
women engaged in a cognitive comparing process assessing the quality of their current bleed 
with past bleeds (e.g. periods) and the time since their last menstruation (i.e. pre-menopausal 
or during the menopause) to conclude if they should or shouldn’t be bleeding.  This finding is 
supported by the illness schema theory of symptoms appraisal (Chapter 2), given that once a 
symptom is perceived, memories are recalled through an active memory search to enable 
comparison between the experiencing symptom and the individual’s illness schemata 
(Leventhal, et al., 1997) or past experiences of bleeding.  Furthermore, one’s illness schema is 
embedded in dominant lay cultural assumptions about how a body should function and how it 
is experienced in a particular culture (St. Claire, 2003), which is used to understand and make 
sense of the PMB symptom and is further supported by sociocultural help-seeking literature 
(e.g. Alonzo, 1979; Hay, 2008; Zola, 1973).  Therefore, findings illuminated the importance 
of understanding women’s experiences of PMB within the context of prior menstrual and 
menopausal experiences.  
The process toward help-seeking for these women appeared to be additionally 
accompanied by an attempt to identify the cause of the bleed.  The women who assessed their 
symptom(s) as a possible sign of cancer, expressed their motivation to seek help with great 
urgency, which is reported in line with findings from a study by Johnson and colleagues 
(2011), wherein half of the women who experienced abnormal bleeding were not aware that it 
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was a warning sign for possible cancer and waited more than one month before seeking 
medical help.  
The decision to seek help was preceded by engagement in a paradoxical cognitive 
process that was characterised by a fear of the unknown, where the decision to seek help is 
made once the desire to know becomes stronger than the fear of knowing, and the benefits of 
help-seeking have outweighed the costs.  Similar concepts have been described in the 
literature.  For example, in a study investigating barriers to help-seeking for symptoms of 
ovarian cancer, worries about what the GP might find upon investigation was reported as a 
key barrier in making the decision to seek help (Low, Waller, Menon, Jones, Reid, & Simon, 
2013a).  Additionally, in a study by Safer et al. (1979) patients who had imagined negative 
consequences as a result of their illness, such as imagining themselves on the operating table, 
took twice as long to seek medical help than individuals who did not have a negative view of 
the consequences.  This fear of the future unknown appears to be a key component in the 
decision to seek help. 
 The theme of the penny dropping moment described a key process in seeking help for 
PMB symptoms.  Here, the penny dropping moment acted in parallel or subsequent to the 
paradox of knowing, and described an instinctual response rather than a cognitive process of 
decision-making.  Here, the symptom experience, which varied between intermittent, 
continuous, monthly bleeding and a ‘one-off show’, reached a threshold where it became all 
consuming and intrusive, given that the bleeding was no longer tolerable in daily life.  This 
experience has close links with Alonzo’s (1984) ‘containment theory’ and Cacioppo and 
colleague’s (1986) ‘threshold of interference’ with daily life, described in Chapter 2.  
However, the immediacy of the penny dropping moment adds a component that was not 
discussed in the literature, whereby the experience of this decision was intuitive or emotional 
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in nature and lacked a conscious deliberation into action.  Participant’s beliefs about when 
women chose to seek help parallels reports from previous literature suggesting that 
individuals are motivated to seek help once they are able to acknowledge a symptom as 
salient enough to reach a threshold of unmanageability in every day life (Macleod et al., 2009; 
Smith, Pope, & Botha, 2005; Andersen, Cacioppo, & Roberts, 1995).  
A study by Tarling et al. (2013) supports the findings of this study that there is a lack 
of resolve after seeking medical help for PMB, suggesting that women who were discharged 
from a PMB service after investigation felt frustrated at the lack of information and support 
they received.  In the context of the present study, within Sandwell and West Birmingham 
Hospitals NHS Trust, each patient is sent an information pamphlet in the post upon receipt of 
an urgent referral.  This pamphlet details the procedures that will be conducted for 
investigation at the clinic and describes the potential causes and outcomes of the 
investigation.  Nevertheless, the pamphlet does not include information about receiving 
support after investigation and, given the current findings, patients may benefit from 
receiving additional information after discharge from investigation for women who are told 
that they are not yet through the menopause.  Women who are post-menopausal are informed 
to self-refer to the clinic if bleeding reoccurs, however those who are not yet post-menopausal 
are discharged and advised to wait until they are through the menopause (i.e. cessation of 
bleeding after 12 months).  Furthermore, as reflected in the sub-theme ‘shared vs. unique 
experience’, it may be beneficial for women to engage in a menopausal support group after 
discharge as a way for women to provide mutual support and share in their experiences of 
their complex journeys through the menopause. 
During the experience of seeking help, women expressed preference for a female 
doctor, which has similarly been reported in the literature for gynaecology and women’s 
 215 
health (Ekeroma, Harillal, 2003; Gray, 1982; Ludwig, 1999; Makam, Mallappa Saroja, & 
Edwards, 2010).  A UK study conducted by Makam and colleagues (2010) reported that 45% 
of women in their study preferred a female gynaecologist over a male, reporting ‘religious 
beliefs’, ‘a better understanding of woman’s problems’, and issues of ‘personal modesty’ as 
some of the reasons for this preference.  However, a study by Gray (1982) reported that her 
patients believed the ability of a doctor to relate to patients on a personal level was more 
important than their gender, and this included taking a personal interest in the patient, 
explaining things in detail and taking the time to be with their patients.  As such, it is 
important to emphasise these skills in GP training and practice to ensure positive doctor-
patient communication, which encourages future help-seeking behaviours (Amy, Aalbord, 
Lyons, & Keranen, 2005; Marlow, Waller & Wardle, 2015). 
The experience of the investigation at the PMB clinic (secondary care) was described 
as uncomfortable at best and intrusive, frightening and painful at its worst.  Despite the 
discomfort experienced, the investigation was accepted as a necessary part of resolving one’s 
gynaecological problem.  Here, the impact of the HCP’s interactions, communications and 
behaviours with and in front of patients were important factors in the experience of medical 
help-seeking.  In describing these interactions, women revealed ‘dismissive’ past experiences 
with male doctors, and the impact of the doctor’s ‘actions’ in front of the patient (Cordingley, 
Mackie, Pilkington, & Bundy, 2009).  The necessary intrusion is therefore understood as an 
experience of a patient giving permission to an outsider (the physician) to cause physical and 
psychological discomfort during an exposure of one’s most private self for the primary 
purpose of gaining an understanding of what is happening within her body, and to put an end 
to the bleeding. 
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It should be acknowledged that results of the study are not meant to be generalisable to 
a wider population and may not reflect the experience of obese women as any different than 
women who are not obese, given that non-obese women may experience similar 
understandings of symptom perception, appraisal, body image concerns and difficulties losing 
weight during or after the menopause (Bloch, 2002; Lewis & Cachelin, 2001).  Moreover, 
non-obese women may experience similar concerns regarding help-seeking for PMB, 
however this was not a comparative, but explorative study and therefore conclusions can only 
be made as they represent the participants of this study. 
Researcher Reflections 
I, the primary researcher and author acknowledge the inherent differences that existed 
between myself and the participants of the study, given that I am a young, non-obese female 
who has not yet experienced the menopause.  Once these differences were acknowledged I 
aimed to work in a transparent way with the participants, rather than letting this inherent 
difference create a barrier between myself and the participant.  Prior to each interview I 
explained to the participant that as a researcher I was interested in learning from her, the 
participant, given that she is the expert on her own experience.  I identified a common stance 
amongst the participants, where upon discussion of the experience of menopause many 
women described their experience from an expert stance, often phrasing their sentences as if 
to teach me about what it is to be a menopausal woman, and about what I can expect to 
experience in the future.  Participants often used words like “we”, “us” and “you” the 
menopause to me.  In contrast when women described their experiences of PMB they often 
had a more experiential stance in describing their own experience as unique from others.  
Here women often used words to describe the uniqueness of their experience by using words 
of “I” and “me”. 
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In discussions surrounding weight and weight-loss it seemed important for 
participants to describe the many activities (particularly exercise) that they currently engaged 
in or planned to begin engaging in for weight-loss (e.g. swimming, running, yoga, going to 
the gym, Zumba).  There was a sense that the participants saw me as a health professional and 
therefore it was important for them to reassure me that they realised the importance of 
exercise on improving their health as though it was assumed that I would likely advise them 
to take steps toward weight-loss.  On several occasions I reminded participants that I was not 
a medical professional and was there only to learn about their experience and not to advise or 
provide information of their condition or concerns.  Participants with medical questions or 
those seeking advice were referred to the clinic nurses after their interview to address any 
medical questions or concerns. 
In the process of data collection I reflected on the personal difficulties I encountered 
during the initial four interviews in which the structure of the interviews restricted the in-
depth exploration of the participants’ experiential telling of their PMB and help-seeking 
journey.  Here I did not use the interview schedule in a flexible approach, and the rigidity of 
the scripted and structured questions (with many prompts) interfered with the flow of the 
conversation-style interview process. Nevertheless, the first four interviews revealed 
descriptions of adequate depth and description to allow for inclusion in the study analysis.  
After alterations were made to the interview schedule to simplify the schedule and remove 
prompts the flow of the interview went more smoothly and allowed for candid inquiry into the 
main experiences of the menopause, PMB and help-seeking. 
Limitations 
A limitation of the study included the heterogeneity of the sample, which included 
participants in varying stages of the menopause (peri-menopausal, menopausal and post-
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menopausal), and a woman whose experience of PMB was understood within the context of 
her breast cancer treatment.  The presence of a current cancer diagnosis, while not 
gynaecological, appeared to greatly influence the interpretation of her PMB experience from 
the perspective of a patient who had undergone many invasive investigations and treatments 
over the past year.  Nevertheless, whilst acknowledging the differences amongst participants 
it should be acknowledged that this represents the patient diversity seen in the Sandwell and 
West Birmingham NHS Trust PMB clinics.  
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CHAPTER 8: GENERAL DISCUSSION  
 
The present research explored the complex and dynamic journey of help-seeking for 
potential symptoms of gynaecological cancers and accessed a high-risk group (i.e. obese 
women) currently underrepresented in the published literature for help-seeking behaviour 
amongst individuals experiencing symptoms of cancer. The thesis provided a novel and 
comprehensive view of the experience and journey to help-seeking and findings challenged 
previous assumptions in the literature about the relationships between obesity, preventative 
screenings and delayed help-seeking for symptoms. 
Thesis Aims and Summary of Findings 
The overall aim of the thesis was to advance our knowledge and understanding of 
help-seeking for symptoms of gynaecological cancers and to identify whether obesity is 
associated with time to help-seeking.  Research built an understanding of the experiences and 
processes of help-seeking for obese women and assessed for the possible differences across 
groups of obese and non-obese women as well as White-European and Black, Asian or 
minority ethnic (BME) groups in time to help-seeking and awareness of gynaecological 
cancers. This was achieved by answering the following research questions: 
(a) What can we learn about help-seeking from the perspective of healthcare 
professionals (HCPs)? (Chapter 4) 
(b) Do knowledge and beliefs about gynaecological cancers (i.e. risk factors and 
symptoms) differ between obese and non-obese women? (Chapters 4 & 5) 
(c) Do knowledge and beliefs about gynaecological cancers (i.e. risk factors and 
symptoms) differ across different ethnic groups? (Chapters 4 & 5) 
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(d) Do knowledge and beliefs about gynaecological cancers (i.e. risk factors and 
symptoms) differ between women who extend time to help-seeking and those who 
do not? (Chapter 5) 
(e) What are the predictors of delay in help-seeking amongst normal weight,  
overweight and obese women? (Chapter 5) 
(f) Are there differences between obese and non-obese women regarding time to help-
seeking? (Chapter 5 & 6) 
(g) Are there differences across ethnicities regarding time to help-seeking? (Chapter 
6) 
(h) What is the experience of an obese woman seeking help for potential symptoms of 
gynaecological cancers? (Chapter 6 & 7) 
The thesis provided a unique perspective from HCPs to adapt practice to meet the 
specific needs of obese patients and highlighted a belief that obese women are more likely to 
delay medical help-seeking for gynaecological cancer symptoms.  Our mixed methods 
research findings supported previous literature that suggests a low awareness of the symptoms 
and risk factors of gynaecological cancers (Boxell et al., 2012; Sheikh & Ogden, 1998; Jayde, 
White & Blomfield, 2010; Low, Waller, Menon, Jones, Reid, & Simon, 2013a; Soliman et al., 
2008) and mixed evidence revealed a limited understanding of the links between obesity and 
the development of some cancers, namely gynaecological cancers (Soliman et al., 2008), and 
a lack of knowledge regarding how weight-loss can reduce their risks for cancer  (see 
Chapters 5 & 7).  No disparities were found in gynaecological cancer awareness, and a low 
awareness was reflected across groups of obese and non-obese women, as well as White 
European and BME groups.  Findings showed that increased body mass index (BMI) was 
associated with extended time to help-seeking along with living in high crime 
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neighbourhoods, and surprisingly, regular attendance at preventative screenings. Additionally, 
no differences were found across ethnicities regarding time to help-seeking.  Overall, the 
present thesis highlights a complex relationship between obesity and help-seeking and 
provides an understanding of how obese women experience and make sense of their complex 
transition through the menopause to post-menopausal bleeding (PMB), and the fully 
embodied experiences of PMB from detection of a bleed (i.e. the shock) to secondary care 
investigation (i.e. the necessary intrusion).  
Despite the distinct nature of PMB, nearly half of the sample took two or more weeks 
to seek help from a HCP.  Findings paralleled previous literature, suggesting that appraisal 
represented the greatest ‘delay’ time along the help-seeking journey (Andersen, Cacioppo & 
Roberts, 1995; Scott, 2010), which may be partially associated with a non-appraisal of 
abnormal bleeding as a warning sign of cancer and thus appraising bleeding as a benign or 
non-serious condition (Andersen, Cacioppo & Roberts, 1995; Cooper et al., 2012; Evans, 
Zeibland and McPherson, 2007; Jones & Johnson, 2012), and recognition of irregular 
bleeding as a part of the natural aging process (e.g. side-effect of the menopause) (see Chapter 
7).  However, the study with HCPs highlighted that often it is not only the patients that 
misinterpret the symptoms, but also the HCPs’ who interpret the vague symptoms of 
gynaecological cancers as benign or due to weight-related issues (e.g. bloating, changes in 
bowel habits, back pain).  This possible misinterpretation of symptoms may extend the time 
to help-seeking and referral (Macleod et al., 2009; Smith, Pope, & Botha, 2005).  
Consequently, findings confirm results from previous research suggesting that appraisal of 
symptoms is a key process along the help-seeking journey, and that HCPs play an important 
role in early detection and providing prompt pathways to treatment.  It is important that 
research identifies the factors that are likely to influence individuals to extend their time to 
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help-seeking, thereby increasing morbidity of disease, particularly amongst those at higher 
risk for disease.  
Findings further suggested that HCPs may hold misconceptions, namely suggesting 
that obese women are more likely to delay medical help-seeking for potential gynaecological 
cancer symptoms than normal weight women, highlighting that HCPs perceived obese women 
to face physical, psychological, social and economic barriers to help-seeking.  Differences 
emerged between the HCPs’ reported beliefs about barriers to care for obese women and the 
perception from the women themselves.  For example, HCPs reported perceived barriers to 
care consistent with previous research suggesting that a larger body size and body 
dissatisfaction would pose as barriers to women choosing to seek help for potential symptoms 
of gynaecological cancers (Amy, Aalbord, Lyons, & Keranen, 2005; Ridolfi & Crowther, 
2013).  However, the patient interview study in Chapter 7 did not support this perception, 
showing that women did not believe that obesity played a role in their time to help-seeking.  
Nevertheless, both patients and HCPs identified concerns with embarrassment in exposing 
one’s body during examination (Szymonia, Cwiek, Berezowska, Branecka-Wozniak, 
Dziobek, & Malinowski, 2009).   
Further evidence from both obese women and the HCPs who work in direct care with 
them, revealed an important lack of awareness for gynaecological symptoms and risk factors, 
namely the links between obesity and the development of gynaecological cancers (Soliman et 
al., 2008).  HCPs largely overestimated the perceived barriers to help-seeking for obese 
women experiencing potential symptoms of gynaecological cancers, however, they may have 
underestimated the number of obese patients seeking gynaecological cancer care services, 
which was reflected in the non-stratified sampling of the study that revealed more than half of 
the participants were obese compared with the estimated 30% from HCPs. 
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 Mixed methods results revealed a limited awareness of the gynaecological symptoms 
and risk factors of cancer, a limited understanding of the association between obesity and the 
development of cancers and a lack of knowledge regarding how weight-loss improves health 
and reduces risks for disease.  Increasing gynaecological awareness, suggestions for future 
research and intervention will be addressed in greater detail in a later section of this chapter.  
 Addressing barriers to help-seeking.  Results from the multiple regression analyses 
suggested that BMI predicts extended time to help-seeking, and hence parallels previous 
research conducted on utilisation of preventative screenings and help-seeking for cancer 
symptoms, which suggest that obese women are more likely to seek healthcare services at 
more advanced stages of the disease (Arndt, Stürmer, Stegmaier, Ziegler, Dhom, & Brenner, 
2002; Maruthur, Bolen, Brancati, & Clark, 2009).  However, contradictory findings from 
analyses conducted as part of Chapters 5 and 6 suggest a more complex and potentially 
curvilinear relationship between BMI and time to help-seeking, such that a positive 
relationship between BMI and time to help-seeking may exist until a certain point, after which 
point there may be no relationship at all.  This may occur at extremes of underweight or 
morbidly obese.  Additionally, findings may have been skewed by the distribution of BMI 
amongst the sample, given that the mean BMI was obese.  Finally, findings may be skewed 
by the distribution of time to help-seeking in the data which suggests a large range of days to 
help-seeking from zero days to eleven years, with more than half of the sample seeking help 
within two weeks of detection.   
The relationship between BMI and time to help-seeking is not explained by body 
image dissatisfaction, despite the correlation between BMI and body image, and the results 
reported do not provide evidence to suggest that body image dissatisfaction is a predictor of 
help-seeking, particularly given that women distinctly stated that their weight had not 
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influenced their time-to-help-seeking (Chapter 7).  Nevertheless, increasing BMI may lead 
women to feel less comfortable about exposing their bodies, thereby creating a more negative 
experience of healthcare services, which has been shown to act as a barrier to help-seeking 
(Amy et al., 2005).  Despite previous research suggestions that body dissatisfaction and 
embarrassment of size may be responsible for this delay (Amy et al., 2005; Ridolfi & 
Crowther, 2013), this association may be less to do with BMI and body dissatisfaction, and 
more to do with women’s embarrassment in exposing their bodies during examination (i.e. the 
necessary intrusion), which is experienced by many women regardless of body size 
(Szymonia et al., 2009) and past experiences with healthcare services (Gould, Fitzgerald, 
Fergs, Clemons, & Baig, 2010; Marlow, Waller, & Wardle, 2015).  Therefore, this 
relationship should be further explored to understand how BMI affects time to help-seeking 
and the intervening factors that influence and mediate this relationship.  
The additional result which identified attendance at regular preventative health 
screenings as predictive of extending time to help-seeking, challenges reports in the literature 
suggesting that previous attendance at preventative health screenings shortens time to help-
seeking for symptoms (O’Mahony & Hegarty, 2009; Quine & Rubin, 1997).  However this 
reported finding from Chapter 5 may again be understood by negative previous interactions 
with HCPs during screenings, which influence future healthcare utilisation (Gould, Fitzgerald, 
Fergs, Clemons, & Baig, 2010; Marlow, Waller, & Wardle, 2015) and may discourage future 
help-seeking for symptoms.  Alternative explanations for understanding this association may 
be that attendance at regular screening programmes may be presenting a false sense of safety 
to women (e.g. women may assume that if there was a problem it would be found at the 
screening), which inadvertently discourages women from seeking help for additional related 
symptoms experienced between screening appointments, such that women may wait until 
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their next scheduled screening to raise concerns about new symptoms rather than booking an 
appointment with their GP.  Additionally, there may be a lack of knowledge about the specific 
purpose and limitations of screening tests (i.e. cervical screenings do not screen for or detect 
all gynaecological cancers) (Marlow, Waller, & Wardle, 2015).  Without the knowledge of 
screening, such appointments may not be perceived by patients to be an appropriate setting to 
raise concerns about symptoms. Nevertheless, such understandings have to the best of our 
knowledge not yet been reported in current research. 
Despite that lack of differences identified across different groups of ethnicity, 
descriptive analyses highlighted an acculturation variable of ‘generations of English speaking 
in the family’, which was associated with ‘markedly extended time’ to help-seeking of more 
than one month after detection of PMB.  Findings highlight the importance of including 
acculturation and migration factors in research across ethnicities and cultures, given the 
limitations of using ethnicity as a descriptive categorisation for various heterogeneous ethnic 
groupings (Bhopal, 2012; Phillimore, 2012). 
Theoretical and Practical Implications 
The empirical chapters of this thesis emphasise the important influence of women’s 
environmental context and social milieu on symptom perception, appraisal and the decision to 
seek help (Burgess, Bish, Hunter, Salkovskis, Michell, Whelehan & Ramirez, 2008; Calnan, 
1983; Chatwin & Sanders, 2013; Goodwin, Fairclough, & Poole, 2013; Mwaka et al., 2015; 
Ramirez, Westcombe, Burgess, Sutton, Littlejohns, & Richards, 1999).  Findings suggest that 
many women choose to confide in family members or a partner (Birt et al., 2014; Scott & 
Grunfeld, 2009; Whitaker, Macleod, Winstanley, Scott, & Wardle, 2015) and/or self-monitor 
their symptoms to see whether their symptom improves or worsens.  The role of the 
individual’s social milieu and the context in which the symptom(s) occur influence the length 
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of time individuals choose to self-monitor their symptoms (Alonzo, 1984) and ultimately 
influences time to help-seeking, given that self-management strategies are taken prior to help-
seeking and may be a barrier to medical help-seeking (Low, Whitaker, Simon, Sekhon, & 
Waller, 2015).  
Chapter 5 highlighted an additional environmental and social factor that impacts help-
seeking, as findings from the multiple regression analyses revealed that individuals who 
reported high levels of safety within their neighbourhoods sought help sooner than those who 
reported being affected by a personal experience of crime in their neighbourhood.  The 
association between neighbourhood crime and extended time to help-seeking may be 
explained by low socio-economic status, lower health literacy (Boxell et al., 2012; Whitaker, 
Scott, & Wardle, 2015), reduced participation in prevention behaviour, and an increase in 
risky health behaviours (e.g. tobacco smoking, unhealthy diet, reduced exercise) (Pampel, 
Krueger, Denney, 2010) when compared with more affluent groups. Therefore, it is important 
for help-seeking theories to include social-economic and environmental factors, which are 
likely to impact time to help-seeking.  
The present research identified additional influencing factors of the HCP (e.g. past 
negative experiences with HCPs) and healthcare system (e.g. alternative routes to care- not 
GP), which impacted on participants’ utilisation of healthcare services and emphasised the 
successful alternative routes to care.  The Chapter 6 mapping study showed that patients who 
sought help from emergency services, regular screening appointments or at comorbidity 
management appointments were all provided with immediate referrals upon their first visit to 
care.  This result was in contrast to some individuals who required more than two visits to 
their GP (who is the recommended pathway to care; Public Health England, 2015) before 
receiving a referral to secondary care.  
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Consequently, sociocultural, economic, personal, and healthcare system factors should 
be integral into a comprehensive help-seeking model.  This suggestion is supported by 
evidence reported in a recent review by Whitaker, Scott and Wardle (2015) that identified the 
important impacts of external factors along the many intervals of the help-seeking journey 
from perception and detection of a symptom to attendance with a HCP.  It is therefore 
important that help-seeking theories include symptom perception processes to build a 
comprehensive framework from which to gain an understanding of help-seeking for 
symptoms, given that external factors impact perception processes  In response to the 
previously identified suggestions for a more integrated and comprehensive help-seeking 
theory, an integrated model was suggested in Chapter 2 that incorporates the key elements of 
each of the three key models employed in the current thesis and influencing factors that 
impact these dynamic processes.  When combined, these models produce a comprehensive 
model of help-seeking that encompasses the processes of symptom perception, symptom 
appraisal, selection and monitoring of coping responses (e.g. self-management) as well as 
making the decision to seek help from a HCP.  Additionally, Figure 8.1, which illustrates the 
lived experience of a patient according to the integrated model to enable the reader to gain an 
understanding of this model in action. 
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Integrated model case example.  Figure 8.1 depicts a case example from Chapter 7 
of participant Carol (age 53) who experienced a “bit of a bleed” the weekend before her 
regular cervical screening appointment.  Before this time, Carol had experienced slight 
bleeding on a couple of occasions over the past year, and had recurrent episodes of thrush.  
However, Carol had not had a menstrual cycle for “about a year”.  Her recent experience of 
vaginal bleeding came as a surprise to her after many months without.   
Carol shared her experiences of health and illness with female family members and 
felt connected with them in a shared experience of diabetes, which ‘runs in the family’ and 
the menopause.  Consequently, she believed that she too should not be bleeding, she “should 
have been over this by now”.  Once the bleeding was discovered she began to ask questions in 
an attempt to find the answers that could enable her to make sense of her experience.  These 
questions explored the perceived or expected timeline of her bleeding, potential consequences 
on her family and lifestyle, and the possibility that cancer could be the cause of her bleeding.  
Her inability to find adequate answers to her questions, the encouragement from her husband 
and family to seek help, and the fear that her bleeding could be a sign of cancer encouraged 
her to attend a pre-arranged screening appointment where she intended to report her recent 
experience of bleeding to a nurse.   
In this case example you can see how psychological, biological, and social factors as 
well as Carol’s personal experiences with previous bleeding played a role in her perception, 
appraisal of the bleeding as a symptom, and ultimately her decision to seek help for her 
experience of bleeding.  Healthcare system factors also played a role in that her cervical 
screening appointment, given that her appointment was scheduled prior to her recent 
experience of bleeding, potentially giving attention to the symptom and increasing the 
likelihood that she would mention it to the HCP during her visit the following week. 
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Figure 8.1. Integrated case example of Carol’s journey to seeking help for PMB. 
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The integrated model acknowledges the dynamic cognitive processes that are involved 
in the experience of appraising a symptom and coming to the decision to seek medical help 
and findings from the current empirical studies support the use of model integration in 
understanding the processes involved in seeking help for a potential symptom of 
gynaecological cancer.  SRM (Leventhal, Brissette, & Leventhal, 2003) provides the 
framework for an individual to develop representations of their illness and answer the 
questions in order to gain an understanding of the changes that have occurred in their body.  
As described in Chapter 7, the decision to seek help was preceded by engagement in a 
paradoxical cognitive process, characterised by a fear of the unknown, where the decision to 
seek help was made once the desire to “know” (i.e. what was wrong with one’s body) had 
become stronger than the fear of knowing and the benefits of help-seeking had outweighed 
the costs.  Carol’s case provided an excellent example of this dynamic, back-and-forth or 
circular process when she said, “Well I wanted to know.  I think-I think I wanted to know.  I 
didn’t want to know, but I wanted to know.  I wanted to know that there was something 
physically wrong.  I don’t know-I don’t know.  I did want to know, that’s why I made the 
decision to come to the clinic and mmm, I did.”  
 Furthermore, Chapter 7 highlighted the important role that an individual’s social and 
personal context has on their appraisal of symptom severity.  For example, participants’ 
beliefs about when women choose to seek help supported findings from Chapter 4 and 
previous literature suggesting that individuals are motivated to seek help when they are able 
to acknowledge a symptom as salient enough to reach a threshold of unmanageability (i.e. the 
penny dropping moment) and in their inability to carry out regular activities of daily life 
(Macleod et al., 2009; Smith, Pope, & Botha, 2005; Andersen, Cacioppo, & Roberts, 1995).  
Additionally, women described a cognitive comparing process, which was used in severity 
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appraisal which assessed the quality of their current bleed with past bleeds (e.g. period) and 
the time since their last menstruation (i.e. pre-menopausal or during the menopause) to 
subsequently conclude whether they should or shouldn’t be bleeding.  Therefore, findings 
illustrated the importance of understanding women’s experience of PMB within the context of 
prior social and personal experiences of menstruation and the menopause.  These dynamic 
and often complex cognitive processes seemingly conflict with the concise clinical guidance 
provided by clinicians, which suggests that women seek help immediately after they 
experience vaginal bleeding if it has been twelve months or more after the cessation of their 
last menstruation (Scottish Intercollegiate Guidelines Network, 2002). This does not fit with 
the confusing experience that many women have when experiencing the menopause and 
PMB, given that there are often exceptions to a rule.  For example, during the menopausal 
transition women’s menstrual cycles change, often becoming more irregular, and the flow of 
the bleeding can become lighter, thereby re-defining their previous definition of a menstrual 
cycle. Additionally, many women may go “about” one year without a bleed or may only 
notice a minor “show of blood” on the toilet tissue while wiping which may not be 
acknowledged as a “bleed”.   
It should further be acknowledged that making the decision to seek help and booking 
an appointment does not infer help-seeking behaviour and as such, social, personal and 
healthcare system factors are involved in carrying a decision into action. For Carol, attending 
her screening appointment did not ensure that she would receive help for her bleeding or even 
that she would seek help for her bleeding.  Carol had to make the choice and remember to 
inform her HCP of her concerns.  Interestingly, Carol did not disclose her bleeding to the 
HCP until after her examination when she was asked directly by the examining nurse if she 
had experienced any recent bleeding, and when the last time was that she had a menstrual 
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bleed. The penny dropping moment described in Chapter 7 provides insight into theory 
development, given that it illustrated an immediacy effect or emotional response to the 
decision to seek help that is partially described by social help-seeking theories such as the 
Alonzo’s (1984) ‘containment theory’ and Cacioppo and colleagues’ (1986) ‘threshold of 
interference’ (see Chapter 2).  However, the immediacy of the penny dropping moment adds 
an apparent emotional response that lacks the conscious deliberation into action.  Help-
seeking literature has identified individuals’ affective state, particularly negative affect and 
fear as influential factors in symptom recognition (Kolk et al., 2003), appraisal (Leventhal, 
1970; Pennebaker, 1985) and help-seeking behaviour (Rogers, 1975; Vassend, Skrondal, 
1999; Watson & Clark, 1984).  However, exploration of the specific roles of emotion in help-
seeking is a fairly recent topic for cancer help-seeking research (Balasooriya-Smeekens, 
Walter, & Scott, 2015).  Therefore, findings suggest further investigation to understand the 
role of emotion to identify key emotions that influence the help-seeking journey (Khakbazan, 
Taghipour, Roudsari, & Mohammadi, 2014; Kubzansky, DeStano, & Gross, 2013).  
Given the complex biopsychosocial influences and the dynamic cognitive processes 
involved in seeking help for PMB, an integrated model facilitates understanding of the many 
influences (both known and unknown) on the journey toward help-seeking for potential 
symptoms of gynaecological cancers.  Given that it is grounded in the Model of Pathways to 
Treatment framework (Scott et al., 2013; Walter et al., 2012), the integrated model may be 
useful in the investigation of both short and long appraisal intervals with acute and chronic 
symptoms of illness (Walter et al., 2012), making it suitable for the various symptoms 
indicative of gynaecological cancers.  Furthermore, this model allows for investigation of 
alternative pathways to care and diagnostic pathways (Walter et al., 2012) that could include 
seeking help from an emergency department, sexual health walk-in clinic, GP service, regular 
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preventative screening appointment and attendance at a regular comorbidity management 
appointment (e.g. for diabetes or hypertension).  Therefore, in the context of PMB this model 
could be used to examine help-seeking for PMB, as an acute (“one off show”) or chronic 
(continuous or cyclical bleeding) experience and can further examine the more vague or non-
specific symptoms indicative of other gynaecological cancers.  
The practical implications of the present thesis and suggestions for changes to 
practice suggest that PMB services should provide additional information to menopausal 
women post-discharge from PMB clinics, and that physicians should be trained to provide 
supportive communication with patients about the risks of obesity and advice on weight-loss.  
Therefore, it is important to emphasise supportive as well as practical communication skills in 
HCP training and practice to ensure positive doctor-patient communication in patient-centred 
care, which has been shown to encourage future help-seeking behaviours (Amy et al., 2005; 
Marlow, Waller & Wardle, 2015).  Furthermore, given the growing number of obese patients 
in healthcare services (Bray, dos Santos Silvia, Moller & Weiderpass, 2005; Calle & Kaaks, 
2004), GP practices must be able to accommodate women of larger sizes, ensuring the 
availability of appropriate equipment, and HCPs should receive training to encourage healthy 
lifestyles amongst their patients as a part of weight and comorbidity management advice. 
Supportive and accommodating care is likely to encourage future utilisation of healthcare 
services amongst obese patients. 
Psychoeducational and peer support services through the menopause.  The 
women who participated in the patient research made a decision to seek help and engaged in 
an active search for the answers to explain what was happening in their bodies, what was 
causing their bleeding and how long it would continue for.  During this time most women 
sought the advice of knowledgeable friends, family members, online sources and HCPs.  
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Nevertheless, women’s questions remained unanswered and for many women symptoms 
remained unresolved despite medical help-seeking due to receiving vague or unclear 
information to reassure them that there was ‘no apparent problem’.  Chapter 7 highlighted the 
need for services to provide post-investigation support for women who are not yet post-
menopausal and have been discharged after PMB investigation to wait until they are “fully” 
through the menopause (i.e. cessation of bleeding after twelve months).  This lack of resolve 
after being discharged from the PMB clinic supports the finding of a study by Tarling and 
colleagues (2013), which suggested that women may benefit from receiving continued 
support after discharge from PMB service. 
Therefore, the study highlighted a gap in the services, whereby women who are 
discharged from PMB clinics as a result of not being through the menopause, may benefit 
from receiving educational information about the common symptoms and possible challenges 
they  may during the menopausal transition.  A key symptom of irregular bleeding during the 
menopause should be highlighted and normalised.  Providing statistical information regarding 
the average estimate or range of time that women may expect this transitional process to last 
may be helpful to enable women to reduce distress surrounding the bodily changes and may 
encourage appropriate help-seeking for abnormal symptoms.   Furthermore, studies have 
shown that providing support during and after the menopausal transition can help to reduce 
distress and improve quality of life and overall wellbeing (Rotem, Kushnir, Levine, & 
Ehrenfeld, 2006; Toral et al., 2013; Yazdkhasti, Keshavarz, Khoei, Hosseini, Esmaeilzadeh, 
Pebdani, & Jafarzadeh, 2012).  Providing patients with the option to participate in a 
menopausal peer support group or psychoeducational programme with other women 
experiencing similar transition difficulties would offer an additional opportunity for women to 
share their experiences and may help women to normalise their experience rather than feeling 
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that they have to endure their difficulties alone.  Such support may encourage future 
appropriate help-seeking behaviours by facilitating early detection through discussion of 
bodily changes/sensations (de Nooijer et al., 2001) and continued engagement with health 
services.  Providing access to such groups may also reduce the amount of “trivial” (Hannay, 
1979) consultations in primary care services and should further reduce the chance of 
inappropriate referrals to PMB clinics amongst those who are not yet post-menopausal.  
Furthermore, providing adequate communication during consultation or communication with 
other HCPs (e.g. nurses) can provide an opportunity to ask patients how they understand the 
cause(s) of their symptoms (Petrie & Weinman, 2012). 
HCP training and accommodating for diversity.  Novel findings of the Chapter 5 
study suggested that women who regularly attended preventative health screenings were more 
likely to delay seeking help. This finding challenges reports in the literature suggesting that 
previous attendance at preventative health screening appointments shortens time to help-
seeking (O’Mahony & Hegarty, 2009; Quine & Rubin, 1997).  However, these findings may 
be explained by negative previous interactions with HCPs during appointments, which 
influence future healthcare utilisation (Gould, Fitzgerald, Fergs, Clemons, & Baig, 2010; 
Marlow, Waller, & Wardle, 2015) and may discourage future help-seeking for symptoms.  
Therefore, it may be necessary to provide communication training to staff, providing 
techniques that can be used to build trusting and positive doctor-patient relationships, thereby 
encouraging future help-seeking and ensuring patient-centred care.  
The empirical finding of the current research further illustrated a perceived need for 
HCPs to receive training that would enable them to empathetically address weight concerns in 
a time-efficient and supportive manner, which would enable the patient and doctor to 
respectfully discuss weight-related risks and encourage healthy lifestyle changes amongst 
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women.  Therefore, despite public health initiatives and clinical guidelines that require HCPs 
to discuss weight-related issues and assist in weight management programmes (e.g. ‘Every 
Contact Counts Initiative’; De Normanville, Payne, & Ion, 2011; National Institute for 
Clinical Excellence [NICE] guidelines, 2014; Royal College of General Practitioners, 2014), 
this study supports findings from previous literature, which suggests that HCPs continue to 
describe weight-related discussions with patients as challenging and uncomfortable (Jackson 
et al., 2013).  Findings of Chapter 7 further suggested novel finding in help-seeking research, 
which suggested a lack of knowledge about the benefits of weight-loss (i.e. how it can help) 
in improving health and wellbeing and reducing the risk of developing some cancers amongst 
obese women, particularly endometrial cancer.  This is important because, training may 
further increase clinicians’ self-efficacy and comfort in discussing weight-related risks and 
supporting weight-loss whilst maintaining a positive doctor-patient relationship.  Although 
weight-loss plans are most suited to primary care services, all HCPs in both primary and 
secondary care services should receive effective communication training.  Furthermore, 
despite women’s expressed preference for a female doctor over a male (in Chapter 7), Gray 
(1982) reported that patients believed the ability of a doctor to relate to patients on a personal 
level was more important than their gender, and this included taking a personal interest in the 
patient, explaining things in detail and taking the time to be with their patients.  A study by 
Maguire and Pitceathly (2002) showed that clinicians who lack proper communication 
training are experienced by patients as lacking the empathy necessary to provide patient-
centred care.  Therefore, it is important for these skills to be emphasised in GP training and 
for practice to foster positive doctor-patient communication that encourages future help-
seeking behaviours (Amy et al., 2005; Marlow, Waller, & Wardle, 2015), which may reduce 
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gender-specific doctor requests that have the potential to cause system delays due to limited 
staff availability.   
Additionally, GP practices must be able to accommodate women of larger sizes, 
ensuring the availability of appropriate equipment and HCPs should receive training to 
encourage healthy lifestyles amongst their patients.  Supportive and accommodating care is 
likely to encourage future utilisation of healthcare services amongst obese patients. In view of 
thesis findings, which suggest a limited awareness of gynaecological cancers, particularly 
regarding the risk of obesity and the development of gynaecological cancers, weight-loss 
advice should be directed toward improvement of health and reduction of risk for common 
obesity-related diseases and cancer.  
Therefore, the current thesis research emphasised the important role that the healthcare 
system practices, patient support services, doctor-patient communication, and availability of 
appropriate equipment has on patient help-seeking for gynaecological cancers.  These factors 
have not been suggested together in previous research on help-seeking in the context of  
gynaecological cancer symptoms.  
Gynaecological awareness research and intervention.  Findings of the thesis are 
consistent with those reported in the literature suggesting that women have a low awareness 
of the symptoms indicative of gynaecological cancers (Boxell et al., 2012; Cooper, Purvis, 
Polonex, Stewart, & Gelb, 2013; Sheikh & Ogden, 1998; Jayde, White & Blomfield, 2010) 
and only 13% were able to identify their symptom of PMB as a warning sign of cancer. 
However, the conclusions cannot be drawn from the current study regarding the relationship 
between knowledge of PMB and time to help-seeking for PMB as a symptom, given that this 
was not specifically addressed in the gynaecological awareness of symptoms measure and 
was referred to as “abnormal bleeding”.  Nevertheless, due to the complexity of the referrals – 
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(which included women who were not post-menopausal) this omission does not affect the 
results of the study and was in line with the aim of the study to identify awareness of common 
symptoms of gynaecological cancers in general.  Future research should measure time to help-
seeking according to identified symptoms to assess for differences in awareness and time to 
help-seeking across specific symptoms of gynaecological cancers. Few studies have been 
reported to test knowledge of gynaecological risk factors, particularly the risk factor of 
obesity on the development of gynaecological cancers (Soliman et al., 2008).  Thus, future 
research should investigate the awareness of risk factor knowledge amongst a larger sample 
across the UK.  Nevertheless, as noted in Chapter 2 and demonstrated in the results of Chapter 
5, knowledge alone does not predict help-seeking behaviour (Murray & McMillan, 1993; 
Scott, 2010; Sheikh & Ogden, 1998) and further efforts should be made to encourage women 
to seek help for symptoms as well as attend preventative screenings.  
The Chapter 5 study revealed no differences in symptom or risk factor knowledge for 
gynaecological cancers across ethnicities and no relationship was found between 
gynaecological cancer awareness and time to help-seeking, suggesting that awareness of 
symptoms and risk factors for gynaecological cancers did not differ between women who 
delayed seeking help and those who did not.  However, most of the participants in the study 
had low to moderate scores of gynaecological awareness, hence the relationship between 
awareness and time to help-seeking may have been stronger for more extreme scores in 
awareness.  Nevertheless, this finding raises a question regarding the effectiveness of 
awareness-based interventions on decreasing time to help-seeking.  Although, it should be 
acknowledged that due to the non-validated nature of this measure and the general overview 
of gynaecological symptoms and risks, the measure may not have related specifically to PMB 
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and therefore may not reflect awareness for PMB specific risks and the associated 
symptom(s).  
Knowledge of obesity as a risk factor is mixed across the studies, suggesting that more 
than half of the women in the study were not able to acknowledge obesity as a risk factor for 
the development of gynaecological cancers.  Yet one third did not identify it as a risk (see 
Chapter 5).  Qualitative results of the Chapter 7 interview study revealed that although most 
women were knowledgeable about the risks that obesity posed on their general health, they 
did not show an awareness of the increased risk associated with cancer (Soliman et al., 2008), 
nor were they able to describe how obesity increases risk for disease.  
The thesis highlighted not only a lack of knowledge of the risks of obesity and disease, 
but also an additional lack of knowledge about the benefits of weight-loss (i.e. how it can 
help) in improving health and wellbeing and reducing the risk of developing some cancers, 
particularly endometrial cancer.  This was depicted in the Chapter 7 IPA study wherein the 
‘catch-22’ described a conflict between the dichotomous decision to choose to treat comorbid 
conditions (e.g. diabetes, hypertension, arthritis) over weight-loss, which suggests 
contradictory definitions of health and weight-loss that do not acknowledge the association 
between obesity and the development of comorbid diseases (Must, Spadano, Coakley, Field, 
Colditz, & Dieta, 1999). Nevertheless, despite women’s lack of knowledge about the risk 
factors of obesity and cancers (Soliman et al., 2008), and an expressed low body esteem or 
‘hatred’ for their weight, women did not believe that their larger body size or personal body 
image played a role in their help-seeking experience or time to help-seeking, which supports 
findings from Chapter 5 suggesting that knowledge of gynaecological cancers was not 
different across participants who extended their time to help-seeking and those who did not.   
Therefore the findings of the thesis studies revealed a lack of awareness of obesity as a risk 
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factor, which may be connected with how they feel about their own weight,the benefits of 
weight-loss on health and their beliefs about their abilities to lose weight. 
Given the limited general awareness about gynaecological cancers amongst women, 
intervention should be developed to improve public awareness of gynaecological cancers.  
Current initiatives, interventions and awareness campaigns in the UK are run by the Cancer 
Research UK, which currently leads the National Awareness and Early Diagnosis Initiative 
and aims to improve awareness of the signs and symptoms of cancer amongst the public, 
encourage those who are experiencing symptoms to seek help earlier than is currently 
reported, and to support primary care in diagnosing cancer earlier.  These aims support 
diagnosis at earlier stages leading to improved patient outcomes for common cancers 
(Department of Health, 2011).  This initiative suggests that earlier presentation to primary 
care for people experiencing potential symptoms of cancer can be achieved through a public 
change in behaviour toward help-seeking.  Government driven campaigns have been running 
since 2010 (Department of Health, 2011; 2014) and evidence has shown effectiveness of 
interventions) to improve symptom awareness and encourage presentations at primary care by 
reducing barriers to help-seeking for various cancer types (Austoker et al., 2009; Department 
of Health, 2014).  However, for gynaecological cancer much of the campaigns have focused 
on prevention strategies and encouraging regular attendance at cervical screenings, expanding 
screening programmes to include ovarian cancer screening (CA125 blood test; UK 
Collaborative Trial of Ovarian Cancer Screening) and encouraging young women to receive 
an HPV vaccination from primary care (Department of Health, 2014).   
A systematic review of research conducted in awareness and early presentation for 
many different cancers (Austoker et al., 2009) reported that interventions targeted to 
individuals may increase cancer awareness, for example by receiving a information and/or a 
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pamphlet from a healthcare professional was most affective. Alternatively, interventions 
delivered to communities (e.g. media campaigns, information available in public space) were 
suggested to promote both cancer awareness and early presentation, although there was 
limited evidence across studies to support this.  In a study by (Robb et al, 2009), awareness of 
many cancer warning signs were low particularly for those from lower socio-economic status 
(SES) or ethnic groups.  Some common barriers to help-seeking included difficulty booking 
an appointment, concerns that one was wasting the doctor’s time and concern about the 
outcome of the investigation.  The report suggested that interventions should combine public 
education (i.e. symptom awareness) with encouragement for people to seek medical advice, 
along with further support at the primary care level.  These suggestions were posited to 
improve early presentation and cancer outcomes.   
Local and national intervention campaigns that work in partnership with primary care 
services have been developed to encourage disadvantaged communities and different ethnic 
groups to seek help promptly for symptoms and to raise awareness of cancer symptoms 
(Department of Health 2011; 2014).  However, there remains a need for culturally sensitive, 
community-based interventions to raise awareness and encourage early presentation (Waller 
et al, 2009).  Common methodologies being used to raise awareness and encourage prompt 
help-seeking for various cancer symptoms include social marketing campaigns to promote the 
early signs and symptoms and the development of local campaigns that bring together 
healthcare professionals, charity organisations and the general public to raise awareness and 
provide accessible information to the public, particularly to those most at risk (e.g. smokers) 
Department of Health, 2011). 
A study by Evans et al., 2014 interviewed GPs to understand their attitudes toward a 
public gynaecological awareness campaigns and addressed their views about the potential 
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impact of increased awareness on primary care services, resulting in increased burdens  
Results of this study identified that GPs believed awareness interventions in the community 
would improve patient’s awareness of gynaecological cancers and would encourage timely 
help-seeking, however they expressed concerns about a resulting increase in rates of 
presentation and costs on primary care resources (e.g. additional consultations, investigations 
and referrals).  Therefore this study suggested that further research be undertaken to compare 
the benefits of earlier diagnosis in gynaecological cancers against costs on resources. 
Further research into gynaecological cancer interventions has revealed mixed evidence 
in the effectiveness of community-based awareness campaigns, with the most being 
distributed via advertisement and TV to increase awareness of gynaecological cancer 
symptoms campaigns.  Such campaigns aim to minimise time to help-seeking or rates of 
gynaecological cancer diagnoses, however evidence suggests an increase in the number of 
gynaecological urgent GP referrals (Department of Health, 2014).  Women under the age of 
50 represent the largest increase in referrals (35%), with women between the ages of 70 and 
79 showing the smallest increase (14%) (Department of Health, 2014).  Therefore, previous 
research highlights that caution should be taken when identifying appropriate methods for 
intervention when the aim is to raise awareness and encourage early presentation of 
gynaecological cancer symptoms, such that it should avoid placing undue cost on healthcare 
resources, including providing unnecessary referrals for symptoms not indicative of 
gynaecological cancers. 
  Nevertheless, given the results of this thesis research, women have shown a low 
awareness of not only the symptoms, but also the risk factors that may lead to the 
development of gynaecological cancers.  Therefore, intervention to improve awareness of 
these two key factors may be important in influencing early detection and diagnosis.   
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  Given that previous research has highlighted the important role of 
sociodemographic factors on disease awareness, intervention should follow a theoretical 
framework to identify patients’ illness beliefs, threat appraisals and affective states while 
acknowledging the sociodemographic factors that affect disease awareness (Boxell et al., 
2012).  To improve cancer awareness, Whitaker et al. (2015) posit that health literacy is a key 
component in effective public awareness campaigns and interventions, such that lower 
literacy may make public health messages more difficult to comprehend (Doak, Doak & 
Meade, 1996) and may account for socio-economic and cultural disease disparities.  
Therefore, it is important for interventions to target high-risk populations and encourage 
women to pay attention to their bodily sensations, to provide education to the public that 
would enable women to accurately appraise their symptom as warning sign of cancer, and to 
enable women to better understand their own personal risk for disease (Whitaker, Scott, & 
Wardle, 2015).  Additionally, women should be positively encouraged to seek help from 
supportive and knowledgeable HCPs while educating women on the importance of early 
presentation on less invasive treatment and improved survival outcomes. 
When targeting populations for interventions and prevention campaigns it is important 
that interventions access the public as a whole and not merely women engaged with 
healthcare services.  This is important, given the influence of social networks on help-seeking 
behaviour (Burgess et al., 2008; Low et al., 2015; Whitaker, Scott, & Wardle, 2015) described 
earlier in this chapter.  Screening programmes should be further aware of what information is 
provided about screening services and prevention programmes, such that there should be a 
clear understanding about the purpose and limitations of cervical screenings (i.e. what it can 
and can’t do) (Marlow, Waller, & Wardle, 2015).  Additionally, services should be cautious 
about presenting a false sense of safety to women attending regular screenings that may 
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influence future help-seeking when women develop potential symptoms of gynaecological 
cancer (between regular screening appointments).  Public health awareness campaigns should 
address the role of preventative screenings as a means of identifying cervical abnormalities to 
detect issues not yet known to the patient and to encourage women not to use screenings as a 
substitute for seeking help for additional symptoms (although detection of other cancers can 
sometimes be an outcome of examination during screenings).  Furthermore, given the number 
of women who choose to self-monitor before seeking help, it may be useful for public health 
campaigns to share common self-management strategies employed by women with 
gynaecological cancer symptoms with the public to build a conscious awareness of self-
management behaviours so that they may be more readily able to identify their own 
behaviours when they engage in self-management behaviours as a substitute for medical help-
seeking.  Information should address the context of the symptom(s) relevant to the at risk 
groups.  For example, the symptom of PMB should be placed in the context of experiencing a 
significant change during the midlife and completion of the menopausal transition (i.e. twelve 
or more months break between bleeds), to distinguish PMB from irregular bleeding during the 
menopause. 
Clear and concise information can be distributed and made available in public settings 
throughout the community (e.g. supermarkets, bus stops, buses, television media) and not 
merely within primary care services.  However, where relevant, interventions individual 
interventions by healthcare professionals should be implemented in primary care (e.g. giving 
patient a pamphlet and/or explaining associated disease risks such as obesity).  Furthermore, 
information should be made available to individuals from diverse cultural and ethnic groups 
(Marlow, Waller, & Wardle, 2015) by providing information in various different languages 
and allowing access to information for individuals who may be unable to read or write.  
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Limitations and Future DirectionsLimitations.  The key limitations of the thesis 
include (a) methodological issues (i.e. the self-report and retrospective methodology of the 
patient help-seeking studies, timing of the study in patients),  (b) the inclusion of people who 
sought help via cervical screening and not at presentation at GP surgeries, and (c) the sample 
size, which may not have had sufficient power given the cross-validation sample, (d) 
recruitment limitations and questionnaire complexity, and (e) the categorisation of ethnicities 
into groups. 
An unexpected lack of association was found between many of the variables in the 
journey to help-seeking studies, which may be due to methodological choices made regarding 
retrospective self-report questionnaires and estimation of dates which were used to measure 
outcome variable for time to help-seeking, rather than actual dates of presentation at GP 
services.  The objectivity of the outcome measure may be challenged given that they were 
obtained from self-report estimation dates that were rounded up or down respectively by two 
weeks, making approximation dates for the beginning, middle and end of the month.  These 
general date estimates may have influenced the findings of Chapter 5 by incorrectly placing a 
participant into an extended time to help-seeking category, due to an incorrect estimate, or in 
Chapter 7 by missing relationships that may have existed between obesity and time to help-
seeking or ethnicities and time to help-seeking, given that time intervals of the patient journey 
were measured in days Therefore, a more objective measure would have been necessary to 
obtain exact dates from GP record systems or to round to the nearest one or two weeks for all 
participants and map the journey to help-seeking accordingly (by one or two week intervals, 
rather than using number of days).  Nevertheless, these issues are common challenges in help-
seeking research.  Much of the research in the field of help-seeking employ retrospective data 
collection methods (Scott & Walter, 2010), and for those who acquire data from GP record 
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systems, not all GP surgeries adequately document patients’ experience of symptoms 
(Kroenke, 2001).  Alternatively a calendar method may be suggested for use in help-seeking 
research, which can aid participant recall by acknowledging crucial events that occurred along 
the journey to help-seeking (van der Vaart, 2004). 
Furthermore, in terms of the self-report methodology, accurate recall of the length of 
time taken for women to become concerned about a symptom or to contact healthcare services 
may have been difficult. To overcome this limitation, data in the form of date of first contact 
and number of contacts made with the PMB clinic prior to the most recent visit should have 
been collected, given that previous visits to the PMB clinic fast-tracks the pathway to 
investigation and diagnosis.  This may have provided a more objective measure of time to 
contacting or visiting healthcare services and would have allowed the number of prior visits to 
be measured as a factor that may have influenced time to help-seeking.   
Although much of the help-seeking research is conducted retrospectively, Andersen et 
al. (1995) suggested that help-seeking behaviour should be examined through longitudinal or 
even experimental designs (Andersen, 1995).  Experimental designs could be used to identify 
influencing factors on symptom perception, appraisal and intention to seek help and to pilot 
interventions (Scott & Walter, 2010).  In the current study another option would have been to 
conduct a longitudinal prospective study tofollow women from the moment they contacted 
their GP to the moment they were seen at the PMB clinic, given that aiming to contacting 
women at the moment they detect PMB would is not feasible.   
Additionally, women who attended the PMB clinic via attending a cervical screening 
rather than seeking help for a symptom may have affected the findings given that they did not 
report a concern prior to seeking help, which was developed under the assumption that ‘time 
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of concern’ would be the first phase of the help-seeking journey, raising questions about the 
definition of the interval ‘recognising a bodily change’. 
Limitations may exist with the sample size, such that the sample size may not hold 
sufficient power for the cross-validation sample, and may have identified stronger 
relationships between variables if there were more participants in the predictor study.  
Therefore, there may have been variables that were not acknowledged by the multiple 
regression analysis, due to the subtle relationships and small sample size.  Nevertheless, for 
the scope of the thesis research the sample size was deemed appropriate according to power 
calculations prior to the cross validation analysis.  An important limitation of the 
questionnaire study involved the complex and lengthy nature of the questionnaire, which may 
be responsible for the incomplete questionnaires returned to the researcher.  A more hands-on 
approach to researcher-guided questionnaire completion may have increased the numbers of 
fully completed questionnaires.  In this approach, the researcher would go through the 
questionnaire with each participant, and those who decide to take the questionnaire home 
could receive a follow-up phone call to aid with completion of the questionnaire.  
Furthermore, phone calls should have been made to participants to complete missing sections 
in mailed questionnaires returned to the researcher (S. T.).  However, phone numbers were 
not provided by participants at the time of consent.  An additional limitation of the Chapter 5 
study was present in the data collection design which involved various times of questionnaire 
completion amongst participants which may have affected participant responses (i.e. in clinic 
prior to seeing the consultant at PMB service and at home after seeing the consultant for 
PMB). 
Finally, the collapsing of ethnicities into the BME grouping encompasses a variety of 
cultures, races and religions that exist in the Birmingham and West Midlands region (Office 
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for National Statistics, 2012), which are not distinguished or defined separately in the current 
study.  Readers must therefore be cautious when interpreting and generalising findings to 
wider cultural contexts.  Grouping ethnic minorities into one generalisable group can be 
problematic given that the UK’s ethnic diversity changes geographically throughout the 
nation.   Furthermore the term ethnicity can include additional perceptions of cultural, socio-
economic, socio-political and genealogical understandings into the definition (Vickers, Craig 
& Atkin, 2012), and grouping Black, Asian and minority ethnic groups together does not 
assume homogeneity across these groups.   
Predicting help-seeking for gynaecological cancer symptoms.  Future research will 
be necessary to: (a) better understand the relationship between BMI and time to help-seeking 
as well as the intervening factors that influence this relationship for women experiencing 
potential symptoms of gynaecological cancers (as described above), (b) to clinically define 
‘immediate’ help-seeking for PMB symptoms described in the literature (Center for Disease 
Control and Prevention, 2014; NICE, 2005; Pan Birmingham Cancer Network, 2015), and (c) 
to understand the role of sociocultural and economic factors on symptom appraisal and the 
decision to seek medical help, as well as to identify disparities in time to help-seeking across 
groups. Furthermore, research should be conducted to explore the integrated model of help-
seeking in the context of gynaecological cancers. 
Future research is needed to identify the relationship between BMI and help-seeking 
for gynaecological cancers, suggesting that future research should employ a design with a 
stratified sample to account for a curvilinear relationship and the complexities of 
understanding the relationship between obesity and medical help-seeking. 
Nevertheless, in order to ensure that the findings of this thesis clinically are relevant 
and to prioritise research in the area, it is important to gain an understanding of the clinical 
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importance of prompt help-seeking and the effect of extending time to help-seeking for 
symptoms of PMB on survival outcomes.  Thus, future research should identify clinical 
evidence for the use of ‘extended time to help-seeking’ (i.e. delay) defined cut-off points for 
PMB using the outcome measure employed in the current thesis (i.e. two or more weeks after 
detection) to identify the potential for increased risk of malignancy after a determined number 
of days from PMB detection.  
  The present research supports the literature which suggests that socio-economic 
factors play a key role in extending time to help-seeking for symptoms of cancer (Low et al., 
2013a; National Cancer Intelligence Network, 2009a), and are associated with reduced cancer 
awareness (Boxell et al., 2012; Power, Simon, Judzczyk, Hiom & Wardle, 2011; Robb et al., 
2009).  Low and colleagues (2013a) posit that this disparity might be due to referral delay 
from GP surgeries to secondary care, however, findings of the present research do not support 
this claim, as results do not identify differences in referrals between White European and 
BME groups or across levels of deprivation.  Alternatively, according to Whitaker, Scott and 
Wardle (2015) lower awareness of symptoms, including poor health literacy, may influence 
misinterpretation of symptoms, hence extending appraisal time amongst patients of low socio-
economic status.  This may explain the late-stage diagnosis reported for ethnic minority and 
low socio-economic groups (National Cancer Intelligence Network, 2009a, 2009b).  
Furthermore, despite the minimal differences found across groups of ethnicity, findings 
appear to suggest that social (i.e. neighbourhood crime) and acculturation factors (i.e. 
generations of English speaking in the family) might be associated with an extended delay to 
help-seeking. Therefore, the thesis proposes that future research should investigate 
sociodemographic factors, health literacy, social capital and disease awareness amongst 
patients seeking help for gynaecological symptoms, and assess for possible disparities of 
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help-seeking across socio-economic groups, ethnicities and obese women, given their 
increased risks of developing gynaecological cancers.  
Given that socio-demographic factors influence symptom perception, appraisal, self-
management behaviours, help-seeking behaviour, health literacy and disease awareness, it is 
important that research examines the factors that interact with the processes of help-seeking 
for cancer symptoms, to form a better understanding of the socio-demographic factors that 
influence symptom interpretation and decisions to seek help (Whitaker et al., 2015).  Such 
research should be used to inform intervention development and improve cancer disparities 
across different sociocultural and economic groups (Madison, Schottenfeld, James, Schwartz, 
& Gruber, 2004; National Cancer Intelligence Network, 2014).  Additionally, research should 
continue to explore help-seeking from alternative routes to care (Ellis-Brookes et al., 2012) 
for gynaecological cancer symptoms (e.g. Emergency services, GP, other) and across levels of 
obesity, socio-economic status and ethnic minority groups with gynaecological cancer 
symptoms. 
In acknowledging the lack of comorbidity reporting in the present research and the 
association between comorbid diseases and gynaecological cancers (e.g. diabetes & 
hypertension), future studies should report the type of comorbid diseases (with medical 
diagnoses) present amongst participants in the sample to assess for the association between 
comorbidities, comorbidity management services, and time to help-seeking.  Barsky and 
colleagues (2001) suggest that pre-existing comorbidities have an important potential to bias 
both attention to bodily sensation(s) and the appraisal of symptoms, thus impacting an 
individual’s method of help-seeking. 
Given the mixed and novel findings derived from the present research, a wider multi-
site study should be conducted across the UK to assess the relationship between BMI and 
 250 
help-seeking and the impact of negative past experiences in help-seeking, attendance at 
preventative healthcare screenings and help-seeking for the various vague and non-specific 
symptoms of gynaecological cancers. 
Conclusion    
Results of the research advanced our knowledge and understanding of help-seeking 
behaviour for symptoms of PMB and the differences that exist between obese women and 
non-obese women in time to help-seeking, as well as the experience of utilising 
gynaecological healthcare services.  Moreover, findings challenged previous assumptions in 
the literature which suggest that obesity acts as a barrier to medical help-seeking and that 
previous attendance at preventative health screenings shortens this time.  The present research 
showed that obese women were not more likely to delay help-seeking when compared to non-
obese women, that attendance at preventative screenings was a predictor of delayed help-
seeking, and low awareness of gynaecological cancers was not associated with delay.  Finally, 
this thesis provides an understanding of the often complex transition through the menopause 
and women’s experiences with making sense of a potential symptom of gynaecological 
cancers. 
This thesis suggests the need for healthcare services to adapt their practice to meet the 
specific needs of obese patients, highlighting potential misconceptions amongst HCPs that 
obese women are more likely to delay help-seeking.  Furthermore, despite the minimal 
differences found across groups of ethnicity, findings appear to suggest that social and 
acculturation factors might be associated with an extended delay to help-seeking and should 
therefore be further explored in future research.  In view of the increasing evidence that 
obesity is a risk factor for the development of gynaecological cancers and the reduction of 
survival rates, a large multicentre study should be conducted to confirm the findings amongst 
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PMB as well as the more vague and non-specific symptoms common of gynaecological 
cancers.
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APPENDIX B 
Chapter 4: Consent form for Participants 
 
 
Understanding the perspective of the healthcare professional in help-seeking among obese women experiencing 
symptoms of gynaecological cancer 
 
 
Consent Form for Participants 
 
 
Please initial each statement to indicate agreement. 
☐   I have read and understood the information sheet for the above study and have been given the opportunity 
to ask questions.  
 
    I understand that my participation is voluntary and that I am free to withdraw from the study up until 
__(JANUARY, 2015)___without having to give any reason and without me being affected or this having any 
negative consequences on my circumstances.  
      
    I agree to provide information that will be used for research purposes only, and understand that all the 
information relating to myself obtained as part of the study will be strictly confidential, and that I will not be 
personally identified in any write-up of the results.  
 
    I understand that information will be stored in secured manual and electronic files and is subject to the 
provisions of the Data Protection Act.  
 
    I consent to being audio and video taped for the purpose of transcription and data collection in this focus 
group discussion. 
 
    I wish to participate in this study under the conditions set out here and in the Information Sheet for 
Participants.  
 
 
Signed:         
 
 
Printed Name:        
 
 
 
Date:      
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APPENDIX C  
Chapter 4:  Information Sheet for Participants  
 
 
Information Sheet for Participants 
 
 
Study Title: Understanding the perspective of the healthcare professional in help-seeking among obese women 
experiencing symptoms of gynaecological cancer. 
 
Introduction: 
You are being invited to take part in the present study. Please take the time to read through the following 
information. Ask the relevant person who provided you with the information sheet if you have any questions or 
would like more information.   
 
What is the purpose of the study? 
The purpose of the present study is to hear about your experiences with obese women presenting with symptoms 
of gynaecological cancers in your healthcare service. We are interested to hear what you think and believe may 
contribute to patient delay in help-seeking for symptoms of gynaecological cancer.  We are also interested in 
learning more about your general beliefs and interpretations about the experience of obesity in women who 
present with symptoms of gynaecological cancers. We are also interested in hearing any suggestions you have 
which may help encourage or facilitate early help-seeking among obese women. The study will also provide a 
knowledge base from which to develop future research on the investigation of barriers to help-seeking from the 
patient perspective and will inform the development of interventions to challenge obese women’s beliefs about 
the symptoms and risk factors for gynaecological cancer and improve help-seeking. 
 
The study is in the form of an interview between you and the principal researcher. It will last 30-40 mins and 
will be audio-recorded to ensure clarity of data collection and transcription.  
 
Why have I been chosen? 
You have been chosen to participate in this study because you have been identified by representatives of your 
field as having experience working in direct care with the population of interest (obese women presenting 
symptoms of gynaecological cancer). 
 
Do I have to take part? / What happens if I take part? 
It is entirely up to you whether you decide to take part in the present study or not. If you decide to take part, you 
will be given this information sheet to keep and a meeting in the form of an interview will be arranged for you, 
which you will be asked to attend. Even if you decide to take part, you are still free to withdraw from the study 
at any time up until a month post completion of the interview, without having to give any reason. 
Withdrawing from the study will not affect you or have any negative consequences on your circumstances.  
 
You will have an option of participating in the interview face-to-face at your place of work, at the University of 
Birmingham Psychology Department, via phone, or Skype. 
 
What happens to my information? 
All information that is obtained from the interview will be uploaded onto a password protected computer for use 
of transcribing. Only the transcriber and research team will have access to these materials. This information will 
then be entered into a computer database, where your information will be assigned a number. The information in 
the database, as well as all study material (i.e., audio files), will be identified by numbers, and can therefore not 
be traced back to you or anyone else. Once the audio files are transcribed all digital copied and original files will 
be deleted. Your name will only appear on your consent form, and the researcher will be the only person who 
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has access to a list linking your name with your number. All study material, including audio records of 
interviews, will be kept in a locked filing cabinet at the University of Birmingham.  
 
Will my taking part in this study be kept confidential? 
All information that is obtained during the course of the study will be kept strictly confidential. No identifiable 
information will be included in any publication using the data of this study.  
 
What will happen to the results of the study? 
The results of the study will be analysed by the research team to identify the experiences of healthcare 
professionals working with obese women presenting symptoms of gynaecological cancer. The results may be 
presented at a conference or published in an academic journal and may be used to inform future research 
regarding the experience of obese women with symptoms of gynaecological cancer Please note that no 
identifiable information will be released in any write-up of the results. If you choose to participate in the study 
and would like to receive a copy of the results or final paper you may state this at the start of the interview and a 
copy of the results will be sent to you via the contact information you provide. 
 
Please contact Sara Tookey with any questions you may have.  
 
If you are interested in participating in this study and have not yet indicated your time preference, please contact 
Sara Tookey and include: - Preferred dates and times which are most convenient for you to complete the interview - Location and mode of interview you prefer (face-to-face at your work or the University, via phone or 
Skype) 
 
 
 
Sara Tookey 
PhD Researcher 
School of Psychology 
University of Birmingham 
Edgbaston, Birmingham 
B15 2TT 
 
 
 
Dr. Beth Grunfeld 
Senior Lecturer and Research Supervisor 
School of Psychology 
University of Birmingham 
Edgbaston, Birmingham 
B15 2TT 
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APPENDIX D 
Chapter 4: Interview Schedule 
1. Exploring Context 
Could you please tell me a bit about your place of work? 
 
What’s your professional role? What kind of patients do you see? What does your office look like? 
 
What percentage of your patients would you say are obese or overweight? 
 In what capacity would do you work with them? 
 
2. Narrowing in on the Patient Process of Coming into Care  
What is the process for a patient to be able to seek your services? 
 
 Do they have to be referred?  
 What does screening entail? 
 What is involved in seeking help for symptoms of gynaecological cancer? 
 
What is the screening process like for obese women? 
Are there difficulties for them/ you? 
Do you regularly make adaptations to aid in the process for them? (i.e. larger equipment, extra time to 
conduct screening, larger gowns) 
What are their attitudes toward vaginal examination? 
Do you always have equipment available for obese patients? What if it wasn’t?  
 
What is the patient process of obese women seeking help? 
Does it differ from non-obese patients in any way? 
What do you believe are the attitudes obese women hold toward seeking help for any health related 
symptom? 
What do you believe to be the barriers for seeking help amongst obese women? 
 
3. Patient and the Healthcare Professional: The Experience 
What do you think women know about the symptoms and risk factors for gynaecological cancer? 
Have you noticed any different beliefs amongst this group? 
What are the motivators to seek help for them? 
What get’s in the way of these women seeking help? 
Does this differ by ethnicity/ race/ culture? 
 
What is it like working with this population? 
 What’s it like to treat them? 
Are their challenges or difficulties in working with the obese female population within your services? 
As part of your role do you advise patients to lose weight? (at what stage in treatment was this?) What is 
that like? 
 
What do you think it would be like to be an obese female service user? 
 What would you notice about your care, the equipment, or your service care providers? 
 
4. Suggestions for improving help-seeking 
And finally, do you have any suggestions on how to improve help seeking in obese women with symptoms of 
gynaecological symptoms? 
Suggested interventions? 
Changes to the clinic, practice, doctor-patient relationship, referral process, resources, equipment. 
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APPENDIX E 
Chapter 5: Definition of Questionnaire Variables 
Definition of Variables 
Variables Method of 
Data-
collection 
Description Inclusion in 
Analysis 
Sociocultural & Demographic Variables   
Age Self-measured  Subtraction of date of birth from date on the consent form. √ 
Marital Status Self-measured Indicated using a categorical variable, including five status designations. √ 
Employment  Self-measured Indicated using a categorical scale, including five status designations.  √ 
Personal 
Deprivation 
Index 
Self-measured Assessed availability of material resources to an individual. Indicated by agreement to the following 
statements (each scored as 1 with maximum score total of 5): No central heating in household; No 
telephone in household; No car available; Do not own home; Receive income support/benefit. 
√ 
Education Level Self-measured Highest level of education completed using a categorical scale ranging from a value of one, indicating 
Less than compulsory education according to UK education standards to a value of 4 for further 
postgraduate education. 
√ 
Years of 
residence  
Self-measured Subtraction of date arrived in the UK to the date on consent form. √ 
Country of 
origin 
Self-measured Open-ended response. √ 
Religion Self-measured Indicated using a categorical scale of 6 possible responses and 2 additional items of ‘none’ and ‘other’. √ 
Language Self-measured Indicated using a categorical scale of 18 possible items and an open-ended option of ‘other’. √ 
Ethnicity Self-measured Indicated using a categorical scale of 17 possible items and an open-ended option of ‘other’. √ 
Generations of 
English 
language  
Self-measured Indicated by ordinal scale of English speaking in family: Self (=1), Parents (=2), Grandparents (=3) & 
Great-grandparents (=4). If ‘none’ is indicated the participant did not speak English. 
√ 
Objective body size/weight & Body image  
Body Mass 
Index 
Measured by 
nurse in clinic 
BMI = x KG / y M(²).; Categories of obesity defined by WHO, 2000. √ 
Underweight Individuals measured at BMI <18.5. √ 
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Normal weight Individuals measured at BMI 18.5-24.9. √ 
Overweight Individuals measured at BMI 24-29.9. √ 
Obese Individuals measured at BMI 30-39.9 with a waist circumference >88cm. √ 
Morbidly obese Individuals measured at BMI >40 with a waist circumference >88cm. √ 
Waist-to-Hip 
Ratio 
Self-measured Measure of cardiovascular health. To determine the ratio, waist measurement is divided by hip 
measurement. 
Detailed instructions for measurement provided to participant with a tape measure. Measures of over .8 
indicate poor cardiovascular health. 
√ 
Body Image Self-measured Sixteen item questionnaire to assess for concerns with one's body shape (BSQ-16A) (Evans & Dolan, 
1993).  
√ 
Mood  
Anxiety and 
Depression 
Scale 
Self-measured The Hospital Anxiety and Depression Scale (HADS) (Zigmund & Snaith, 1983). Assesses mood using 
the 14 item scale assessing for mood in the past week scoring participants into ranges of anxiety and 
depression; (0-7, normal), (8-10, moderate) and (16-21, severe).  
√ 
Illness Perceptions  
Illness 
Perceptions 
Questionnaire- 
Revised 
Self-measured The Revised-Illness Perceptions Questionnaire (IPQ-R) (Moss-Morris et al., 2002; Weinman, Petrie, 
Sharpe, & Walker, 2000) was adapted to assess PMB and gynaecological cancer specific beliefs. Scales 
include Identity, Timeline, Consequences, Cause, and Control of the participants; current condition. 
Wording and terms were changed to include symptoms of gynaecological cancers and the word illness 
was changed to ‘condition’, as participants are pre-diagnosis and an assumption of future diagnosis could 
increase anxiety.  
√ 
Identity  Identity of a participant's condition measures using a symptom identification scale requiring participants 
identify if they experienced any of the listed symptoms.  
EXCLUDED 
Timeline (Acute/Chronic) Items of the subscale measure length of time they believe their condition and/symptoms will last from 
acute (short time) to chronic (long time). Assessed by 6 statements requiring identification of level of 
agreement. 
√ 
Timeline (Cyclical) Items of the subscale measure if participant believes the symptoms are cyclical nature. Assessed by 4 
statements requiring identification of level of agreement. 
√ 
Consequences Items of the subscale measure the perceived consequences of the condition on one's personal and social 
life. Assessed by 6 statements requiring identification of level of agreement. 
√ 
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Control Items of the subscale measure perceived amount of control one has over their condition, effectiveness of 
treatment and treatment control and the effectiveness of prevention and ability to prevent future 
diagnosis. Assessed by 11 statements requiring identification of level of agreement. 
√ 
Illness Coherence Items of the subscale measure participants’ understanding and possible confusion related to their 
condition. Assessed by 5 statements requiring identification of level of agreement. 
√ 
 Emotional Representations Items of the subscale measure associated emotional responses of fear, anxiety, anger, depressed mood 
and general upset. Assessed by 5 statements requiring identification of level of agreement. 
√ 
Gynaecological cancer awareness  
Knowledge of 
risk factors & 
Knowledge of 
symptoms 
Self-measured Gynaecological cancer awareness is assessed using 2 tests where a participant must indicate identify risk 
factors and symptoms of gynaecological cancers from a list of possible risk factors and symptoms.  
Knowledge of symptoms included 17 items and knowledge of risk factors was 20 items.  
√ 
Social influences  
Social Capital 
 
Self-measured Social capital is defined as the degree of social cohesion with social networks, familial relationships and 
reciprocal trust within a community, which constitutes social belonging and civic identity (Morrow, 
1999). The measure was derived from National Centre for Social Research and University College 
London (2011) and Gootaert, Narayan, Jones & Woolcock (2004) shortened version. 
INCLUDED 
SUB-
SCALES 
Past health behaviours  
Health History  Self-measured A twelve item scale requiring identification of level of agreement on statements relating health history 
practices (i.e. regular participation in screening programmes, diet and exercise practices) informed by 
gynaecological cancer literature. Previous attendance at screening was the used as a single item in 
analysis. 
INCLUDED 
SUB-
SCALES 
Outcome variable  
Time to help-
seeking 
Self-measured Time to help seeking will be assessed by specific questions mapping four points along the help-seeking 
journey to medical care for post-menopausal bleeding symptom(s) (first recognition of somatic change, 
recognition of concern, booking doctor’s appointment, and attending doctor’s appointment for 
symptom). Questions and associated Symptom Flow Chart follows the Anderson Delay Model 
(Anderson, Cacioppo & Roberts, 1995) Dates are be comprehensively acquired through the Flow Chart 
and associated questions.  
 
 Extended time Extended time to help-seeking is defined by delaying help-seeking more than two weeks after detection 
of PMB and before attendance at a healthcare service. 
√ 
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APPENDIX F 
Chapters 5 & 6: Full Questionnaire  
 
Instructions for filling in the questionnaire 
 
Before you begin this questionnaire booklet please write your full name in the upper right-
hand corner of this page.  If you have any difficulties completing this questionnaire or have 
any additional questions while completing this booklet please contact the lead researcher, 
Sara Tookey. 
 
Primary Researcher: Sara Tookey 
PhD Researcher 
School of Psychology, University of Birmingham 
Edgbaston, Birmingham 
B15 2TT 
 
 
 
This booklet consists of 12 pages consisting of 10 different sections. You will first be asked to 
answer questions about how you are feeling on an emotional level today. The following 
section will ask you about how feel about your body in a body image questionnaire. 
Questions relating to your social environment and community in which you live will be 
asked. After these sections have been completed the booklet will present you with questions 
related to your experiences with healthcare, gynaecological symptoms and your beliefs about 
health and illness. These sections will also ask you to explain how you came to seek help at 
the Post Menopausal Clinic today. The final section will ask you to fill out basic demographic 
questions. 
After completing this booklet questionnaire you will be provided with a detachable debrief 
form  (on the last page of the booklet) that you may take home with you. The debrief form 
will review with you the purpose of the study and provide you with additional contact details 
for any further questions and support.  
 
Please place your completed booklets into the pre-paid envelope provided. You may 
place this directly into the post or deliver the sealed envelope to the Post Menopausal Clinic 
receptionist where it will be placed into the clinic mail to be sent directly to the Primary 
Researcher, Sara Tookey. 
 
When working through this booklet please read the instructions provided for each 
section before answering the questions.   
  
 324 
How are you feeling today? 
The following questions are designed to understand your current emotions and feelings. Please tick the 
corresponding box to the right of each statement that best represents how you have been feeling in the 
past week. Please tick only one box for each statement.  
1 I feel tense or ‘wound up Most of the 
time 
A lot of the 
time 
From time to 
time, 
occasionally 
Not at all 
2 I still enjoy the things I use to enjoy Definitely as 
much 
Not quite so 
much Only a little  Hardly at all 
3 I get a sort of frightened feeling as if 
something awful is about to happen 
Very 
definitely and 
quite badly 
Yes, but not 
too badly 
A little, but it 
doesn’t worry 
me 
Not at all 
4 I can laugh and see the funny side of 
things 
As much as I 
always could 
Not quite so 
much now 
Definitely not 
so much now Not at all 
5 Worrying thoughts go through my mind A great deal 
of the time 
A lot of the 
time Not too often Very little  
6 I feel cheerful  
 Never Not often Sometimes  
Most of the 
time 
7 I can sit at ease and feel relaxed Definitely Usually Not often Not at all 
8 I feel as if I am slowed down Nearly all the 
time Very often Sometimes Not at all 
9 I get a sort of frightened feeling like 
‘butterflies’ in the stomach Not at all Occasionally Quite often Very often 
10 I have lost interest in my appearance 
Definitely 
I don’t take 
as much care 
as I should 
I may not 
take quite as 
much care 
I take just as 
much care as 
ever 
11 I feel restless as if I have to be on the 
move 
Very much 
indeed Quite a lot 
Not very 
much Not at all 
12 I look forward with enjoyment to things As much as I 
ever did 
Rather less 
than I used to 
Definitely 
less than I 
used to 
Hardly at all 
13 I get sudden feelings of panic Very often 
indeed Quite often 
Not very 
often Not at all 
14 I can enjoy a good book or radio or 
television programme 
Often Sometimes Not often Very seldom 
 
  
 325 
How do you feel about your body?  
We would like to know how you have been feeling about your appearance over the PAST FOUR 
WEEKS.  Please read each question and tick the appropriate answer box to the right.  Please answer 
all the questions. 
 
1 Has feeling bored made you brood about your shape? Never   Rarely Sometimes Often Very Often Always 
2 Have you thought that your thighs, hips or bottom are too 
large for the rest of you? 
Never   Rarely Sometimes Often Very Often Always 
3 Have you worried about your flesh being not firm enough? Never   Rarely Sometimes Often Very Often Always 
4 Have you felt so bad about your shape that you have cried? Never   Rarely Sometimes Often Very Often Always 
5 Have you avoided running because your flesh might 
wobble? 
Never   Rarely Sometimes Often Very Often Always 
6 Has being with thin women made you feel self-conscious 
about your shape? 
Never   Rarely Sometimes Often Very Often Always 
7 Have you worried about your thighs spreading out when 
sitting down? 
Never   Rarely Sometimes Often Very Often Always 
8 Has eating even a small amount of food made you feel fat? Never   Rarely Sometimes Often Very Often Always 
9 Have you avoided wearing clothes which make you 
particularly aware of the shape of your body? 
Never   Rarely Sometimes Often Very Often Always 
10 Has eating sweets, cakes, or other high calorie food made 
you feel fat? 
Never   Rarely Sometimes Often Very Often Always 
11 Have you felt ashamed of your body? Never   Rarely Sometimes Often Very Often Always 
12 Has worry about your shape made you diet? Never   Rarely Sometimes Often Very Often Always 
13 Have you felt happiest about your shape when your 
stomach has been empty (e.g. in the morning)? 
Never   Rarely Sometimes Often Very Often Always 
14 Have you felt that it is not fair that other women are 
thinner than you? 
Never   Rarely Sometimes Often Very Often Always 
15 Have you worried about your flesh being dimply? Never   Rarely Sometimes Often Very Often Always 
16 Has worry about your shape made you feel you ought to 
exercise? 
Never   Rarely Sometimes Often Very Often Always 
   BSQ-16A © Evans & Dolan, 1993.   
Measuring your hips and waist 
It is now time to use the tape measure provided at the back of each flyer to measure your hips and 
waist in centimetres. Please carefully take the tape-measure out of the envelope. Be careful not to 
tear it.  Please ensure that you are taking this measurement under your clothing unless you are 
wearing tight clothing. 
Using the diagram below as a guide, please measure you waist and hips with your tape measure. 
 
 
Waist   Measurement: In centimetres  
1) Take 4-5 consecutive natural breaths 
2) Place the tape measure at the midpoint between the top of your hipbone and 
the lowest point of your rib.  (This is usually the narrowest part of your 
midsection) 
3) Try to ensure that your tape measure is directly across this middle section.   
*If you are having difficulty please ask for assistance from another person. 
Hip Measurement: In centimetres 
1) Place the tape measure around the largest area of your buttocks and upper 
thigh.  
My waist measurement in centimetres is:  
                                                                         ________ 
 (take measurement to the nearest .5cm) 
My hip measurement in centimetres is:  
                                                                         ________ 
 (take measurement to the nearest .5cm) 
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PLEASE TELL US ABOUT YOUR SOCIAL NETWORK AND COMMUNITY 
We are also interested to see how a person’s social environment or community can impact health beliefs and 
behaviours. As such we are interested to hear how you experience your neighbourhood, community and your 
available social support. Please indicate yes or no for the following items. 
 
Neighbourhood 
I would like to start by asking you about the neighbourhood in which you live. Answer the 
following yes or no questions by ticking the boxes on the right. 
Is it a place you enjoy living in? o Yes o No 
Is it a place where you personally feel safe? o Yes o No 
Is it a place where neighbours look after each other or not? o Yes o No 
Has it good facilities for young children or not? o Yes o No 
Has it good local transport or not? o Yes o No 
Has it good leisure facilities for people like yourself or not? o Yes o No 
 
Please tick yes or no for the following three statements to indicate if you have experienced any of the 
following in the last 12 months. 
I have had a personal experience of theft, mugging, break-in or other crime. o Yes o No 
I have had a personal experience of verbal abuse due to race or colour o Yes o No 
I have had a personal experience of a physical attack due to race or colour o Yes o No 
Community Activity 
Have you done any of the following in the past fortnight? Please indicate yes or not by the following 
statements. 
I attended an adult education or night-class course o Yes o No 
I participated in a voluntary group or local community group o Yes o No 
I participated in community or religious activities o Yes o No 
How long have you lived in this area/neighbourhood? 
o 10 or more years o 4-9 years o 2-3 years o 1 year or less 
Social Support 
Please indicate yes or no for the following. 
Do you have any close friends or close relatives that you see or speak to 
on a regular bases? 
o Yes o No 
 
Please tick one circle which best describes these relationships? 
o Close contact with friends and relatives 
o Close contact with relatives only 
o Close contact with friends only  
o No close contact with friends/relatives   
 
Have you done any of the following in the past fortnight? Please indicate yes or no by the following 
statements by ticking in the corresponding box.   
 
Health History Questionnaire 
 Yes No   Yes No 
I visited relatives    I visited friends   
I had relatives visit me    I had friends visit me   
I have gone out with relatives    I have gone out with friends   
I have spoken to relatives on the phone    I have spoken to friends on the phone   
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We are interested to hear about your health practices and lifestyle choices. Please indicate how much you 
agree or disagree with the statements by ticking the appropriate box. 
  Health History Strongly 
Disagree 
Disagree Neither 
Agree nor 
Disagree 
Agree Strongly 
Agree 
1 I regularly attend the doctor for preventative 
screenings 
          
2 I eat healthily           
3 I exercise regularly           
4 I am a smoker           
5 I attend regularly scheduled mammograms           
6 I conduct regular breast self-checking 
behaviour 
          
7 My body weight is overweight or obese            
11 I have a chronic health condition that is 
different from the condition which has 
brought me in today 
          
12 I drink more than 4 drinks of alcohol in a day      
 
 
We are interested in your own personal views of how you now see the current medical problem that brought you into 
the clinic today. When we use the term ‘problem’ we are referring to the symptom or symptoms which you believe 
have brought you in to see us today. Please indicate how much you agree or disagree with the following 
statements about the current medical problem that has brought you into the clinic today, and the associated 
symptom(s) you’ve been experiencing by ticking the appropriate box.  
 
  VIEWS ABOUT YOUR CURRENT MEDICAL 
PROBLEM 
Strongly 
Disagree 
Disagree Neither 
Agree Nor 
Disagree 
Agree Strongly 
Agree 
1 My current problem will last a short time            
2 My current problem is likely to be permanent 
rather than temporary  
          
3 My current problem has major consequences on 
my life  
          
4 There is nothing which can help my current 
problem 
          
5 My symptom(s) will last for a long time            
6 This symptom(s) will pass quickly            
7 I expect to have this symptom(s) for the rest of my 
life  
          
8 My current problem is a serious one            
9 My current problem does not have much effect on 
my life  
          
10 My current problem strongly affects the way others 
see me  
          
11 My current problem has serious financial 
consequences  
          
12 My current problem causes difficulties for those 
who are close to me  
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  VIEWS ABOUT YOUR CURRENT MEDICAL 
PROBLEM 
Strongly 
Disagree 
Disagree Neither 
Agree Nor 
Disagree 
Agree Strongly 
Agree 
13 There is a lot which I can do to control symptoms            
14 The symptoms of my current problem are puzzling 
to me  
          
15 Nothing I do will affect my current problem in the 
future 
          
16 What I do can determine whether my current 
problem gets better or worse  
          
17 When I think about my current problem I get upset            
18 The negative effects of my current problem can be 
prevented (avoided) by medical care  
          
19 The course of my current problem depends on me            
20 My current problem is a mystery to me            
21 I have the power to influence my current problem 
now & for the future  
          
22 My actions will have no effect on future outcomes 
of my current problem  
          
23 My symptom(s) is very unpredictable            
24 I get depressed when I think about my current 
problem  
          
25 Medical care through the post-menopausal clinic 
can control my current problem  
          
26 My current problem will improve in time            
27 Having this current problem makes me feel 
anxious  
          
28 There is very little that can be done to improve my 
current problem  
          
29 My current problem does not worry me            
30 My symptom(s) come and go in cycles            
31 My current problem makes me feel angry            
32 Medical care will be effective in curing my current 
problem 
          
33 I don't understand my current problem            
34 My current problem makes me feel afraid            
35 My current problem doesn't make any sense to me            
36 I go through cycles in which my current problem 
gets better and worse  
          
37 I have a clear picture or understanding of my 
current problem  
          
38 The symptom(s) of my current problem change a 
great deal from day to day  
          
What do YOU think are the three main causes of your current medical problem? 
1. _____________________________________________________ 
2. _____________________________________________________ 
3. _____________________________________________________ 
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RISK FACTORS FOR GYNAECOLOGICAL CANCER 
Up until now we have been interested in post-menopausal bleeding and symptoms you may have 
experienced related to this. We would like to ask you about gynaecological cancers in general. 
Gynaecological cancers are cancers that develop within a woman’s reproductive system. 
Gynaecological cancer includes cancers of the cervix (cervical cancer), ovaries (ovarian cancer), 
womb (endometrial cancer or uterine cancer), genitals (vulvar cancer), or birth canal (vaginal cancer). 
 
Please indicate if you believe that the following people could be at increased risk for 
developing gynaecological cancer(s) by an ticking in the YES or NO box.  
 
  Which of the following are risk factors of gynaecological cancers YES NO 
RF1 Women between the age of 50 and 60     
RF2 Women who meet criteria for obesity     
RF3 Women with high blood pressure     
RF4 Women with Polycystic Ovarian Syndrome     
RF5 Women who’ve birthed to more than 3 children     
RF6 Women who have never been pregnant     
RF7 Women who have taken birth control pills (contraceptives)     
RF8 Women who have taken hormone replacement therapy     
RF9 Women who have been infected by the Flu virus in the past 5 years     
RF10 Women with diabetes     
RF11 Women with a family history of other cancers (not gynaecologic)     
RF12 Women a history of multiple sexual partners     
RF13 Women with mutations in the genes BRCA1 and BRCA2      
RF14 Women with poor oral hygiene     
RF15 Women with a history of human papilloma virus HPV infection     
RF16 Women who smoke cigarettes     
RF17 Women who have had their first pregnancy after 20 years old     
RF18 Women with prior cancer diagnosis     
RF19 Women who have experienced late menopause     
RF20 Women who have experienced infertility     
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Have you ever felt at higher risk of disease than others around you? 
 
 
When you first sought help how much more or less did you think you were at risk of developing cancer than 
others around you?  
o More at risk o At similar risk to others o Less at risk 
 
Currently how much do you think you are at risk of being diagnosed with a cancer than others?  
o More at risk o At similar risk to others o Less at risk 
 
 
 
SYMPTOMS OF GYNAECOLOGICAL CANCER 
Below is a list of symptoms that may or may not be related to gynaecological cancer. Please indicate 
if you believe they are symptoms of gynaecological cancer or not. 
Abdominal bloating   Yes   No 
Loss of appetite/weight   Yes   No 
Constipation   Yes   No 
Severe or recurrent headaches   Yes   No 
Changes in bowel or bladder habits   Yes   No 
Fatigue   Yes   No 
Vaginal discharge   Yes   No 
Numbness of fingers and toes   Yes   No 
Indigestion   Yes   No 
Lower Abdominal Pain   Yes   No 
Pain during intercourse   Yes   No 
Unexplained Weight gain/increased waist size   Yes   No 
Lower back pain   Yes   No 
Cough   Yes   No 
Vaginal Pain   Yes   No 
Vaginal Ulcers   Yes   No 
Lump or wart-like growth on vulvar   Yes   No 
 
o Yes o No 
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Your Journey to the Clinic 
The next section will be used to map out your journey from the moment you noticed a symptom until 
the day that brought you into the Post-menopausal Bleeding Clinic for your first appointment. For 
each question please indicate to the best of your knowledge the date, season, and year when you 
recall having these experiences.   
1) When did you first begin to notice that there was a change(s)/symptom(s) in your body? 
 
Date:____________ (dd/mm/yyyy)   Season:___________ 
1.a. What bodily change did you experience?  
 
 
 
 
 
2) When did you first realise that the symptom(s)/changes(s) was something to be concerned about? 
 
Date:____________ (dd/mm/yyyy)   Season:___________ 
2.a. Please explain why you felt the symptom was something to be concerned about? 
 
 
 
 
 
 
3) Please begin Symtpom Flow Chart on next page. The flow chart wil ask you questions related to the 
symptom(s)/change(s) which has brought you into the post-menopausal clinic. 
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(Write'in'box)''
Date:'day/month/year'
When%did%you%ﬁrst%no/ce%your%post2
menopausal%bleeding%symptom?%
'
'
What%did%you%do%in%response%to%this?%(select%all%that%apply)%
o  I'looked'up'the'
symptom'online'
o  I'remedied'the'
problem'with'over=the=
counter'medicine'or'an'
alterna?ve'approach'to'
medicine'
(aromatherapy,'
acupuncture,'
psychotherapy,'etc.)'
o  I'conﬁded'in'another'
person'
o  I'monitored'my'symptoms'to'
see'if'they'would'improve'or'
worsen'
o  I'tried'not'to'think'about'it'
o  I'assumed'it'was'normal'
o  I'assumed'it'was'due'to'another'
condi?on'I'have'(diabetes,'
arthri?s,'anaemia,'etc.)''
o  I'altered'my'diet'and/or'exercise''
o  I'consulted'a'pharmacist'
o  I'contacted'a'healthcare'
professional'
o  Other'
(Write'in'box)'
If%Other,%what%please%write%
what%you%did%in%box%below%
o  Yes' o  No'''''
(Move&to&
next&page)'
Did%these%work?%
'
'
If%Yes,%how%long%did%this%
relief%generally%last?%
o  A'family'member'
o  A'signiﬁcant'other'
o  A'friend'
o  A'health'care'
professional'
o  A'pharmacy'shop'
assistant'or'
pharmacist'
o  An'online'help'source'
o  Other'
'
If%‘I%conﬁded%in%another%
person’,%from%%
whom%did%you%ﬁrst%conﬁde%
in%/seek%advice?%
%%%%BEGIN%HERE%1
2%
2a%
2b%
3
3a%
o  Less'than'two'days'
o  A'week'or'more'
o  A'month'or'more'
o  More'than'3'months'
'
o  More'than'6'months'
o  For'one'year'
o  For'a'year'or'more'
o  For'more'than'2'years'
Protocol&V1.8&10/04/13&
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o  Sought'help'
immediately'from'
Emergency'
Services'
ARer%your%ini/al%response%to%your%symptom%what%did%
you%do?%
4
o  Booked'an'
appointment'with'
a'doctor'
o  Other'OR% OR%
What%date%did%you%seek%
emergency%services?%)%
What%date%did%you%contact%your%
doctor%to%book%an%appointment?%
(Write'in'box)''
Date:'day/month/year'
What%did%you%do?%(List%other%
things%you%did%before%
seeking%medical%help%for%
your%symptom)%
%
What%route%did%you%take%when%
you%sought%medical%help?%
o  Booked'an'appointment'
with'a'doctor'
o  Saw'help'immediately'
from'Emergency'Services'
o  Referred'immediately'to'
post=menopausal'
bleeding'clinic''
(Write'in'box)''
Date:'day/month/year'
What%date%did%you%aUend%your%
ﬁrst%doctor’s%appointment?%%
Were%you%referred%to%the%post2menopausal%bleeding%clinic%
at%your%ﬁrst%visit%to%medical%services?%
o  Yes' o  No'
If%‘No’,%how%many%visits%did%you%make%to%a%doctor%
before%you%were%referred%to%the%post2menopausal%
clinic%for%your%symptom?%
o  Twice'
o  More'than'3'?mes'
A% B% C%
From%the%/me%you%recognised%this%symptom%how%long%did%it%take%
you%to%seek%medical%care%for%this%symptom%(example:%GP%or%A&E)?%
o  Immediately'
o  Within'3'days'
o  Within'2'weeks'
o  Within'1'month'
o  Within'3'months'
o  Within'6'months'
o  A'year'or'more'
o  More'than'3'years'
5%%
(Write'in'box)'
(Write'in'box)''
Date:'day/month/year'
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Basic demographic questions 
 
What is your date of birth?  __________          
dd/mm/yy 
      
What is your gender?         o    Male o    Female    
What is the highest level of 
education you have 
completed? 
o    Less than 
compulsory for 
UK education 
standards (Did not 
complete school 
education) 
o    Compulsory levels of 
education (Primary and 
secondary education up ages 
16-18) 
o    Above compulsory 
levels of education 
(Higher education 
Bachelor’s degree, 
other tertiary 
education) 
o    Further 
post graduate 
education 
(Masters, 
Doctorate, 
etc.) 
What is your employment 
status? 
o    Currently 
employed 
o    Homemaker 
o    Sick leave 
o    Retired 
o    Student  
o    Self-employed 
o    Unemploy
ed 
  
What is your current 
marital status? 
o    Single, never 
married 
o    Live with 
long-term partner 
o    Married 
o    Widowed 
o    Separated 
  
o    Divorced 
 
  
Please indicate if you 
identify with any of the 
following statements 
o    I have no 
central heating in 
the household 
o        I have no 
car available  
o    I do not own a home 
o    I have no telephone 
o    I receive income 
support/social security 
benefit 
 
 
O none 
What is your Ethnicity/Race 
(please select all that apply): 
o    White  
o    British 
o    Irish 
o    Eastern 
European 
o    Other White:  
o    Black Caribbean 
o    Black African 
o    Black British 
o     White and Asian 
o     Other Mixed  
 
o    Chinese or 
other ethnic groups 
o    Other ethnic 
group(s):  
________________ 
o    South Asian 
or Asian British 
o    Indian 
o    Pakistani 
o    Bangladeshi 
o    Other Asian  
What is you religious 
affiliation? 
o        Catholic 
o        Christian 
o        Jewish 
o        Muslim 
o        Hindu 
o        Buddhist 
o        None 
o        Other:    
What is your country of origin or birth?  
___________________ 
   
If you have moved to the UK from another 
country, when did you arrive in the UK to live? 
mm/yy    ________/_________ 
  
Languages commonly spoken (please select all 
that apply): 
o    English  
o    Pahari       
o     Punjabi        
o     Sindhi 
o     Bengali 
o     Sylheti  
o     Arabic 
o    Urdu         
o    Japanese     
o    Chinese 
o    Swahili 
o    Hausa 
o    Eastern European 
o    Hindi    
o    Pashto  
o    Gujarati     
o    Mirpuri 
o    Kutchhi 
o    Other: 
______________ 
Please indicate who in your family speaks/spoke 
English (select all that apply): 
o    Self o    Parent(s) o    Grandparent(s) o    Great-
grandparent(s) 
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APPENDIX G 
Chapters 5 & 7: Study Design Flow Chart 
 
 
Par$cipants+who+indicated+interest+in+IPA+(Study+4)+
par$cipa$on+are+assessed+for+eligibility+
A+face=to=face+in=depth+interview+with+
CI++is+booked+in+clinic+room+(n=10)+
Interview+is+conducted+in+clinic+
(Sandwell/+City+Hospital)+
Ques$onnaire+is+completed+
in+clinic+or+at+home++by+
par$cipants+and+sent+to+CI+
(n=276)+
Eligible+(Study+4)+par$cipants+(BMI>36+&+receipt+of+diagnosis+
nega$ve+of+gynae+cancer)+are+contacted+via+mail/email/phone+
as+indicated+on+ques$onnaire+consent+to+arrange+interview+
Clinic+notes+accessed+Data+recorded++
(BMI+&+diagnosis)+
Those+who++wish+not++to+
par$cipate+will+reply+with+slip+
provided+and+will+not+receive+
a+reminder+pack.+
Reminder+packs+(with+
duplicate+ques$onnaire+&+
reminder+cover+leVer)+will+be+
sent+to+those+who+have+not+
returned+their+ques$onnaire+
aWer+3+weeks+of+ﬁrst+receipt+
of+ques$onnaire.+
Studies(2(&(4:+Researcher+aVends+PMB+and+approaches+
pa$ents+in+wai$ng+area+(Sandwell+&+City+Hospital).+
Pa$ents+are+invited+in+person+to+par$cipate+in+the+study.+
Researcher+is+available+in+clinic+to+answer+ques$ons+
regarding+study.+
Interested+pa$ents+are+provided+with+a+PIS,+consent+
form,+debrief+sheet+to+pa$ents+who+have+not+been+given+
the+ques$onnaire+in+clinic+wai$ng+area.+
Ques$onnaires+
reviewed+by+
researcher+
Ques$onnaires+
not+returned+
No+
further+
contact+
Par$cipants+
opted+out+of+IPA+
(Study+4)+
No+
further+
contact+
Interview+reminder+leVer+
sent+to+par$cipants+with+
Pa$ent+Informa$on+Sheet+
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APPENDIX H 
Chapters 5 & 6: Information Sheet for Participants 
 
  
Location: Sandwell Hospital PMB Clinic  
Sheet for Participants (Phase 1) 
 
Study Title: Help-seeking for gynaecological symptoms: A Questionnaire study 
 
Introduction: 
My name is Sara Tookey and I am Doctoral Researcher at the University of Birmingham. I would like to 
invite you to take part in a study about your experience of seeking help for your gynaecological 
symptoms, from the moment you recognised that something was not right, until now. Please take the time 
to read through the following information. Ask a staff member or researcher if you have any questions or 
would like more information.   
 
What is the purpose of the study? 
The purpose of the study is to gain an understanding of the things that lead women to seek help for 
gynaecological symptoms as well as the things that get in the way of seeking help. We’d like to know 
how this process has been for you. How did you get the advice or help you needed when you noticed the 
symptom? When did you decide to see a healthcare professional?   
 
The study is in the form of a paper questionnaire pack. It will take 30-40 mins to complete. Paper 
questionnaire packets are available in the clinic.  
 
Why have I been chosen? 
Any woman who attends the Post-menopausal Bleeding Clinic is eligible to participate in this study.  
 
Do I have to take part? / What happens if I take part? 
It is entirely up to you whether you decide to take part in the study or not. If you participate in the 
questionnaire you will be asked about your health beliefs and your experience of help seeking before 
attending the Post-menopausal Bleeding Clinic in Birmingham. In this questionnaire you will also be 
asked questions about your knowledge of gynaecological cancers. Please do not worry about this, we just 
want to gain a better understanding of all patients who attend the clinic. No information you provide will 
be linked to your medical notes and your decision to participate in this study will not impact your care in 
any way. If you do feel distressed at any point regarding the process of filling in the questionnaire you 
may contact the researcher or discuss this with a clinic staff and appropriate action will be taken 
according to the PMB clinic policy. 
 
We will ask you to allow us to access your chart notes at two time points during the study (Initial clinic 
visit and 6 month follow-up to confirm any diagnosis) and your name and date will be required for 
accessing this information. Your chart will be accessed solely for the purpose of obtaining height, weight 
and per cent body fat, which will have been measured by medical personnel at the time of initial clinic 
visit. The second time we access your notes will be to confirm the diagnosis (if any) given in clinic. 
Hospital Trust policies will be followed in accessing clinic notes and no identifiable information will be 
linked to your questionnaire responses.  
 
On the consent form for this study you will also be asked if you wish to be contacted for a possible 
participation a future phase 2  study (consent for this is optional). 
Even if you decide to take part, you are free to withdraw at any time up until a month after completion of 
  
Sandwell & West Birmingham Hospitals 
NHS Trust 
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the questionnaire without having to give any reason. Withdrawing from the study will not affect you or 
have any negative consequences on your circumstances.  All the information you provided for the study 
will be destroyed and will no longer be part of the results of the study. 
 
What happens to my information? 
All information that is obtained from the questionnaire will be stored in a locked filing cabinet at the 
University of Birmingham where only the study researchers will have access to this information and will 
be assigned a unique number code that cannot not be traced back to you or anyone else. Your name will 
only appear on your consent form, and the researcher will be the only person who has access to a list 
linking your name with your number. All data will be stored securely at the University according to the 
University of Birmingham’s Code of Practice for Research for 10 years. Your clinic chart will be 
accessed twice (as stated above). NHS trust policies will be followed in accessing clinic notes and no 
identifying data will be linked with the data.  
 
Will my taking part in this study be kept confidential? 
Yes. All information that is obtained from the study will be kept strictly confidential. No identifiable 
information will be included in any publication using the data of this study. Good Clinical Practice codes 
will be followed and any concerns will be reported to clinic staff member to determine appropriate 
action.  
 
What will happen to the results of the study? 
The results of the study may be presented at a conference or published in an academic journal and may 
be used to inform future research regarding seeking help for potential symptoms of gynaecological 
cancer. Again, no identifiable information will be released in any write-up of the results. If you choose to 
participate in the study you may request to receive a copy of the results by contacting the researcher.  
 
Please contact SWBH Patient PALS advice and liaison service (PALS) for hospital/trust assistance you 
have concerns or complaints regarding this research: 0121 507 5836 
 
Please contact Sara Tookey with any questions you may have.  
Primary Researcher: 
Sara Tookey 
PhD Researcher 
School of Psychology 
University of Birmingham 
Edgbaston, Birmingham 
B15 2TT;  
 
Supervisory Researcher: 
Dr. Beth Grunfeld 
Senior Lecturer and Research Supervisor 
School of Psychology 
University of Birmingham 
Edgbaston, Birmingham 
B15 2TT;  
Consultant Supervisor at Clinic: 
Mr. Joe Kabukoba, MD 
Post-menopausal Clinic Consultant 
Sandwell Hospital 
Sandwell & West Birmingham Hospitals 
NHS Trust 
 
Consultant Supervisor at Clinic: 
Mrs. Shagaf Bakour, MD 
Consultant Gynaecologist,  
Birmingham City Hospital  
Sandwell and West Birmingham Hospitals NHS  
 
If you wish not to participate please remove the below slip and you will not receive a 
reminder packet in three weeks time. 
 
I, _____________________________ (insert full name here) wish not to participate in the 
Help-seeking for gynaecological symptoms: A Questionnaire study. Please do not contact me 
in the future regarding taking part in this study. 
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APPENDIX I 
Chapters 5 & 6: Consent Form for Participants 
 
Sandwell/City Hospital PMB Clinic: Health beliefs and help-seeking for gynaecological symptoms: 
A Questionnaire study 
 
Consent Form for Participants 
 
Please tick each statement to the left AND initial to the right of each statement indicate agreement. 
   I have read and understood the information sheet for the above study and have been given the opportunity to ask 
questions.  
 
    I understand that my participation is voluntary and that I am free to withdraw from the study up until 2 
months without having to give any reason and without me being affected or this having any negative 
consequences on my circumstances.  
 
    I agree to provide information that will be used for research purposes only, and understand that all the 
information relating to myself obtained as part of the study will be strictly confidential, and that I will not 
be personally identified in any write-up of the results.  
 
    I understand that relevant data collected during the study may be looked at by individuals from the 
University of Birmingham’s Psychology research team, and from regulatory authorities of the NHS Trust , 
where it is relevant to my taking part in this research. I give permission for these individuals to have access 
to this data. 
 
    I understand that information will be stored in secured manual and electronic files and is subject to the 
provisions of the Data Protection Act.  
 
   I consent to the researcher accessing my patient notes twice to retrieve the following information: Height, 
weight, % body fat, and hip-to-waist ratio if available, and investigation results/diagnosis received up to 6 
months after interview and I understand that I must provide my name and date of birth for access. 
 
    I wish to participate in this study under the conditions set out here and in the Information Sheet for 
Participants.  
 
Optional consent for future contact:  
We are also interested in finding out more about the experience of help-seeking for post-menopausal bleeding 
symptoms through an in-depth conversational interview. In principle would you object to being contacted to 
participate in a Phase 2 of this study within the next 12 months? Please indicate by ticking and providing your 
preferred contact information below. 
  I would not object to future participation.   Contact Details:     
  I would like to receive a summary of the study results.                
Printed Name:      Participant Signature:      
 
 
Date of Birth: _______________________Date Agreed:      
  
Sandwell & West Birmingham Hospitals 
NHS Trust 
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APPENDIX J 
Chapters 5 & 6: Debrief Form for Participants  
  
Sandwell/City Hospital PMB Clinic: Debrief form (Questionnaire Study) 
 
Study Title: Help-seeking for gynaecological symptoms: A Questionnaire study  
Thank you for choosing to participate in this research study  
 
PARTICIPANT’S COPY: You may keep this debrief form for your own records 
 
Thank you for agreeing to participate in this study investigating the experience of seeking 
help for your gynaecological symptoms. We asked you questions about your own journey 
from the moment you noticed the bodily change (a symptom) to your attendance at the Post-
menopausal clinic.  
 
The results of the study will be used to see if there are certain factors that may predict how 
quickly an individual seeks help for abnormal gynaecological symptoms. Factors being 
investigated included: (a) demographic factors, (c) ethnic and cultural factors, (d) previous 
health behaviours, (e) knowledge of symptoms and risks for disease, (f) weight and size, (g) 
using social network for support, (h) body size/shape satisfaction. It is important to 
understand how women seek help for gynaecological symptoms so that we may be able to 
implement an intervention to encourage women to seek help more quickly. 
 
If you would like to speak with someone about any concerns which may have been brought to 
light by this research please speak with a clinic staff member. Any questions regarding the 
research please contact the researchers below.  
 
What next?  
Your study participation is complete. We will access your chart notes through the clinic and 
will acquire your weight and height and body fat percentage which is measured by the clinic 
healthcare professional. In the next six months the researcher will access your chart notes 
once more to document your diagnosis. 
  
Even if you decided to take part, you are still free to withdraw from the study at any time up 
until a month post after completion of the questionnaire, without having to give any 
reason. Withdrawing from the study will not affect you or have any negative consequences on 
your circumstances.  If you wish to withdraw please contact the researcher below (Sara 
Tookey). 
 
What happens to my information? 
All information that is obtained from the questionnaire will uploaded onto a password-
protected computer and paper questionnaires will be stored in a locked filing cabinet at the 
University of Birmingham where only the study researchers will have access to this 
information. Your questionnaire dose not have your name on it, this will be on the separate 
  
Sandwell & West Birmingham Hospitals 
NHS Trust 
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instructions page only, which will be kept separate from your completed questionnaire. This 
information will then be entered into a computer database, where your information will be 
assigned a number. The information in the database, as well as all study material will be 
identified by numbers, and can therefore not be traced back to you or anyone else. Your name 
will only appear on your consent form, and the researcher will be the only person who has 
access to a list linking your name with your number.   
 
Your clinic chart will be accessed twice (as stated above). Your personal information will not 
be linked to the data at any time and will be coded so that you will not be identifiable in the 
study data. NHS trust policies will be followed in accessing clinic notes and no identifying 
data will be linked with the data. 
All data will be stored securely at the University according to the University of Birmingham’s 
Code of Practice for Research for 10 years. 
 
Will my taking part in this study be kept confidential? 
Yes. All information that is obtained during the course of the study will be kept strictly 
confidential. No identifiable information will be included in any publication using the data of 
this study. Good Clinical Practice codes will be followed and if you should happen to disclose 
intent to harm yourself or others, a clinic staff member will be informed and clinic/trust 
policy will determine appropriate safety response action.  
 
What will happen to the results of the study? 
The results of the study will be analysed by the research team to identify the barriers to help-
seeking for women who have sought help for abnormal gynaecological symptoms and will 
explore factors that may impact process of coming to seek help for such symptoms. The 
results may be presented at a conference or published in an academic journal and may be used 
to inform future research regarding the experience of help seeking for post-menopausal 
bleeding. Please note that no identifiable information will be released in any write-up of the 
results. If you choose to participate in the study you may request to receive a copy of the 
results by contacting the researcher.  
Please contact SWBH Patient PALS advice and liaison service (PALS) for hospital/trust 
assistance you have concerns or complaints regarding this research: 0121 507 5836 
 
Primary Researcher: 
Sara Tookey 
PhD Researcher 
School of Psychology 
University of Birmingham 
Edgbaston, Birmingham 
B15 2TT;  
Supervisory Researcher: 
Dr. Beth Grunfeld 
Senior Lecturer and Research Supervisor 
School of Psychology 
University of Birmingham 
Edgbaston, Birmingham 
B15 2TT  
Consultant Supervisor at Clinic: 
Mr. Joe Kabukoba, MD 
Post-menopausal Clinic Consultant 
Sandwell Hospital 
Sandwell & West Birmingham Hospitals 
NHS Trust 
 
Consultant Supervisor at Clinic: 
Mrs. Shagaf Bakour, MD 
Consultant Gynaecologist,  
Birmingham City Hospital  
Sandwell and West Birmingham Hospitals 
NHS  
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APPENDIX K 
Chapter 5: Reliability Statistics of Measures 
Body shape questionnaire-16A (BSQ-16A) 
 
Reliability Statistics 
   Cronbach's Alpha N of Items 
   0.94 16 
   
     Item-Total Statistics 
  
  
Scale 
Mean if 
Item 
Deleted 
Scale 
Variance 
if Item 
Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's Alpha if Item 
Deleted 
BSQ16A1 36.45 283.146 0.613 0.938 
BSQ16A2 36.25 269.969 0.727 0.935 
BSQ16A3 36.02 274.036 0.671 0.937 
BSQ16A4 37.16 283.454 0.686 0.936 
BSQ16A5 37.27 284.817 0.594 0.938 
BSQ16A6 36.83 275.406 0.766 0.934 
BSQ16A7 36.98 276.048 0.742 0.935 
BSQ16A8 37.04 283.047 0.649 0.937 
BSQ16A9 35.95 273.998 0.699 0.936 
BSQ16A10 36.39 273.234 0.739 0.935 
BSQ16A11 36.52 268.142 0.812 0.933 
BSQ16A12 36.3 274.609 0.675 0.937 
BSQ16A13 36.37 287.688 0.442 0.942 
BSQ16A14 37.04 278.871 0.687 0.936 
BSQ16A15 37.05 280.294 0.698 0.936 
BSQ16A16 36.03 272.732 0.737 0.935 
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IPQ-R: Subscale ‘Timeline’  
 
Reliability Statistics 
Cronbach's Alpha N of Items 
0.738 6 
Item-Total Statistics 
 
Scale 
Mean if 
Item 
Deleted 
Scale 
Variance if 
Item 
Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's Alpha 
if Item Deleted 
IP2Timeline 12.3 12.467 0.521 0.687 
IP6RTimeline 11.94 12.558 0.513 0.69 
IP26RTimeline 12.41 16.15 0.138 0.776 
IP1RTimeline 11.95 13.436 0.38 0.729 
IP5Timeline 12.45 11.664 0.658 0.644 
IP7Timeline 12.72 11.98 0.637 0.653 
 
IPQ-R: Subscale ‘Timeline Cyclical’  
 Reliability Statistics 
Cronbach's Alpha      N of Items 
0.591               4 
 
Item-Total Statistics 
  
 
Scale 
Mean if 
Item 
Deleted 
Scale 
Variance if 
Item 
Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
IP23TimelineCyclical 8.16 8.683 0.065 0.721 
IP30TimelineCyclical 8.62 5.667 0.54 0.375 
IP36TimelineCyclical 8.85 5.865 0.489 0.42 
IP38TimelineCyclical 9.01 6.387 0.44 0.467 
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IPQ-R: Subscale ‘Consequences’  
 Reliability Statistics 
 Cronbach's Alpha N of Items 
 0.649 6 
  
Item-Total Statistics 
  
 
Scale 
Mean if 
Item 
Deleted 
Scale 
Variance if 
Item 
Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
IP9RConsequences 11.03 13.987 0.178 0.687 
IP3Consequences 11.45 11.606 0.484 0.562 
IP8Consequences 11.53 12.87 0.438 0.585 
IP10Consequences 12.37 13.087 0.497 0.572 
IP11Consequences 12.4 14.429 0.309 0.629 
IP12Consequences 11.85 11.872 0.43 0.586 
 
IPQ-R: Subscale ‘Illness Coherence’  
 
Reliability Statistics 
Cronbach's Alpha N of Items 
0.805 5 
 
Item-Total Statistics 
  
 
Scale Mean 
if Item 
Deleted 
Scale 
Variance if 
Item 
Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if 
Item 
Deleted 
IP14RIllnessCoherence 12.43   15.174 0.572 0.775 
IP20RIllnessCoherence 12.54 14.96 0.67 0.743 
IP35RIllnessCoherence 12.14   15.582 0.637 0.754 
IP33RIllnessCoherence 12.13 14.99 0.691 0.736 
IP37IllnessCoherence 12.15   17.767 0.397 0.822 
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IPQ-R: Subscale ‘Personal Control’  
 
Reliability Statistics 
Cronbach's Alpha N of Items 
.472 6 
 
 
Item-Total Statistics 
 Scale Mean 
if Item 
Deleted 
Scale 
Variance if 
Item Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
IP13PeronalControl 14.99 10.794 .234 .427 
IP15RPersonalControl 14.32 12.172 .058 .516 
IP16PersonalControl 14.63 9.611 .403 .330 
IP19PersonalControl 14.83 9.718 .379 .343 
IP21PersonalControl 14.60 9.007 .464 .285 
IP22RPersonalControl 14.29 12.994 -.056 .574 
 
 
IPQ-R: Subscale ‘Treatment Control’  
 
Reliability Statistics 
 Cronbach's Alpha N of Items 
 0.648 5 
  
Item-Total Statistics 
 
Scale Mean 
if Item 
Deleted 
Scale 
Variance if 
Item Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if 
Item Deleted 
IP4RTreatmentControl 14.45 8.51 0.242 0.674 
IP28RTreatmentControl 14.58 8.435 0.295 0.645 
IP32TreatmentControl 14.71 7.511 0.515 0.542 
IP25TreatmentControl 14.59 7.367 0.571 0.517 
IP18TreatmentControl 14.78 7.772 0.426 0.583 
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IPQ-R: Subscale ‘Emotional Representations’  
 
Reliability Statistics 
 Cronbach's Alpha N of Items 
 0.835 6 
  
Item-Total Statistics 
   
 
Scale Mean 
if Item 
Deleted 
Scale 
Variance if 
Item Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
IP29REmotionalRep 14.17 27.441 0.413 0.845 
IP17EmotionalRep 14.5 24.132 0.664 0.797 
IP24EmotionalRep 14.68 22.612 0.738 0.78 
IP27EmotionalRep 14.15 24.115 0.677 0.795 
IP31EmotionalRep 15.06 26.877 0.456 0.837 
IP34EmotionalRep 14.57 23.294 0.715 0.786 
 
‘Symptoms’ Knowledge  
Reliability Statistics 
  Cronbach's Alpha N of Items  
  0.501 17  
  
     Item-Total Statistics 
 
 
Scale Mean if 
Item Deleted 
Scale Variance if 
Item Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
Symptoms1 10.16   5.63 0.234 0.471 
Symptoms2 10.11  5.354 0.395 0.436 
Symptoms3 10.34 5.599 0.221 0.473 
Symptoms4 10.09 6.547 -0.162 0.55 
Symptoms5 10.06 5.57 0.319 0.455 
Symptoms6 10.49 7.009 -0.342 0.589 
Symptoms7 10.6 7.046 -0.377 0.584 
Symptoms8 10.01 6.195 0.02 0.511 
Symptoms9 10.56 6.082 0.041 0.512 
Symptoms10 10.01 5.509 0.409 0.442 
Symptoms11 10.07 5.238 0.491 0.418 
Symptoms12 10.26 5.415 0.309 0.452 
Symptoms13 10.18 5.416 0.329 0.448 
Symptoms14 10.16 6.466 -0.13 0.548 
Symptoms15 10.02 5.213 0.572 0.408 
Symptoms16 10.15 5.215 0.445 0.422 
Symptoms17 10.09 5.489 0.341 0.449 
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‘Risk-Factors’ Knowledge  
Reliability Statistics  
  Cronbach's Alpha N of Items 
   0.539 20 
   
Item-Total Statistics 
   
 
Scale Mean if 
Item Deleted 
Scale Variance 
if Item Deleted 
Corrected
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
RF1 11.95 7.153 0.293 0.508 
RF2 12.03 6.688 0.451 0.477 
RF3 12.32 6.89 0.307 0.5 
RF4 12.01 6.888 0.376 0.492 
RF5 11.99 8.348 -0.24 0.589 
RF6 12.4 6.975 0.29 0.504 
RF7 12.33 8.658 -0.331 0.614 
RF8 12.09 7.215 0.195 0.522 
RF9 11.86 8.106 -0.148 0.564 
RF10 12.38 7.058 0.251 0.512 
RF11 11.97 7.086 0.31 0.504 
RF12 12.06 6.91 0.337 0.497 
RF13 12.05 6.681 0.443 0.477 
RF14 12.09 8.427 -0.259 0.599 
RF15 12.01 6.814 0.411 0.485 
RF16 11.98 7.049 0.318 0.503 
RF17 11.93 8.225 -0.197 0.578 
RF18 11.91 7.24 0.291 0.51 
RF19 12.41 7.212 0.195 0.522 
RF20 12.54 7.144 0.287 0.508 
 
Mood HADS: ‘Anxiety’ Subscale  
Reliability Statistics  
  Cronbach's Alpha N of Items 
   0.862 7 
   
Item-Total Statistics 
   
 
Scale Mean if 
Item Deleted 
Scale Variance 
if Item Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
HADS1A 7.34 19.929 0.598 0.847 
HADS3A 7.32 18.04 0.731 0.828 
HADS5A 7.12 18.824 0.673 0.837 
HADS7A 7.51 20.692 0.598 0.848 
HADS9A 7.48 20.168 0.672 0.839 
HADS11A 7.2 19.65 0.486 0.867 
HADS13A 7.39 18.656 0.711 0.831 
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Mood HADS: ‘Anxiety’ Subscale  
Reliability Statistics  
  Cronbach's Alpha N of Items 
   0.785 7 
    
Item-Total Statistics 
  
 
Scale Mean if 
Item Deleted 
Scale Variance 
if Item Deleted 
Corrected Item-
Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
HADS2D 4.18 10.235 0.473 0.765 
HADS4D 4.3 10.139 0.557 0.751 
HADS6D 4.23 9.983 0.575 0.747 
HADS8D 3.54 9.75 0.481 0.765 
HADS10D 4.26 9.779 0.528 0.755 
HADS12D 4.08 9.346 0.594 0.741 
HADS14D 4.42 10.684 0.384 0.781 
 
Social Capital: Subscale ‘Neighbourhood Crime’ and Safety  
 
Reliability Statistics 
   Cronbach's Alphaa N of Items 
   -0.03 3 
        Item-Total Statistics 
   
 
Scale 
Mean if 
Item 
Deleted 
Scale 
Variance if 
Item 
Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
Neighbourhood7 -0.02 0.028 -0.026 0.018 
Neighbourhood8 -0.07 0.103 -0.035 0.018 
Neighbourhood9 -0.1 0.115 0.023 -.063a 
 
Social Capital: Subscale ‘Community Engagement’ Reliability Statistics 
 
Reliability Statistics  
   Cronbach's Alpha N of Items 
   0.208 4 
   
Item-Total Statistics 
    
 
Scale Mean 
if Item 
Deleted 
Scale Variance 
if Item Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
CommunityActivity1 2.95 0.992 0.265 0.079 
CommunityActivity2 2.93 0.915 0.25 0.04 
CommunityActivity3 2.8 0.851 0.125 0.133 
CommunityActivity4 0.37 0.626 -0.028 0.527 
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HHQ: Subscale ‘Previous Health Behaviours’  
 
Reliability Statistics 
Cronbach's Alpha N of Items 
  0.259 3 
   
Item-Total Statistics 
   
 
Scale Mean if 
Item Deleted 
Scale Variance 
if Item Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
HHQ1 7.43 3.122 0.111 0.262 
HHQ2 7.25 3.986 0.102 0.262 
HHQ6 7.35 2.666 0.216 -.006a 
a The value is negative due to a negative average covariance among items. This violates 
reliability model assumptions. You may want to check item codings. 
  
HHQ: Subscale ‘Health Promoting Behaviours’  
 
Reliability Statistics 
Cronbach's Alpha N of Items 
   0.529 2 
        
Item-Total Statistics 
   
 
Scale Mean if 
Item Deleted 
Scale 
Variance if 
Item Deleted 
Corrected Item-
Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
HHQ2 3.15 1.748 0.375 . 
HHQ3 3.77 0.97 0.375 . 
     
HHQ: Subscale ‘Health Harming Behaviours’  
 
Reliability Statistics 
   Cronbach's Alphaa N of Items 
   -0.424 2 
    
Item-Total Statistics 
   
 
Scale Mean if 
Item Deleted 
Scale 
Variance if 
Item Deleted 
Corrected Item-
Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
HHQ4R 1.56 1.271 -0.179 . 
HHQ9R 4.27 1.943 -0.179 . 
 349 
APPENDIX L 
Chapter 5: Frequency table- Data Screening 
Time to help-seeking Frequency Table 
 
Frequency % Valid % Cumulative % 
0 
1 
2 
3 
4 
5 
6 
7 
9 
10 
11 
13 
14 
15 
16 
17 
18 
19 
20 
21 
23 
28 
30 
33 
35 
37 
44 
45 
60 
61 
62 
66 
70 
72 
76 
79 
9 5.5 5.5 5.5  
4 2.4 2.4 7.9  
11 6.7 6.7 14.6  
16 9.8 9.8 24.4  
4 2.4 2.4 26.8  
4 2.4 2.4 29.3  
10 6.1 6.1 35.4  
13 7.9 7.9 43.3  
4 2.4 2.4 45.7  
2 1.2 1.2 47.0  
1 .6 .6 47.6  
1 .6 .6 48.2  
14 8.5 8.5 56.7  
1 .6 .6 57.3  
4 2.4 2.4 59.8  
2 1.2 1.2 61.0  
2 1.2 1.2 62.2  
2 1.2 1.2 63.4  
2 1.2 1.2 64.6  
3 1.8 1.8 66.5  
1 .6 .6 67.1  
3 1.8 1.8 68.9  
6 3.7 3.7 72.6  
2 1.2 1.2 73.8  
1 .6 .6 74.4  
1 .6 .6 75.0  
2 1.2 1.2 76.2  
1 .6 .6 76.8  
2 1.2 1.2 78.0  
1 .6 .6 78.7  
1 .6 .6 79.3  
1 .6 .6 79.9  
2 1.2 1.2 81.1  
1 .6 .6 81.7  
1 .6 .6 82.3  
1 .6 .6 82.9  
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80 
84 
89 
98 
116 
118 
122 
158 
162 
180 
218 
245 
251 
278 
305 
360 
400 
720 
780 
930 
1800 
1810 
2880 
3031 
3960 
Total 
2 1.2 1.2 84.1  
1 .6 .6 84.8  
1 .6 .6 85.4  
1 .6 .6 86.0  
1 .6 .6 86.6  
1 .6 .6 87.2  
1 .6 .6 87.8  
1 .6 .6 88.4  
1 .6 .6 89.0  
2 1.2 1.2 90.2  
1 .6 .6 90.9  
1 .6 .6 91.5  
1 .6 .6 92.1  
1 .6 .6 92.7  
1 .6 .6 93.3  
1 .6 .6 93.9  
1 .6 .6 94.5  
2 1.2 1.2 95.7  
1 .6 .6 96.3  
1 .6 .6 97.0  
1 .6 .6 97.6  
1 .6 .6 98.2  
1 .6 .6 98.8  
1 .6 .6 99.4  
1 .6 .6 100.0  
164 100.0 100.0   
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HADS: Subscale ‘Anxiety’ Frequency Table   
 
Frequency % Valid % Cumulative % 
0 7 4.3 4.3 4.3 
1 7 4.3 4.3 8.6 
1 1 .6 .6 9.2 
2 7 4.3 4.3 13.5 
3 5 3.0 3.1 16.6 
4 8 4.9 4.9 21.5 
5 10 6.1 6.1 27.6 
6 2 1.2 1.2 28.8 
6 13 7.9 8.0 36.8 
7 19 11.6 11.7 48.5 
8 13 7.9 8.0 56.4 
8 1 .6 .6 57.1 
9 11 6.7 6.7 63.8 
10 10 6.1 6.1 69.9 
11 5 3.0 3.1 73.0 
12 7 4.3 4.3 77.3 
13 8 4.9 4.9 82.2 
14 5 3.0 3.1 85.3 
15 3 1.8 1.8 87.1 
16 7 4.3 4.3 91.4 
17 5 3.0 3.1 94.5 
18 4 2.4 2.5 96.9 
19 3 1.8 1.8 98.8 
20 1 .6 .6 99.4 
21 1 .6 .6 100.0 
Total 163 99.4 100.0  
Missing 1 .6   
 164 100.0   
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HADS: Subscale ‘Depression’ Frequency Table     
  Frequency % 
Valid 
% Cumulative % 
0 16 9.8 9.8 9.8 
1 25 15.2 15.3 25.2 
2 14 8.5 8.6 33.7 
2 1 .6 .6 34.4 
3 18 11.0 11.0 45.4 
4 1 .6 .6 46.0 
4 7 4.3 4.3 50.3 
5 1 .6 .6 50.9 
5 14 8.5 8.6 59.5 
6 10 6.1 6.1 65.6 
7 10 6.1 6.1 71.8 
8 15 9.1 9.2 81.0 
9 8 4.9 4.9 85.9 
10 8 4.9 4.9 90.8 
11 1 .6 .6 91.4 
11 6 3.7 3.7 95.1 
12 1 .6 .6 95.7 
12 3 1.8 1.8 97.5 
13 2 1.2 1.2 98.8 
14 1 .6 .6 99.4 
20 1 .6 .6 100.0 
Total 163 99.4 100.0  
Missing 1 .6   
 164 100.0   
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IPQ-R: Subscale ‘Timeline’ Frequency Table 
 
 
Frequency % Valid % Cumulative %  
8 2 1.2 1.2 1.2 
9 1 .6 .6 1.8 
10 7 4.3 4.3 6.1 
11 2 1.2 1.2 7.3 
11 9 5.5 5.5 12.8 
12 9 5.5 5.5 18.3 
13 18 11.0 11.0 29.3 
14 24 14.6 14.6 43.9 
15 18 11.0 11.0 54.9 
16 1 .6 .6 55.5 
16 23 14.0 14.0 69.5 
17 18 11.0 11.0 80.5 
18 13 7.9 7.9 88.4 
19 6 3.7 3.7 92.1 
20 4 2.4 2.4 94.5 
21 3 1.8 1.8 96.3 
22 1 .6 .6 97.0 
23 2 1.2 1.2 98.2 
24 2 1.2 1.2 99.4 
26 1 .6 .6 100.0 
Total 164 100.0 100.0  
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IPQ-R: Subscale’ Timeline Cyclical’ Frequency Table 
   Frequency % Valid % Cumulative %  
4 3 1.8 1.9 1.9  
5 1 0.6 0.6 2.5  
6 7 4.3 4.3 6.8  
7 9 5.5 5.6 12.3  
8 9 5.5 5.6 17.9  
9 12 7.3 7.4 25.3  
10 20 12.2 12.3 37.7  
11 2 1.2 1.2 38.9  
11 16 9.8 9.9 48.8  
12 22 13.4 13.6 62.3  
13 13 7.9 8.0 70.4  
14 19 11.6 11.7 82.1  
15 13 7.9 8.0 90.1  
16 9 5.5 5.6 95.7  
17 1 0.6 0.6 96.3  
18 1 0.6 0.6 96.9  
19 3 1.8 1.9 98.8  
20 2 1.2 1.2 100.0  
Total 162 98.8 100   
Missing 2 1.2  
  Total 164 100 
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IPQ-R: Subscale ‘Consequences’ Frequency Table    
 
Frequency    % Valid % Cumulative %  
6 6 3.7 3.7 3.7  
7 3 1.8 1.8 5.5  
8 6 3.7 3.7 9.1  
9 8 4.9 4.9 14.0  
10 10 6.1 6.1 20.1  
11 12 7.3 7.3 27.4  
12 15 9.1 9.1 36.6  
13 10 6.1 6.1 42.7  
14 23 14.0 14.0 56.7  
15 10 6.1 6.1 62.8  
16 1 0.6 0.6 63.4  
16 20 12.2 12.2 75.6  
17 1 0.6 0.6 76.2  
17 10 6.1 6.1 82.3  
18 11 6.7 6.7 89.0  
19 4 2.4 2.4 91.5  
20 4 2.4 2.4 93.9  
21 3 1.8 1.8 95.7  
22 2 1.2 1.2 97.0  
23 2 1.2 1.2 98.2  
25 1 0.6 0.6 98.8  
26 1 0.6 0.6 99.4  
29 1 0.6 0.6 100.0  
Total  154 100.0 100.0 
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IPQ-R: Subscale ‘Personal Control’ Frequency Table 
   Frequency % Valid % Cumulative % 
6 1 0.6 0.6 0.6  
7 1 0.6 0.6 1.2  
9 1 0.6 0.6 1.8  
10 6 3.7 3.7 5.5  
12 4 2.4 2.4 7.9  
13 7 4.3 4.3 12.2  
14 10 6.1 6.1 18.3  
15 9 5.5 5.5 23.8  
16 24 14.6 14.6 38.4  
17 17 10.4 10.4 48.8  
18 26 15.9 15.9 64.6  
19 14 8.5 8.5 73.2  
20 1 0.6 0.6 73.8  
20 12 7.3 7.3 81.1  
21 7 4.4 4.4 85.4  
22 9 5.5 5.5 90.9  
23 7 4.3 4.3 95.1  
24 2 1.2 1.2 96.3  
25 2 1.2 1.2 97.6  
25 1 0.6 0.6 98.2  
26 1 0.6 0.6 98.8  
27 1 0.6 0.6 99.4  
30 1 0.6 0.6 100.0  
Total   164 100.0 100.0  
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IPQ-R: Subscale ‘Treatment Control’ Frequency Table  
  
Frequency    % Valid % Cumulative % 
9 2 1.2 1.2 1.2 
10 1 .6 .6 1.9 
11 2 1.2 1.2 3.1 
13 7 4.3 4.3 7.4 
14 4 2.4 2.5 9.9 
15 15 9.1 9.3 19.1 
16 17 10.4 10.5 29.9 
17 20 12.2 12.3 42.0 
18 13 7.9 8.0 50.0 
19 13 7.9 8.0 58.0 
20 29 17.7 17.9 75.9 
21 13 7.9 8.0 84.0 
22 10 6.1 6.2 90.1 
23 6 3.7 3.7 93.8 
24 77 4.3 4.3 98.1 
25 43 1.8 1.9 100.0 
Total 162 98. 100.0 
 Missing 1 .6 
  Total 164 100.0 
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IPQ-R: Subscale ‘Illness Coherence’ Frequency Table 
 
Frequency % 
Valid 
% Cumulative %  
5 5 3.0 3.1 3.1  
7 1 0.6 0.6 3.7  
8 4 2.4 2.5 6.1  
9 8 4.9 4.9 11.0  
10 15 9.1 9.2 20.2  
11 9 5.5 5.5 25.8  
12 11 6.7 6.7 32.5  
13 1 0.6 0.6 33.1  
13 6 3.7 3.7 36.8  
14 10 6.1 6.1 42.9  
15 14 8.5 8.6 51.5  
16 13 7.9 8.0 59.5  
16 1 0.6 0.6 60.1  
17 14 8.5 8.6 68.7  
18 12 7.3 7.4 76.1  
19 6 3.7 3.7 79.8  
20 9 5.5 5.5 85.3  
21 4 2.4 2.5 87.7  
21 1 0.6 0.6 88.3  
22 4 2.4 2.5 90.8  
23 1 0.6 0.6 91.4  
24 1 0.6 0.6 92.0  
24 6 3.7 3.7 95.7  
25 7 4.3 4.3 100.0  
Total 163 99.4 100.0  
 Missing 1 0.6  
  Total       164 176 100 
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IPQ-R: Subscale ‘Emotional Representations’ Frequency Table 
 
Frequency % Valid % Cumulative %  
6 5 3.0 3.1 3.1  
7 3 1.8 1.9 4.9  
8 1 0.6 0.6 5.6  
9 7 4.3 4.3 9.9  
10 7 4.3 4.3 14.2  
11 2 1.2 1.2 15.4  
12 11 6.7 6.8 22.2  
13 12 7.3 7.4 29.6  
14 14 8.5 8.6 38.3  
15 5 3.0 3.1 41.4  
16 5 3.0 3.1 44.4  
17 1 0.6 0.6 45.1  
17 9 5.5 5.6 50.6  
18 9 5.5 5.6 56.2  
19 9 5.5 5.6 61.7  
19 2 1.2 1.2 63.0  
20 7 4.3 4.3 67.3  
21 9 5.5 5.6 72.8  
22 12 7.3 7.4 80.2  
23 6 3.7 3.7 84.0  
24 9 5.5 5.6 89.5  
25 3 1.8 1.9 91.4  
26 7 0.6 4.3 95.7  
27 3 1.8 1.9 97.5  
28 21 0.6 0.6 98.1  
29 3 1.8 1.9 100.0  
Total 162 98.8 100.0   
Missing 2 1.2  
  Total 164 100.0 100.0     
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‘Body Shape’ (BSQ16A) Frequency Table 
    Frequency % Valid % Cumulative % 
16 13 7.9 7.9 7.9 
18 8 4.9 4.9 12.8 
19 1 0.6 0.6 13.4 
20 5 3.0 3.0 16.5 
20 1 0.6 0.6 17.1 
21 2 1.2 1.2 18.3 
22 3 1.8 1.8 20.1 
24 5 3.0 3.0 23.2 
25 2 1.2 1.2 24.4 
26 1 0.6 0.6 25.0 
26 4 1.2 1.2 27.4 
27 1 0.6 0.6 28.0 
28 2 1.2 1.2 29.3 
29 6 3.7 3.7 32.9 
30 8 4.9 4.9 37.8 
31 1 0.6 0.6 38.4 
31 4 2.4 2.4 40.9 
32 5 3.0 3.0 43.9 
33 4 2.4 2.4 46.3 
33 1 0.6 0.6 47.0 
34 4 2.4 2.4 49.4 
35 3 1.8 1.8 51.2 
36 3 1.8 1.8 53.0 
37 6 3.7 3.7 56.7 
38 2 1.2 1.2 57.9 
39 3 1.8 1.8 59.8 
40 1 0.6 0.6 60.4 
41 3 1.8 1.8 62.2 
42 1 0.6 0.6 62.8 
43 1 0.6 0.6 63.4 
43 2 1.2 1.2 64.6 
44 1 0.6 0.6 65.2 
44 2 1.2 1.2 66.5 
46 1 0.6 0.6 67.1 
47 2 1.2 1.2 68.3 
48 3 1.8 1.8 70.1 
49 6 3.7 3.7 73.9 
50 1 0.6 0.6 74.4 
51 2 1.2 1.2 75.6 
53 1 0.6 0.6 76.2 
54 1 0.6 0.6 76.8 
55 4 2.4 2.4 79.3 
 361 
56 3 1.8 1.8 81.1 
57 1 0.6 0.6 81.7 
58 3 1.8 1.8 83.5 
59 1 0.6 0.6 84.1 
61 3 1.8 1.8 86.0 
62 2 1.2 1.2 87.2 
63 2 1.2 1.2 88.4 
64 3 1.8 1.8 90.2 
66 2 1.2 1.2 91.5 
66 1 0.6 0.6 92.1 
68 1 0.6 0.6 92.7 
69 1 0.6 0.6 93.3 
70 2 1.2 1.2 94.5 
72 1 0.6 0.6 95.1 
75 1 0.6 0.6 95.7 
76 1 0.6 0.6 96.3 
77 3 1.8 1.8 98.2 
78 1 0.6 0.6 98.8 
79 1 0.6 0.6 99.4 
80 1 0.6 0.6 100.0 
Total 164 100.0 100.0 
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‘Risk Factor’ Knowledge Frequency Table   
 
Frequency % Valid % 
Cumulativ
e %  
5 3 1.8 1.9 1.9  
7 2 1.2 1.2 3.1  
8 10 6.1 6.2 9.3  
8 1 0.6 0.6 9.9  
9 7 4.3 4.3 14.2  
9 1 0.6 0.6 14.8  
10 7 4.3 4.3 19.1  
11 13 7.9 8.0 27.2  
12 1 0.6 0.6 27.8  
12 16 9.8 9.9 37.7  
13 1 0.6 0.6 38.3  
13 1 0.6 0.6 38.9  
13 1 0.6 0.6 39.5  
13 1 0.6 0.6 40.1  
13 27 16.5 16.7 56.8  
14 1 0.6 0.6 57.4  
14 26 15.9 16.1 73.5  
15 18 11.0 11.1 84.6  
16 2 1.2 1.2 85.8  
16 16 9.8 9.9 95.7  
17 4 2.4 2.5 98.1  
18 3 1.8 1.9 100.0  
Total 162 98.8 100.0 
  Missing 2 1.2    
Total 164 100      
      ‘Perceived Risk’ Frequency Table 
 
  Frequency % Valid % Cumulative % 
Less at risk 26 15.9 16.1 16.1  
At similar risk 102 62.2 63.4 79.5  
More at risk than others around 
you 33 20.1 20.5 100.0  
Total 161 98.2 100.0   
Missing   3 1.8  
  Total 164 100.0 100.0 
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‘Symptom Knowledge’ Frequency Table     
 
Frequency % 
Valid 
% Cumulative %  
3 1 0.6    0.6    0.6 
4 1 0.6    0.6     1.2 
5 5 3.0    3.0     4.3 
6 5 3.0   3.0     7.3 
7 4 2.4    2.4     9.8 
7 1 0.6    0.6     10.4 
8 11 6.7    6.7     17.1 
9 17 10.4    10.4     27.4 
10 1 0.6    0.6     28.0 
10 22 13.4    13.4     41.5 
11 18 11.0    11.0     52.4 
12 34 20.7    20.2     73.2 
13 23 14.0    14.0     87.2 
14 15 9.1    9.1     96.3 
15 5 3.0    3.0     99.4 
17 1 0.6    0.6     100.0 
Total 164 100.0    100.0 
  
‘Waist-hip-ratio’ Frequency Table 
 
Frequency % Valid % Cumulative %  
0.45 1 0.6 0.7 0.7  
0.50 1 0.6 0.7 1.3  
0.54 1 0.6 0.7 2.0  
0.68 1 0.6 0.7 2.7  
0.68 1 0.6 0.7 3.4  
0.73 1 0.6 0.7 4.0  
0.73 1 0.6 0.7 4.7  
0.74 1 0.6 0.7 5.4  
0.74 1 0.6 0.7 6.0  
0.74 1 0.6 0.7 6.7  
0.75 1 0.6 0.7 7.4  
0.75 1 0.6 0.7 8.1  
0.75 1 0.6 0.7 8.7  
0.75 1 0.6 0.7 9.4  
0.75 1 0.6 0.7 10.1  
0.76 1 0.6 0.7 10.7  
0.76 1 0.6 0.7 11.4  
0.77 1 0.6 0.7 12.1  
0.77 2 1.2 1.7 13.4  
0.77 1 0.6 0.7 14.1  
0.78 1 0.6 0.7 14.8  
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0.78 1 0.6 0.7 15.4  
0.78 1 0.6 0.7 16.1  
0.79 1 0.6 0.7 16.8  
0.79 1 0.6 0.7 17.4  
0.79 1 0.6 0.7 18.1  
0.79 1 0.6 0.7 18.8  
0.79 1 0.6 0.7 19.5  
0.79 1 0.6 0.7 20.1  
0.80 1 0.6 0.7 20.8  
0.80 1 0.6 0.7 21.5  
0.80 1 0.6 0.7 22.8  
0.80 2 1.2 1.3 21.5  
0.80 1 0.6 0.7 22.8  
0.80 1 0.6 0.7 23.5  
0.81 1 0.6 0.7 24.2  
0.81 3 1.8 2.0 24.8  
0.81 1 0.6 0.7 26.8  
0.81 1 0.6 0.7 27.5  
0.81 1 0.6 0.7 28.2  
0.82 1 0.6 0.7 28.9  
0.82 1 0.6 0.7 29.5  
0.82 1 0.6 0.7 30.2  
0.82 1 0.6 0.7 30.9  
0.82 1 0.6 0.7 31.5  
0.82 1 0.6 0.7 32.3  
0.82 1 0.6 0.7 32.9  
0.82 1 0.6 0.7 33.6  
0.83 1 0.6 0.7 34.2  
0.83 1 0.6 0.7 34.9  
0.83 1 0.6 0.7 35.6  
0.83 1 0.6 0.7 36.2  
0.83 1 0.6 0.7 36.9  
0.83 1 0.6 0.7 37.9  
0.84 1 0.6 0.7 38.3  
0.84 1 0.6 0.7 38.9  
0.84 2 1.2 1.3 39.6  
0.84 1 0.6 0.7 40.3  
0.84 2 1.2 1.3 41.6  
0.84 1 0.6 0.7 42.3  
0.84 1 0.6 0.7 43.6  
0.84 1 0.6 0.7 44.3  
0.84 1 0.6 0.7 45.0  
0.84 1 0.6 0.7 45.6  
0.84 1 0.6 0.7 46.3  
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0.84 1 0.6 0.7 47.0  
0.85 1 0.6 0.7 47.7  
0.85 1 0.6 0.7 48.3  
0.85 1 0.6 0.7 49.0  
0.85 1 0.6 0.7 49.7  
0.85 1 0.6 0.7 50.3  
0.85 1 0.6 0.7 51.0  
0.85 1 0.6 0.7 51.7  
0.85 1 0.6 0.7 52.3  
0.86 1 0.6 0. 53.0  
0.86 1 0.6 0.6 53.7  
0.86 2 1.3 1.3 54.4  
0.86 1 0.6 0.7 55.0  
0.86 1 0.6 0.7 56.4  
0.86 1 0.6 0.7 57.0  
0.86 1 0.6 0.7 57.7  
0.86 1 0.6 0.7 58.4  
0.86 1 0.6 0.7 59.1  
0.86 1 0.6 0.7 60.4  
0.86 1 0.6 0.7 61.1  
0.86 1 0.6 0.7 61.7  
0.86 1 0.6 0.7 62.4  
0.87 1 0.6 0.7 63.1  
0.87 1 0.6 0.7 63.8  
0.87 2 1.2 1.3 64.4  
0.87 1 0.6 0.6 65.8  
0.87 1 0.6 0.7 66.4  
0.87 1 0.6 0.7 67.1  
0.87 1 0.6 0.7 67.8  
0.87 1 0.6 0.7 68.5  
0.87 1 0.6 0.7 69.1  
0.87 2 1.2 1.3 69.8  
0.87 1 0.6 0.7 71.1  
0.87 1 0.6 0.7 71.8  
0.88 1 0.6 0.7 72.5  
0.88 2 1.2 1.3 73.2  
0.88 1 0.6 0.7 74.5  
0.89 1 0.6 0.7 75.2  
0.89 1 0.6 0.7 75.8  
0.89 1 0.6 0.7 76.5  
0.89 2 1.2 1.3 77.2  
0.89 1 0.6 0.7 78.5  
0.89 1 0.6 0.7 79.2  
0.89 1 0.6 0.7 79.9  
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0.89 1 0.6 0.7 80.5  
0.89 2 1.2 1.3 81.2  
0.90 1 0.6 0.7 83.2  
0.90 1 0.6 0.7 83.9  
0.90 1 0.6 0.7 84.5  
0.90 1 0.6 0.7 85.2  
0.91 1 0.6 0.7 85.1  
0.91 1 0.6 0.7 86.6  
0.91 1 0.6 0.7 87.2  
0.91 1 0.6 0.7 87.9  
0.92 1 0.6 0.7 88.6  
0.92 1 0.6 0.7 89.3  
0.93 1 0.6 0.7 89.9  
0.93 1 0.6 0.7 90.6  
0.93 1 0.6 0.7 91.3  
0.94 1 0.6 0.7 91.9  
0.94 1 0.6 0.7 92.6  
0.95 2 0.6 0.7 93.3  
0.95 1 0.6 0.7 94.6  
0.98 1 0.6 0.7 95.3  
0.99 1 0.6 0.7 96.0  
0.99 1 0.6 0.7 96.6  
1.00 2 1.3 1.3 98.0  
1.06 1 0.6 0.7 98.7  
1.48 1 0.6 0. 99.3  
1.58 1 0.6 0.7 100.0  
Total 149 90.3 100.0  
 Missing 15 16 9.1 
  Total 164 176 100.0     
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BMI Frequency Table 
   Frequency % Valid % Cumulative % 
19 1 0.6 0.6 0.6  
20 1 0.6 0.6 1.3  
21 2 1.2 1.3 2.6  
21 1 0.6 0.6 3.2  
21 3 1.8 1.9 5.1  
22 1 0.6 0.6 5.8  
22 1 0.6 0.6 6.4  
22 2 1.2 1.3 7.7  
23 1 0.6 0.6 8.3  
23 2 1.2 1.3 9.6  
23 1 0.6 0.6 10.3  
23 1 0.6 0.6 10.9  
23 3 0.6 1.8 11.5  
24 2 1.2 1.3 12.8  
24 2 1.2 1.3 14.1  
24 2 1.2 1.3 15.4  
24 3 1.8 1.9 17.3  
24 1 0.6 0.6 17.9  
24 1 0.6 0.6 18.6  
24 2 1.2 1.3 19.9  
25 1 0.6 0.6 20.5  
25 1 0.6 0.6 21.2  
25 1 0.6 0.6 21.8  
25 2 1.2 1.3 23.1  
26 3 1.8 1.9 25.0  
26 1 0.6 0.6 25.6  
26 1 0.6 0.6 26.3  
26 1 0.6 0.6 26.9  
26 1 0.6 0.6 27.6  
26 1 0.6 1.3 28.2  
26 1 0.6 0.6 28.8  
26 1 0.6 0.6 29.5  
26 1 0.6 0.6 30.1  
27 1 0.6 0.6 30.8  
27 1 0.6 0.6 31.4  
27 1 0.6 0.6 32.1  
27 3 1.8 1.9 34.0  
27 1 0.6 0.6 34.6  
27 1 0.6 0.6 35.9  
27 1 0.6 0.6 36.5  
28 2 1.2 1.3 37.8  
28 1 0.6 0.6 38.5  
 368 
28 1 0.6 0.6 39.1  
28 1 0.6 0.6 39.7  
28 1 0.6 0.6 40.4  
28 1 0.6 0.6 41.0  
29 1 0.6 0.6 41.7  
29 1 1.2 1.3 42.3  
29 2 0.6 0.6 43.6  
30 1 0.6 0.6 44.2  
30 1 0.6 0.6 44.9  
30 3 1.8 1.9 46.8  
30 6 3.7 3.8 50.6  
30 1 0.6 0.6 51.3  
30 2 1.2 1.3 52.6  
30 1 0.6 0.6 53.2  
31 1 0.6 0.6 53.8  
31 3 1.8 1.9 55.8  
31 1 0.6 0.6 56.4  
31 1 0.6 0.6 57.1  
31 1 0.6 0.6 57.7  
32 3 1.8 1.9 59.6  
32 2 1.2 1.2 60.9  
32 2 1.2 1.2 62.2  
32 4 2.4 2.5 64.7  
32 3 1.8 1.9 66.7  
32 1 0.6 0.6 67.3  
33 1 0.6 0.6 67.9  
33 1 0.6 0.6 68.6  
33 2 0.6 0.6 69.9  
34 1 0.6 0.6 70.5  
34 1 0.6 0.6 71.2  
35 1 0.6 0.6 71.8  
35 1 0.6 0.6 72.4  
35 1 0.6 0.6 73.1  
35 2 1.2 1.3 74.4  
36 2 1.2 1.3 75.6  
36 1 0.6 0.6 76.3  
36 2 1.2 1.3 77.6  
36 1 0.6 0.6 78.2  
37 1 0.6 0.6 78.8  
37 3 1.8 1.9 80.8  
37 1 0.6 0.6 81.4  
38 1 0.6 0.6 82.1  
39 2 1.2 1.3 83.3  
39 1 0.6 0.6 84.0  
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40 1 0.6 0.6 84.6  
40 1 0.6 0.6 85.3  
40 1 0.6 0.6 85.9  
41 1 0.6 0.6 86.5  
42 2 1.2 1.3 87.8  
42 1 0.6 0.6 88.5  
42 1 0.6 0.6 89.1  
43 1 0.6 0.6 89.7  
43 1 0.6 0.6 90.4  
43 1 0.6 0.6 91.0  
44 1 0.6 0.6 91.7  
45 1 0.6 0.6 92.3  
46 1 0.6 0.6 92.9  
46 1 0.6 0.6 93.6  
48 1 0.6 0.6 94.2  
48 1 0.6 0.6 94.9  
50 1 0.6 0.6 95.5  
53 1 0.6 0.6 96.2  
54 2 1.2 1.3 97.4  
60 1 0.6 0.6 98.1  
61 1 0.6 0.6 98.7  
62 1 0.6 0.6 99.4  
69 1 0.6 0.6 100.0  
Total 156 95.1 100   
Missing 8 4.9  
  Total 154 100.0 100 
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Ethnicity Categories Frequency Table 
 
Frequency % Valid % Cumulative %  
White European 131 79.9 82.4 82.4  
Black African 11 6.7 6.9 89.3  
South 
Asian/Asian 
British 17 10.4 10.7 100.0  
Other  97 100   
Total 159 3.0    
Missing 5 100  
  Total 131 79.9 82.4 
              
Years residing in UK Frequency Table    
 
Frequency % Valid % Cumulative %  
1-5 yrs 1 0.6 0.6 0.6  
5-10 yrs 2 1.2 1.2 1.8  
10-20 years 4 2.4 2.4 4.3  
20+ years 17 10.4 10.4 14.6  
British Born 140 85.4 85.4 100.0  
Total 164 100.0 100.0   
      Generations of English Speaking Frequency Table 
 
Frequency % Valid % Cumulative %  
0 4 2.4 2.4 2.4  
1 12 7.3 7.3 9.8  
2 15 9.1 9.1 18.9  
3 5 3.0 3.0 22.0  
4 128 78.0 78.0 100.0  
Total 164 100.0 100.0   
      HHQ: Subscale ‘Previous Health Behaviours’ Frequency Table 
 
Frequency % Valid % Cumulative %  
1 115 70.1 70.6 70.6  
2 48 29.3 29.4 100.0  
Total 163 99.4 100.0   
Missing 1 0.6  
  Total 164 100.0 
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HHQ: Subscale ‘Health Promoting Behaviours’ Frequency Table 
 
Frequency % Valid % Cumulative %  
1 84 51.2 51.5 51.5  
2 79 48.2 48.5 100.0  
Total 163 99.4 100.0   
Missing 1 0.6  
  Total 164 100.0 
    
HHQ: Subscale ‘Health Harming Behaviours’ Frequency Table Frequency 
Table 
 
Frequency       % Valid % Cumulative %  
2 6 3.7 3.8 3.8  
3 2 1.2 1.3 5.1  
4 8 4.9 5.1 10.1  
5 9 5.5 5.7 15.8  
6 29 17.7 18.4 34.2  
7 25 15.2 15.8 50.0  
8 38 23.2 24.1 74.1  
9 18 11.0 11.4 85.4  
10 23 14.0 14.6 100.0  
Total 158 96.3 100.0  
 Missing 6            3.7 
  Total 164 100.0 
  
  
      HHQ: Subscale ‘Perceived Body Weight’ Frequency Table 
 
Frequency       % Valid % Cumulative %  
2 2 1.2 1.2 1.2  
3 2 1.2 1.2 2.5  
4 18 11.0 11.0 13.5  
5 18 11.0 11.0 24.5  
6 27 16.5 16.6 41.1  
7 23 14.0 14.1 55.2  
8 39 23.8 23.9 79.1  
9 18 11.0 11.0 90.2  
10 16 9.8 9.8 100.0  
Total 163 99.4 100.0   
Missing 1 0.6  
  Total 164 100.0 
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HHQ: Subscale Present ‘Comorbidities’ Frequency Table 
 
Frequency       % Valid % Cumulative %  
2 95 57.9 59 59  
3 16 9.8 9.9 68.9  
4 10 6.1 6.2 75.2  
5 7 4.3 4.3 79.5  
6 23 14 14.3 93.8  
7 4 2.4 2.5 96.3  
8 2 1.2 1.2 97.5  
9 1 0.6 0.6 98.1  
10 3 1.8 1.9 100.0  
Total 161 98.2 100.0  
 Missing 3 1.8  
  Total 164 100.0  
 
  
      Social Capital: Subscale ‘Neighbourhood Belonging’ Frequency Table 
 
Frequency       % Valid % Cumulative %  
-4 4 2.4 2.4 2.4  
-2 3 1.8 1.8 4.3  
0 15 9.1 9.1 13.4  
1 1 0.6 0.6 14  
1 1 0.6 0.6 14.6  
2 35 21.3 21.3 36.0  
4 1 0.6 0.6 36.6  
4 45 27.4 27.4 64.0  
6 59 36.0 36.0 100.0  
Total 164 100.0 100.0    
      Social Capital: Subscale ‘Neighbourhood Crime’ Frequency Table 
 
Frequency       % Valid % Cumulative %  
-1 19 11.6 11.6 11.6  
0 142 86.6 86.6 98.2  
1 3 1.8 1.8 100.0  
Total 164 100.0 100.0    
      Social Capital: Subscale ‘Community Activity’ Frequency Table 
 
Frequency       % Valid % Cumulative %  
1 2 1.2 1.2 1.2  
2 2 1.2 1.2 2.4  
3 3 1.8 1.8 4.3  
4 2 1.2 1.2 5.5  
5 13 7.9 7.9 13.4  
Total 3 1.8 1.8 15.2  
Missing 1 0.6 0.6 15.9 
 Total 31 18.9 18.9 34.8   
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Social Capital: Subscale Social Support Frequency Table 
 
Frequency 
      
% Valid % 
Cumulati
ve %  
-5 2 1.2 1.2 1.2  
-4 2 1.2 1.2 2.4  
-2 3 1.8 1.8 4.3  
-1 2 1.2 1.2 5.5  
No close contact with 
friends/family 13 7.9 7.9 13.4  
Close contact with relatives or 
friends only 3 1.8 1.8 15.2  
1 1 0.6 0.6 15.9  
2 31 18.9 18.9 34.8  
3 7 4.3 4.3 39  
3 1 0.6 0.6 39.6  
4 39 23.8 23.8 63.4  
5 9 5.5 5.5 68.9  
6 51 31.1 31.1 100.0  
Total 164 100.0 100.0   
      Social Capital: Subscale Number of Contacts Frequency Table 
 
Frequency       % Valid % Cumulative %  
0 5 3.0 3.0 3.0  
0-2 contacts 8 4.9 4.9 7.9  
2-3  contacts 17 10.4 10.4 18.3  
4 or more contacts 98 59.8 59.8 78.0  
4 24 14.6 14.6 92.7  
5 9 5.5 5.5 98.2  
5 1 0.6 0.6 98.8  
6 1 0.6 0.6 99.4  
9 1 0.6 0.6 100.0  
Total 164 100.0 100.0   
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APPENDIX M 
Chapter 5: Aarhus statements checklist & descriptive statistics 
The Aarhus checklist (Weller et al., 2012)   DEFINITIONS OF TIME POINTS AND INTERVALS  Yes/No   
1. For studies requiring the measurement of an interval, are the 
beginning and end points of this interval clearly defined?   Yes 
pg. 129; 
154-157 
2. For all time points and intervals described, are there precise, 
transparent and repeatable definitions, and is the complexity of time 
points such as the date of first symptom and date of first presentation 
addressed?   
 
pg. 129-
130; 154-
157 
For studies that require an estimate of the date of first symptom:    
3. Do the researchers refer to a theoretical framework 
underpinning definition of this time point?   Yes 
Chp 2 & 
pg. 120; 
pg.128 
 
4. Is there a discussion of the different biases influencing 
measurement of this time point?   Yes 
Chp 2 & 
pg. 120; 
150 
For studies that require measurement of a date of first presentation to 
healthcare:   
 5. Do the researchers discuss the complexity of the date of first 
presentation?  Yes 
pg. 128-
130; 154-
157 
For studies that require measurement of a date of referral:    6. Do the researchers discuss the nature of the referral and provide 
adequate detail – for example, whether it was for investigation or 
consultation by a colleague in secondary care?  
Yes 
pg. 16-
18; 133; 
155-157; 
174 
For studies that require measurement of the date of diagnosis:    7. Do the researchers use an existing hierarchical rationale for 
the date of diagnosis measurement?   N/A 
 8. Is the healthcare context in which the study is based fully 
described?   N/A 
 9. Do the questions on time points and/or intervals clearly 
derive from stated definitions?   N/A 
 10.           Do researchers acknowledge the need for theoretical 
validation and make reference to the theoretical framework(s) 
underpinning measurement and analysis of the time points?   
N/A 
 11.           Has a validated instrument been used?   N/A 
 12.           Have the researchers included a copy of their 
instrument?   N/A 
 13.           Is there some discussion of how reliability and 
validity (trustworthiness) has been established?   N/A 
 14.           Do researchers acknowledge the need for theoretical 
validation and make reference to the theoretical framework(s) N/A 
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underpinning measurement and analysis of the time points?   
15.           Is there discussion of the different biases influencing 
measurement of the time points, such as how and when the question is 
asked and who is being asked?   
N/A 
 16.           Is the timing of the interview in relation to the date of 
diagnosis provided?   N/A 
 17.           Is there any triangulation of self-reported data with 
other data sources such as case notes?   N/A 
 18.           Is data analysis described in full including how and 
why data are categorised, how missing and incomplete data are 
managed, and how outliers at both ends of the spectrum are accounted 
for?   
N/A 
 For studies using primary case-note audit and database analysis:    19.           Case-note analysis: is there a clear and precise 
description of how case-note data were used to ascertain time points 
with an acknowledgment of limitations of such data?   
N/A 
 20.           For database analysis: is there a thorough description 
of the database chosen including sampling coverage and completeness 
of information?   
N/A 
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Descriptive Statistics: Exploring data outliers 
 N Min. Max. Mean Std. Deviation 
Mood      
 Anxiety 163 0 21 8.45 5.057 
 Depression 163 0 20 4.92 3.843 
Illness Perception Questionnaire      
 Timeline 164 8 26 15.16 3.170 
Timecycle 162 4 20 11.54 3.273 
Consequences 164 6 29 14.03 4.161 
Personal Control 164 6 30 17.53 3.776 
Treatment Control 162 9 25 18.33 3.272 
Illness Coherence 163 5 25 15.27 4.906 
Emotional Representation 162 6 29 17.25 5.731 
Body Shape Questionnaire 164 16 80 39.09 17.408 
Risk Factors [Knowledge] 162 5 18 12.75 2.705 
Symptoms [Knowledge] 164 3 17 10.82 2.547 
Health History Questionnaire      
Preventative Health Behav. 163 1 2 1.29 .457 
Health Promoting Behav. 163 1 2 1.48 .501 
Health Harming Behav. 158 2 10 7.22 2.001 
Perceived Body Weight 163 2 10 6.93 1.920 
Comorbidities 161 2 10 3.32 1.970 
Social Capital      
Neighbourhood Belonging 164 -4 6 3.58 2.438 
Neighbourhood Crime 164 -1 1 -.10 .354 
Community Activity 163 1 5 3.58 1.583 
Social Support 164 -5 6 3.48 2.467 
Number of contacts 164 0 9 3.03 1.119 
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Comparing ‘markedly extended time’ to help-seeking (i.e. more than 1 month) and ‘timely' help-seeking (within 2 weeks) 
  markedly extended time' help-seekers (>1 month) 'timely' help-seekers (within 2 weeks) 
Variable(s) N (Total N = 50)  % Mean 
Std. 
Deviation Range 
N (Total 
N = 83)  % Mean 
Std. 
Deviation Range 
Age 50   59.08 8.77 38 - 79 83   59.22 9.83 41 - 85 
WaistHipR 43  0.85 0.14 .50 – 1.50 76  0.85 0.12 .45 – 1.48 
BMI 49  31.12 8.52 19 - 62 78  32.99 9.4 47 - 69 
Obesity 49      78     
Non-obese 24 49.00%     27 34.60%    
Obese 25 51.00%     51 65.40%    
Education 46      80     
Less than compulsory 6 13.00%     5 6.30%    
Compulsory 24 52.20%     57 71.80%    
Above compulsory 16 34.80%     18 18.80%    
Postgraduate 0 0.00%     3 3.80%    
Marital Status 47      82     
Single 10 21.30%     14 8.50%    
Married 24 51.10%     44 53.70%    
Widowed 5 10.60%     13 15.90%    
Divorced/Separated 7 17.00%     11 12.50%    
Deprivation 48      82     
None 30 62.50%     12 65.90%    
Minimal 12 25.00%     18 22.00%    
Slight 2 4.32%     7 8.50%    
Moderate 4 8.30%     3 3.70%    
Ethnicities 46      82     
White European 32 69.60%     73 89.00%    
Black African/Other 5 10.90%     3 3.70%    
South Asian/Other Asian 9 19.60%     6 7.30%    
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Variable(s) N (Total N = 50)  % Mean 
Std. 
Deviation Range 
N (Total 
N = 50)  % Mean 
Std. 
Deviation Range 
Years in UK 50      83     
1-5 yrs in UK 1 2.00%     1 1.20%    
10-20 yrs in UK 4 8.00%     0 0.00%    
20+ yrs in UK 7 14.00%     8 9.60%    
British Born 38 76.00%     74 89.20%    
Religion 46      82     
Catholic/Christian 28 60.80%     57 69.50%    
Muslim 2 4.30%     1 1.20%    
Hindu 1 2.30%     1 1.20%    
Sikh 4 8.70%     4 4.90%    
None 9 19.60%     15 18.30%    
Other 2 4.30%     4 4.90%    Generations English in 
Family  50      68     
Non-English speaking 1 2.00%     2 2.40%    
First generation 6 12.00%     5 6.00%    
Second generation 10 20.00%     8 9.60%    All of family English 
speaking 33 66.00%     68 81.90%    
Clinical Outcomes 50      83     
Endometrial cancer 2 4.00%     5 6.00%    
Cervical pre-cancer 0 0.00%     1 1.20%    
Monitoring ovarian cyst 3 6.00%     5 6.00%    Hysterectomy (due to 
cancer risk) 7 14.00%     2 2.40%    
Discharged after 
investigation/benign biopsy 24 48.00%     42 50.60%    
Benign Polyp(s)/ Fibroid(s) 6 12.40%     13 15.70%    
Discharged due to non-
attendance at follow-up 1 2.00%     3 3.60%    
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Variable(s) N (Total N = 50)  % Mean 
Std. 
Deviation Range 
N (Total 
N = 50)  % Mean 
Std. 
Deviation Range 
Other Cause (e.g. urinary 
issue, womb prolapse, 
atrophic vaginosis, problem 
with coil) 
6 12.00%     9 10.80%    
Incorrect referral from GP 1 2.00%     3 1.20%    
Mood       82   
  Anxiety 50  8.44 4.66 0 -21 82  8.82 4.75  0 - 20 
Depression 50  4.87 3.66 0 - 13 82  5.06 3.57  0 - 14 
Illness Perception        83    
  Timeline 50  15.22 3.16 8 - 24 83  15.03 2.69 9 - 23 
Timecycle 48  11.53 3.11 4 - 17 83  11.38 3.16 4 - 19 
Consequences 50  15.25 3.76 9 - 26 83  13.77 3.94 6 - 29 
Personal Control 50  17.39 3.71 10 - 27 83  17.32 3.82 6 - 26 
Treatment Control 48  18.19 3.19 10 - 24 83  18.14 2.97 9 - 24 
Illness Coherence 49  15.76 5.00 5 - 24 83  14.5 5.02 5 - 25 
Emotional Representation 49  17.33 5.57 6 - 26 83  17.3 5.98 6 - 29 
Body Shape 50  38.76 17.57 16 - 80 83  39.63 17.57 16 - 80 
Risk factor knowledge 49  13.27 2.48 5 - 18 83  12.41 2.48  5 - 18 
Personal risk 50      81     Less at risk 8 16.00%     14 17.30%    At similar risk 33 66.00%     50 61.70%  
  More at risk than others 9 18.00%     17 21.00%    Symptom Knowledge 50  10.99 2.45   5 - 15 83    
3 - 17 
Health History         
    Preventative Health Behav. 49  1.96 0.20 1 - 2 83    
1 - 2 
Health Promoting Behav. 49  2 0.00 2 - 2 81    
1 - 2 
Health Harming Behav. 48  7.25 2.02 2 - 10 82 
   
2 - 10 
Perceived Body Weight 50  6.58 1.70 3 - 10 83    
2 - 10 
Comorbidities 48  3.21 1.95 2 - 10 83    
2 - 10 
Social Capital             50      83 
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Variable(s) N (Total N = 50)  % Mean 
Std. 
Deviation Range 
N (Total 
N = 50)  % Mean 
Std. 
Deviation Range 
Neighbourhood 
Belonging 50  3.87 1.95 - 4 - 6 83 
   
-1 - 6 
Neighbourhood Crime 50  -0.06 2.57 -1 - 1 83    
-1 - 1 
Community Activity 50  3.22 0.31 1 - 5 83    
1 - 5 
Social Support 50  3.81 1.70 -4 - 6 83    
-5 - 6 
Presence of concern 22      28     Concern before help-
seeking 20      5 
    No Concern before help-
seeking 2      23   
  Method of help-seeking 50      73     Emergency (A&E) 2 4.00%     3 3.60%    GP Surgery 30 60.00%     73 88.00% 
   Other: 
Screening/comorbidity 
appointment 
18 36.00%     7 
8.40% 
   Valid N (listwise) 50         50 
     
 381 
Chi-square statistic of difference between markedly delayed and timely help-seeking 
group and ‘Generations of English Speaking in Family’ 
Crosstabs table: Generations of English Speaking in Family across markedly 
delayed & timely help-seeking group 
 Generations of English Speaking in 
Family amongst timely help-seeking 
grp. 
0 1 2 3 4 Total 
Generations of 
English Speaking 
in Family amongst 
markedly delayed 
grp. 
No English 
speakers 
0 0 0 0 1 1 
1st generation 0 1 0 2 3 6 
2 generations 0 2 2 0 4 8 
3 generations 0 0 0 0 2 2 
All of family 
English speaking 
1 2 0 0 30 33 
Total 1 5 2 2 40 50 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 30.777a 16 .014 
Likelihood Ratio 21.755 16 .151 
Linear-by-Linear Association 2.618 1 .106 
N of Valid Cases 50   
a. 23 cells (92.0%) have expected count less than 5. The minimum 
expected count is .02. 
 
 
 382 
Descriptive statistics on measures for obese and non-obese participants 
Descriptive Statistics: Measures for obese and non-obese participants 
 N Mean Std. 
Deviation 
Min. Max
. 
 Anxiety 
Non-obese 68 7.91 5.182 0 20 
Obese 87 8.91 4.856 0 21 
Total 155 8.47 5.010 0 21 
Depression 
Non-obese 68 4.28 4.042 0 20 
Obese 87 5.44 3.572 0 13 
Total 155 4.93 3.816 0 20 
Timeline 
Non-obese 68 15.17 2.931 8 24 
Obese 88 15.02 3.285 8 26 
Total 156 15.08 3.127 8 26 
Timecycle 
Non-obese 67 10.79 3.518 4 20 
Obese 87 12.09 2.940 6 19 
Total 154 11.52 3.259 4 20 
Consequences 
Non-obese 68 13.10 4.056 6 26 
Obese 88 14.74 4.161 6 29 
Total 156 14.02 4.182 6 29 
Personal Control 
Non-obese 68 17.38 3.681 10 30 
Obese 88 17.73 3.788 6 27 
Total 156 17.58 3.734 6 30 
Treatment Control 
Non-obese 67 17.87 3.576 9 25 
Obese 87 18.57 3.002 9 24 
Total 154 18.27 3.272 9 25 
Illness Coherence 
Non-obese 67 15.81 5.065 5 25 
Obese- 88 15.07 4.793 5 25 
Total 155 15.39 4.910 5 25 
Emotional Representation 
Non-obese 66 16.13 5.756 6 28 
Obese 88 17.95 5.504 6 29 
Total 154 17.17 5.667 6 29 
Body Shape  
Non-obese 68 34.69 16.771 16 79 
Obese- 88 42.88 17.024 16 80 
Total 156 39.31 17.345 16 80 
Risk Factors [Knowledge] 
Non-obese 68 12.94 2.493 5 16 
Obese 87 12.58 2.889 5 18 
Total 155 12.74 2.720 5 18 
Symptoms [Knowledge] 
Non-obese 68 10.99 2.440 5 17 
Obese 88 10.77 2.589 3 15 
Total 156 10.87 2.520 3 17 
Preventative health Behav. Non-obese 68 1.37 .486 1 2 
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Obese 87 1.25 .437 1 2 
Total 155 1.30 .461 1 2 
Health Promoting Behav. 
Non-obese 68 1.57 .498 1 2 
Obese 87 1.43 .497 1 2 
Total 155 1.49 .502 1 2 
Health Harming Behav. 
Non-obese 66 6.94 1.937 2 10 
Obese 84 7.48 2.021 2 10 
Total 150 7.24 1.996 2 10 
Perceived Body Weight 
Non-obese 67 7.49 1.972 2 10 
Obese 88 6.55 1.774 2 10 
Total 155 6.95 1.915 2 10 
Comorbidities 
Non-obese 66 3.21 1.696 2 8 
Obese 87 3.39 2.098 2 10 
Total 153 3.31 1.931 2 10 
Neighbourhood Belonging 
Non-obese 68 3.62 2.522 -4 6 
Obese 88 3.61 2.453 -4 6 
Total 156 3.61 2.475 -4 6 
Neighbourhood Crime 
Non-obese 68 -.12 .325 -1 0 
Obese 88 -.08 .378 -1 1 
Total 156 -.10 .355 -1 1 
Community Activity 
Non-obese 68 3.72 1.582 1 5 
Obese 87 3.38 1.601 1 5 
Total 155 3.53 1.597 1 5 
Social Support 
Non-obese 68 3.50 2.560 -5 6 
Obese 88 3.53 2.480 -5 6 
Total 156 3.52 2.507 -5 6 
Number of contacts 
Non-obese 68 2.97 1.106 0 6 
Obese 88 3.09 1.178 0 9 
Total 156 3.04 1.145 0 9 
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Descriptive statistics on measures for ethnicities 
Descriptive Statistics: measures for ethnicities 
 N Mean Std. 
Deviation 
Min. Max. 
Anxiety 
 
White European 130 8.60 5.039 0 21 
Black African/ other 11 5.56 4.891 0 14 
South Asian/Asian British 17 9.29 5.051 0 18 
Total 158 8.46 5.067 0 21 
Depression 
White European 130 4.86 3.850 0 20 
Black African/ other 11 3.45 3.643 0 11 
South Asian/Asian British 17 5.43 3.840 0 13 
Total 158 4.83 3.834 0 20 
Timeline 
 
White European 131 15.09 3.193 8 26 
Black African/ other 11 17.36 2.976 13 23 
South Asian/Asian British 17 14.18 2.899 10 23 
Total 159 15.15 3.201 8 26 
Timecycle 
 
White European 131 11.37 3.230 4 20 
Black African/ other 11 12.73 4.197 6 19 
South Asian/Asian British 17 11.92 2.976 6 18 
Total 159 11.52 3.277 4 20 
Consequences 
 
White European 131 13.80 4.034 6 26 
Black African/ other 11 14.73 4.077 6 22 
South Asian/Asian British 17 14.41 5.112 8 29 
Total 159 13.93 4.144 6 29 
Personal Control 
 
White European 131 17.66 3.697 6 27 
Black African/ other 11 18.09 5.300 7 30 
South Asian/Asian British 17 16.59 3.589 10 23 
Total 159 17.57 3.802 6 30 
Treatment Control 
 
White European 131 18.25 3.216 9 25 
Black African/ other 11 19.45 3.503 15 25 
South Asian/Asian British 17 18.24 3.817 10 24 
Total 159 18.33 3.295 9 25 
Illness Coherence 
White European 131 15.34 4.786 5 25 
Black African/ other 11 15.36 5.555 8 25 
South Asian/Asian British 17 14.91 5.472 5 25 
Total 159 15.29 4.884 5 25 
 
Emotional 
Representation 
 
White European 130 17.28 5.629 6 29 
Black African/ other 11 14.82 6.691 6 26 
South Asian/Asian British 17 17.95 5.806 6 27 
Total 158 17.18 5.726 6 29 
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Body Shape  
White European 131 39.89 17.911 16 80 
Black African/ other 11 32.75 18.362 16 61 
South Asian/Asian British 17 35.57 12.956 16 66 
Total 159 38.93 17.519 16 80 
Risk Factors 
[Knowledge] 
 
White European 130 12.87 2.619 5 18 
Black African/ other 11 12.13 2.802 7 16 
South Asian/Asian British 17 12.20 3.438 5 17 
Total 158 12.74 2.722 5 18 
Symptoms 
[Knowledge] 
 
White European 131 10.97 2.496 3 15 
Black African/ other 11 11.22 3.003 6 17 
South Asian/Asian British 17 10.09 2.399 5 14 
Total 159 10.89 2.522 3 17 
Preventative Health 
Behav. 
White European 131 1.24 .431 1 2 
Black African/ other 10 1.40 .516 1 2 
South Asian/Asian British 17 1.47 .514 1 2 
Total 158 1.28 .450 1 2 
Health Promoting 
Behav. 
White European 131 1.44 .499 1 2 
Black African/ other 10 1.70 .483 1 2 
South Asian/Asian British 17 1.59 .507 1 2 
Total 158 1.47 .501 1 2 
Health Harming 
Behav. 
 
White European 125 7.06 2.092 2 10 
Black African/ other 11 7.45 1.635 6 10 
South Asian/Asian British 17 8.00 1.581 5 10 
Total 153 7.19 2.025 2 10 
Perceived Body 
Weight 
 
White European 130 6.92 1.967 2 10 
Black African/ other 11 6.82 1.834 4 9 
South Asian/Asian British 17 7.35 1.498 5 10 
Total 158 6.96 1.908 2 10 
Comorbidities 
 
White European 129 3.43 1.999 2 10 
Black African/ other 11 2.55 1.293 2 6 
South Asian/Asian British 16 2.94 2.175 2 10 
Total 156 3.31 1.983 2 10 
Neighborhood 
Belonging 
White European 131 3.34 2.506 -4 6 
Black African/ other 11 5.09 1.375 2 6 
South Asian/Asian British 17 4.59 2.093 0 6 
Total 159 3.60 2.459 -4 6 
 
Neighborhood 
Crime 
White European 131 -.11 .356 -1 1 
Black African/ other 11 -.09 .302 -1 0 
South Asian/Asian British 17 -.12 .332 -1 0 
Total 159 -.11 .348 -1 1 
Community Activity White European 130 3.61 1.568 1 5 
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Black African/ other 11 3.18 1.779 1 5 
South Asian/Asian British 17 3.88 1.616 1 5 
Total 158 3.61 1.583 1 5 
Social Support 
 
White European 131 3.23 2.546 -5 6 
Black African/ other 11 5.00 1.342 2 6 
South Asian/Asian British 17 4.47 2.095 0 6 
Total 159 3.49 2.492 -5 6 
Number of contacts 
White European 131 2.91 .954 0 6 
Black African/ other 11 3.27 1.618 0 5 
South Asian/Asian British 17 3.35 1.057 1 5 
Total 159 2.98 1.026 0 6 
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Descriptive statistics on measures according to outcome variable of extended time  
 
Descriptive Statistics: Measures to measures for extended time 
 N Mean Std. 
Deviation 
Anxiety 
 
H-S within 2 weeks 82 8.62 5.063 
H-S 2 weeks or more 81 8.29 5.078 
Total 163 8.45 5.057 
Depression 
 
H-S within 2 weeks 82 4.75 3.570 
H-S 2 weeks or more 81 5.08 4.117 
Total 163 4.92 3.843 
Timeline 
 
 
H-S within 2 weeks 83 15.03 2.691 
H-S 2 weeks or more 81 15.29 3.607 
Total 164 15.16 3.170 
Timecycle 
 
H-S within 2 weeks 83 11.38 3.155 
H-S 2 weeks or more 79 11.71 3.405 
Total 162 11.54 3.273 
Consequences 
 
H-S within 2 weeks 83 13.77 3.943 
H-S 2 weeks or more 81 14.29 4.383 
Total 164 14.03 4.161 
Personal Control 
 
 
H-S within 2 weeks 83 17.32 3.824 
H-S 2 weeks or more 81 17.75 3.737 
Total 164 17.53 3.776 
Treatment Control 
 
 
H-S within 2 weeks 83 18.14 2.972 
H-S 2 weeks or more 79 18.52 3.569 
Total 162 18.33 3.272 
Illness Coherence 
H-S within 2 weeks 83 14.50 5.020 
H-S 2 weeks or more 80 16.07 4.684 
Total 163 15.27 4.906 
Emotional Representation 
 
H-S within 2 weeks 82 17.30 5.979 
H-S 2 weeks or more 80 17.19 5.502 
Total 162 17.25 5.731 
Body Shape Questionnaire 
H-S within 2 weeks 83 39.63 18.036 
H-S 2 weeks or more 81 38.55 16.835 
Total 164 39.09 17.408 
Risk Factors [Knowledge] 
 
H-S within 2 weeks 83 12.41 2.987 
H-S 2 weeks or more 79 13.10 2.338 
Total 162 12.75 2.705 
 
Symptoms [Knowledge] 
 
H-S within 2 weeks 83 10.77 2.677 
H-S 2 weeks or more 81 10.88 2.423 
Total 164 10.82 2.547 
Preventative health Behav. H-S within 2 weeks 83 1.02 .154 
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H-S 2 weeks or more 80 1.58 .497 
Total 163 1.29 .457 
Health Promoting Behav. 
H-S within 2 weeks 83 1.06 .239 
H-S 2 weeks or more 80 1.93 .265 
Total 163 1.48 .501 
Health Harming Behav. 
 
 
H-S within 2 weeks 81 7.17 1.935 
H-S 2 weeks or more 77 7.26 2.080 
Total 158 7.22 2.001 
Perceived Body Weight 
 
 
H-S within 2 weeks 82 7.07 1.776 
H-S 2 weeks or more 81 6.78 2.055 
Total 163 6.93 1.920 
Comorbidities 
 
H-S within 2 weeks 83 3.46 2.126 
H-S 2 weeks or more 78 3.17 1.790 
Total 161 3.32 1.970 
Neighbourhood Belonging 
H-S within 2 weeks 83 3.33 2.293 
H-S 2 weeks or more 81 3.85 2.565 
Total 164 3.58 2.438 
Neighbourhood Crime 
 
 
H-S within 2 weeks 83 -.10 .370 
H-S 2 weeks or more 81 -.10 .339 
Total 164 -.10 .354 
Community Activity 
 
H-S within 2 weeks 83 3.87 1.496 
H-S 2 weeks or more 80 3.28 1.622 
Total 163 3.58 1.583 
Social Support 
 
 
H-S within 2 weeks 83 3.23 2.327 
H-S 2 weeks or more 81 3.75 2.591 
Total 164 3.48 2.467 
Social Capital: Number of 
contacts 
 
H-S within 2 weeks 83 2.92 .962 
H-S 2 weeks or more 81 3.15 1.256 
Total 164 3.03 1.119 
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APPENDIX N 
Chapter 5: Frequency Table of all Ethnic Categories 
Ethnicity 
 Frequency % Valid % Cumulative % 
White 
British 
Other White 
Black Caribbean 
Black African 
Asian 
Other 
Afro-Caribbean 
South-Asian/Asian-British 
Indian 
Pakistani 
Bangladeshi 
Black 
Total 
119 
11 
1 
2 
2 
1 
0 
3 
2 
11 
1 
1 
3 
159 
5 
74.2 74.8 71.2 
6.1 6.9 80.0 
.3 .6 80.6 
1.1 1.3 81.8 
1.1 1.3 82.9 
.3 .6 83.5 
0.0 0.0 85.3 
1.5 1.9 87.6 
1.1 1.3 88.8 
6.1 6.9 97.6 
.3 .6 98.2 
.3 .6 98.8 
1.7 1.9 100.0 
96.6 100.0  
Missing 3.4   
Total 131 100.0   
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APPENDIX O 
Chapter 5: Correlation Matrix of Variables 
 
** p < 0.01; * p < 0.05 
1 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34
1 Time/to/help5seeking/ 5
2 HHQ:/Previous/behav. .012 5
3 HHQ:Health/promoting/behav. 5.082 .162* 5
4 HHQ:/Health/harming/behav. 5.061 5.128 5.118 5
5 HHQ:/Perceived/body/weight .020 5.183* .186* .087 5
6 HHQ:/Comorbidities 5.119 5.097 .124 .040 .225** 5
7 Neighborhood/belonging .119 .138 .157* 5.040 .041 .096 5
8 Neighborhood/crime 5.171* 5.043 5.071 .178* .011 .166* .024 5
9 Community/activity .020 5.013 5.014 5.176* 5.033 5.007 .073 .008 5
10 Social/support .028 .062 .082 5.058 5.058 5.078 .209** 5.037 5.046 5
11 Number/of/contacts 5.020 .249** .055 5.234** .031 5.065 .225** 5.036 .069 .203** 5
12 Delay/(2/wks) .305** 5.013 5.106 5.061 5.031 5.157* .118 .019 .054 .040 .001 5
13 Ethnicity/White/BAME .027 .142 .068 5.135 5.006 5.014 .224** 5.016 .136 5.003 .032 .148 5
14 Method/of/help5seeking .101 5.048 5.029 .027 .044 5.110 .117 5.060 5.131 .157* 5.087 .258** .014 5
15 Obese/Non5obese .069 5.035 5.167* 5.008 5.297** 5.152 5.041 5.035 5.005 .104 5.084 5.221** 5.184* 5.011 5
16 Age .054 5.096 .240** 5.065 .023 5.068 .018 .031 .167* .030 .017 5.068 5.059 .110 .122 5
17 Employment .045 .027 .040 5.041 .017 5.131 5.055 .068 .024 5.167* .000 .097 .048 .129 5.008 .315** 5
18 Years/in/the/UK 5.210** 5.112 5.054 .104 .069 .046 5.128 5.052 .044 .077 .105 5.137 5.580** 5.017 .048 .036 .003 5
19 BMI .096 .090 5.238** 5.006 5.338** 5.140 .013 5.060 .003 .016 .024 5.148 .004 .031 .531** 5.027 5.041 .036 5
20 HADS:/Anxiety .060 .041 5.240** .110 5.121 5.068 5.355** 5.116 5.166* 5.028 5.029 5.056 5.070 5.096 .190* 5.191* .072 5.033 .140 5
21 HADS:/Depression .066 .058 5.330** .121 5.170* 5.227** 5.303** 5.061 5.126 5.037 5.046 .054 5.006 .071 .244** 5.133 .142 5.050 .156* .684** 5
22 IPQ:/timeline .208** 5.146 .180* .145 .118 5.049 .032 5.064 5.029 5.021 5.128 .039 .025 .074 .115 .061 .189* 5.021 .014 .024 .044 5
23 IPQ:/timecycle .010 .028 5.161* .153* 5.134 5.091 5.004 5.068 .070 .025 5.221** .024 .127 .007 .139 5.176* 5.025 5.049 .180* .187* .185* .147 5
24 IPQ:/consequenes .141 5.025 5.278** .184* 5.091 5.164* 5.022 5.067 5.098 .018 5.038 .080 .131 .082 .167* 5.125 .063 5.133 .223** .392** .393** .262** .310** 5
25 IPQ:/personal/control 5.015 .027 .123 .064 .078 .065 .061 5.071 5.005 .057 .009 .002 5.041 .084 5.086 .019 .016 .001 .059 5.088 5.151* .145 .088 5.024 5
26 IPQ:/treatment/control 5.032 .175* 5.039 5.127 .046 .037 .058 5.102 .109 .032 5.017 .039 .069 5.065 5.016 .006 5.035 5.156* .034 5.021 5.046 5.185* .121 .031 .361** 5
27 IPQ:/illness/coherence .002 .063 .036 5.035 5.069 .021 .037 .033 .177* 5.009 .009 .132 5.025 .002 5.185* 5.143 5.015 5.108 5.124 5.167* 5.200** 5.017 5.194* 5.155* .288** .041 5
28 IPQ:/emotional/rep. .045 .102 5.091 .090 5.207** 5.089 5.149 5.102 5.134 .090 5.057 5.030 .042 5.072 .205** 5.120 .055 5.061 .155* .576** .445** .155* .434** .577** 5.077 .102 5.310** 5
29 BSQ 5.040 .085 5.254** .118 5.353** 5.080 5.148 5.115 5.066 5.115 5.083 5.009 5.094 5.138 .128 5.418** 5.012 5.005 .237** .421** .386** 5.098 .254** .210** 5.009 .080 .066 .343** 5
30 Risk/factor/awareness .044 .093 .149 5.032 .004 5.078 .110 5.101 5.084 .049 5.126 .137 5.070 .139 .015 5.026 .100 5.001 5.051 .021 .034 .032 5.025 5.080 .118 .176* .067 .040 .124 5
31 Personal/risk .049 .083 5.105 5.012 5.140 5.063 .025 5.147 5.106 .089 .163* 5.037 5.098 5.016 .184* 5.093 5.097 .114 .094 .276** .272** 5.064 .034 .215** .023 .048 5.082 .192* .151* .247** 5
32 Symptom/awareness 5.036 .035 .125 5.168* 5.142 5.146 5.033 5.031 .041 5.081 5.174* .001 5.075 .075 5.074 .030 .035 .071 5.042 5.007 .016 .062 .003 5.143 .085 .048 .121 5.002 .113 .360** .014 5
33 Waist5to5hip/ratio .039 .114 5.022 .067 5.075 .092 .030 .012 5.179* .154 5.048 .031 .012 5.063 .117 .044 5.096 5.036 .089 .055 .030 5.064 .068 .026 .099 .023 5.187* .029 5.029 .067 5.026 5.136 5
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APPENDIX P 
Chapter 5: Results 
R Code for the estimation and cross validation of the regression models 
options(echo=TRUE) 
options(comment="") 
options(warnings=FALSE) 
 
library(stargazer) 
library(foreign) 
library(bootStepAIC) 
library(MASS) 
 
cval=function(ay,py, dfmod){ 
   
  atab = matrix(nrow=6, ncol=6) 
   
  atab[1, 1] = "Source" 
  atab[1,2] = "Degrees of Freedom" 
  atab[1,3] = "Sum of Squares" 
  atab[1,4] = "Mean Squares" 
  atab[1,5] = "F" 
  atab[1,6] = "p(F)" 
   
  atab[2,1] = "Model" 
  atab[2,2] = dfmod 
 
  SSm=0 
  SSerr=0 
  SStot=0 
   
  for(i in 1:length(ay)){ 
    SSm = SSm + ((py[i]-mean(ay))^2) 
    SSerr = SSerr + ((ay[i]-py[i])^2) 
    SStot = SStot +((ay[i]-mean(ay))^2) 
    } 
   
  atab[2,3] = SSm 
  atab[2,4] = SSm/dfmod 
   
  atab[3,1] = "Error" 
  dferr = (length(ay)-dfmod-1) 
  atab[3,2] = dferr 
   
  atab[3,3] = SSerr 
  atab[3,4] = SSerr/dferr 
   
  f=(SSm/dfmod)/(SSerr/dferr) 
  atab[2,5] = (SSm/dfmod)/(SSerr/dferr) 
  atab[2,6] = pf(q=f, df1=dfmod, df2=dferr, lower.tail=FALSE) 
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  atab[4,1] = "Total" 
  atab[4,2] = length(ay)-1 
  atab[4,3] = SStot 
   
  atab[6,1] = "R^2 = " 
  atab[6,2] = SSm/SStot 
 
  return(atab) 
  } 
 
d=read.spss(choose.files(), use.value.labels=T, use.missings=T, to.data.frame=T) 
 
dest = subset(d, Sample==1) 
dval = subset(d, Sample==0) 
 
cat("\nThe estimation sample contains ", nrow(dest), " participants and the validation sample contains 
", nrow(dval), " participants.") 
 
# Model Estimation 
 
cat("Model Estimation") 
 
d1 = dest[complete.cases(dest), ] 
 
min.model = lm(Totaltime2~ 1, data=d1) 
fwd.model = step(min.model, direction="forward", scope=(~ HADS_Anx + HADS_Dep + timeline + 
timecycl + conseque + perscon + treatcon + illcoher + emotrepr + BSQ + RF + Personalrisk + SX + 
WaistHipR + BMI_2 + ETH_CAT + GEN_ENG_2 + HHQPrevBxSUM + HHQHealthPromBxSUM 
+ HHQHealthHarmBxSUM + HHQBWPercep + HHQComorbid + NeighborhoodBelongSUM + 
NeighborhoodCrimeSUM + CommunityActivitySUM + Socialsupport + Contacts), trace=F) 
 
summary(fwd.model) 
 
form=formula(fwd.model$call) 
 
lfit = lm(formula=form, data=d1) 
bfit= boot.stepAIC(lfit,data=dest,B=5000, direction="both") # this calculation will take several 
minutes 
 
cat("\n\n The optimised model from the original data is\n\n") 
print(bfit$OrigStepAIC) 
 
s=data.frame(bfit$Sign) 
names(s) = c("Positive Sign", "Negative Sign") 
s = s[order(row.names(s)),] 
si=bfit$Significance 
si=data.frame(si) 
si = si[order(row.names(si)),] 
s = data.frame(s, "Significant" = si) 
s=data.frame(row.names(s), s[,3], s[,1], s[,2]) 
names(s) = c("Covariate"," % Significant", "% Positive Coeff", "% Negative Coef")  
print(s[order(-s[,2]),]) 
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# the estimate of the final model from the entire estimation sample  
 
efit1 = lm(Totaltime2 ~ HHQPrevBxSUM + BMI_2 + NeighborhoodCrimeSUM + emotrepr, 
data=dest) 
efit2 = lm(Totaltime2 ~ HHQPrevBxSUM + BMI_2 + NeighborhoodCrimeSUM, data=dest) 
 
summary(efit1) 
summary(efit2) 
 
# validation 
 
a = dval$Totaltime2 
 
p1 = predict(efit1, newdata=dval) 
p2 = predict(efit2, newdata=dval) 
 
dv = data.frame(a, p1, p2) 
dv=dv[complete.cases(dv),] 
 
a = dv$a 
p1=dv$p1 
p2=dv$p2 
 
print(efit1$call) 
t=cval(ay=a, py=p1, dfmod=4) 
stargazer(t,digits=2,type="text") 
 
print(efit2$call) 
t=cval(ay=a, py=p2, dfmod=3) 
stargazer(t,digits=2,type="text") 
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T-test: Gynaecological awareness (symptoms) and obesity 
 
Group Statistics 
 Obese N Mean Std. Deviation Std. Error Mean 
Symptoms 
Non-obese 74 10.85 2.474 .288 
Obese-Morbidly obese 91 10.79 2.566 .269 
 
Independent Samples Test 
 Levene's Test 
for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Symptoms 
Equal variances 
assumed 
.183 .670 .155 163 .877 .061 .395 -.719 .842 
Equal variances 
not assumed 
  
.155 158.332 .877 .061 .394 -.717 .839 
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T-test: Gynaecological awareness (risk factors) and obesity 
 
Group Statistics 
 Obese N Mean Std. Deviation Std. Error Mean 
Risk 
factors 
Non-obese 75 12.88 2.752 .318 
Obese-Morbidly obese 90 12.60 2.853 .301 
 
Independent Samples Test 
 Levene's Test 
for Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Risk 
factors 
Equal variances 
assumed 
.012 .914 .622 163 .535 .273 .439 -.594 1.140 
Equal variances 
not assumed 
  
.624 159.510 .534 .273 .437 -.591 1.137 
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Chi-square test: Knowledge of obesity as a risk factor obese and non-obese 
 
Chi-Square Tests: Testing for difference in knowledge of obesity as a risk fact across 
groups of obese/non-obese 
 Value df Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .454a 1 .500   
Continuity Correctionb .243 1 .622   
Likelihood Ratio .457 1 .499   
Fisher's Exact Test    .589 .312 
Linear-by-Linear Association .451 1 .502   
N of Valid Cases 155     
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
18.86. 
b. Computed only for a 2x2 table 
 
Chi-square test: Knowledge of obesity as a risk factor across ethnicities 
 
Chi-Square Tests: Testing for difference in knowledge of obesity as a risk 
fact across groups of obese/non-obese 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square .705a 2 .703 
Likelihood Ratio .670 2 .715 
Linear-by-Linear Association .320 1 .572 
N of Valid Cases 158   
a. 2 cells (33.3%) have expected count less than 5. The minimum 
expected count is 2.92. 
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Oneway ANOVA for ethnicity and gynaecological cancer knowledge (symptoms & risk-
factors) and extended time to help-seeking 2 weeks 
 
Descriptive Statistics  
 N Mea
n 
Std. Deviation 
Risk Factors 
[Knowledge] 
 
White European 130 12.87 2.619 
Black African/ other 11 12.13 2.802 
South Asian/Asian British 17 12.20 3.438 
Total 158 12.74 2.722 
Symptoms 
[Knowledge] 
 
White European 131 10.97 2.496 
Black African/ other 11 11.22 3.003 
South Asian/Asian British 17 10.09 2.399 
Total 159 10.89 2.522 
 
ANOVA 
 Sum of 
Squares 
df Mean 
Square 
F Sig. 
Symptoms 
Between Groups 12.863 2 6.432 1.011 .366 
Within Groups 992.077 155 6.359   
Total 1163.368 158    
Risk factors 
Between Groups 11.184 2 5.592 .752 .473 
Within Groups 11152.184 155 7.433   
Total 1163.368 157    
 
Group Statistics 
 Delay_2wk N Mean Std. 
Deviation 
Std. Error 
Mean 
Symptoms 
Within 2 wks 83 10.77 2.677 .294 
More than 2 wks 80 10.91 2.429 .272 
Risk factors 
Within 2 wks 83 12.41 2.987 .328 
More than 2 wks 78 13.18 2.247 .254 
 398 
APPENDIX Q 
Chapter 6: Results  
Chi-square tests between White European/BME participants and obesity according to BMI 
Ethnicity WE/BME groups and Obesity (BMI) Crosstabulation 
 Obese Total 
Non-obese Obese 
Ethnicity 
White/ 
BME 
White 
European 
Count 58 69 127 
% within Ethnicity 
WE/BME 
45.7% 54.3% 100.0% 
% within Obese 78.4% 79.3% 78.9% 
% of Total 36.0% 42.9% 78.9% 
BME 
Count 16 18 34 
% within Ethnicity 
WE/BME 
47.1% 52.9% 100.0% 
% within Obese 21.6% 20.7% 21.1% 
% of Total 9.9% 11.2% 21.1% 
Total 
Count 74 87 161 
% within Ethnicity 
WE/BME 
46.0% 54.0% 100.0% 
% within Obese 100.0% 100.0% 100.0% 
% of Total 46.0% 54.0% 100.0% 
* WE= White European; BME = Black, Asian and minority ethnic groups; WHR = Waist-hip-ratio; OB = Obese; NO = Not obese 
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Chi-Square Tests 
 Value df Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .021a 1 .885   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .021 1 .885   
Fisher's Exact Test    1.000 .518 
Linear-by-Linear Association .021 1 .886   
N of Valid Cases 161     
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
15.63. 
b. Computed only for a 2x2 table 
* WE= White European; BME = Black, Asian and minority ethnic groups 
 
Chi-square tests: White European & British, Asian and minority ethnic (BME) participants regarding waist-to-hip ratio 
WE/BME groups and Obesity (Waist-hip ratio) Crosstabulation 
 WHR_OB_NO Total 
Non-obese (.85 
or less) 
Obese 
(>.85) 
Ethnicity
WE/ 
BME 
White 
European 
Count 66 57 123 
% within Ethnicity 
WE/BME 
53.7% 46.3% 100.0% 
% within 
WHR_OB_NO 
81.5% 80.3% 80.9% 
% of Total 43.4% 37.5% 80.9% 
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BME 
Count 15 14 29 
% within Ethnicity 
WE/BME 
51.7% 48.3% 100.0% 
% within 
WHR_OB_NO 
18.5% 19.7% 19.1% 
% of Total 9.9% 9.2% 19.1% 
Total 
Count 81 71 152 
% within Ethnicity 
WE/BME 
53.3% 46.7% 100.0% 
% within 
WHR_OB_NO 
100.0% 100.0% 100.0% 
% of Total 53.3% 46.7% 100.0% 
* WE= White European; BME = Black, Asian and minority ethnic groups; WHR = Waist-hip-ratio; OB = Obese; NO = Not obese 
 
Chi-Square Tests 
 Value df Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .035a 1 .851   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .035 1 .851   
Fisher's Exact Test    1.000 .506 
Linear-by-Linear 
Association 
.035 1 .852 
  
N of Valid Cases 152     
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
13.55. b. Computed only for a 2x2 table 
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Method of medical help-seeking: Frequency table 
 
Method of help-seeking Frequency Table 
Medical help-seeking type Frequency Percent Valid 
Percent 
Cumulative 
Percent 
Valid 
A&E 6 3.4 3.5 3.5 
GP 134 76.1 77.9 81.4 
Other: 
Smear/comorbid_ 
apt 
32 18.2 18.6 100.0 
Total 172 97.7 100.0  
Missing 99 4 2.3   
Total 176 100.0   
 
 
Presence of concern before medical help-seeking: Frequency table 
 
Presence of Concern Frequency Table 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
No concern 20 11.4 11.8 11.8 
Concern present 150 85.2 88.2 100.0 
Total 170 96.6 100.0  
Missing 99 6 3.4   
Total 176 100.0   
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APPENDIX R 
Chapter 6: Results of Methods to Help-seeking and the Journey to Help-seeking 
Descriptive Statistics: Detection to Concern and Methods of Help-seeking 
 N Mean Std. Deviation Std. Error 95% Confidence Interval for 
Mean 
Minimum Maximum 
Lower Bound Upper Bound 
A&E 6 10.33 25.311 10.333 -16.23 36.90 0 62 
GP 127 19.04 104.612 9.283 .67 37.41 0 903 
Other: Smear/comorbid 
apt 
32 80.06 322.595 57.027 -36.25 196.37 0 1810 
Total 165 30.56 169.395 13.187 4.52 56.60 0 1810 
 
Oneway ANOVA: Methods of Help-seeking and Days from Detection to Concern  
 Sum of Squares df Mean Square F Sig. 
Between Groups 97726.692 2 48863.346 1.718 .183 
Within Groups 4608206.011 162 28445.716   
Total 4705932.703 164    
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Descriptive Statistics: Booking to attendance and methods of help-seeking 
 N Mean Std. 
Deviation 
Std. 
Error 
95% Confidence Interval for Mean 
Lower Bound Upper Bound 
A&E 6 .17 .408 .167 -.26 .60 
GP 128 3.17 4.869 .430 2.32 4.02 
Other: Smear/comorbid_apt 32 9.53 30.952 5.472 -1.63 20.69 
Total 166 4.29 14.323 1.112 2.09 6.48 
 
Oneway ANOVA of methods of help-seeking and days from booking to attendance 
 Sum of Squares df Mean Square F Sig. 
Between Groups 1141.100 2 570.550 2.843 .061 
Within Groups 32709.021 163 200.669   
Total 33850.120 165    
 
Descriptive Statistics: Total time to help-seeking 
 N Mean Std. 
Deviation 
Std. 
Error 
95% Confidence Interval for Mean 
Lower Bound Upper Bound 
A&E 6 171.67 372.334 152.005 -219.07 562.41 
GP 126 106.07 475.669 42.376 22.20 189.94 
Other: Smear/comorbid_apt 32 244.41 584.995 103.414 33.49 455.32 
Total 164 135.46 495.879 38.722 59.00 211.92 
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Oneway ANOVA: Methods of Help-seeking and Total time to Help-seeking 
 Sum of Squares df Mean Square F Sig. 
Between Groups 496507.371 2 248253.686 1.010 .367 
Within Groups 39584613.409 161 245867.164   
Total 40081120.780 163    
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APPENDIX S 
Chapter 6: Results of Flow Chart Mapping Intervals Between Events for Obese and Non-obese groups 
Descriptive Statistics for all participants 
 Detect to 
booking 
Detect to 
concern 
Concern Booking to 
attend 
Visits for Referral Total time 
N 
Valid 164 166 170 166 166 164 
Missing 12 10 6 10 10 12 
Mean 128.70 30.40 .88 4.29 1.41 135.46 
Std. Deviation 496.272 168.894 .323 14.323 4.582 495.879 
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Event 1: Days from detection to concern for obese and non-obese women: t-test 
 
Descriptive Statistics 
 Obese N Mean Std. 
Deviation 
Std. Error 
Mean 
Detect to concern 
Non-obese 71 33.00 214.462 25.452 
Obese 87 20.43 90.918 9.747 
 
Independent Samples Test 
 Levene's Test for 
Equality of Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Detect to 
concern 
Equal variances 
assumed 
.600 .440 .495 156 .621 12.575 25.386 -37.571 62.720 
Equal variances 
not assumed 
  
.461 90.456 .646 12.575 27.255 -41.568 66.717 
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A chi-square test between the obese and non-obese women and the presence of concern before seeking help 
 
Obesity and Concern Crosstabulation 
 Concern Total 
No concern Concern present 3 
Obese 
Non-obese 
Count 7 67 0 74 
% within Obese 9.5% 90.5% 0.0% 100.0% 
% within Concern 38.9% 46.9% 0.0% 45.7% 
% of Total 4.3% 41.4% 0.0% 45.7% 
Obese 
Count 11 76 1 88 
% within Obese 12.5% 86.4% 1.1% 100.0% 
% within Concern 61.1% 53.1% 100.0% 54.3% 
% of Total 6.8% 46.9% 0.6% 54.3% 
Total 
Count 18 143 1 162 
% within Obese 11.1% 88.3% 0.6% 100.0% 
% within Concern 100.0% 100.0% 100.0% 100.0% 
% of Total 11.1% 88.3% 0.6% 100.0% 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 1.255a 2 .534 
Likelihood Ratio 1.638 2 .441 
Linear-by-Linear Association .019 1 .891 
N of Valid Cases 162   
a. 2 cells (33.3%) have expected count less than 5. The minimum expected count is .46. 
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Event 2: Days from detection to booking for obese and non-obese women: t-test 
 
Descriptive Statistics 
 Obese N Mean Std. Deviation Std. Error Mean 
Detection to 
booking 
Non-obese 71 112.37 422.046 50.088 
Obese 85 152.82 572.170 62.060 
 
Independent Samples Test 
 Levene's Test for 
Equality of Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Detection to 
booking 
Equal variances 
assumed 
1.179 .279 -.494 154 .622 -40.457 81.907 -202.264 121.349 
Equal variances 
not assumed 
  
-.507 
151.7
89 
.613 -40.457 79.751 -198.023 117.109 
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Event 3: Days from booking to attendance to healthcare for obese and non-obese women: t-test  
 
Descriptive Statistics 
 Obese N Mean Std. Deviation Std. Error Mean 
Book to attend 
Non-obese 71 3.68 5.366 .637 
Obese 86 4.90 19.276 2.079 
 
Independent Samples Test 
 Levene's Test for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Booking to 
attendance 
Equal 
variances 
assumed 
1.743 .189 -.516 155 .606 -1.219 2.361 -5.883 3.444 
Equal 
variances not 
assumed 
  
-.561 100.630 .576 -1.219 2.174 -5.532 3.093 
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Event 4: Referral and methods of help-seeking (Emergency services, GP surgery, Other): Descriptive Statistics & T-test 
Descriptive Statistics 
 
Referral N Mean Std. 
Deviation 
Std. 
Error 
Mean 
Help-seeking 
method 
Immediate 
referral 
156 2.17 .466 .037 
2+ visits before 
referral 
10 2.00 .000 .000 
 
Independent Samples Test 
 Levene's Test for Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Help-
seeking 
method 
Equal 
variances 
assumed 
11.672 .001 1.128  164 .261    .167   .148 -.125 .458 
Equal 
variances 
not 
assumed 
  
4.467 155.000 .000   .167   .037 .093 .240 
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Referral from first visit for obese and non-obese women: Chi-square test 
 
Referral from first visit and Obesity Crosstabulation 
Count Obese Total 
Non-obese Obese 
Referral visits 
0 0 1 1 
Immediate referral 67 80 147 
2+ visits before referral 4 5 9 
60 0 1 1 
Total 71 87 158 
 
Chi-Square Tests 
 Val
ue 
df Asymp. Sig. (2-sided) 
Pearson Chi-Square 
1.65
8a 
3 .646 
Likelihood Ratio 
2.41
2 
3 .491 
Linear-by-Linear Association .791 1 .374 
N of Valid Cases 158   
a. 6 cells (75.0%) have expected count less than 5. The minimum 
expected count is .45. 
 
Visits for Referral Frequency Table 
                        Frequency Percent Valid % Cumulative 
% 
 
0 
Immediate referral 
2+ visits before 
referral 
60 
Total 
1 .6 .6 .6  
154 87.5 92.8 93.4  
10 5.7 6.0 99.4  
1 .6 .6 100.0  
166 94.3 100.0  
 
Missing 99 10 5.7   
Total 176 100.0   
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Total time to help-seeking from detection to medical help-seeking for non-obese and obese: t-test 
 
Descriptive Statistics 
 Obese N Mean Std. Deviation Std. Error Mean 
Total time 
Non-obese 69 118.91 427.166 51.425 
Obese 86 160.81 568.471 61.300 
 Independent Samples Test 
 Levene's Test for Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence Interval 
of the Difference 
Lower Upper 
Total 
time 
Equal 
variances 
assumed 
1.090    .298 -.508 153 .612 41.901 82.510 204.906 121.104 
Equal 
variances not 
assumed 
  
-.524 152.392 .601a 41.901 80.014 199.980 116.178 
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APPENDIX T 
Chapter 6: Results of Flow Chart Mapping Events for White European and Black, Asian and Minority Ethnic group (BME) 
Event 1: Days from detection to concern for White European and BME groups: t-test 
 
Descriptive Statistics 
 Ethnicity WE/BME N Mean Std. 
Deviation 
Std. Error 
Mean 
Detection to concern 
White European 
1
3
1 
27.13 176.835 15.450 
BME 
3
0 
48.73 146.953 26.830 
 
Independent Samples Test 
 Levene's Test for 
Equality of Variances 
t-test for Equality of Means 
F      Sig. t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Detection to concern 
Equal variances 
assumed 
.604     .438 -.621 159 .535 -21.604 34.767 -90.269 47.062 
Equal variances 
not assumed 
  
-.698 50.191 .489 -21.604 30.960 -83.783 40.576 
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Chi-square test between the White European and BME groups and the presence of concern before seeking help 
 
Ethnicity: White European/BME groups and Concern Crosstabulation 
 Concern Total 
No concern Concern present 3 
Ethnicity W/BME 
White European 
Count 17 115 1 133 
% within Ethnicity W/BME 12.8% 86.5% 0.8% 100.0% 
% within Concern 85.0% 79.9% 100.0% 80.6% 
% of Total 10.3% 69.7% 0.6% 80.6% 
Non-white 
Count 3 29 0 32 
% within Ethnicity W/BME 9.4% 90.6% 0.0% 100.0% 
% within Concern 15.0% 20.1% 0.0% 19.4% 
% of Total 1.8% 17.6% 0.0% 19.4% 
Total 
Count 19 144 1 164 
% within Ethnicity W/BME 12.1% 87.3% 0.6% 100.0% 
% within Concern 100.0% 100.0% 100.0% 100.0% 
% of Total 12.1% 87.3% 0.6% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square .539a 2 .764 
Likelihood Ratio .745 2 .689 
Linear-by-Linear Association .070 1 .792 
N of Valid Cases 164   
a. 3 cells (50.0%) have expected count less than 5. The minimum 
expected count is .19. 
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Event 2: Days from detection to booking for White European and Black Minority Ethnic groups: t-test 
 
Descriptive Statistics 
 Ethnicity WE/BME N Mean Std. Deviation Std. Error Mean 
Detection to 
booking 
White European 131 109.20 471.947 41.234 
BME 28 174.68 552.572 104.426 
 
Independent Samples Test 
 Levene's Test for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence Interval 
of the Difference 
Lower Upper 
Detection to 
booking 
Equal 
variances 
assumed 
.679 .411 -.646 157 .519 -65.480 101.345 -265.656 134.695 
Equal 
variances not 
assumed 
  
-.583 35.895 .563 -65.480 112.272 -293.202 162.242 
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Event 3: Time from booking to attendance for White European and Black Minority Ethnic groups: t-test  
 
Descriptive Statistics 
 Ethnicity WE/BME N Mean Std. Deviation Std. Error Mean 
Book to attend 
White European 131 3.84 13.661 1.194 
BME 29 3.48 4.990 .927 
* WE= White European; BME = Black, Asian and minority ethnic groups 
 
Independent Samples Test 
 Levene's Test for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-tailed) Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Book to attend 
Equal 
variances 
assumed 
.274 .601 .138 158 .890 .357 2.579 -4.738 5.451 
Equal 
variances not 
assumed 
  
.236 124.294 .814 .357 1.511 -2.634 3.348 
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Event 4: Referral from first visit for White European and BME groups: Chi-square test 
 
Number of visits for referral and Ethnicity WE/BME Crosstabulation 
Count Ethnicity WE/BME Total 
White 
European 
Non-white 
Referral visit 
Immediate referral 126 25 151 
2+ visits before referral 6 4 10 
Total 132 29 161 
WE= White European; BME = Black, Asian and minority ethnic groups;  
WHR = Waist-hip-ratio; OB = Obese; NO = Not obese 
 
Chi-Square Tests 
 Value df Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact 
Sig. (1-
sided) 
Pearson Chi-Square 3.490a 1 .062   
Continuity Correctionb 2.083 1 .149   
Likelihood Ratio 2.857 1 .091   
Fisher's Exact Test    .082 .082 
Linear-by-Linear Association 3.469 1 .063   
N of Valid Cases 161     
a. 1 cells (25.0%) have expected count less than 5. The minimum expected count is 
1.80. 
b. Computed only for a 2x2 table 
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T-test: Total time to help-seeking from detection to medical help-seeking for non-obese and obese  
 
Descriptive Statistics 
 Ethnicity WE/BME N Mean Std. Deviation Std. Error Mean 
Total time 
White European 130 113.91 473.097 41.493 
BME 28 192.50 552.260 104.367 
* WE= White European; BME = Black, Asian and minority ethnic groups 
 
Independent Samples Test 
 Levene's Test for Equality 
of Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Total time 
Equal 
variances 
assumed 
.855 .357 -.773 156 .440 -78.592 101.612 -279.306 122.122 
Equal 
variances not 
assumed 
  
-.700 36.022 .489 -78.592 112.313 -306.369 149.185 
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APPENDIX U 
Chapter 7: Participant Information Sheet for Interview 
	
	 	
Location:	Sandwell	Hospital	PMB	Clinic		
	
Information	Sheet	for	Participants	(Phase	2)	
	
Study	Title:	Help-seeking for post-menopausal bleeding symptoms: An interview study 	
Introduction	My	name	is	Sara	Tookey	and	I	am	a	Doctoral	Researcher	at	the	University	of	Birmingham.	I	would	like	to	invite	you	to	take	part	in	a	study	in	an	interview	study.	Please	take	the	time	to	read	through	the	following	information.	Ask	a	staff	member	or	researcher	if	you	have	any	questions	or	would	like	more	information.				
What	is	the	purpose	of	the	study?	The	purpose	of	the	study	is	to	explore	your	experience	of	help-seeking	in	greater	detail.	We	are	interested	in	hearing	about	your	experience	of	seeking	help	for	your	gynaecological	symptoms	(from	the	moment	you	recognised	that	something	was	not	right,	until	now)	and	whether	or	not	body	image	or	size	plays	and	role	in	this	experience.				
Why	have	I	been	chosen?	Any	woman	who	attends	the	Post-menopausal	Bleeding	Clinic	and	is	identified	by	a	consultant	as	meeting	the	eligibility	criteria	of	having	a	BMI	of	40	or	above.			
Do	I	have	to	take	part?	/	What	happens	if	I	take	part?	To	participate	in	this	study	you	will	have	participated	in	Part	1	of	the	study	to	complete	associated	questionnaire.	Upon	completion	of	the	questionnaire,	an	interview	will	be	scheduled	(or	a	time	convenient	to	you)	at	the	clinic	with	the	researcher.	Your	consultant	will	have	identified	you	as	eligible	to	participate	in	this	study.	The	interview	allows	you	to	share	your	experience	and	expand	on	the	answers	you	provided	in	the	questionnaire.	You	may	bring	along	a	partner	or	trusted	friend	to	help	you	recall	the	events	leading	up	to	you	seeking	help	and	to	support	you	during	this	process	if	you	wish.	If	you	do	feel	distressed	at	any	point	regarding	the	interviewer	please	share	this	with	the	interviewer	who	will	be	there	to	provide	you	with	support	during	the	process.	Contact	information	for	further	support	will	be	given	after	completion	of	the	interview.	
	The	information	you	provided	in	the	questionnaire	will	be	used	to	explore	your	responses	and	to	allow	you	to	share	your	experience	in	a	conversational	environment.	You	are	invited	to	bring	a	partner	or	close	friend/family	member	to	the	interview	to	support	you	and	help	you	to	recall	certain	events	that	may	have	occurred	around	the	time	you	first	noticed	your	bodily	change.			Even	if	you	decide	to	take	part,	you	are	free	to	withdraw	from	the	study	at	any	time	up	until	a	month	after	
completion	of	the	interview,	without	having	to	give	any	reason.	Withdrawing	from	the	study	will	not	affect	your	care	or	have	any	negative	consequences	on	your	circumstances.		You	may	also	choose	to	withdraw	from	any	part	of	the	study	and	request	for	all	or	part	of	your	data	to	be	destroyed.		
	
What	happens	to	my	information?	All	information	that	is	obtained	from	the	interview	will	be	uploaded	onto	a	password-protected	computer	and	any	paper	material	will	be	stored	in	a	locked	filing	cabinet	at	the	University	of	Birmingham	where	only	the	study	researchers	will	have	access	to	this	information.	Interviews	will	be	audio-recorded	for	the	purpose	of	transcribing	your	spoken	words	into	text	for	analysis	and	direct	quotations	will	be	used	in	
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reporting	results.	However,	these	quotes	would	not	contain	any	information	that	would	allow	you	to	be	identified.	Only	the	research	team	will	have	access	to	original	materials.	This	material	will	be	anonymised	(i.e.	references	to	people,	places,	organisations	and	other	potentially	identifying	material)	and	systematically	altered	in	the	transcripts.	Participants	and	all	participant	data	(including	audio	files),	will	be	identified	by	numbers,	and	can	therefore	not	be	traced	back	to	you	or	anyone	else.	Once	the	audio	files	are	transcribed	digital	copies	will	be	deleted.	Your	name	will	only	appear	on	your	consent	form,	and	the	researcher	will	be	the	only	person	who	has	access	to	a	list	linking	your	name	with	your	number.		All	 data	will	 be	 stored	 securely	 at	 the	 University	 according	 to	 the	 University	 of	 Birmingham’s	 Code	 of	Practice	for	Research	for	10	years.		
Will	my	taking	part	in	this	study	be	kept	confidential?	All	information	that	is	obtained	during	the	course	of	the	study	will	be	kept	strictly	confidential.	No	identifiable	information	will	be	included	in	any	publication	using	the	data	of	this	study.	Your	responses	will	not	be	passed	onto	your	clinical	care	team.	Good	Clinical	Practice	codes	will	be	followed	and	if	you	should	happen	to	disclose	intent	to	harm	yourself	or	others,	a	clinic	staff	member	will	be	informed	and	clinic/trust	policy	will	determine	appropriate	safety	response	action.			
What	will	happen	to	the	results	of	the	study?	The	results	of	the	study	will	be	analysed	by	the	research	team	to	identify	motivators	and	barriers	to	help-seeking	for	women	who	have	sought	help	for	abnormal	gynaecological	symptoms.	The	results	may	be	presented	at	a	conference	or	published	in	an	academic	journal	and	may	be	used	to	inform	future	research	regarding	the	experience	coming	to	seek	help	for	potential	symptoms	of	gynaecological	cancer.	Please	note	that	no	identifiable	information	will	be	released	in	any	write-up	of	the	results.	If	you	choose	to	participate	in	the	study	you	may	request	to	receive	a	copy	of	the	results	by	contacting	the	researcher.			
Please	contact	SWBH	Patient	PALS	advice	and	liaison	service	(PALS)	for	hospital/trust	assistance	you	
have	concerns	or	complaints	regarding	this	research:	0121	507	5836 
	Please	contact	Sara	Tookey	with	any	questions	or	if	you	have	not	yet	indicated	your	interview	time	preference.	Sara	will	then	arrange	a	date	and	time	that	is	convenient.		
Primary	Researcher:	
Sara	Tookey	PhD	Researcher	School	of	Psychology	University	of	Birmingham	Edgbaston,	Birmingham	.ac.uk		
Supervisory	Researcher:	Dr.	Beth	Grunfeld	Senior	Lecturer	and	Research	Supervisor	School	of	Psychology	University	of	Birmingham	Edgbaston,	Birmingham	ham.ac.uk		ervisor	at	Clinic:	Mr.	Joe	Kabukoba,	MD	Post-menopausal	Clinic	Consultant	Sandwell	Hospital	Sandwell	&	West	Birmingham	Hospitals	NHS	Trust	Secretary:	0121	507	3763	
ervisor	at	Clinic:	Mrs.	Shagaf	Bakour,	MD	Consultant	Gynaecologist,		Birmingham	City	Hospital		Sandwell	and	West	Birmingham	Hospitals	NHS			
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APPENDIX V 
Chapter 7: Participant Consent Form for Interview 
	
	 	
Help-seeking for post-menopausal bleeding symptoms: An interview study 
	
Consent	Form	for	Participants	Please	tick	each	statement	to	the	left	AND	initial	to	the	right	of	each	statement	indicate	agreement.	
☐	 I	have	read	and	understood	the	information	sheet	for	the	above	study	and	have		been	given	the	opportunity	to	ask	questions.			
☐	 I	understand	that	my	participation	is	voluntary	and	that	I	am	free	to	withdraw	from	the	study	up	until	 ____________	 	(the	specific	date	will	be	entered	here	on	the	day	of	the	interview)	without	having	 to	 give	 any	 reason	 and	 without	 me	 being	 affected	 or	 this	 having	 any	 negative	consequences	on	my	circumstances.		
☐	 I	agree	 to	provide	 information	 that	will	be	used	 for	research	purposes	only,	and	understand	that	 all	 the	 information	 relating	 to	 myself	 obtained	 as	 part	 of	 the	 study	 will	 be	 strictly	confidential,	and	that	I	will	not	be	personally	identified	in	any	write-up	of	the	results.			
☐	 I	 understand	 that	 relevant	 data	 collected	 during	 the	 study	may	 be	 looked	 at	 by	 individuals	from	 the	 University	 of	 Birmingham’s	 Psychology	 research	 team,	 and	 from	 regulatory	authorities	 of	 the	 NHS	 Trust,	 where	 it	 is	 relevant	 to	my	 taking	 part	 in	 this	 research.	 I	 give	permission	for	these	individuals	to	have	access	to	this	data.		
☐	 I	 understand	 that	 information	 will	 be	 stored	 in	 secured	 manual	 and	 electronic	 files	 and	 is	subject	to	the	provisions	of	the	Data	Protection	Act.			
☐	 I	consent	to	being	audio-taped	for	the	purpose	of	transcription	and	that	the	audio	data	will	be	deleted	once	transcription	is	complete.			
☐	 I	understand	that	the	Good	Clinical	Practice	codes	will	be	followed	and	as	such,	if	you	should	happen	 to	disclose	 intent	 to	harm	yourself	or	others,	 a	 clinic	 staff	member	will	be	 informed	and	clinic/trust	policy	will	determine	appropriate	safety	response	action.		
☐	 I	wish	to	participate	in	this	study	under	the	conditions	set	out	here	and	in	the	Information	Sheet	for	Participants.			Printed	Name:		 	 	 	 		Signature:		 	 	 	 		Researcher	Signature:		 	 	 	 		Date	Agreed:		 	 	 	Thank	you	very	much	for	agreeing	to	participate	in	this	study!
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APPENDIX W 
Chapter 7: Interview Schedule  Version1.8-	amended 
Introduction:		I	wonder	if	we	could	begin	by	having	you	tell	me	a	bit	about	why	you	were	referred	to	the		PMB	clinic	and	what	the	results	of	your	investigation	was?	How	does	that	make	you	feel	to	know	that	you	do	not	have	a	diagnosis?		
1.		Menopause	Could	you	please	tell	me	about	your	experience	with	menopause?		Symptoms,	changes	in	your	body	at	the	time?	How	would	you	describe	your	body	image	at	the	time?		How	did	you	feel	about	your	body	and	the	changes	you	were	experiencing?	How	did	you	understand	what	was	happening	in	your	body	at	that	time?	Did	you	make	use	of	your	healthcare	professional	or	GP	during	this	time?		 Medicine?		 Did	your	GP	discuss	weight	or	weight	changes	with	you	during	this	time?		
2.	Recognition	of	change	(symptom)	After	you’d	stopped	bleeding,	when	did	you	notice	bleeding	or	a	change	in	your	body?		 What	happened?	What	was	that	like	for	you?		How	did	you	understand	what	was	happening?		 Or	the	experience	of	you	as	a	women?		 What	does	it	mean	for	you	as	a	woman?		
3.	Concern	When	did	you	notice	that	it	was	something	to	be	concerned	about?		 Why	was	it	concerning?	/What	were	your	worries?	What	was	your	visit	to	the	GP/HCP	like?		 How	did	you	feel	about	the	visit?		 Expectations?			 How	did	it	go?		 What	BI	brought	up	as	an	issue	in	this	conversation	at	all?		
4.	Is	there	anything	that	you	might	have	done	differently	(looking	back)?	
	 Do	you	think	you	made	the	choices	that	others	would?		 Or	was	it	based	on	things	that	were	important	specifically	to	you?
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Original	Interview	Schedule		Version	1.8		
	
Introduction:	Thank	you	again	for	meeting	with	me	today.	This	interview	should	last	roughly	one	hour	and	will	be	flow	more	like	a	conversation	than	a	structured	interview.	I	do	have	some	specific	questions	that	I	will	be	asking,	but	please	know	that	there	are	no	right	or	wrong	answers	here.	I	am	here	to	learn	from	you	and	to	hear	about	your	own	experiences	gynaecological	symptoms,	which	lead	you	to	seek	help	from	the	Post	Menopausal	Clinic.		I	wonder	if	we	could	begin	by	having	you	tell	me	a	bit	about	why	you	were	referred	to	the	PMB	clinic	and	what	the	results	of	your	investigation	was?	How	does	that	make	you	feel	to	know	that	you	do	not	have	a	diagnosis?		
1.	Step	1:	First	Recognition	of	change	
Could	you	please	tell	me	when	it	was	that	you	first	noticed	that	something	was	not	quite	
right	with	your	body?	Could	you	describe	this	symptom	for	me?		What	did	you	think	it	might	be	at	first?	When	was	this?	What	else	was	going	on	during	this	time?	(Mark	date	on	blank	calendar	provided)	Where	were	you	and	what	was	going	on	at	the	time?	What	was	that	like	for	you?	What	was	that	like	for	those	around	you?		At	the	time	what	did	you	think	was	causing	this?		 Did	you	think	your	weight,	size	or	body	shape	had	anything	to	do	with	this?		
2.	Step	2:	Recognition	of	concern	
When	did	you	first	become	concerned	with	this	symptom/bodily	change	__(will	use	
participant’s	identifying	word	for	their	experience	here)?	(Mark	date	on	blank	calendar	provided)	What	were	your	concerns	about	this?	How	long	did	this	concern	last	for?	Please	explain	this	for	me.		What	did	you	do	in	response	to	this	concern?	(for	example,	did	you	speak	to	a	friend,	seek	the	help	of	a	healthcare	professional,	etc.)	How	well	did	these	work	in	relieving	your	concern?	I	wonder	whether	there	were	things	going	on	in	your	social	or	personal	life	that	could	have	affected	the	way	you	responded	to	this	__	(again	will	use	participant’s	own	words	to	describe	the	identity	of	their	experience).	Could	there	have	been	things	you	did	or	didn’t	do	as	a	result	of	this	concern?	Was	you	weight	a	consideration	at	all	in	how	you	decided	to	respond	to	this	concern?		Were	you	able	to	confide	in	another	person?	What	was	this	like?	
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	 	 Who	was	this	person	and	what	did	you	discuss?	
How	long	did	it	take	you	to	open	up	to	another	person?	(Mark	on	calendar	
when	they	confided	in	another	person)	How	did	the	other	person	respond?		
3.	Booking	the	Doctor’s	appointment/	seeking	immediate	help	
When	did	you	realise	that	this	was	an	issue	that	needed	to	be	assessed	by	a	medical	
healthcare	professional?	(Mark	date	on	blank	calendar	provided)		 What	was	it	like	when	you	realised	this?		 How	did	you	feel	about	it?		 What	is	it	like	for	you	to	see	a	doctor	for	a	medical	concern?		 	 When	was	the	last	time	you	saw	a	doctor	and	what	was	that	like	for	you?		 	Were	there	issues	or	concerns	that	you	had	to	consider	booking	an	appointment?	What	things	made	it	difficult	for	you	to	make	when	contact	with	a	healthcare	professional?		Again	I’m	wondering	if	there	were	things	going	on	in	you	social,	professional	or	personal	life	that	could	have	affected	the	way	you	responded	to	this	__	(again	will	use	participant’s	own	words	to	describe	the	identity	of	their	experience).	Also,	were	there	things	that	you	had	to	consider	regarding	you	weight	or	body	size	that	you	think	a	slimmer	person	may	not	need	to	consider?		How	did	you	make	the	first	contact	to	see	a	healthcare	professional	for	your	__	(again	will	use	participant’s	own	words	to	describe	the	identity	of	their	experience)?		 Why	did	you	arrange	a	visit?			 	 If	you	sought	immediate/	urgent	care	how	did	you	do	this?		 	 What	was	this	experience	like	for	you?		 	 How	easy	or	difficult	was	it	and	why?		 	Were	there	things	going	on	in	your	social,	professional	or	personal	life	that	could	have	affected	the	way	you	responded	to	this	__	(again	will	use	participant’s	own	words	to	describe	the	identity	of	their	experience).		 How	did	you	feel	just	before	you	made	contact?	How	did	you	feel	during?	How	did	you	feel	after	you	made	the	phone	call?		
When	was	your	appointment	arranged	for?	(Mark	on	calendar	provided)		What	was	it	like	to	wait	for	your	appointment?		 	 	 	
4.	Attending	the	doctor’s	appointment	
When	did	you	attend	your	initial	doctor’s	appointment	for	this__	(again	will	use	participant’s	own	words	to	describe	the	identity	of	their	experience)?	(Mark	on	calendar	provided)-if	date	attended	is	different	than	the	date	booked	from	previous	question,	will	
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enquire	about	reason	for	this	change	and	possible	cancellation	of	previous	appointment(s).		 How	was	it	getting	there	(logistically,	physically,	emotionally)?		 How	did	you	feel	on	the	day?	What	concerns	did	you	have	about	your	visit?	What	did	you	plan	to	say	to	the	doctor?		 What	was	the	office	like?	Where	there	things	about	the	aesthetics,	staff	attitudes	or	accessibility	of	services	that	made	this	experience	challenging	or	difficult	for	you?	If	so	what	were	they?		 What	was	that	like	for	you?	How	were	you	treated	by	staff?	How	did	you	feel	waiting	for	your	appointment	in	the	clinic?		 	What	did	you	explain	was	the	issue	to	your	doctor?		 How	did	the	doctor	respond	to	you?		 Do	you	feel	that	your	doctor	understood	your	concerns?		How	do	you	know	this?	What	did	your	doctor	do	in	response?		Was	there	an	examination?	If	so,	what	was	that	like	for	you?		 How	did	the	way	you	feel	about	your	body	affect	the	way	you	experienced	this?		 How	did	your	weight	play	a	role	in	how	you	experienced	this?			 How	did	your	culture	or	values	play	a	role	in	how	you	experienced	this?		 	Did	you	receive	a	referral	for	the	post-menopausal	bleeding	clinic	during	this	appointment?		 If	so,	what	was	that	like	to	hear	that	you	needed	this	referral?		 If	not,	what	did	the	doctor	assume	was	the	issue?		 	 What	advice	or	solution	did	they	give	you	for	your	problem?		
5.	Assessing	for	barriers	and	delay	If	situations	where	different	do	you	think	you	could	have	sought	help	sooner?		 	 What	would	have	needed	to	be	different?	Could	your	weight	have	anything	have	impacted	your	time	to	seeking	help?	If	so,	how?	What	issues	did	you	have	to	face	in	this	process	that	perhaps	a	slimmer	woman	would	not?	Could	you	explain	if	you	think	your	social	or	cultural	values	may	have	affected	this	time	to	seeking	help	from	a	doctor	(by	slowing	or	speeding	up	the	time	to	seeking	help	from	the	moment	you	noticed	your	__	(again	will	use	participant’s	own	words	to	describe	the	identity	of	their	experience)	to	the	moment	you	sought	help	from	a	healthcare	professional?		 				
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APPENDIX X 
Chapter 7: Participant Debrief Form for Interview 
	
	 	
Location:	Sandwell	General	Hospital	PMB	Clinic		
	
	
Debriefing	form	(Interview	study)	
	
Study	Title:	Help-seeking	for	gynaecological	symptoms:	An	Interview	Study		
	
Thank	you	for	choosing	to	participate	in	this	research	study.		Thank	you	again	for	agreeing	to	participate	in	this	interview	investigating	the	experience	of	seeking	help	for	your	gynaecological	symptoms,	from	the	moment	of	symptom	recognition	to	Post-menopausal	clinic	appointment.	In	this	interview	we	used	the	answers	you	provided	in	the	questionnaire	study	you	participated	in	to	guide	an	in-depth	interview.	We	were	interested	in	your	individual	experience	of	seeking	help	for	your	symptom,	your	feelings	about	attending	your	medical	appointments	and	what	motivated	you	or	stood	in	the	way	of	you	seeking	medical	help.	We	were	also	interested	to	understand	the	other	things	you	did	to	cope	with	your	symptom	(for	example,	seeking	advice	from	a	family	or	friend).			You	were	approached	to	participate,	as	you	attended	Post-menopausal	bleeding	services	and	met	the	inclusion	criteria	for	this	study.		If	you	would	like	to	speak	with	someone	with	any	concerns	that	may	have	been	brought	to	light	by	this	research	please	speak	with	a	clinic	staff	member.	Any	questions	regarding	the	research	please	contact	the	researchers	below.		
	
What	next?	Your	study	participation	is	complete.	We	will	access	your	chart	notes	through	the	clinic	and	will	acquire	your	weight	and	height	and	body	 fat	percentage,	which	 is	measured	by	the	 clinic	 healthcare	professional.	 In	 the	next	 six	months	 the	 researcher	will	 access	 you	 chart	notes	once	more	to	confirm	the	presence	or	lack	of	diagnosis.			Even	 if	 you	decided	 to	 take	part,	 you	are	 still	 free	 to	withdraw	 from	 the	study	at	any	 time	up	until	a	month	post	after	completion	of	the	questionnaire	and	interview,	without	having	to	give	 any	 reason.	 Withdrawing	 from	 the	 study	 will	 not	 affect	 you	 or	 have	 any	 negative	consequences	 on	 your	 circumstances.	 	 If	 you	wish	 to	withdraw	 please	 contact	 the	 researcher	below	(Sara	Tookey).		
What	happens	to	my	information?	All	information	that	is	obtained	from	the	questionnaire	will	uploaded	onto	a	password-protected	computer	and	paper	questionnaires	will	be	stored	in	a	locked	filing	cabinet	at	the	University	of	Birmingham	where	only	the	study	researchers	will	have	access	to	this	information.	This	information	will	then	be	entered	into	a	computer	database,	where	your	information	will	be	
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assigned	a	number.	The	information	in	the	database,	as	well	as	all	study	material	will	be	identified	by	numbers,	and	can	therefore	not	be	traced	back	to	you	or	anyone	else.	Your	name	will	only	appear	on	your	consent	form,	and	the	researcher	will	be	the	only	person	who	has	access	to	a	list	linking	your	name	with	your	number.				Your	clinic	chart	will	be	accessed	twice	(as	stated	above).	Your	personal	information	will	not	be	linked	to	the	data	at	any	time	and	will	be	coded	so	that	you	will	not	be	identifiable	in	the	study	data.	NHS	trust	policies	will	be	followed	in	accessing	clinic	notes	and	no	identifying	data	will	be	linked	with	the	data.	All	 data	will	 be	 stored	 securely	 at	 the	University	 according	 to	 the	University	 of	Birmingham’s	Code	of	Practice	for	Research	for	10	years.		
Will	my	taking	part	in	this	study	be	kept	confidential?	Yes.	All	information	that	is	obtained	during	the	course	of	the	study	will	be	kept	strictly	confidential.	No	identifiable	information	will	be	included	in	any	publication	using	the	data	of	this	study.	Good	Clinical	Practice	codes	will	be	followed	and	if	you	should	happen	to	disclose	intent	to	harm	yourself	or	others,	a	clinic	staff	member	will	be	informed	and	clinic/trust	policy	will	determine	appropriate	safety	response	action.		
	
What	will	happen	to	the	results	of	the	study?	The	results	of	the	study	will	be	analysed	by	the	research	team	to	identify	the	barriers	to	help-seeking	for	women	who	have	sought	help	for	abnormal	gynaecological	symptoms	and	will	explore	factors	that	may	impact	process	of	coming	to	seek	help	for	such	symptoms.	The	results	may	be	presented	at	a	conference	or	published	in	an	academic	journal	and	may	be	used	to	inform	future	research	regarding	the	experience	coming	to	seek	help	for	potential	symptoms	of	gynaecological	cancer.	Please	note	that	no	identifiable	information	will	be	released	in	any	write-up	of	the	results.	If	you	choose	to	participate	in	the	study	you	may	request	to	receive	a	copy	of	the	results	by	contacting	the	researcher.			
Please	contact	SWBH	Patient	PALS	advice	and	liaison	service	(PALS)	for	hospital/trust	assistance	you	
have	concerns	or	complaints	regarding	this	research:	0121	507	5836 	
Primary	Researcher:	
Sara	Tookey	PhD	Researcher	School	of	Psychology	University	of	Birmingham	Edgbaston,	Birmingham	.ac.uk		
Supervisory	Researcher:	Dr.	Beth	Grunfeld	Senior	Lecturer	and	Research	Supervisor	School	of	Psychology	University	of	Birmingham	Edgbaston,	Birmingham	B15	2TT	e.a.grunfeld@bham.ac.uk	01214143402	ervisor	at	Clinic:	Mr.	Joe	Kabukoba,	MD	Post-menopausal	Clinic	Consultant	Sandwell	Hospital	Sandwell	&	West	Birmingham	Hospitals	NHS	Trust	Secretary:	0121	507	3763	
Consultant	Supervisor	at	Clinic:	Mrs.	Shagaf	Bakour,	MD	Consultant	Gynaecologist,		Birmingham	City	Hospital		Sandwell	and	West	Birmingham	Hospitals	NHS			
		
	 429 
APPENDIX Y 
Chapter 7: Case Summaries 
SUE Case Summary number: BMI 36; Time to booking= 11 days; booking to 
attendance= 1 month; Total time to help-seeking= 41 days 
 
Experience of the Menopause: “Mickledy-pickeldy” journey through menopause. Confusion 
as to what stage of menopause she’s in as she feels she should be post menopause or 
menopausal by now, but was told earlier she was peri-menopasal (unclear of definition). 
 
Experience of PMB: Bleeding came in cycles until it became a constant and she was 
bleeding more often than not.  Bleeding had become the norm and relief was short lived. It 
was more than just a period. Bleeding began to interfere with daily life and responsibilities, 
and she was fearful that the bleeding would be exposed in social situations. She felt 
unprotected outside the home.    
 
Making sense of PMB: Making sense of PMB was done along with the attempt to make a 
link with additional symptoms of sickness (flu like symptoms and pain) experienced, despite 
doctor stating these are unrelated. Symptom was experienced as severe, because it was NOT 
associated with symptoms of going through the menopause.  
 
Reason(s) for delay: Bleeding became the norm. Every bleed feels like it could be the last. 
Finds it difficult to book a doctor’s appointment (without having to wait). 
 
Position: It is the patient’s responsibility to demand care, although there is also a personal 
apprehension in accusing or confronting healthcare services with problems. She often 
minimises her own experience and symptoms as not that bad.   
 
Process: The process of help seeking began with cyclical bleeding, which turned to a more 
constant state of bleeding. This became the norm, but was still acknowledged as not quite 
right. She felt that at some point she would stop bleeding and this would confirm that she was 
post-menopausal (the stopping), but when she didn’t and the bleeding kept on going the 
interference with daily life and the desire to make it stop brought her in to seek help. 
 
Experience of help-seeking: Felt welcomed in clinic by friendly reception staff and lady 
doctor who listened to symptoms without instilling fear. Difficulty opening up to people 
about body issues (private, feel stupid because you don’t know what’s going on in your own 
body), and there is an expectation that on must open up to healthcare professionals.  
 
Experience after help-seeking: “still a bit up in the air “. “Don’t feel like I’ve been able to 
close the book on that bit”. The questions remain unanswered as the results of secondary care 
tests were unclear or undelivered. The search continues (for an explanation for her bodily 
experience). Symptoms continue despite seeking help. 
 
Previous help-seeking experiences: Previous negative experience with male doctor where 
she felt judged and dismissive of symptoms. 
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Reasons for seeking help: Reached the tipping point, symptoms had persisted too long and 
she was fed up and in pain) (“The penny dropped”). Sickness was severe and symptoms 
became unbearable (“head was going to explode”). 
 
Knowledge of Gynae cancer/menopause: Bleeding after menopause is not right; 
Menopause means no more bleeding. Weight affects health, but not gynaecological issues (of 
bleeding). 
 
Researcher Reflection: She had a strong desire to be prepared for her interview and found it 
difficult to recall dates of help-seeking (Symptoms recognition and appointments). 
 
Evidence for Themes 
 
The ambiguous enmeshment of PMB and menopause: Uncertain ambiguity 
distinguishes the processes of menopause and PMB as a process of ambiguity that keeps 
resurfacing, hanging on and that is never resolved. 
 
The shock of a bleed (after months without) 
“Yea it was just lovely not having to think, ‘Oh have I got anything? Have I got to wear 
something?’ You know, (sigh). “ 
 
“I hadn’t had a period in quite some time, erm, I couldn’t work out whether it was a year, 
slightly under, slightly over… Um, well it was a bit of a shock, because I wasn’t expecting 
anything,”… 
 
“I might have gone for months and months and months and had a weeks worth, and then 
months and months and months and then you know, nothing for- I’m pretty certain it was 
about a year. And then BANG that happened, and it was heavy. And as I say, I’d never gone 
like so many weeks with it constantly like that.” 
 
No-one has the answers 
“Yea, because I’m terrible, but there’s so many people saying, “if you’ve got a label for 
something- If you can put a label on it, you know what you’re dealing with”.” 
 
The unknown vs. the known 
“As I say, it’s a bit like it’s [my period] reversed it’s role. Normally you’d have so many 
weeks off and a week’s period, so many weeks off, and it’s like it’s swapped.” 
 
The paradox of knowing 
… 
Searching for a cause 
“I had really high temperature spikes to the point where my head felt like it was going to 
explode, and it wasn’t just, ‘oh I’m having a granny’, you know the heat and the not feel to 
well. It really knocked me for sick. And then-and then after that’s when I came on.” 
 
Still up in the air/ Book remains open 
“Erm, so really I feel a bit like- still a bit up in the air. I-I know that they took a lining sample 
and that appeared to be okay. There was a growth or whatever, but they’re not dually worried 
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about that. But that-that’s as far as I am. So I don’t feel like I’ve been able to close the book 
on that bit.” 
 
“I think from a person’s point of view that’s experienced the journey I don’t feel like I’ve got 
an answer at the end of it.” 
 
“And unfortunately it’s all come back to square one now. However, I’ve been told that there’s 
nothing horribly wrong down there so. And then you kind of just have to remind yourself that 
perhaps this will just carry on for as long as it wants to carry on.” 
 
The conflict with severity 
“At the time I thought, ‘Oh that’s it. Finished and done’, but it came back again.” 
 
Weight and the uncertain risk 
“Erm no I’m not sure that my weight has had a causing of the problem or an adverse affect on 
what’s going on, but erm, obviously you’ve mentioned body image” 
 
The chaotic body: Embodied Symptoms or a chaotic nature because of unpredictable 
experience of menopause and PMB. There are a set of embodied issues that are involved 
in the process of help-seeking for PMB. You can’t take them out of the aging process, 
the weight-struggle, or the hatred of their body. This is all part of the chaotic body. 
 
Shared vs. unique experience 
“Erm yea I’d talked to my sister. Erm and she had been telling me to, “well, get yourself to 
the doctor’s, get yourself to the doctor’s”. Because she has actually had problems, always, 
erm through her life” 
 
Exposing the chaotic body (e.g. weight gain, hot flushes, bleeding) 
“I couldn’t do as much as I wanted to do, and then I had to keep nipping back in and out of 
the house, and when you’re somewhere strange- rather than your own home you-you’ve got 
to be protected don’t you?” 
 
The internal hatred and mistrust 
“I haven’t got a very good body image so. 
 
The catch-22 of weight-loss and health 
“And of course the thing is you’ve got to kind of open up to people haven’t you? You know, 
erm but I have been trying to lose weight and I’ve lost about half a stone, erm but yea 
(laugh).” 
 
The penny dropped: What is it that makes women think something isn’t right here and 
to seek help. 
 
Relief as short lived 
“Well I assumed I was [post-menopausal] anyway, because I-I’d been going through it for a 
number of years where it’s been like months and months and months and then I’d have a 
	 432 
couple of days, and then it’d be months and months and months again, and so- I mean this has 
been going of for probably about 8-8 years.” 
 
“I-I think I remember having about a week thinking, ‘(gasp) this is nice- no period’,  
 
The penny dropped (i.e. the decision to seek help) 
“Um, well it was a bit of a shock, because I wasn’t expecting anything, cause I’m not having 
anything for such a while, and I thought, well they say you can. Erm so I was okay with that 
happening, but it didn’t stop and I started to get worried.” 
 
[Sister was] yea, actively encouraging [me to seek help]... I think it, erm, the penny dropped 
for me when it had gone like- I think like maybe two months I think it was.” 
 
“I was down in Cambridge with my daughter and I kept having to go in and out, in and out 
the house possibly every hour, every couple of hours just to make sure that everything was 
okay still. I thought, ‘no this isn’t right’.” 
 
 Interactions with healthcare for investigation toward treatment are uncomfortable at 
best and frightening, painful and intrusive at worst. 
 
The feminine approach 
Male doctor-“He said, “ I don’t think you’re through the menopause, but there is a stage prior 
to the menopause”. That’s what he explained it to me, but anyway, we left it at that. And 
when this happened, erm then I thought, ‘Right I’m going to go and see a lady doctor’. And 
luckily I saw a LOVELY lady doctor.” 
 
“Erm it-it-it probably wasn’t, but how it felt was, “oh it’s women’s problems it will sort itself 
out. It’s your age, this is what you have to expect”. He probably didn’t say that, but that’s how 
it felt it came across. 
 
Female doctor- “Erm well she actively listened, and she obviously knew more than I did, and 
she was reassuring, you know, straight away, “Right we’ll have these blood tests done, that 
blood test done”. I says, “Look, I’m so tired all the while. I’ve had enough, dah dah dah”, and 
you know, that kind of thing; “ Right we’ll test for this this and this”. So erm she found out 
that my folic acid was a little low, erm, so it just felt like somebody was actively doing 
something for ME” 
 
Doctors’ actions are greater than the words they speak 
“As I say she actively listened. I told her about everything and it didn’t feel like it was going 
on deaf ears.” 
 
The necessary intrusion 
“opening up into, you know, what is kind of a private side of your life. You think- you- not 
many people find it easy to talk about what’s going on with your body and I think the worst 
thing is when YOU don’t understand it. You feel a bit stupid as well… , so the worry about 
opening up to people was frightening.” 
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WENDY Case Summary: BMI 54; Time to booking= 2 days; Booking to attendance= 0 
days; Total time to help-seeking= 2 days 
 
Experience of the Menopause: She believes menopause is defined by age and occurs after 
40. 
 
Experience of PMB: “What’s wrong with me now?” Bleeding mimicked normal past periods 
with one difference (blackish colour). The bleeding lasted one week and included large clots. 
She hadn’t bled for 3 years. She tried not to think about symptoms of bleeding, but it was 
unavoidable, “I couldn’t could I?”   
 
Making sense of PMB: PMB is explained as connected to her mental health problems and 
“fatness”. The bleed was understood as the last bleed of the menopause. After this she 
probably wouldn’t bleed again and then she’d be considered post-menopausal. 
 
Reason(s) for delay: n/a 
 
Position: Unclear/complex story of menopause not separated from her PMB experience. 
Potential causes of PMB are difficult to discuss retrospectively. 
 
Experience of help-seeking: Sought help “straight away” (within two weeks) and was seen 
straight away by her requested female doctor whom she has a positive relationship with and 
whom she visits regularly for mental and physical health problems. No examination was 
conducted at GP “If you’re bleeding they don’t examine you”.  
Received social support from friends and children, but didn’t inform children of PMB because 
she didn’t want them to worry before she knew what was wrong (not until after help-seeking). 
What is not yet known is confusing and thus is not be shared with family. Doctor reassured 
her that everything was fine without explanation, but what does that mean? 
 
Experience after help-seeking: Questions remain unanswered (why did I bleed?) “Doctor’s 
said everything is fine, because they found nothing at all. Secondary care investigation 
involves unpleasant examination “they shove it in ya”. 
 
Previous help-seeking experiences: Doctor advised for weight-loss and prescribed 
medication. She has never felt judged by her female GP. She experienced a negative had a 
painful examination with a previous male doctor, which reminded her of sexual assault from 
father as a child. 
 
Reasons for seeking help: Recognition of abnormality raises concern. Knew “I shouldn’t be 
going through this so there must be something wrong” and the fear of cancer motivated her 
undergo the examination despite physical and psychological discomfort. Comorbid illness 
(diabetes and mental illness) sped up time to help-seeking and help received, because she was 
used to frequent visits.  
 
Knowledge of Gynae cancer/menopause: She feels she’s too old to bleed and that bleeding 
has something to do with her “fatness”.  
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Researcher Reflection: There is a difficulty in recalling dates of appointments and 
symptoms, and the story of her menopause was unclear and difficult to understand (enmeshed 
with the experience of PMB). It also appears that she has a desire to share her story of mental 
illness rather than her bleeding 
It seemed important that researcher knows she is doing things to improve her health and 
weight as she often listed off the health behaviours she does to try to lose weight (swimming, 
running, walking).  
Difficulty understanding the thoughts behind decision to seek help or recognition of 
symptoms and concerns. 
 
Body Image: She prioritises other health problems over weight-loss, but there is still the 
desire to “not get bigger” . 
Desire to live for kids inspire weight-loss or avoidance of weight gain and help-seeking 
behaviour. She has experienced negative weight-judgement and bullying from “the people on 
the street calling her “fat bastard”. She’s not judged by friends who help her stand up against 
the bullying, she “get’s blazed for it by other people though”. Still she worries and cries about 
her weight when she’s on her own.  
She has been unsuccessful at previous attempts to lose weight. 
 
Evidence for themes 
 
The ambiguous enmeshment of PMB and menopause:  
 
The shock of a bleed (after months without) 
I came on, and I used to come on every month, but now because I’ve stopped- and after a long 
time I came on again, that’s why I got worried. I thought, ‘why am I coming back on again? I 
shouldn’t be coming back on again.’ Cause I’m 50 now anyway. 
 
 “Because I was- I thought there was something wrong with me, because the blood was like 
black…” 
 
“I don’t want it to come back on neither. It’s not nice. Don’t like it… All my clothes gets 
dirty. When I was young I used to come on really heavy. When I was young.” 
 
No-one has the answers 
“What’s happening to me?” 
 
“They said that everything was fine, because I-they found nothing at all. They said eh 
everything’s okay in there.” 
 
And yet, “I can’t understand that why I came back on after three years… I shouldn’t be 
coming on.” 
 
The unknown vs. the known 
“Because I’m 50 years old and I shouldn’t be coming on.” 
 
The paradox of knowing 
“When I came here was- I got scared. I was thinking, ‘what’s gonna happen to me?’ 
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“the next day I was at the doctors asking the doctor, “what’s wrong with me”. 
 
“It’s all right. I was worried when I first went in. Cause I don’t want it. I told them I don’t 
want it. They said okay, and I just got over it.” 
 
Searching for a cause 
“Could have had anything, but this, they said was all right.” 
 
 “But I didn’t know what it was at first. Then I went to my GP. My GP said that yea, they 
referred me here to have it checked out.” 
 
“When you start thinking a lot then you start getting ill. Then you start to say, “oh, what’s 
wrong now? Might be something wrong with me.” 
 
Still up in the air/ Book remains open 
“They said that everything was fine, because I-they found nothing at all. They said eh 
everything’s okay in there.” 
 
And yet, “I can’t understand that why I came back on after three years… I shouldn’t be 
coming on.” 
 
The conflict with severity 
… 
Weight and the uncertain risk 
… 
The chaotic body:  
 
Shared vs. unique experience 
“I said [to friend], “yea I’m bleeding. That’s why I have to go[…] I said it was for a week. 
She said, “that long?” 
 
Exposing the chaotic body (e.g. weight gain, hot flushes, bleeding) 
“When that happened to me I booked with my GP, because I couldn’t sit down and that was 
keep on coming.” 
 
The internal hatred and mistrust 
“I don’t like it when I’m big. You know like when people say to me- swearing at me and 
saying things.” 
 
“Then I stay in my house. Since I’ve known P2F and [friend] I go around to their house a lot 
and I don’t stay home that much, because I know that I’ve got somebody. It used to be when I 
would get out of the house I used to get abused and blazed and all that before, and now I don’t 
get none of that. Before I used to get a lot of swearing.” 
 
The catch-22 of weight-loss and health 
“I’ve been taking that medication every day. And that could be putting on my weight. 
Sometimes I worry about myself. I don’t want to get more bigger.” 
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“My doctor sent me to Heartlands Hospital, because I stopped breathing 52 times. Yea. I’m 
on a sleep apnoea machine.” 
 
“I walk slowly. Don’t walk fast […] I have arthritis in my feet so that’s why.” 
 
The penny dropped 
 
Relief as short lived 
“Exception to the rule: “After that [a week of bleeding], touch wood, I haven’t come on. I 
haven’t come back on at all[…]I get out of breath if I don’t have my machine.[..]” 
 
The penny dropped (i.e. the decision to seek help) 
“When that happened to me I booked with my GP, because I couldn’t sit down and that was 
keep on coming.” 
 
 Interactions with healthcare for investigation toward treatment are uncomfortable at 
best and frightening, painful and intrusive at worst. 
 
The feminine approach 
“I went down to go to my doctors. I go to the lady doctor. I go to the lady doctor.” 
 
“Because when I go in and they’re really kind to you and they’re really lovely to you. They 
hug you. They talk to ya. It’s really good. My-my doctors really good.” 
 
“not nice. Cause this is the first time a man doctor done it.” 
 
Doctors’ actions are greater than the words they speak 
… 
The necessary intrusion 
“[The examination] It wasn’t nice… It hurts… when they shove it in ya.” 
 
P2: They put that metal thing in to make it wide. 
P2F: Yea, but remember you weren’t relaxing as they kept telling ya to relax. 
P2: I know I can’t do it. I can’t. 
“P2: It’s all right. I was worried when I first went in. Cause I don’t want it. I told them I don’t 
want it. They said okay, and I just got over it. 
R: Okay, so you managed to get through it. What made it so that you were able to go through 
it? 
P2: Do you know, I don’t want cancer.” 
 
 
  
	 437 
JUNE Case Summary: BMI 37; Time to booking= 30 days; Booking to attendance= 7 
days; Total time to help-seeking= 37 days 
 
Experience of the Menopause: “Didn’t have much problem going through the menopause” 
No bleeding since 46. After menopause believed there should be no more problems: “you sort 
of think that’s the end of it […] you’re not going to have any more problems with it”.  
 
Experience of PMB: Holiday was interrupted by bleeding when she first noticed it on the 
toilet. Looked up symptoms on the Internet (forum) but felt they were talking about bleeding 
during the menopause and this didn’t relate to her. She only told her husband about the bleed 
although she was more worried than she let on. She experienced the symptoms as silent- it did 
not cause her any pain or discomfort. Each bleed was experience as the last bleed, “You think 
it might be just a one off.” Symptoms weren’t accompanied by any pain or discomfort, “It 
was insignificant”. “I couldn’t rationalise into in my head as being serious.” 
She bled for one month before booking an appointment.  
 
Making sense of PMB: “where’s that coming from thinking, have I scratched myself?” “I 
couldn’t quite put my finger on why it was happening”, because hadn’t got any knowledge or 
experience of it happening to anybody else. She didn’t think cancer could be a cause until she 
looked it up on the Internet.   
 
Reason(s) for delay: The severity of the symptoms didn’t make sense, “I feel perfectly well. 
I don’t feel as though there is anything wrong with me [..] Which is sort of weird because 
you’re head’s saying, ‘you really should get that sorted out, but your body’s thinking, ‘Oh I 
feel okay!”( Doesn’t signify severity)”. “if I’d have felt unwell as well as spotting I would 
have been a bit more worried”. Illness is a strange concept to her, because family hasn’t’ been 
ill. Illness “wasn’t in my sphere of acknowledgment” 
Furthermore she didn’t see the point in wasting the doctor’s time “if I know that I’m okay, 
sort myself out with a few tablets or rest, or whatever.” “they’ve got enough people to see that 
are really ill, and possibly I’m not as ill as they are. 
 
Position: It was important for her to be able to accurately recall dates and be prepared for 
interview. She takes the blame for painful examinations by suggesting that “possibly was just 
tensing at the same time”. She prefers a lady doctor to a male doctor for gynaecological 
problems: “I just thought I’m more comfortable with a lady doctor.” “Old fashioned I 
suppose”-; “To be with somebody that understands what you’re going through. Because she’s 
fairly educated she feels she should have known something about post-menopausal bleeding 
 
Process: Ignored smear test letters for two years and when experienced PMB she knew 
something was not right but because she didn’t feel unwell she didn’t experience it as severe 
enough to seek help, until she looked on the Internet and it mentioned cancer.  She then 
booked an appointment for a smear test and was advised to book an appointment with the 
doctor (which took one week because she requested a lady doctor). After seeing the female 
doctor she was given a referral for the PMB clinic.  
 
Experience of help-seeking: Smear test was “quite painful”. Booking an appointment took 
one week to get a lady doctor’s appointment that fit into her schedule had to book around 
work commitments. She does not have a regular doctor and see’s someone new each time, but 
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the reception is always very efficient and welcoming. Doctor was a good doctor, she provided 
information without “scare mongering” explained that the bleeding could be a symptom of 
cancer and the lining of the womb needed to be checked. The doctor also told her she needs to 
be visiting the doctor more regularly. Referral was “rather quick”. 
 
Experience after help-seeking: Her positive experience made her wonder why people dislike 
going to the hospital, but in comparison to other negative hospital experiences she’s heard 
about from friends, she understood why. 
 
Previous help-seeking experiences: “I got told off actually  [for not coming in for smear 
test..] about two years ago. They said, ‘ I haven’t seen you for 6 years’. I said, ‘well that’s 
because I wasn’t ill for 6 years’. – Reason for visit was for swollen ankle. 
  
Reasons for seeking help: Thinking about a recent experience of a friend who felt “perfectly 
well, or thought she was, and had to go to the hospital for that”, made her think of exceptions 
to the understanding that if you’re unwell you’ll feel unwell, “because just because you’re 
feeling okay, don’t mean everything’s okay”. Symptom’s are concerning because “it’s been 
15 years since I’ve had my period and it carried on happening which affirmed that it wasn’t 
just a “one-off” 
If information about PMB was more readily available she would have sought help sooner. 
 
Knowledge of Gynae cancer/menopause: “I had to look up on the Internet to see how 
common it was”, and the answer was surprising”. Knowledge about causes come from family 
history with mum having had fibroids. We know a lot about menopause, we don’t know about 
the things that happen afterwards.”  
Knowledge of obesity risks: “being overweight does actually give you more chances of things 
(diseases?)”, personalises her risk by saying “and I’m not particular skinny.”  
 
Researcher Reflection: Significant life events (holidays and birthdays) helped to recollect 
dates. Husband provided perspective on her attitude against seeing doctor for illnesses. 
 
Body Image: She has never been skinny, but “I’m probably the heaviest now than I’ve ever 
been” 
 
Evidence for themes 
 
The ambiguous enmeshment of PMB and menopause:  
 
The shock of a bleed (after months without) 
“…but it-it was the vagina so, yea, that was a bit worrying, because it’s 15 years since I’ve 
had my period, so you know, I didn’t know- this shouldn’t be happening.” 
 
No-one has the answers 
“I was a bit more worried about it, because I wasn’t aware that this sort of thing happened. It- 
nobody I knew had ever mentioned it, so I thought, ‘Oh this is odd’” 
 
The unknown vs. the known 
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“Yea, and when I’d been to the doctor’s I mentioned it to the women at work, and actually 
they didn’t know much about it either, and I think cause one or two where in there 40s, 50s. 
So although we know a lot about the menopause we don’t know about the things that happen 
afterwards. You sort of think that’s the end of it, you know, you’re not going to have any 
more problems with it.“ 
 
“I had to look it up on the Internet to see how common it was and I was quite surprised.” 
 
The paradox of knowing 
.. 
Searching for a cause 
“I thought it might be a cyst or a polyp or something, because my mum had fibroids many 
years ago when she was expecting my brother actually. She was in her 30s and I thought, 
‘well maybe it’s something like that if it’s a family sort of inherited thing.” 
 
“I thought, ‘ where’s that coming from’ thinking, ‘have I scratched myself? What?’ 
 
“Two or three [times visited websites], because one of the ones- one of the sites I found, 
people that had it were still going through the menopause, so I thought, ‘well that doesn’t 
really apply to me’. So I did have another search to see if I could find sort of- but there wasn’t 
a lot actually about people that had gone totally through the menopause for several years and 
then had the symptoms.” 
 
Still up in the air/ Book remains open 
… 
The conflict with severity 
“I feel perfectly well. I don’t feel as though there is anything wrong with me [..] Which is sort 
of weird because you’re head’s saying, ‘you really should get that sorted out, but your body’s 
thinking, ‘Oh I feel okay! […] I think if I’d have felt unwell as well as spotting I would have 
been a bit more worried, but the fact that I felt perfectly well, and that this was just a bit odd.” 
 
“If I know that I’m okay, sort myself out with a few tablets or rest, or whatever…they’ve got 
enough people to see that are really ill, and possibly I’m not as ill as they are.” 
 
Weight and the uncertain risk 
P3: Yea, because you do see a lot of things in press now that being overweight does actually 
give you more chances of things and I’m not particularly skinny. I’ve never been skinny, but 
I’m probably the heaviest now than I’ve ever been. 
R: Okay. Have you thought about how, erm being overweight would cause bleeding at all? 
P3: No. No, I couldn’t work that one out. 
 
 
The chaotic body:  
 
Shared vs. unique experience 
“We know a lot about menopause, we don’t know about the things that happen afterwards.” 
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“My family doesn’t have a history of illness or operations or things like that. It wasn’t in my 
sphere of acknowledgement if you know what I mean, and of course- so it did worry me, 
unusual.” 
 
Exposing the chaotic body (e.g. weight gain, hot flushes, bleeding) 
 
“having any spotting at all and then quite a bit of spotting, and then it would stop again. 
So[…]it was just, yea all over the place.” 
 
The internal hatred and mistrust 
…. 
The catch-22 of weight-loss and health 
“I’m probably the heaviest now than I’ve ever been” 
 
The penny dropped 
 
Relief as short lived 
“it’s been 15 years since I’ve had my period and it carried on happening which affirmed that 
it wasn’t just a “one-off” 
 
“Yea, because I wasn’t getting it all the time. It was intermittent as well, because I could go 2 
or 3 days without having any spotting at all and then quite a bit of spotting, and then it would 
stop again.”  
 
The penny dropped (i.e. the decision to seek help) 
“You know you think it might be just a one-off, but then it carried on happening so I thought, 
okay this isn’t right. “ 
 
“It’s got to have been about 6 weeks before I thought, ‘well this must be serious, because it’s 
not going away’.” 
 
 Interactions with healthcare for investigation toward treatment are uncomfortable at 
best and frightening, painful and intrusive at worst. 
 
The feminine approach 
“I just thought I’m more comfortable with a lady doctor […] Old fashioned I suppose” 
 
“Erm she sort of took me through a few what-what it could be. She did mention that it could 
be cancer, but it could be the lining of the womb so it needed to be checked out. Yes.” 
 
“Yea, just to be with somebody that understands what your going through (laugh).” 
 
Doctors’ actions are greater than the words they speak 
“Well she didn’t seem to think that-… Well she didn’t scare monger, let’s put it that way. She 
was very matter of a fact when she was talking to me and asking me- a bit like I was having a 
conversation. It was very comfortable, very informative actually, because I hadn’t realised 
how common it was. “ 
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The necessary intrusion 
“She stopped, because it was getting too uncomfortable, and that’s when she said, yes you 
really should see a doctor. So I booked the appointment with the doctor, and actually the 
doctor managed to be able to do the examination without it being too painful.” 
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CAROL Case Summary: BMI: 62; Time to booking= 305 days; booking to attendance= 
0 days; Total time to help-seeking= 305 days 
 
Experience of the Menopause: She shared in her experience of menopause with most of the 
female members in her family, “because we were all more or less on the same path”. 
Menopause is when you’re still having your period; she doesn’t seem to fit the definition of 
menopausal (confusing). Unsure of what it means to be menopausal. Thrush symptom 
replaced the period. Thrush is her “body clearing out what was in the body during 
childbearing age and due to hormones during menopause”. Consistency of symptoms starts to 
wear you down 
 
Experience of PMB: The initial bleed was just a “show of blood” (brief and once) and she 
does not consider it an actual bleed. She noticed it when wiping. Time since last period makes 
a bleeding now abnormal, but then the pattern of recurrent bleeding symptoms creates 
normalcy. Symptoms continue and are on-going. 
 
Making sense of PMB: She was unsure if she was menopausal because her bodily experience 
of symptom doesn’t match her definition of menopausal OR post-menopausal, because she 
believes she shouldn’t be bleeding either way. She believes that PMB was caused by 
psychological stress. 
 
Reason(s) for delay: Was not concerned about PMB. 
 
Position: Is it the patients’ responsibility to find out the answers by asking their doctor rather 
than waiting for the answers to be given to them by the doctors, and attending preventative 
screenings is important.  
 
Process: Experienced a slight bleed and was not concerned. Because she had a cervical 
screening booked a couple of days after, she attended and mentioned it to her doctor (under 
the encouragement of her husband). She was referred to PMB clinic who told her she was still 
going through the menopause. Her bleed then returned after secondary care visit. 
 
Experience of help-seeking: Convenient help-seeking at pre-booked screening appointment 
and mentioned bleeding to nurses. Communications about her symptoms between nurses and 
doctors in front of her raises concerns and was frightening. The concern didn’t exist until she 
witnessed the healthcare professionals’ concern. Witnessing their concern had a greater 
impact than the comforting words they spoke, stating not to worry, but that they want to refer 
her to a specialist to be safe “their actions were greater than the words they spoke”. HCP 
concern brought detrimental thinking “I wonder if I’ve got cancer”. 
When she attended the PMB clinic she experienced a Paradox of knowing: Wanting to know, 
but not wanting to know that something is wrong, because experiences future dread about 
what she would do with familial and financial responsibilities if things were medically 
“dreadfully wrong”. She was “walking out with the weight of the world on my shoulders”. 
The examination was uncomfortable, “I’d just been clamped open, BUT STILL”, I didn’t 
mind it, because wanted answers. She received the results of test that her bleeding was caused 
be her not yet being through the menopause. 
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Experience after help-seeking: She was given “menopause” as the reason for her bleed, but 
if she’s not yet through the menopause then how much longer will this last? Doctors told her 
probably still going through the menopause. When does the tunnel end, “They’ve told me not 
to worry about it; so I’m not worried, but how long does that go on for?” 
 
Previous help-seeking experiences: Last visit to doctor was for common comorbid concern 
(swelling of ankles with diabetes). Her regular comorbidity GP visits builds strong 
relationship with nurses.  
  
Reasons for seeking help: The wanting to know is stronger than not wanting/ fear of 
knowing.  
 
Knowledge of Gynae cancer/menopause: 
Knowledge of menopause: She knows that menopause is a change in hormones, and that if 
you’ve had a proper bleed a year ago means no longer going through the menopause.  
Knowledge of obesity as a risk factor for “diabetes, heart attack (the normal ones) and all the 
ones that can kill ya” 
Knowledge of gynaecological cancer: Believes it can’t kill you 
 
Researcher Reflection: It’s difficult to remember actual dates of the help-seeking process, 
but recalling personal events (birthdays, holidays) help to recollect dates. There was an 
acknowledgement of the age gap by the participant. It was difficult to raise the issue about 
body image and researcher found that the participant responses to weight related questions 
were short and dismissive.  
 
Body Image: Weight/size does not play a role in the decision or experience of seeking help 
because, “it’s all necessary isn’t it”. 
 
Evidence for themes 
 
The ambiguous enmeshment of PMB and menopause:  
 
The shock of a bleed (after months without) 
“Yea. It wasn’t actually a bleed. It was almost like a show. So- so it wasn’t an actual bleed. It 
was just that I hadn’t had anything for quite a few months.” 
 
No-one has the answers 
“They’ve told me not to worry about it; so I’m not worried, but how long does that go on 
for?” 
 
“I suppose at the end of the day I got the letter to say, you know, nothing was-nothing was 
wrong, but you still haven’t gone through the menopause yet, you know. You know, but they 
didn’t say anything about why I’m just trickling or not even just trickling but spotting. 
There’s no answers to that. It’s just that, ‘you’ve not gone through the change yet’. But I’m 
not having a proper period as such […] it’s definitely not regular. I don’t suppose that’s all 
part of the course…?” 
 
The unknown vs. the known 
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“I didn’t actually think it was anything to be- Until they, well until they went into, you know, 
all actions. Before they’d phoned the doctor and get the clinic and stuff I didn’t think anything 
of it.” 
 
“Answers. I just wanted to know what was wrong with me […] Yea, and then I probably 
would have had some questions, but I hadn’t planned anything, because I didn’t know what 
was going to go on.” 
 
The paradox of knowing 
“Well I wanted to know. I think-I think I wanted to know. I didn’t want to know, but I wanted 
to know. I wanted to know that there was something physically wrong? I don’t know-I don’t 
know. I did want to know, and I just wanted, yea, I just wanted to know. That’s why I made 
the decision to come to the clinic and mmm. I did.” 
 
“I was a bit nervous, yea. A bit nervous, yea, thinking I was going to walk out with the weight 
of the world on my shoulders.” 
 
“I don’t know, I had lots of thoughts didn’t I? What was I gonna do? How was I gonna tell 
people what was going on, and you know, what was gonna happen? How I was gonna pay the 
bills. You know, I was thinking like all sorts of things, all sorts of things.” 
 
“But then after hearing that, “actually we’ve got a concern because you’ve bled”. It was like, 
‘Oh shit. That’s connected to that and that’s connected to that’” 
 
Searching for a cause 
Thrush & bleeding: “I just thought that with my hormones changing and everything else it 
was just coming back[…] It was unusual now, but I just assumed it was because  my body 
was changing.” 
 
“I was thinking like, I was thinking detrimental really, “I wonder if I’ve got cancer”. That sort 
of thought.” 
 
 “It might-I’m thinking that it might have something to do with psychological or- I don’t 
know. I don’t know.” 
 
Still up in the air/ Book remains open 
“What they said was that they didn’t think that erm I’d started the menopause yet, because 
I’m still having bleeds. Erm, and they-what they- the neck of my womb was still too thin or 
something, or too thick or whatever. So that was a sign that I hadn’t started the menopause. 
[…] Well it’s supposed to mean that I’m still supposed to be having my periods, but I don’t.” 
 
“My mind’s been rested assured in that it’s nothing serious, but still I haven’t…I’ve not been 
given any hard and fast answers on why it’s happening or what I should be looking out for 
and if it’s mixed with, “you need to probably come back to us”, you know, I’m sort of left at, 
“okay and you haven’t gone through the menopause so that’s kind of normal that you should 
be bleeding”. And as I said before, how long is this going to go on? And, do you know what I 
mean? I’ve had no indication as to…” 
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The conflict with severity 
“Yea. It wasn’t actually a bleed. It was almost like a show. So- so it wasn’t an actual bleed. It 
was just that I hadn’t had anything for quite a few months.” 
 
“I was concerned only because it had been so long since I had seen any bleeding, but I 
wasn’t- I was concerned, but I wasn’t.” 
 
Weight and the uncertain risk 
R: What do you know about weight and risk for diseases? 
P4: Oh, well the normal ones like erm diabetes and erm, heart attack and stuff like that. I’ve 
heard those ones, but nothing else really, and all the ones that can kill ya (laugh). 
 
The chaotic body:  
 
Shared vs. unique experience 
“I started noticing the change was probably back in October, November last year when I 
probably thought, because my sisters were going through it I probably thought I was going 
through it. So I just assumed that everything that happened, because we were all more or less 
on the same path. Like, “This has happened”- “Oh yes I remember this happened” and then 
the other one would say, “Nah this has happened” and I would say, “oh yea I remember that’s 
happened, because there’s only like two years between us all. So we were like- and my mum 
said that she went through when she was like in her 50s and whatever, so we just assumed 
that, you know, everyone was following everyone down. So even  my younger sister’s gone 
through it before it.” 
 
Exposing the chaotic body (e.g. weight gain, hot flushes, bleeding) 
“Well it’s supposed to mean that I’m still supposed to be having my periods, but I don’t.” 
 
The internal hatred and mistrust 
“Well it’s supposed to mean that I’m still supposed to be having my periods, but I don’t.” 
 
The catch-22 of weight-loss and health 
… 
The penny dropped 
 
Relief as short lived 
“Yea. It wasn’t actually a bleed. It was almost like a show. So- so it wasn’t an actual bleed. It 
was just that I hadn’t had anything for quite a few months.” 
 
“It was- It was gone as quick as it came to be honest.” 
 
The penny dropped (i.e. the decision to seek help) 
“By that time I was worried, thinking I should have been over this by now, and it was as far as 
I’m aware a year, so I should have been over that bleeding by now. So I took the bleeding to 
be something else you see, something a bit more serious at that point.” 
 
 Interactions with healthcare for investigation toward treatment are uncomfortable at 
best and frightening, painful and intrusive at worst. 
	 446 
 
The feminine approach 
“For my smear test. And there’s like the regular four nurses and it’s like, you know, well I do 
know them all, because I go there for asthma and my iron and blood tests and so I see them all 
the time” 
 
“Well constantly talking about something completely different (laugh) was good (laugh). Yea, 
and telling you what they’re going to do, why they’re going to do it. So all that’s sort of said 
before you actually lie down, so you know what they’re going to do and everything else. By 
the time you get to that point we’re talking about something completely different- what 
happened with, I don’t know, Grandchildren or something. So it’s all like over and done with 
by the time you’ve finished having the consult so.” 
 
Doctors’ actions are greater than the words they speak 
“I think they tried to explain to me as plainly as possible that it was nothing to worry about, 
but at the end of the day you were still you’re still thinking, ‘well actually’. But I think that 
the way that things happened it was like, “Oh, that’s happened, I need to phone the doctor” 
and then they phone the doctor and the doctor said, “Refer to the clinic”, and it was like I was 
like just watching all this happening and thinking, ‘I wonder if that’s like something serious 
like’ sort of thing. So, I went away thinking not really about what they said, but more about 
what I was thinking about and that it might be something serious and I’m meant to get it 
sorted.” 
 
The necessary intrusion 
“I’d just been clamped open, BUT STILL[…] It’s all necessary isn’t it.” 
 
“It’s always feels awkward, but it’s all right. It’s all right” 
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MICHELLE Case Summary: BMI: 39; Time to booking= 3 days; booking to 
attendance: 0 days; Total time to help-seeking= 3 days  
 
Key Descriptive: PMB is confirmation that her body is breaking down. A series of multiple 
shocks one after the other, with no ending in sight (diagnosis of breast cancer, treatment, 
menopause, PMB). 
 
Experience of the Menopause: Too young to be going through the menopause. A unique 
experience unlike most, where she was confronted with the experience abruptly and was in 
shock. Early menopausal experience was a side-effect of breast cancer treatment (Tamoxifen). 
Her first experience of a hot flush was met with fear and panic; “I thought I was having a 
heart attack”. A hot flush is the hottest fire burning up through the body from the inside out, 
like a severe flu.  Hot flushes are socially embarrassing, because the menopause and a 
woman’s older age are made public and create an inescapable situation. Women in the 
menopause seen as old and “decrepit.” Menopause means she can no longer enjoy the things 
she used to (e.g. is no longer able to have children) and not being able to have children is 
being closer to death. 
 
Experience of PMB: The experience of PMB was part of an overwhelming year-long 
struggle with breast cancer diagnosis and treatment, and was experienced as a negative side-
effect of Tamoxifen cancer treatment “Cancer struggle is being on a treadmill without an end 
point and getting nowhere”. She felt “Panic because you think it’s cancer. I did think straight 
away that, ‘this is not right. I’m bleeding on the Tamoxifen.” The bleed was different from a 
normal period, more severe with discharge, big clots of blood, and painful. It was 
unpredictable and she needed protection when she left the house. The was a frightening 
experience and reminded her of a previous miscarriage, a “Dragging down and feeling the 
pull feeling”. 
The experience of PMB came with a series of continuous shocks: of help-seeking, 
investigations, diagnosis, treatments and complications. The problem is not the PMB it’s the 
breast cancer “I blame the cancer. It’s ruined everything.” 
 
Making sense of PMB: PMB was confirmation that her body was breaking down and that the 
cancer had moved to her lower region from her breast, and her lack of control or inability to 
stop it. “You know, there’s something wrong. You know, you think, ‘No way is that right’. 
“Everything is against me”. Thinking about and trying to make sense of the PMB makes 
things more difficult, the symptom doesn’t have to bother you, but the thoughts make you 
panic. Thickening of the womb caused the bleed and is a sign of cancer caused by breast 
cancer treatment Tamoxifen. 
 
Reason(s) for delay: There are none. 
 
Position:  
The supportive husband- The supportive husband tries to help by minimising her problems 
and acknowledges the difficulty and severity of her experience; Emotional response to how 
she felt about her body during the time prior to the bleeding.  
An emotional response to the body: experience of the body during bleeding: “I hated it”.  
Personal unique experience- She is the only one to go through her cancer experience (unique 
only to her), and “most women don’t have cancer when they have PMB” 
	 448 
Beliefs of help-seeking- Seeking help is “no biggie” “so just get it checked” 
 
Process: Series of medical problems/events that seemed to come on one after the next and it 
continues to feel like there is no end to it (with the diagnosis of breast cancer, depression, 
complications during surgery and recovery, and then bleeding and complication with results). 
The impact of these events has lead her to develop a pessimism regarding her health in that 
any abnormality now means cancer and she is coming closer and closer to death, feeling that 
there is not much more to look forward to. 
 
Experience of help-seeking: Prepared for doctors to say the cancer had spread from her 
breast, “oh no not again”. Thinking ahead about what will need to be done to remove the risk 
is the helping and hurting risk-reduction trade-off of seeking help and receiving treatment. By 
exposing one’s body to medicine you give up control and ownership; Uncertainty of 
investigation results. Furthermore, there is a removal of choice in what happens to her body, 
the team of “doctor’s decide what to do next”.  
 
Experience after help-seeking: Doctors were unable to give her a definitive yes or no and 
she left unsure. Question about if she was menopausal left answered. 
 “My feelings, my body was going- just falling apart; Can no longer trust or count on the 
body to function properly.”  
 
Previous help-seeking experiences: A recent frequency of examinations makes examination 
the norm, however, past experience of seeking help for serious gynaecological concerns 
(ectopic & miscarriage) and for breast cancer makes the experience of help-seeking 
petrifying. “You lose everything. You lose your dignity… Nothing’s private anymore” “It 
doesn’t feel like my life… My body don’t belong to me anymore”  
 
Reasons for seeking help: The knowledge that she shouldn’t be bleeding brought her in to 
seek help. Body awareness to know when something is wrong and knows how to seek help. 
 
Knowledge of Gynae cancer/menopause: She believes that losing weight might help cancer 
to not return, however, a healthy-lifestyle is more beneficial than weight-loss. Body aware is 
gained from previous health experiences: an awareness of her body. Knowledge that the 
thickening of the womb caused the bleed and is a sign of cancer caused by breast cancer 
treatment Tamoxifen 
 
Researcher Reflection: Unclear if she’s still undergoing treatment for breast cancer though 
she uses past tense to describe, “I’ve had erm, breast cancer”. 
The struggle and lack of control continues to the present.  
It seemed important to her that the researcher knows that she’s doing things to better her 
health. 
The role of the supportive husband is sometimes invisible/ forgotten “he is lost”. 
 
Body Image: The catch-22 of weight-loss and health- Breast cancer treatment makes weight-
loss difficult and the prevention of cancer is made difficult by side-effects of treatment 
medication. Furthermore, comorbid illness (arthritis) make healthy-lifestyle changes 
(exercise) difficult. 
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Body image issues are nothing new, but it’s worse with the loss of ownership. “I just hate it. I 
hate my weight. I hate how I look. I got scars.” 
 
Evidence for themes: 
 
The ambiguous enmeshment of PMB and menopause:  
 
The shock of a bleed (after months without) 
“Yea, like a discharge and it was like erm big clots; there was a lot of blood. LOTS of blood. 
Erm.. (sigh). Awful, just AWFULL pain, erm, irritability. You know, just like you would a 
period, but it was just- it was more severe than a period. […] Clots about that size [hold up 
fingers in the size of a golf ball] coming out you know. Like liver. 
 
“It was just- cause I have, I’ve had a miscarriage in the past and I’ve- it felt like a miscarriage 
which, you know like the dragging down and the feeling pull- the pull feeling you know. 
That’s how it felt, like I was having a miscarriage, but obviously I wasn’t… He’s been done 
(laugh) [pointing over to husband].” 
 
“One day I found tingling up here and I thought, ‘What? What’s this?’ You know I couldn’t 
understand it. I thought, you know I was having a heart attack or-or, I don’t know what I 
thought. I just thought- I panicked. I had a panic attack, because I didn’t know what this was, 
because I’d never experienced anything that powerful before.” 
 
No-one has the answers 
“Pre-menopausal, yea. So that’s before menopause. So what’s the difference as menopause or 
pre-menopausal.” 
 
The unknown vs. the known 
“I shouldn’t be bleeding if I’m in the… on the Tamoxifen so my uterus has gone from 3 mil 
to 15 mil thick since I’ve been on the Tamoxifen, which is may last year.” 
“You know, there’s something wrong. You know, you think, ‘No way is that right’.  
 
“People saying you know, “It’s come back”, “It’s gone somewhere else, or” You know, 
there’s always a risk. And this is what they’re thinking here is that the cancer has come back. 
Well it’s gone down below now. That’s why they’re doing all the procedures, because of it 
being like, thickened” 
 
The paradox of knowing 
“Panic because you think it’s cancer. I did think straight away that, ‘this is not right. I’m 
bleeding on the Tamoxifen. It’s cancer, and I just thought, ‘ oh no not again’. You know, and 
I was thinking, you know, far into the future., “Oh God it’s going to be radio-therapy, I’m 
going to lose my hair and chemo and all that.’ DO you know what I mean? I was just thinking 
the worst.” 
 
Searching for a cause 
“Panic because you think it’s cancer. I did think straight away that, ‘this is not right. I’m 
bleeding on the Tamoxifen.” 
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“It’s just like, ‘Well, what’s going on’. You know, not knowing what’s happening to your 
body. You know, it’s just coming away and you think, ‘OH God, what’s this? Am I dying? Is 
it cancer?” 
 
Still up in the air/ Book remains open 
“I haven’t had a break for, since March last year. I feel like I’m on a treadmill where it’s just 
constantly on and on and on and there’s no stop to it. And I thought that as soon as I get the 
cancer away that would be it. There would be no more. I could get on with my life. You 
know, try and do something with my life. But at the moment I feel stand still, at a stand still. I 
can’t go forward. It’s awful, you know, just “Can I finish with that doctor?”, but no it’s just 
the three. It’s hard work.” 
 
The conflict with severity 
“It was just- cause I have, I’ve had a miscarriage in the past and I’ve- it felt like a miscarriage 
which, you know like the dragging down and the feeling pull- the pull feeling you know. 
That’s how it felt, like I was having a miscarriage, but obviously I wasn’t… He’s been done 
(laugh) [pointing over to husband]. You know, so it’s not- it was just after being on the 
Tamoxifen.” 
 
Weight and the uncertain risk 
P5: There’s nothing nothing I can do. I can lose weight I suppose. But I have tried, haven’t I. 
I’ve tried hard haven’t I?” 
R: Mmm. And losing weight, what would that do? How would that help?  
P5: [long pause] I don’t think it would. You know, I eat healthily. So I – you know, I do eat 
healthily, don’t we [looking at husband]? […] So, I think that’s the main thing, if you eat 
healthily. If you eat- you eat healthily then you know, that’s a help. But other than that there’s 
nothing you can do. There’s nothing… Nothing. Is there? (laugh) 
 
The chaotic body:  
 
Shared vs. unique experience 
“- it’s vile and like- like I went straight into it. Like other people sort of- if they’re not on the 
tamoxifen they gradually build up to it, because obviously they’re going into the menopause 
gradually. I went in straight away. So it was like everything just went in, straight away 
(ppshhoow).  “ 
 
“…most women don’t have cancer when they have PMB” 
 
“Yea, but it’s different it’s completely different to YOU going through it. ME going through 
it. You know and you speak to people, you hear of things.” 
 
Exposing the chaotic body (e.g. weight gain, hot flushes, bleeding) 
“Erm, it’s nothing that I’ve ever experienced before. It was like a real, I don’t know… inner 
fire. You know it’s just sort of like (whoorfff)[makes the noise of a roaring fire].  Really, 
Woaah! And it is, it’s inside it’s not I outside. It’s in like in your body. You know like if you 
go on holiday, you’re hot, you know and you can feel a hot heat on your body [pointing to her 
arms]. But this is inside and it’s weird. A weird feeling of heat. Erm, like you’re burning up 
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inside. You know when you’ve got like a severe flu. It’s that heat. It’s that heat and it’s 
horrible. Really REALLY horrible” 
 
“No, it’s I was constantly wearing protection because it was like I didn’t know where I was- I 
could just suddenly lose a clot, you know, and it was like, ‘Oh my God what’s this?’. 
 
“Old, decrepit. Just a few words to, you know, I remember thinking when I was younger, 
women going through the menopause are like old. You know, erm… like their life’s, over. Do 
you know what I mean? I can’t really explain it. It’s like they’re looking at me and thinking, 
‘Oh God she’s old and decrepit’ (lauh). You know? To go through that- the change, there’s no 
purpose anymore, purpose in life. It’s a sign of getting old isn’t it? DO you know what I 
mean?” […]Yea, it means that I don’t feel old and decrepit, but other people who haven’t 
been in the menopause, that’s how they look at me, as being old and decrepit. Because I’m 
going through the menopause. You know, I’m getting hot flushes and because you can see 
that. You know, you can physically see it. You know what I mean? 
 
The internal hatred and mistrust 
“I just hate it. I hate my weight. I hate how I look. I’ve got scars. Scars across here [pointing 
to chest]. Erm, Just really hate it. I hate my body.” 
 
“I hated it. HATED what- I’d got no control. I-I’ve, my feelings, my body was going- just 
falling apart. It felt as though Ah, something else. You know, what else can go wrong? Your 
heart, cancer… You know. (Sigh) I’m getting a bit teary now [began to cry]. (Giggle).“ 
 
The catch-22 of weight-loss and health 
“Cause I’ve got bad knees and feet. I’ve got erm problems with my heels as well you know, 
I’ve had operations on them.” 
 
“Severe arthritis. It’s been blamed for a lot of things that- but, how can I put this? I try hard to 
lose weight. I TRY so hard. So, you know, I can’t explain it. I can’t explain it. Sorry… I 
suppose I blame myself. I blame myself for getting like this. But I do try and not to be like 
this if you know what I mean. It’s the tablets [for breast cancer treatment][…] Because my 
sister, when she started on the tablet, what I’m on she ballooned. You know and it is hard 
isn’t it.” 
 
“So that was one of the risks. It takes cancer away from there [pointing to breast], but could 
put it there [pointing to groin area]. (laugh)” 
 
The penny dropped 
 
Relief as short lived 
“Dragging down and feeling the pull feeling” 
 
The penny dropped (i.e. the decision to seek help) 
 
“It was about two months after [starting Tamoxifen treatment] no about 6 weeks and I started 
bleeding and it was quite heavy and erm, big clots and awful awful. Pain was really bad.” 
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“And like when I started seeing those big clots I thought, ‘OH my God’. You know, there’s 
something wrong. You know, you think, ‘No way is that right’. You know, even when you 
get your period you have little clots, you know. Normal- normal clots, but it was like pink, the 
blood was like fresh. It wasn’t like a period blood like red. This was pink and with the clots, 
so it was a lot lighter and I thought, ‘That’s not right. That’s not right at all’. 
 
 Interactions with healthcare for investigation toward treatment are uncomfortable at 
best and frightening, painful and intrusive at worst. 
 
The feminine approach 
“you know like when you have your smear it’s like undignified and so you go along and you 
have your smear and it’s a women, but it’s a male doctor so it would have been embarrassing 
having a male. And because I know the doctor so well, as well.” 
 
Doctors’ actions are greater than the words they speak 
… 
The necessary intrusion 
“My body don’t belong to me anymore. It belongs to- cause everyone’s seen it and everyone’s 
been there (laugh) and touching and- It just feels that- that you just don’t, ugh, just, you know, 
strip off your- you know everything just goes. Where before you’d say, oh get a bit upset 
about having to lie down and get an- examined, but now you just you- (laugh). Do you know? 
You just lose, you lose everything. You lose your dignity. You loose everything. Nothing’s 
private anymore. You know, your body’s not your own and it’s given up. It does give up.” 
 
“So when he says, “Hop up on the couch and take your pants off”. You just do it, because it’s 
norm- the norm now. You know, so it was- going to the doctor’s didn’t bother me at all. I just 
went, but I think if it had happened 12 months ago or longer, you know it would have 
bothered me. It would have- I would have thought I can’t. You know, it’s too embarrassing, 
no no no no.” 
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SHARON Case Summary: BMI 46; Time to booking= 3 days; Booking to attendance= 3 
days; Total time to help-seeking= 6 days 
 
Experience of the Menopause: Confusion, no answers as to what is causing the symptoms 
(i.e. thyroid problem, menopause) or how long she’ll be going through the menopause. A 
tunnel with no end in site (no one can say how far in or close to the end she is). 
 
Experience of PMB:  Sought help twice for PMB. First was an emergency thought to be due 
to Warfarin problem. Second was thought to be a problem with the Mirena coil (i.e. 
replacement). 
Frightening, lack of control, socially embarrassing, something was seriously the matter (i.e. 
11 days, heavy bleeding), unprepared (i.e. needed towels, underwear, shower curtains, 
avoided sitting, and made frequent visits to the toilet -every 5 minutes). 
 
Experience of help-seeking: Initially thought it was an emergency Warfarin problem. 
History of cancer in the family and Google symptom search (says cancer) that encouraged her 
to seek help. 
Discovered a different problem on second visit for PMB (contraceptive issue). Help-seeking 
is “taking the simple solution rather than continued suffering”.  
 
Position: Embodied experience, “It was pouring out of me”, “made me feel horrible, dirty”. 
Indicates her unique experience and does not claim to be an expert in the experience of PMB 
or menopause. 
 
Process: “The” symptoms of menopause are expected (e.g. “the heat”, “the skin”) until the 
weight-gain. But weight is different. When the topic of weight emerges in the interview she 
expresses deep emotion (crying) in telling the experience of her inability to lose weight. 
 
Experience after help-seeking: The questions remain unanswered. Didn’t get what she came 
into the doctor for.  
 
Researcher’s reflection: Medication seemed to interfere with experience of menopause, 
confusing the experience. 
 
Body image: Great emotion and frustration accompanies the experience of weight gain and 
the inability to loose weight after menopause. 
 
Evidence for themes 
 
The ambiguous enmeshment of PMB and menopause:  
 
The shock of a bleed (after months without) 
“So, erm I haven’t had a lot of physical problems with the heat and stuff like that. I take 
Menopace which I find seems to help. It seems to – erm there’s less hot flushes. There’s less 
mood swings. Could all be in my head, but it’s working it’s working.” 
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“And then when I had the big- first big bleed in the August, I didn’t know what that was. I’d 
had a Mirena coil for a lot of years and it was obviously less effective. It was never for 
contraceptive, it was for heavy periods that I had it.” 
 
No-one has the answers 
“I’ve had my blood tests done and that’s fine, but you just don’t know whether all or these 
things are all the menopause or all of that, or a bit of each. Or it’s just that one. I just don’t 
know. I do struggle a bit with confusion over why I feel like I do. Whether it’s the menopause 
or whether it’s something else?” 
 
The unknown vs. the known 
Menopause- “I feel and I have felt for about two years that I’ve been going through it, but I 
wasn’t quite sure, because I had a Mirena coil.” 
 
“I think a lot with these sites- […]I think a lot of the sites at the top are sponsored aren’t they. 
So they’re clinics and they’re- and so you go to the first one and they’re always, “this could 
happen so you need to-“. Whereas if you onto NHS choices straight away, and this is where I 
know I’m sensible and this is what I should do […] erm then you start thinking all manner of 
stuff; that that’s it. I’m going to die of cancer, I’m going to die and I’m going to be gone 
within 12 months and you know it’s probably been there for months and it’s only now starting 
to have symptoms.” 
 
The paradox of knowing 
“But this time it came on and because it was so bad and obviously coming in here and they’re 
saying, “Oh we have to do this, that and the other” and whatever, it got me a bit more worried 
about it that I think the first time, but as it’s- you know when they said the lining has gone 
from 3 millimetres to 20 from the last scan that I had, sounded serious.” 
 
“I’d rather have it checked and be told there’s nothing than be sitting and wondering and 
worrying unnecessarily, and just go get it sorted out and then it’s finished and you know what 
it is. Even if it’s not very nice you know what it is and you can deal with it whatever way.” 
 
Searching for a cause 
“I assumed it was that the coil had basically come to the end of it’s shelf like, because it was 
in 3 or 4 years longer than it should have been” 
 
Still up in the air/ Book remains open 
“all I want to know is, are there tests that you can say that, yea, “Yea, you’re in the middle. 
You’re coming towards the end.” But I don’t even know if that exists so. So, but he didn’t say 
it didn’t exist, other than, that all we know is when you’ve completely finished. […] I think 
for me I would rather have that kind of information. Erm, but I obviously didn’t get it.” 
 
The conflict with severity 
… 
Weight and the uncertain risk 
… 
 
The chaotic body:  
	 455 
 
Shared vs. unique experience 
Luckily I was like, ‘’Oh you’re so bloody stupid. How may other women do you think have 
had it? They were fine. You’ll be fine.” So, yea.  
 
“But having come from a family with lots of different types of cancer, erm, cervical, breast, 
stomach, bowel… you just, you’re drawn to it I think Because you think, ‘well everyone else 
has had it, so therefore I must’. “ 
 
Exposing the chaotic body (e.g. weight gain, hot flushes, bleeding) 
“But obviously at work and stuff I just feel like I’m- I get hot and that- I feel like that I’m a 
bit riffy, and people will think- I know I’m not, because I’m like really clean and stuff, but I 
think it’s just like gets into your head a bit and then once you start worrying about stuff, or me 
anyway.” 
 
“It’s a bit (sigh) frightening, because of the amount and the size of the clots, and having an 
office based sit down job, I was- because the two times it came on it came on suddenly 
without warning and it literally poured out of me and my jeans were wet and everything and I 
had to- both times, once I was at work, the last first one and this one I’d gone for counselling 
and I’d got out of the car and I thought ‘Oh’ being an age I thought (laugh) I must have weed 
myself, but obviously I realised it was blood so I had to go back home. But it’s- it is 
frightening. It’s embarrassing.” 
 
“I was sitting in the back of my cousins car and I had towels all over the place, which again is 
embarrassing. And then when I got there they go cream settees. And I was like, “Oh GOD I 
don’t want to sit down!” So I stood up and like, so they must have thought I was a bit mad as 
to why I wouldn’t sit down. But I had to go to the toilet every 5 minutes just to make sure 
that- because I think you get, well I do anyway, get a bit obsessed. ‘Oh I can feel a bit, so I’d 
better go to the toilet otherwise it’s gonna leak through’. Ern, so it’s just it’s not very nice. It’s 
not very pleasant.” 
 
“I feel and I’ve been saying to people at work, “Do I look red? Do I look red? Am I sweaty? 
Are my trousers alright? Can you see anything?” And I mean there was nothing. Cause I kept 
going to the loo to make sure there wasn’t. But I think it just stars to get into your head 
doesn’t it? “ 
 
The internal hatred and mistrust 
“And I used to do- two years ago I was doing back-to-back spin classes, and I was 15 stone. 
I’d lost 3 stone and I was just going under 15 stone- 15.10 or something like that. But I was 
going 6 days a week. I was doing back-to-back spins. Even though I’m quite big I’ve always 
been quite fit. Erm, but the last 12 months with all the problems with the bleeding and- it’s 
just… I just feel crap. [Begins to tear up] Sorry.” 
 
The catch-22 of weight-loss and health 
“I don’t know if it’s a coincidence, but I’ve had quite a bad time the last twelve or eighteen 
months with my family. And, because I had lost quite a lot of weight and I do feel I’ve put a 
lot on quickly, and it’s all around the bottom, and it’s difficult to shift it. So that’s kind of, and 
I don’t know whether that’s the menopause […] I suppose I’m just clutching at anything to 
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see if it’s that or just eating and drinking too much. I don’t know […] If that’s the reason for 
it, because I-I don’t eat unhealthily as such. I probably drink a bit too much drink, beer and 
stuff, and probably the times I’m eating is wrong, but I don’t eat takeaways, don’t have fish 
and chips and stuff like that. It’s like salad and vegetables and what have you. Erm, erm, but I 
had, as I say, lost lots of weight, but I was doing a lot of exercise and then like this started. 
Like, my sister was not well, so it’s probably a combination of everything.” 
 
“I’ve started putting weight on even though I was going to the gym and trying to eat healthily 
I was putting more and more weight on, and because of the way I was feeling with the- no 
with my thyroid before.” 
 
The penny dropped 
 
Relief as short lived 
“It was horrible. Horrible, nasty.” 
 
The penny dropped (i.e. the decision to seek help) 
“I don’t think it’s very pleasant. It’s- there’s lots of different reasons. The mess of it, the 
embarrassment of it and the fact that you can’t control it. And even if you wear underwear 
that – with pads and stuff it still always manages to get around it somehow. So I had- for the 
11 days I had to have two for three towels on me and they- two or three towels on top of me 
and a shower curtain on top of the bed, you know on top of the bottom sheet. Not because I 
didn’t- I didn’t bled through in the night, but I was frightened to and I think I was going a bit 
obsessed with it all.” 
 
“I think it make you, well it made me feel dirty, like there’s something seriously the matter 
with me. And then Google it and everything. As soon as you Google it, cancer is the first 
thing so you start thinking, Oh shit” 
 
 Interactions with healthcare for investigation toward treatment are uncomfortable at 
best and frightening, painful and intrusive at worst. 
 
The feminine approach 
“So I went to the doctor and it- and it was- I don’t know whether it was [that he was] a man, 
but he was like, “well if it is it is [hot flushes]. You know, not a lot can be done about it. 
You’re just going to have to role with it sort of thing […]. He didn’t really, he didn’t really- I 
suppose he kind of dismissed it really. I didn’t- I came out more fed up that when I went in.” 
 
Doctors’ actions are greater than the words they speak 
“But thankfully the- I don’t’ know whether they’re healthcare assistants or nurses that are in 
there when the senior nurse is doing it, the way they’re chit chatting around you it kind of 
distracts you from it anyway. So that’s-that sort of engaging in a bit of conversation with 
them sort of takes away from what’s going on down there.” 
 
The necessary intrusion 
“Stressed out, because it’s one of those examinations where you  need to be relaxed really, 
because the more tense you are the worse it is for them to try and open up the speculum and 
do what they have got to do if I’m like, trying to shut everything down to stop them so. Erm, 
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and-and even though I try and relax it’s-it’s just- it’s just not nice is it, that’s particular part of 
it” 
 
“I’d rather do that than sit at home suffering and not do anything. Erm, because I don’t know I 
just don’t think it’s worth it. That’s what the hospitals and the doctors are there for isn’t’ it?” 
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STACY Case Summary: BMI: 39; Time to booking= 0 days; booking to attendance= 0 
days; Total time to help-seeking= 0 days 
 
Experience of the Menopause: Experience of hot flushes, “I can feel heat coming all up my 
body, my face goes very very red [and burning of the ears] and I’m just sweating really really 
bad”. It is socially embarrassing and interrupts on nights out, interrupting the dancing, there’s 
no escape “if I were at home I’d just fling everything off, but obviously you can’t when 
you’re out, but that’s how intense I get”. Advice from friends doesn’t help relieve her of hot 
flushes. She went on HRT to reduce bleeding during menopause and help with other 
symptoms of menopause which also included dry skin all over body, in private area, and 
pimples. Being period-free feels great, and no matter how much of a hindrance hot flushes 
are, the experience of menopause is better than her previous experience of regular heavy 
periods, “Felt really naff” about periods”. She has been told she’s in the peri-menopausal 
stage of menopause. Peri-menopausal means, “I suppose on the borderline of still having 
slight periods, but not still having your periods.”  
Experience of PMB: Episodes of irregular spotting 3 times over a year. Each lasted 3 – 5 
days. Experience of bleed is different than normal period, lighter, not painful and no tugging. 
There wasn’t a lot of blood, but enough to wear a pad. After history of difficult periods, 
Difficulty history with periods (long lasting, heavy, fatigued, and interrupted daily life). “Oh 
God, it’s all going to start again now. Bleeding again after being period-free for 5 or 6 months 
and feeling that she was through the menopause and therefore done with bleeding, left her 
feeling deflated and disappointed.  
 
 
Reason for seeking help: “This isn’t right. It needs acting on straight away in case it could 
be cancer.” 
Reason(s) for delay: … 
 
Position: Initial voice is very manner of fact as though reporting incidents to a doctor. 
Awareness of the position of the researcher as different and unknowing of her experience of 
obesity, therefore she often takes the expert position to teach the researcher about the 
experience of those like her.  
Supportive role of family member is to be level headed and attend appointments with her. 
It’s the patient’s responsibility to insist to be seen by a healthcare professional 
Her stance moves from an expert stance to a personal one through the course of the interview. 
 
Process: Phoned the GP straight away on second episode of bleeding and because had been to 
PMB for first bleed was fast tracked to the PMB clinic (within one week). 
 
Making sense of PMB: “This isn’t normal, why I’m bleeding again?” Things become 
concerning when they are not normal/ordinary, because it is unknown. “I always think the 
worst.” The worst thing that the bleeding could mean is cancer and thought bleeding was 
connected to abnormal smear results (cervical problem). Hypo-thyroidism discovered during 
time of bleeding denotes a connection between the two conditions. She made herself ill with 
worry = mental health illness of depression and panic attacks, thinking that it could be cancer. 
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Experience of help-seeking: Used to feel embarrassed undressing in front of doctor, but it’s 
the furthest thing from her mind now. The mind-set that she’s not unlike other patients (she’s 
not the only one) “you need to sort this problem out. They see different sizes every day. 
They’re not going to take any notice” During visit, fear interferes with comprehension of 
information communicated by consultant during visit, because she is fearing the worst. So it 
has been very difficult” “just had it in my head that it’s not going to be good news and I 
don’t’ know why. I think it’s because of the, how many times I’ve got the re-occurring bleeds, 
and they seem to have been getting worse each time. Yea.” Daughter is positive support 
system against illness worry; with her during visit and does the listening for her. Received 
conflicting information from gynae consultants as to whether or not to investigate bleeding 
that creates a distrust about their knowledge in what’s best for the patient, “I was just unsure 
that they knew what they were talking about.” Do doctors really know best?  
 
Experience after help-seeking: The bleeding continued, and worstened to heavy long lasting 
bleeds, losing clots. Even though she’s been looking forward to her holiday the results of the 
biopsy has been weighing on her mind. “the last few times I’ve had to come up here, I’ve just 
had a really negative effect on everything going on… I can’t wait till it’s all over and done 
with.” She’s been told the bleeding will stop once the polyp has been removed and she can’t 
wait.  
 
Previous help-seeking experiences: Didn’t attend screenings until she was in her 40s, 
because was frightened and embarrassed to show body to a male doctor. However is now 
familiar with the service due to attendance at regular screenings for abnormal smears. 
Reasons for seeking help: Things that are not normality need to be addressed by medical 
help: “You know so it was a big change for me and that’s why I new I needed to get on top of 
it and get it sorted out.” The knowledge that smears can save your life over-rides the 
embarrassment of the examination and showing body to a male doctor - if they don’t look 
they can’t help. Jade Goody celebrity gnae cancer death: “I think it brought to light that if you 
didn’t go in for your smears, cancer could quickly spread, and I think that did frighten a lot of 
people and prompted them into having smears.”  
 
Knowledge of Gynae cancer/menopause: She has an awareness of the consequences of not 
attending screenings and that womb thickening is a bad thing. Is confused about the stages of 
menopause and what each stage means, nevertheless she understands that menopause is a long 
lasting condition that can sometimes last  up to 5-10 years. 
 
Researcher Reflection: Information regarding menopausal stages, what they mean and how 
long they’ll last is not explained to patients by doctors? Conflicting medical advice, put the 
decision on the patient and that is what made her not follow up on the first PMB 
investigation, because the decision for investigation should be made my the doctor and not the 
patient?  
 
Body Image: “I hate my body”: Significant weight gain over the past 4 years that’s been a 
struggle to keep off. Feels at a standstill. It’s difficult finding nice clothes that fit which is 
important, because she wants to fit in with friends who where their nice clothes better than 
she does due to slimmer figures. I would never wear shorts. Weight gain was caused by a 
combination of stopping smoking, underactive thyroid, and asthmas steroid treatment (weight 
	 460 
is a side effect of steroid treatment), and being alone and depressed which encourages bad 
eating habits. Losing weight is a catch-22 that is frustrating, because the methods of losing 
weight can flair up her comorbid asthma, which is treated by using weight-gaining steroids. 
GP gave Slimming World vouchers, but they didn’t help, need more help losing weight to 
teach appropriate exercise rather than just controlling what she eats. Weight impact: “I’ve 
found the weight gain very very hard to live with to be honest”. Feels disgusted that she’s let 
herself get like this when she sees her naked body in the mirror. There is self-blame at times 
for allowing the weight gain, but obesity what also not caused only by her doing, but by her 
health problems (catch-22 of treating co-morbidities). 
Evidence for themes: 
 
The ambiguous enmeshment of PMB and menopause:  
 
The shock of a bleed (after months without) 
“You’re just not prepared for it. Obviously because I hadn’t had bleeds for months and 
months I didn’t keep any sanitary wear in the house, you know, so it was a big shock having 
to go out and start buying things again.” 
 
“I did find it very very stressful and to be honest when I did have the bleed I was really 
disappointed, because I thought I’d finished with periods. I didn’t honestly realise that you 
could be in the menopause up to 10 years.” 
 
“I didn’t have any pain neither. I’ve always had painful periods, but with this I didn’t. I didn’t 
have any period pains or the tugging, so again I felt that that was something different for me.” 
 
No-one has the answers 
“Yea, and I’ve tried different things, because all of my friends are 10 and 15 years older than 
me. We all met as part of a bereavement  group and I’ve had different advice. One’s told me 
to try ginger, cod liver oil, and I’ve tried everything, and for me nothing works for me at all 
[to relieve hot flushes]” 
 
“Yea I saw two different consultants here, because I used to come here an awful lot, but I 
think that was because of my irregular smears and everything like that.” […]I was just unsure 
that they knew what they were talking about.” 
 
The unknown vs. the known 
“This isn’t normal, why I’m bleeding again?” Things become concerning when they are not 
normal/ordinary, because it is unknown. “I always think the worst.” 
 
“Erm, and for me I’m a worrier so it’s made me quite ill, but it’s just because of the way I 
am.” 
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The paradox of knowing 
“just had it in my head that it’s not going to be good news and I don’t’ know why. I think it’s 
because of the, how many times I’ve got the re-occurring bleeds, and they seem to have been 
getting worse each time. Yea.” 
 
“She [the doctor] was trying to sort of make me see sense in saying sort of, “Look don’t 
worry yet until you’ve had all the tests and everything like that.” You know, but for me it’s a 
big thing, and I don’t really- and I do fear the worst all the time. So it has been very difficult 
for me. Very stressful.” 
 
Searching for a cause 
“Cancer. That’s what I thought straight away, without listening to anything they were saying. 
Everything just went over my head.” 
 
Still up in the air/ Book remains open 
“I haven’t been able to go out because the bleeding’s been so bad. I had to be rushed to 
hospital a fortnight ago on the evening, because I was losing that much blood and really huge 
clots. Erm and that’s when they gave me tablets to control the bleed” 
 
“Yea so it’s been very very hard. I can’t wait till it’s all over and done with. Yea. I’m hoping 
that when the polyp has been removed, that’s it then. I’ve been told it will be, so I can’t wait.” 
 
The conflict with severity 
“I’d got up out of bed. I hadn’t actually felt anything, but there was blood on my pyjamas” 
 
Weight and the uncertain risk 
“I’ve put an awful lot of weight on, but they’ve also discovered I’ve got an under-active 
thyroid as well round about the same time that my periods where becoming irregular so I 
think that’s contributed as well to be honest.” 
 
The chaotic body:  
 
Shared vs. unique experience 
“I used to feel so embarrassed of if I’d have to see the doctor and knowing that I’d have to 
strip off. Now I don’t. It’s the furthest thing from my mind. Now I just go with, ‘you need to 
sort this problem out. They see different sizes every day. They’re not going to take any 
notice’.” 
 
“I know, one of my friends who’s 62, she still has the flushes now and she’s been period free 
for over 10 years, but she is still getting the flushes. So I’m not sure. I don’t know.” 
 
Exposing the chaotic body (e.g. weight gain, hot flushes, bleeding) 
“I can feel heat coming all up my body, my face goes very very red [and burning of the ears] 
and I’m just sweating really really bad”. It is socially embarrassing and interrupts on nights 
out, interrupting the dancing, there’s no escape “if I were at home I’d just fling everything off, 
but obviously you can’t when you’re out, but that’s how intense I get”. 
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“Always constantly having to put cream on, because I just feel so tight and itchy [vaginal 
skin], yea. But the GP said to me, “If you take the HRT it would rule everything like this out”. 
But I just didn’t want to take it, because she said it will give you your periods back.” 
 
Hot flushes: “I find them very annoying to be honest. I can just be sitting normally out with 
friends and then all of a sudden I can feel heat coming all up my body, my face goes very 
very red and I’m just sweating really really bad to- I carry now with me, it’s like a water mist 
and I always spray my face and I’m constantly fanning myself while I’m out, and also clothes, 
it’s changed the way I wear my clothes when I’m out on an evening. I only wear very very 
light clothing, because otherwise I’ll just sweat terrible.” 
 
The internal hatred and mistrust 
“I just hate the roundness of my body. I used to be quite… Nowhere near as slim as you, but I 
used to have quite a nice figure where I was happy with, but now I have so many different 
rolls of fat. You know, and I struggle to find clothes, nice clothes anyway.” 
 
“I still like wearing my cropped trousers, but I don’t feel as if I can dress as lightly. I would 
never wear shorts. I wear shorts in my back garden. I would never wear them on holiday, 
because I just feel that my body is so horrible at the minute.” 
 
 “Yea, it’s really frustrating for me and I do view my body differently than how I did like 5 
years ago. I was so much more happy with my shape and everything like that and I mean now 
I know I’ve got to lose 5 and a half stone to be what I should be for my height.” 
 
“Because I’ve battled with depression as well, yea and I think for me being at one alone- 
especially when I sitting watching telly at night it’s the easiest thing to pick up a packet of 
crisps, you know, while you’re watching the telly.” 
 
The catch-22 of weight-loss and health 
“I’m very aware that with my weight and my shape I can do so much to change it, but then if I 
start exercising I might make myself ill with my asthma, then I have to go onto steroids. 
Steroids naturally make me gain weight. So for me it’s been like a catch-22. So I’ve found it 
very very frustrating.” 
 
“Well some days I can get up and get in the shower and as I’m getting dressed I can look at 
myself and feel real disgusted that I’ve let myself get like this. But to a certain extent it is my 
own doing, but a lot of it is health problems as well. So, and I’ve found that as I’ve got older 
it’s definitely a lot harder to lose the weight. It really is.” 
 
 “So I have to strive to lose the weight as best as I can really. I find it hard to use gyms, 
because my asthma. Erm, I do a lot of walking which can level me out and I can lose a few 
pounds, but I have bad eating habits as well, which doesn’t help […]” 
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The penny dropped  
 
Relief as short lived 
“So then I went from about March, April to nothing at all to the November so it was roughly 
about 5, 6 months and then it just started up again.” 
 
The penny dropped (i.e. the decision to seek help) 
“This isn’t right. It needs acting on straight away in case it could be cancer.” 
 
 Interactions with healthcare for investigation toward treatment are uncomfortable at 
best and frightening, painful and intrusive at worst. 
 
The feminine approach 
“I find them quite painful, erm and at my GPs you could never guarantee to see a lady, and I 
just found it so embarrassing seeing a man doctor.” 
 
“Even though now I know that it’s something that can save your life and so I don’t care if 
someone looks at me now.” 
 
Doctors’ actions are greater than the words they speak 
“Worrying for me, but with me even though they’ll talk to me and tell me what things are it 
doesn’t stay in there. Whereas when I bring my daughter with me she takes in everything 
they’re saying and then she can say to me later, “This is what it is”. But for me it’s just a fear 
thing and I think that’s why I don’t keep it stored. So you know I think it was a real worry to 
me.” 
 
“Cancer. That’s what I thought straight away, without listening to anything they were saying. 
Everything just went over my head.” 
 
The necessary intrusion 
“I think it [Jade Goody celebrity death] brought to light that if you didn’t go in for your 
smears, cancer could quickly spread, and I think that did frighten a lot of people and prompted 
them into having smears. I know for myself I decided that if I wanted to stay healthy it’s 
something I had got to have checked. You know, and that’s why I just started to have my 
smears then on a regular basis.” 
 
“Yea, and I’m not embarrassed by a doctor looking at my body anymore, because I know that 
if they don’t look they can’t help. Even though I feel really strongly about my body, I know 
that if it’s something they need to do then they just need to do it.” 
 
